[{"title":"COVID19 coagulopathy in Caucasian patients","googleId":"ZKtIoAFfMs0J","googleLink":"https://onlinelibrary.wiley.com/doi/abs/10.1111/bjh.16749","googleCitationCount":246,"googleAuthor":"H Fogarty","doi":"10.1111/bjh.16749","elsevierAuthor":"Fogarty H.","publicationName":"British Journal of Haematology","elsevierCoverDate":"2020-06-01","elsevierCoverDisplayDate":"1 June 2020","elsevierCitationCount":"110"},{"title":"Thromboembolic risk and anticoagulant therapy in COVID‐19 patients: emerging evidence and call for action","googleId":"y0qmMRFTaVUJ","googleLink":"https://onlinelibrary.wiley.com/doi/abs/10.1111/bjh.16727","googleCitationCount":270,"googleAuthor":"A Kollias","doi":"10.1111/bjh.16727","elsevierAuthor":"Kollias A.","publicationName":"British Journal of Haematology","elsevierCoverDate":"2020-06-01","elsevierCoverDisplayDate":"1 June 2020","elsevierCitationCount":"151"},{"title":"Relationships among lymphocyte subsets, cytokines, and the pulmonary inflammation index in coronavirus (COVID‐19) infected patients","googleId":"E1VAVq0EevIJ","googleLink":"https://onlinelibrary.wiley.com/doi/abs/10.1111/bjh.16659","googleCitationCount":135,"googleAuthor":"","doi":"10.1111/bjh.16659","elsevierAuthor":"Wan S.","publicationName":"British Journal of Haematology","elsevierCoverDate":"2020-05-01","elsevierCoverDisplayDate":"1 May 2020","elsevierCitationCount":"97"},{"title":"Changes in blood coagulation in patients with severe coronavirus disease 2019 (COVID‐19): a meta‐analysis","googleId":"sIWnQln-0VIJ","googleLink":"https://onlinelibrary.wiley.com/doi/abs/10.1111/bjh.16725","googleCitationCount":88,"googleAuthor":"","doi":"10.1111/bjh.16725","elsevierAuthor":"Xiong M.","publicationName":"British Journal of Haematology","elsevierCoverDate":"2020-06-01","elsevierCoverDisplayDate":"1 June 2020","elsevierCitationCount":"56"},{"title":"Autoimmune haemolytic anaemia associated with COVID‐19 infection","googleId":"fSJryjFJgpYJ","googleLink":"https://onlinelibrary.wiley.com/doi/abs/10.1111/bjh.16794","googleCitationCount":88,"googleAuthor":"","doi":"10.1111/bjh.16794","elsevierAuthor":"Lazarian G.","publicationName":"British Journal of Haematology","elsevierCoverDate":"2020-07-01","elsevierCoverDisplayDate":"1 July 2020","elsevierCitationCount":"53"},{"title":"Severe COVID‐19 infection and thrombotic microangiopathy: success does not come easily","googleId":"sZm2hbW1QHUJ","googleLink":"https://onlinelibrary.wiley.com/doi/abs/10.1111/bjh.16783","googleCitationCount":74,"googleAuthor":"E Gavriilaki","doi":"10.1111/bjh.16783","elsevierAuthor":"Gavriilaki E.","publicationName":"British Journal of Haematology","elsevierCoverDate":"2020-06-01","elsevierCoverDisplayDate":"1 June 2020","elsevierCitationCount":"43"},{"title":"Association between ABO blood groups and risk of SARS‐CoV‐2 pneumonia","googleId":"MCsOp7wtnrwJ","googleLink":"https://onlinelibrary.wiley.com/doi/abs/10.1111/bjh.16797","googleCitationCount":86,"googleAuthor":"","doi":"10.1111/bjh.16797","elsevierAuthor":"Li J.","publicationName":"British Journal of Haematology","elsevierCoverDate":"2020-07-01","elsevierCoverDisplayDate":"1 July 2020","elsevierCitationCount":"43"},{"title":"Survival study of hospitalised patients with concurrent COVID‐19 and haematological malignancies","googleId":"v7ZWBZlDEZ4J","googleLink":"https://onlinelibrary.wiley.com/doi/abs/10.1111/bjh.16801","googleCitationCount":66,"googleAuthor":"","doi":"10.1111/bjh.16801","elsevierAuthor":"Martín-Moro F.","publicationName":"British Journal of Haematology","elsevierCoverDate":"2020-07-01","elsevierCoverDisplayDate":"1 July 2020","elsevierCitationCount":"46"},{"title":"Care of haematology patients in a COVID‐19 epidemic","googleId":"znu3bD2nycsJ","googleLink":"https://www.ncbi.nlm.nih.gov/pmc/articles/pmc7161908/","googleCitationCount":58,"googleAuthor":"J Willan","doi":"10.1111/bjh.16620","elsevierAuthor":"Willan J.","publicationName":"British Journal of Haematology","elsevierCoverDate":"2020-04-01","elsevierCoverDisplayDate":"1 April 2020","elsevierCitationCount":"37"},{"title":"COVID‐19 infection in patients with sickle cell disease","googleId":"cUWCEwvwTXcJ","googleLink":"https://onlinelibrary.wiley.com/doi/abs/10.1111/bjh.16734","googleCitationCount":49,"googleAuthor":"SL Saraf","doi":"10.1111/bjh.16734","elsevierAuthor":"Hussain F.A.","publicationName":"British Journal of Haematology","elsevierCoverDate":"2020-06-01","elsevierCoverDisplayDate":"1 June 2020","elsevierCitationCount":"29"},{"title":"COVID‐19‐associated immune thrombocytopenia","googleId":"PTrAr0Gej44J","googleLink":"https://onlinelibrary.wiley.com/doi/abs/10.1111/bjh.16850","googleCitationCount":54,"googleAuthor":"","doi":"10.1111/bjh.16850","elsevierAuthor":"Bomhof G.","publicationName":"British Journal of Haematology","elsevierCoverDate":"2020-07-01","elsevierCoverDisplayDate":"1 July 2020","elsevierCitationCount":"31"},{"title":"Eculizumab in paroxysmal nocturnal haemoglobinuria and atypical haemolytic uraemic syndrome: 10‐year pharmacovigilance analysis","googleId":"CtoAPxBdhwoJ","googleLink":"https://onlinelibrary.wiley.com/doi/abs/10.1111/bjh.15790","googleCitationCount":56,"googleAuthor":"","doi":"10.1111/bjh.15790","elsevierAuthor":"Socié G.","publicationName":"British Journal of Haematology","elsevierCoverDate":"2019-04-01","elsevierCoverDisplayDate":"April 2019","elsevierCitationCount":"43"},{"title":"Acute aorto‐iliac and mesenteric arterial thromboses as presenting features of COVID‐19","googleId":"S6Tk100vxnkJ","googleLink":"https://onlinelibrary.wiley.com/doi/abs/10.1111/bjh.16760","googleCitationCount":41,"googleAuthor":"","doi":"10.1111/bjh.16760","elsevierAuthor":"Vulliamy P.","publicationName":"British Journal of Haematology","elsevierCoverDate":"2020-06-01","elsevierCoverDisplayDate":"1 June 2020","elsevierCitationCount":"20"},{"title":"Real‐world assessment of the clinical impact of symptomatic infection with severe acute respiratory syndrome coronavirus (COVID‐19 disease) in patients with …","googleId":"yULq3kwTa4wJ","googleLink":"https://onlinelibrary.wiley.com/doi/abs/10.1111/bjh.16874","googleCitationCount":39,"googleAuthor":"G Cook","doi":"10.1111/bjh.16874","elsevierAuthor":"Cook G.","publicationName":"British Journal of Haematology","elsevierCoverDate":"2020-07-01","elsevierCoverDisplayDate":"1 July 2020","elsevierCitationCount":"25"},{"title":"First Covid‐19 maternal mortality in the UK associated with thrombotic complications","googleId":"G3d1II4OjY8J","googleLink":"https://onlinelibrary.wiley.com/doi/abs/10.1111/bjh.16849","googleCitationCount":44,"googleAuthor":"","doi":"10.1111/bjh.16849","elsevierAuthor":"Ahmed I.","publicationName":"British Journal of Haematology","elsevierCoverDate":"2020-07-01","elsevierCoverDisplayDate":"1 July 2020","elsevierCitationCount":"24"},{"title":"Clinical outcome of coronavirus disease 2019 in haemato‐oncology patients","googleId":"Rps8pf_UX64J","googleLink":"https://onlinelibrary.wiley.com/doi/abs/10.1111/bjh.16852","googleCitationCount":41,"googleAuthor":"JK Davies","doi":"10.1111/bjh.16852","elsevierAuthor":"Aries J.A.","publicationName":"British Journal of Haematology","elsevierCoverDate":"2020-07-01","elsevierCoverDisplayDate":"1 July 2020","elsevierCitationCount":"29"},{"title":"Dynamic relationship between D‐dimer and COVID‐19 severity","googleId":"gI56dlHPEI0J","googleLink":"https://onlinelibrary.wiley.com/doi/abs/10.1111/bjh.16811","googleCitationCount":44,"googleAuthor":"","doi":"10.1111/bjh.16811","elsevierAuthor":"Li Y.","publicationName":"British Journal of Haematology","elsevierCoverDate":"2020-07-01","elsevierCoverDisplayDate":"1 July 2020","elsevierCitationCount":"22"},{"title":"COVID‐19 and ABO blood group: another viewpoint","googleId":"2rO5G8nTgVQJ","googleLink":"https://onlinelibrary.wiley.com/doi/abs/10.1111/bjh.16884","googleCitationCount":51,"googleAuthor":"","doi":"10.1111/bjh.16884","elsevierAuthor":"Gérard C.","publicationName":"British Journal of Haematology","elsevierCoverDate":"2020-07-01","elsevierCoverDisplayDate":"1 July 2020","elsevierCitationCount":"24"},{"title":"Practical guidance for the management of adults with immune thrombocytopenia during the COVID‐19 pandemic","googleId":"3egyNIx53uQJ","googleLink":"https://onlinelibrary.wiley.com/doi/abs/10.1111/bjh.16775","googleCitationCount":26,"googleAuthor":"M Murphy","doi":"10.1111/bjh.16775","elsevierAuthor":"Pavord S.","publicationName":"British Journal of Haematology","elsevierCoverDate":"2020-06-01","elsevierCoverDisplayDate":"1 June 2020","elsevierCitationCount":"15"},{"title":"Prevalence of venous thromboembolism in critically ill patients with COVID‐19","googleId":"XNxtMzLqQwUJ","googleLink":"https://onlinelibrary.wiley.com/doi/abs/10.1111/bjh.16908","googleCitationCount":29,"googleAuthor":"JA Hippensteel","doi":"10.1111/bjh.16908","elsevierAuthor":"Hippensteel J.A.","publicationName":"British Journal of Haematology","elsevierCoverDate":"2020-08-01","elsevierCoverDisplayDate":"1 August 2020","elsevierCitationCount":"14"},{"title":"How do we plan hematopoietic cell transplant and cellular therapy with the looming COVID‐19 threat?","googleId":"85d-URuoir0J","googleLink":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7161755/","googleCitationCount":28,"googleAuthor":"B Dholaria","doi":"10.1111/bjh.16597","elsevierAuthor":"Dholaria B.","publicationName":"British Journal of Haematology","elsevierCoverDate":"2020-04-01","elsevierCoverDisplayDate":"1 April 2020","elsevierCitationCount":"16"},{"title":"COVID‐19 infection and sickle cell disease: a UK centre experience","googleId":"LLcdaTekZkgJ","googleLink":"https://onlinelibrary.wiley.com/doi/abs/10.1111/bjh.16779","googleCitationCount":33,"googleAuthor":"","doi":"10.1111/bjh.16779","elsevierAuthor":"McCloskey K.A.","publicationName":"British Journal of Haematology","elsevierCoverDate":"2020-07-01","elsevierCoverDisplayDate":"1 July 2020","elsevierCitationCount":"21"},{"title":"Protective role of Bruton tyrosine kinase inhibitors in patients with chronic lymphocytic leukaemia and COVID‐19","googleId":"nf0gztpJTy0J","googleLink":"https://onlinelibrary.wiley.com/doi/abs/10.1111/bjh.16863","googleCitationCount":26,"googleAuthor":"S Thibaud","doi":"10.1111/bjh.16863","elsevierAuthor":"Thibaud S.","publicationName":"British Journal of Haematology","elsevierCoverDate":"2020-07-01","elsevierCoverDisplayDate":"1 July 2020","elsevierCitationCount":"14"},{"title":"Incidence of and risk factors for major haemorrhage in patients treated with ibrutinib: an integrated analysis","googleId":"gBQ5MV2IG_wJ","googleLink":"https://onlinelibrary.wiley.com/doi/abs/10.1111/bjh.15690","googleCitationCount":38,"googleAuthor":"J Moslehi","doi":"10.1111/bjh.15690","elsevierAuthor":"Brown J.R.","publicationName":"British Journal of Haematology","elsevierCoverDate":"2019-02-01","elsevierCoverDisplayDate":"Februaryy 2019","elsevierCitationCount":"26"},{"title":"Evans syndrome in a patient with COVID‐19","googleId":"wT6jLE6vlcgJ","googleLink":"https://onlinelibrary.wiley.com/doi/abs/10.1111/bjh.16846","googleCitationCount":25,"googleAuthor":"","doi":"10.1111/bjh.16846","elsevierAuthor":"Li M.","publicationName":"British Journal of Haematology","elsevierCoverDate":"2020-07-01","elsevierCoverDisplayDate":"1 July 2020","elsevierCitationCount":"14"},{"title":"Mutation‐enhanced international prognostic systems for essential thrombocythaemia and polycythaemia vera","googleId":"cS2UNSsjHTYJ","googleLink":"https://onlinelibrary.wiley.com/doi/abs/10.1111/bjh.16380","googleCitationCount":23,"googleAuthor":"P Guglielmelli","doi":"10.1111/bjh.16380","elsevierAuthor":"Tefferi A.","publicationName":"British Journal of Haematology","elsevierCoverDate":"2020-04-01","elsevierCoverDisplayDate":"1 April 2020","elsevierCitationCount":"16"},{"title":"Arterial thromboembolic complications in COVID‐19 in low‐risk patients despite prophylaxis","googleId":"SHaRd8iLvrAJ","googleLink":"https://onlinelibrary.wiley.com/doi/abs/10.1111/bjh.16792","googleCitationCount":23,"googleAuthor":"DO Griffin","doi":"10.1111/bjh.16792","elsevierAuthor":"Griffin D.O.","publicationName":"British Journal of Haematology","elsevierCoverDate":"2020-07-01","elsevierCoverDisplayDate":"1 July 2020","elsevierCitationCount":"17"},{"title":"Differentiation syndrome in acute promyelocytic leukaemia","googleId":"_3zLNnwaNLgJ","googleLink":"https://onlinelibrary.wiley.com/doi/abs/10.1111/bjh.16151","googleCitationCount":24,"googleAuthor":"M Stahl","doi":"10.1111/bjh.16151","elsevierAuthor":"Stahl M.","publicationName":"British Journal of Haematology","elsevierCoverDate":"2019-10-01","elsevierCoverDisplayDate":"1 October 2019","elsevierCitationCount":"16"},{"title":"Persisting SARS‐CoV‐2 viraemia after rituximab therapy: two cases with fatal outcome and a review of the literature","googleId":"9y9FtAoFxk4J","googleLink":"https://onlinelibrary.wiley.com/doi/abs/10.1111/bjh.16896","googleCitationCount":26,"googleAuthor":"","doi":"10.1111/bjh.16896","elsevierAuthor":"Tepasse P.R.","publicationName":"British Journal of Haematology","elsevierCoverDate":"2020-07-01","elsevierCoverDisplayDate":"1 July 2020","elsevierCitationCount":"14"},{"title":"Amelioration of COVID‐19‐related cytokine storm syndrome: parallels to chimeric antigen receptor‐T cell cytokine release syndrome","googleId":"fhbF8-GuOIMJ","googleLink":"https://onlinelibrary.wiley.com/doi/abs/10.1111/bjh.16961","googleCitationCount":18,"googleAuthor":"","doi":"10.1111/bjh.16961","elsevierAuthor":"Hoiland R.L.","publicationName":"British Journal of Haematology","elsevierCoverDate":"2020-08-01","elsevierCoverDisplayDate":"1 August 2020","elsevierCitationCount":"11"},{"title":"Phase 1 study of selinexor plus carfilzomib and dexamethasone for the treatment of relapsed/refractory multiple myeloma","googleId":"UwUOeJPcDcUJ","googleLink":"https://onlinelibrary.wiley.com/doi/abs/10.1111/bjh.15969","googleCitationCount":25,"googleAuthor":"","doi":"10.1111/bjh.15969","elsevierAuthor":"Jakubowiak A.J.","publicationName":"British Journal of Haematology","elsevierCoverDate":"2019-01-01","elsevierCoverDisplayDate":"2019","elsevierCitationCount":"20"},{"title":"Protecting vulnerable patients with inherited anaemias from unnecessary death during the COVID‐19 pandemic","googleId":"yOOlq4L4QuEJ","googleLink":"https://onlinelibrary.wiley.com/doi/abs/10.1111/bjh.16687","googleCitationCount":25,"googleAuthor":"","doi":"10.1111/bjh.16687","elsevierAuthor":"Roy N.B.A.","publicationName":"British Journal of Haematology","elsevierCoverDate":"2020-05-01","elsevierCoverDisplayDate":"1 May 2020","elsevierCitationCount":"21"},{"title":"A guideline for the diagnosis and management of polycythaemia vera","googleId":"DyZf7D4rOSoJ","googleLink":"http://orca.cf.ac.uk/115831/1/PV%20Guideline%20revision%20accepted%20changes%202018.pdf","googleCitationCount":38,"googleAuthor":"MF McMullin"},{"title":"Efficacy of therapeutic plasma exchange in severe COVID‐19 patients","googleId":"K4hI3xa1kbYJ","googleLink":"https://onlinelibrary.wiley.com/doi/abs/10.1111/bjh.16890","googleCitationCount":26,"googleAuthor":"","doi":"10.1111/bjh.16890","elsevierAuthor":"Zhang L.","publicationName":"British Journal of Haematology","elsevierCoverDate":"2020-08-01","elsevierCoverDisplayDate":"1 August 2020","elsevierCitationCount":"13"},{"title":"Clinical outcomes and risk factors for severe COVID‐19 in patients with haematological disorders receiving chemo‐or immunotherapy","googleId":"2Y9UMt7g3GgJ","googleLink":"https://onlinelibrary.wiley.com/doi/abs/10.1111/bjh.17027","googleCitationCount":18,"googleAuthor":"","doi":"10.1111/bjh.17027","elsevierAuthor":"Fox T.A.","publicationName":"British Journal of Haematology","elsevierCoverDate":"2020-10-01","elsevierCoverDisplayDate":"1 October 2020","elsevierCitationCount":"10"},{"title":"Delayed‐phase thrombocytopenia in patients with coronavirus disease 2019 (COVID‐19)","googleId":"8cJgUJ-dAAQJ","googleLink":"https://onlinelibrary.wiley.com/doi/abs/10.1111/bjh.16885","googleCitationCount":19,"googleAuthor":"","doi":"10.1111/bjh.16885","elsevierAuthor":"Chen W.","publicationName":"British Journal of Haematology","elsevierCoverDate":"2020-07-01","elsevierCoverDisplayDate":"1 July 2020","elsevierCitationCount":"9"},{"title":"Patients with sickle cell disease and suspected COVID‐19 in a paediatric intensive care unit","googleId":"0Z75l5WDYvsJ","googleLink":"https://onlinelibrary.wiley.com/doi/abs/10.1111/bjh.16802","googleCitationCount":22,"googleAuthor":"","doi":"10.1111/bjh.16802","elsevierAuthor":"Heilbronner C.","publicationName":"British Journal of Haematology","elsevierCoverDate":"2020-07-01","elsevierCoverDisplayDate":"1 July 2020","elsevierCitationCount":"12"},{"title":"CXCR4 mutation subtypes impact response and survival outcomes in patients with Waldenström macroglobulinaemia treated with ibrutinib","googleId":"Z3ZaZYzPa10J","googleLink":"https://onlinelibrary.wiley.com/doi/abs/10.1111/bjh.16088","googleCitationCount":27,"googleAuthor":"JJ Castillo","doi":"10.1111/bjh.16088","elsevierAuthor":"Castillo J.J.","publicationName":"British Journal of Haematology","elsevierCoverDate":"2019-11-01","elsevierCoverDisplayDate":"1 November 2019","elsevierCitationCount":"19"},{"title":"Simultaneous onset of COVID‐19 and autoimmune haemolytic anaemia","googleId":"TZhMna-iA_UJ","googleLink":"https://onlinelibrary.wiley.com/doi/abs/10.1111/bjh.16786","googleCitationCount":45,"googleAuthor":"","doi":"10.1111/bjh.16786","elsevierAuthor":"Lopez C.","publicationName":"British Journal of Haematology","elsevierCoverDate":"2020-07-01","elsevierCoverDisplayDate":"1 July 2020","elsevierCitationCount":"27"},{"title":"A guideline for the management of specific situations in polycythaemia vera and secondary erythrocytosis: a British Society for Haematology Guideline","googleId":"n-KQcYiAmmMJ","googleLink":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6519221/","googleCitationCount":31,"googleAuthor":"MFF McMullin","doi":"10.1111/bjh.15647","elsevierAuthor":"McMullin M.F.F.","publicationName":"British Journal of Haematology","elsevierCoverDate":"2019-01-01","elsevierCoverDisplayDate":"January 2019","elsevierCitationCount":"21"},{"title":"More on 'Association between ABO blood groups and risk of SARS‐CoV‐2 pneumonia'","googleId":"Ouz_1mgJoNAJ","googleLink":"https://onlinelibrary.wiley.com/doi/abs/10.1111/bjh.16845","googleCitationCount":16,"googleAuthor":"JM O'Sullivan","doi":"10.1111/bjh.16845","elsevierAuthor":"O’Sullivan J.M.","publicationName":"British Journal of Haematology","elsevierCoverDate":"2020-07-01","elsevierCoverDisplayDate":"1 July 2020","elsevierCitationCount":"10"},{"title":"Poor outcome and prolonged persistence of SARS‐CoV‐2 RNA in COVID‐19 patients with haematological malignancies; King's College Hospital experience","googleId":"obsbyBhWVOYJ","googleLink":"https://onlinelibrary.wiley.com/doi/abs/10.1111/bjh.16935","googleCitationCount":23,"googleAuthor":"","doi":"10.1111/bjh.16935","elsevierAuthor":"Shah V.","publicationName":"British Journal of Haematology","elsevierCoverDate":"2020-09-01","elsevierCoverDisplayDate":"1 September 2020","elsevierCitationCount":"15"},{"title":"Interleukin 6‐blockade treatment for severe COVID‐19 in two patients with multiple myeloma","googleId":"3cOddNwIRFkJ","googleLink":"https://onlinelibrary.wiley.com/doi/abs/10.1111/bjh.16787","googleCitationCount":20,"googleAuthor":"A Chaidos","doi":"10.1111/bjh.16787","elsevierAuthor":"Chaidos A.","publicationName":"British Journal of Haematology","elsevierCoverDate":"2020-07-01","elsevierCoverDisplayDate":"1 July 2020","elsevierCitationCount":"10"},{"title":"The association between severe COVID‐19 and low platelet count: evidence from 31 observational studies involving 7613 participants","googleId":"vuyeS0gR_AIJ","googleLink":"https://onlinelibrary.wiley.com/doi/abs/10.1111/bjh.16817","googleCitationCount":19,"googleAuthor":"","doi":"10.1111/bjh.16817","elsevierAuthor":"Jiang S.Q.","publicationName":"British Journal of Haematology","elsevierCoverDate":"2020-07-01","elsevierCoverDisplayDate":"1 July 2020","elsevierCitationCount":"18"},{"title":"Interleukin‐1 blockade with anakinra in acute leukaemia patients with severe COVID‐19 pneumonia appears safe and may result in clinical improvement","googleId":"ONaRlN5hVWcJ","googleLink":"https://onlinelibrary.wiley.com/doi/abs/10.1111/bjh.16873","googleCitationCount":21,"googleAuthor":"","doi":"10.1111/bjh.16873","elsevierAuthor":"Day J.W.","publicationName":"British Journal of Haematology","elsevierCoverDate":"2020-07-01","elsevierCoverDisplayDate":"1 July 2020","elsevierCitationCount":"14"},{"title":"Managing sickle cell patients with COVID‐19 infection: the need to pool our collective experience","googleId":"KL2hoSXDhz8J","googleLink":"https://onlinelibrary.wiley.com/doi/abs/10.1111/bjh.16880","googleCitationCount":17,"googleAuthor":"","doi":"10.1111/bjh.16880","elsevierAuthor":"Sahu K.K.","publicationName":"British Journal of Haematology","elsevierCoverDate":"2020-07-01","elsevierCoverDisplayDate":"1 July 2020","elsevierCitationCount":"11"},{"title":"Thrombocytopenia as an initial manifestation of COVID‐19; case series and literature review","googleId":"SIiZ-DCl5coJ","googleLink":"https://onlinelibrary.wiley.com/doi/abs/10.1111/bjh.16769","googleCitationCount":22,"googleAuthor":"","doi":"10.1111/bjh.16769","elsevierAuthor":"Ahmed M.Z.","publicationName":"British Journal of Haematology","elsevierCoverDate":"2020-06-01","elsevierCoverDisplayDate":"1 June 2020","elsevierCitationCount":"17"},{"title":"Advances in understanding the pathogenesis of red cell membrane disorders","googleId":"KdQ7s2vJk2gJ","googleLink":"https://onlinelibrary.wiley.com/doi/abs/10.1111/bjh.16126","googleCitationCount":19,"googleAuthor":"A Iolascon","doi":"10.1111/bjh.16126","elsevierAuthor":"Iolascon A.","publicationName":"British Journal of Haematology","elsevierCoverDate":"2019-10-01","elsevierCoverDisplayDate":"1 October 2019","elsevierCitationCount":"15"},{"title":"Biology and therapy of primary mediastinal B‐cell lymphoma: current status and future directions","googleId":"swroaLQwxJAJ","googleLink":"https://onlinelibrary.wiley.com/doi/abs/10.1111/bjh.15778","googleCitationCount":25,"googleAuthor":"C Keane","doi":"10.1111/bjh.15778","elsevierAuthor":"Lees C.","publicationName":"British Journal of Haematology","elsevierCoverDate":"2019-04-01","elsevierCoverDisplayDate":"April 2019","elsevierCitationCount":"15"},{"title":"Is molecular mimicry the culprit in the autoimmune haemolytic anaemia affecting patients with COVID‐19?","googleId":"qMmN0B-BRAoJ","googleLink":"https://onlinelibrary.wiley.com/doi/abs/10.1111/bjh.16883","googleCitationCount":20,"googleAuthor":"","doi":"10.1111/bjh.16883","elsevierAuthor":"Angileri F.","publicationName":"British Journal of Haematology","elsevierCoverDate":"2020-07-01","elsevierCoverDisplayDate":"1 July 2020","elsevierCitationCount":"9"},{"title":"Re The source of elevated plasma D‐dimer levels in COVID‐19 infection","googleId":"pcuqxy_SVAwJ","googleLink":"https://onlinelibrary.wiley.com/doi/abs/10.1111/bjh.16907","googleCitationCount":18,"googleAuthor":"M Levi","doi":"10.1111/bjh.16907","elsevierAuthor":"Hunt B.J.","publicationName":"British Journal of Haematology","elsevierCoverDate":"2020-08-01","elsevierCoverDisplayDate":"1 August 2020","elsevierCitationCount":"11"},{"title":"Pembrolizumab combined with lenalidomide and low‐dose dexamethasone for relapsed or refractory multiple myeloma: phase I KEYNOTE‐023 study","googleId":"W9FS2cE_V2cJ","googleLink":"https://onlinelibrary.wiley.com/doi/abs/10.1111/bjh.15946?af=R","googleCitationCount":24,"googleAuthor":"MV Mateos","doi":"10.1111/bjh.15946","elsevierAuthor":"Mateos M.V.","publicationName":"British Journal of Haematology","elsevierCoverDate":"2019-01-01","elsevierCoverDisplayDate":"2019","elsevierCitationCount":"21"},{"title":"SARS‐CoV‐2 infection anxieties and general population restrictions delay diagnosis and treatment of acute haematological malignancies","googleId":"CknpA_b8Dn4J","googleLink":"https://onlinelibrary.wiley.com/doi/abs/10.1111/bjh.16785","googleCitationCount":18,"googleAuthor":"","doi":"10.1111/bjh.16785","elsevierAuthor":"Molica M.","publicationName":"British Journal of Haematology","elsevierCoverDate":"2020-07-01","elsevierCoverDisplayDate":"1 July 2020","elsevierCitationCount":"13"},{"title":"How we manage patients with pyruvate kinase deficiency","googleId":"0a0ByzznOMUJ","googleLink":"https://onlinelibrary.wiley.com/doi/abs/10.1111/bjh.15758","googleCitationCount":24,"googleAuthor":"","doi":"10.1111/bjh.15758","elsevierAuthor":"","publicationName":"British Journal of Haematology","elsevierCoverDate":"2019-05-01","elsevierCoverDisplayDate":"May 2019","elsevierCitationCount":"0"},{"title":"Citrullinated histone H3, a biomarker for neutrophil extracellular trap formation, predicts the risk of mortality in patients with cancer","googleId":"I-4aHx3R4tUJ","googleLink":"https://onlinelibrary.wiley.com/doi/abs/10.1111/bjh.15906","googleCitationCount":22,"googleAuthor":"F Posch","doi":"10.1111/bjh.15906","elsevierAuthor":"Grilz E.","publicationName":"British Journal of Haematology","elsevierCoverDate":"2019-07-01","elsevierCoverDisplayDate":"July 2019","elsevierCitationCount":"17"},{"title":"Increased CD95 (Fas) and PD‐1 expression in peripheral blood T lymphocytes in COVID‐19 patients","googleId":"TcpgnHRVb2QJ","googleLink":"https://onlinelibrary.wiley.com/doi/abs/10.1111/bjh.17034","googleCitationCount":14,"googleAuthor":"","doi":"10.1111/bjh.17034","elsevierAuthor":"Bellesi S.","publicationName":"British Journal of Haematology","elsevierCoverDate":"2020-10-01","elsevierCoverDisplayDate":"1 October 2020","elsevierCitationCount":"9"},{"title":"Terminal complement inhibition dampens the inflammation during COVID‐19","googleId":"qAzSuzhYbM4J","googleLink":"https://onlinelibrary.wiley.com/doi/abs/10.1111/bjh.16916","googleCitationCount":15,"googleAuthor":"AG Kulasekararaj","doi":"10.1111/bjh.16916","elsevierAuthor":"Kulasekararaj A.G.","publicationName":"British Journal of Haematology","elsevierCoverDate":"2020-08-01","elsevierCoverDisplayDate":"1 August 2020","elsevierCitationCount":"7"},{"title":"Cold agglutinin autoimmune haemolytic anaemia associated with novel coronavirus (COVID‐19)","googleId":"06emACHpxT0J","googleLink":"https://onlinelibrary.wiley.com/doi/abs/10.1111/bjh.16892","googleCitationCount":19,"googleAuthor":"T Pawar","doi":"10.1111/bjh.16892","elsevierAuthor":"Zagorski E.","publicationName":"British Journal of Haematology","elsevierCoverDate":"2020-08-01","elsevierCoverDisplayDate":"1 August 2020","elsevierCitationCount":"9"},{"title":"Prophylactic donor lymphocyte infusion after allogeneic stem cell transplantation in acute leukaemia–a matched pair analysis by the Acute Leukaemia Working Party …","googleId":"J8j5oE8LWSEJ","googleLink":"https://onlinelibrary.wiley.com/doi/abs/10.1111/bjh.15691","googleCitationCount":27,"googleAuthor":"M Labopin","doi":"10.1111/bjh.15691","elsevierAuthor":"Schmid C.","publicationName":"British Journal of Haematology","elsevierCoverDate":"2019-03-01","elsevierCoverDisplayDate":"March 2019","elsevierCitationCount":"15"},{"title":"Red cell transfusion in outpatients with myelodysplastic syndromes: a feasibility and exploratory randomised trial","googleId":"qdpwBNfKbxwJ","googleLink":"https://onlinelibrary.wiley.com/doi/abs/10.1111/bjh.16347","googleCitationCount":14,"googleAuthor":"ZK McQuilten","doi":"10.1111/bjh.16347","elsevierAuthor":"Stanworth S.J.","publicationName":"British Journal of Haematology","elsevierCoverDate":"2020-04-01","elsevierCoverDisplayDate":"1 April 2020","elsevierCitationCount":"10"},{"title":"Daratumumab proves safe and highly effective in AL amyloidosis","googleId":"w_luDgUN8nEJ","googleLink":"https://onlinelibrary.wiley.com/doi/abs/10.1111/bjh.15455?af=R","googleCitationCount":32,"googleAuthor":"J Khouri","doi":"10.1111/bjh.15455","elsevierAuthor":"Khouri J.","publicationName":"British Journal of Haematology","elsevierCoverDate":"2019-04-01","elsevierCoverDisplayDate":"April 2019","elsevierCitationCount":"25"},{"title":"Combination lenalidomide‐rituximab immunotherapy activates anti‐tumour immunity and induces tumour cell death by complementary mechanisms of action in …","googleId":"2D5y6eLDYxMJ","googleLink":"https://onlinelibrary.wiley.com/doi/abs/10.1111/bjh.15797","googleCitationCount":20,"googleAuthor":"","doi":"10.1111/bjh.15797","elsevierAuthor":"Chiu H.","publicationName":"British Journal of Haematology","elsevierCoverDate":"2019-04-01","elsevierCoverDisplayDate":"April 2019","elsevierCitationCount":"13"},{"title":"How we deal with the COVID‐19 epidemic in an Italian paediatric onco‐haematology clinic located in a region with a high density of cases","googleId":"2TR_rJ6HPEsJ","googleLink":"https://onlinelibrary.wiley.com/doi/abs/10.1111/bjh.16699","googleCitationCount":17,"googleAuthor":"","doi":"10.1111/bjh.16699","elsevierAuthor":"Sainati L.","publicationName":"British Journal of Haematology","elsevierCoverDate":"2020-05-01","elsevierCoverDisplayDate":"1 May 2020","elsevierCitationCount":"6"},{"title":"Daratumumab, bortezomib, cyclophosphamide and dexamethasone in newly diagnosed and relapsed multiple myeloma: LYRA study","googleId":"9K00xgyLkU0J","googleLink":"https://onlinelibrary.wiley.com/doi/abs/10.1111/bjh.15806","googleCitationCount":23,"googleAuthor":"","doi":"10.1111/bjh.15806","elsevierAuthor":"Yimer H.","publicationName":"British Journal of Haematology","elsevierCoverDate":"2019-05-01","elsevierCoverDisplayDate":"May 2019","elsevierCitationCount":"17"},{"title":"M7‐FLIPI is not prognostic in follicular lymphoma patients with first‐line rituximab chemo‐free therapy","googleId":"7NRD3mxZVsYJ","googleLink":"https://onlinelibrary.wiley.com/doi/abs/10.1111/bjh.16159","googleCitationCount":18,"googleAuthor":"","doi":"10.1111/bjh.16159","elsevierAuthor":"Lockmer S.","publicationName":"British Journal of Haematology","elsevierCoverDate":"2020-01-01","elsevierCoverDisplayDate":"1 January 2020","elsevierCitationCount":"12"},{"title":"Anti‐A isohaemagglutinin titres and SARS‐CoV‐2 neutralization: implications for children and convalescent plasma selection","googleId":"-eEyFBZzP6kJ","googleLink":"https://onlinelibrary.wiley.com/doi/abs/10.1111/bjh.16932","googleCitationCount":20,"googleAuthor":"D Focosi","doi":"10.1111/bjh.16932","elsevierAuthor":"Focosi D.","publicationName":"British Journal of Haematology","elsevierCoverDate":"2020-08-01","elsevierCoverDisplayDate":"1 August 2020","elsevierCitationCount":"11"},{"title":"Guidelines for the diagnosis and management of primary central nervous system diffuse large B-cell lymphoma","googleId":"L2URzApl1oIJ","googleLink":"https://pubmed.ncbi.nlm.nih.gov/30467845/","googleCitationCount":26,"googleAuthor":"J Smith","doi":"10.1111/bjh.15661,","elsevierAuthor":"Fox C.P.","publicationName":"British Journal of Haematology","elsevierCoverDate":"2019-02-01","elsevierCoverDisplayDate":"Februaryy 2019","elsevierCitationCount":"18"},{"title":"Inhibition of Band 3 tyrosine phosphorylation: a new mechanism for treatment of sickle cell disease","googleId":"mDIeHwqmUssJ","googleLink":"https://onlinelibrary.wiley.com/doi/abs/10.1111/bjh.16671","googleCitationCount":10,"googleAuthor":"P Noomuna","doi":"10.1111/bjh.16671","elsevierAuthor":"Noomuna P.","publicationName":"British Journal of Haematology","elsevierCoverDate":"2020-08-01","elsevierCoverDisplayDate":"1 August 2020","elsevierCitationCount":"7"},{"title":"Ibrutinib monotherapy outside of clinical trial setting in Waldenström macroglobulinaemia: practice patterns, toxicities and outcomes","googleId":"dorW8G0z9XQJ","googleLink":"https://onlinelibrary.wiley.com/doi/abs/10.1111/bjh.16168","googleCitationCount":19,"googleAuthor":"JP Abeykoon","doi":"10.1111/bjh.16168","elsevierAuthor":"Abeykoon J.P.","publicationName":"British Journal of Haematology","elsevierCoverDate":"2020-02-01","elsevierCoverDisplayDate":"1 February 2020","elsevierCitationCount":"13"},{"title":"Therapeutic use of regulatory T cells for graft‐versus‐host disease","googleId":"ww3UhFDZmKsJ","googleLink":"https://onlinelibrary.wiley.com/doi/abs/10.1111/bjh.16157","googleCitationCount":17,"googleAuthor":"AY Rudensky","doi":"10.1111/bjh.16157","elsevierAuthor":"Elias S.","publicationName":"British Journal of Haematology","elsevierCoverDate":"2019-10-01","elsevierCoverDisplayDate":"1 October 2019","elsevierCitationCount":"11"},{"title":"Prevalence and mortality in β‐thalassaemias due to outbreak of novel coronavirus disease (COVID‐19): the nationwide Iranian experience","googleId":"4FxzK0U78_IJ","googleLink":"https://onlinelibrary.wiley.com/doi/abs/10.1111/bjh.16911","googleCitationCount":15,"googleAuthor":"S Haghpanah","doi":"10.1111/bjh.16911","elsevierAuthor":"Karimi M.","publicationName":"British Journal of Haematology","elsevierCoverDate":"2020-08-01","elsevierCoverDisplayDate":"1 August 2020","elsevierCitationCount":"10"},{"title":"Therapeutic gene editing in haematological disorders with CRISPR/Cas9","googleId":"BKSIip-KpugJ","googleLink":"https://onlinelibrary.wiley.com/doi/abs/10.1111/bjh.15851","googleCitationCount":19,"googleAuthor":"RO Bak","doi":"10.1111/bjh.15851","elsevierAuthor":"Jensen T.I.","publicationName":"British Journal of Haematology","elsevierCoverDate":"2019-06-01","elsevierCoverDisplayDate":"June 2019","elsevierCitationCount":"10"},{"title":"Myelofibrosis biology and contemporary management","googleId":"SMSogR0yqM0J","googleLink":"https://onlinelibrary.wiley.com/doi/abs/10.1111/bjh.16576","googleCitationCount":14,"googleAuthor":"","doi":"10.1111/bjh.16576","elsevierAuthor":"Gangat N.","publicationName":"British Journal of Haematology","elsevierCoverDate":"2020-10-01","elsevierCoverDisplayDate":"1 October 2020","elsevierCitationCount":"8"},{"title":"Bortezomib reinduction chemotherapy in high‐risk ALL in first relapse: a report from the Children's Oncology Group","googleId":"XDCWQFLEexEJ","googleLink":"https://onlinelibrary.wiley.com/doi/abs/10.1111/bjh.15919","googleCitationCount":19,"googleAuthor":"TM Horton","doi":"10.1111/bjh.15919","elsevierAuthor":"Horton T.M.","publicationName":"British Journal of Haematology","elsevierCoverDate":"2019-07-01","elsevierCoverDisplayDate":"July 2019","elsevierCitationCount":"12"},{"title":"Pre‐and post‐serial metagenomic analysis of gut microbiota as a prognostic factor in patients undergoing haematopoietic stem cell transplantation","googleId":"ql4ggmmbwisJ","googleLink":"https://onlinelibrary.wiley.com/doi/abs/10.1111/bjh.16205","googleCitationCount":14,"googleAuthor":"","doi":"10.1111/bjh.16205","elsevierAuthor":"Kusakabe S.","publicationName":"British Journal of Haematology","elsevierCoverDate":"2020-02-01","elsevierCoverDisplayDate":"1 February 2020","elsevierCitationCount":"9"},{"title":"Second primary cancers in patients with acute lymphoblastic, chronic lymphocytic and hairy cell leukaemia","googleId":"S7gvSgd4wpwJ","googleLink":"https://onlinelibrary.wiley.com/doi/abs/10.1111/bjh.15777","googleCitationCount":21,"googleAuthor":"S Chattopadhyay","doi":"10.1111/bjh.15777","elsevierAuthor":"Zheng G.","publicationName":"British Journal of Haematology","elsevierCoverDate":"2019-04-01","elsevierCoverDisplayDate":"April 2019","elsevierCitationCount":"16"},{"title":"Osteoarticular infections in paediatric sickle cell disease: in the era of multidrugresistant bacteria","googleId":"4ckVIC88xk4J","googleLink":"http://repositorio.chlc.min-saude.pt/bitstream/10400.17/3540/1/Br%20J%20Haematol%202020_189_e147.pdf","googleCitationCount":1,"googleAuthor":""},{"title":"How we manage Philadelphia‐negative myeloproliferative neoplasms in pregnancy","googleId":"R1GiFHr7c54J","googleLink":"https://onlinelibrary.wiley.com/doi/abs/10.1111/bjh.16453","googleCitationCount":11,"googleAuthor":"","doi":"10.1111/bjh.16453","elsevierAuthor":"Robinson S.E.","publicationName":"British Journal of Haematology","elsevierCoverDate":"2020-05-01","elsevierCoverDisplayDate":"1 May 2020","elsevierCitationCount":"7"},{"title":"Anticoagulation with Argatroban in patients with acute antithrombin deficiency in severe COVID‐19","googleId":"5z6lLVoH-wwJ","googleLink":"https://onlinelibrary.wiley.com/doi/abs/10.1111/bjh.16927","googleCitationCount":14,"googleAuthor":"","doi":"10.1111/bjh.16927","elsevierAuthor":"Arachchillage D.J.","publicationName":"British Journal of Haematology","elsevierCoverDate":"2020-09-01","elsevierCoverDisplayDate":"1 September 2020","elsevierCitationCount":"7"},{"title":"Smoking, blood cells and myeloproliferative neoplasms: meta‐analysis and Mendelian randomization of 2· 3 million people","googleId":"_RzZmhfx2vEJ","googleLink":"https://onlinelibrary.wiley.com/doi/abs/10.1111/bjh.16321","googleCitationCount":11,"googleAuthor":"AD Kjaergaard","doi":"10.1111/bjh.16321","elsevierAuthor":"Jayasuriya N.A.","publicationName":"British Journal of Haematology","elsevierCoverDate":"2020-04-01","elsevierCoverDisplayDate":"1 April 2020","elsevierCitationCount":"8"},{"title":"ABO phenotype and death in critically ill patients with COVID‐19","googleId":"dUHWXi6HN-4J","googleLink":"https://onlinelibrary.wiley.com/doi/abs/10.1111/bjh.16984","googleCitationCount":18,"googleAuthor":"H Al‐Samkari","doi":"10.1111/bjh.16984","elsevierAuthor":"Leaf R.K.","publicationName":"British Journal of Haematology","elsevierCoverDate":"2020-08-01","elsevierCoverDisplayDate":"1 August 2020","elsevierCitationCount":"9"},{"title":"Thrombocytopenia is independently associated with poor outcome in patients hospitalized for COVID‐19","googleId":"GlBRzk72Xz8J","googleLink":"https://onlinelibrary.wiley.com/doi/abs/10.1111/bjh.16950","googleCitationCount":13,"googleAuthor":"","doi":"10.1111/bjh.16950","elsevierAuthor":"Maquet J.","publicationName":"British Journal of Haematology","elsevierCoverDate":"2020-09-01","elsevierCoverDisplayDate":"1 September 2020","elsevierCitationCount":"8"},{"title":"Allogeneic haematopoietic cell transplantation impacts on outcomes of mantle cell lymphoma with TP53 alterations","googleId":"hB2oucpLjIgJ","googleLink":"https://onlinelibrary.wiley.com/doi/abs/10.1111/bjh.15721","googleCitationCount":26,"googleAuthor":"RJ Lin","doi":"10.1111/bjh.15721","elsevierAuthor":"Lin R.J.","publicationName":"British Journal of Haematology","elsevierCoverDate":"2019-03-01","elsevierCoverDisplayDate":"March 2019","elsevierCitationCount":"17"},{"title":"Fetal and neonatal alloimmune thrombocytopenia: recommendations for evidence‐based practice, an international approach","googleId":"hD9Z8nw2Kt8J","googleLink":"https://onlinelibrary.wiley.com/doi/abs/10.1111/bjh.15813","googleCitationCount":20,"googleAuthor":"L Lieberman","doi":"10.1111/bjh.15813","elsevierAuthor":"Lieberman L.","publicationName":"British Journal of Haematology","elsevierCoverDate":"2019-05-01","elsevierCoverDisplayDate":"May 2019","elsevierCitationCount":"15"},{"title":"Diagnosis of intravascular large B cell lymphoma: novel insights into clinicopathological features from 42 patients at a single institution over 20 years","googleId":"9kiEGAbC9yQJ","googleLink":"https://onlinelibrary.wiley.com/doi/abs/10.1111/bjh.16081","googleCitationCount":17,"googleAuthor":"","doi":"10.1111/bjh.16081","elsevierAuthor":"Matsue K.","publicationName":"British Journal of Haematology","elsevierCoverDate":"2019-11-01","elsevierCoverDisplayDate":"1 November 2019","elsevierCitationCount":"11"},{"title":"Favourable outcome of coronavirus disease 2019 in a 1‐year‐old girl with acute myeloid leukaemia and severe treatment‐induced immunosuppression","googleId":"Hf9UcNqn3kwJ","googleLink":"https://onlinelibrary.wiley.com/doi/abs/10.1111/bjh.16781","googleCitationCount":13,"googleAuthor":"E Sieni","doi":"10.1111/bjh.16781","elsevierAuthor":"Sieni E.","publicationName":"British Journal of Haematology","elsevierCoverDate":"2020-06-01","elsevierCoverDisplayDate":"1 June 2020","elsevierCitationCount":"11"},{"title":"Diagnosis of Hodgkin lymphoma in the modern era","googleId":"Eb4ux9WDmZsJ","googleLink":"https://onlinelibrary.wiley.com/doi/abs/10.1111/bjh.15614","googleCitationCount":24,"googleAuthor":"JP Balakrishna","doi":"10.1111/bjh.15614","elsevierAuthor":"Wang H.W.","publicationName":"British Journal of Haematology","elsevierCoverDate":"2019-01-01","elsevierCoverDisplayDate":"January 2019","elsevierCitationCount":"15"},{"title":"The pathogenesis, diagnosis and management of congenital dyserythropoietic anaemia type I","googleId":"ZNYyTq681h4J","googleLink":"https://onlinelibrary.wiley.com/doi/abs/10.1111/bjh.15817","googleCitationCount":19,"googleAuthor":"","doi":"10.1111/bjh.15817","elsevierAuthor":"Roy N.B.A.","publicationName":"British Journal of Haematology","elsevierCoverDate":"2019-05-01","elsevierCoverDisplayDate":"May 2019","elsevierCitationCount":"10"},{"title":"Discontinuation of imatinib in children with chronic myeloid leukaemia in sustained deep molecular remission: results of the STOP IMAPED study","googleId":"gYW4wk3DJugJ","googleLink":"https://onlinelibrary.wiley.com/doi/abs/10.1111/bjh.15826","googleCitationCount":19,"googleAuthor":"","doi":"10.1111/bjh.15826","elsevierAuthor":"de Bruijn C.","publicationName":"British Journal of Haematology","elsevierCoverDate":"2019-05-01","elsevierCoverDisplayDate":"May 2019","elsevierCitationCount":"12"},{"title":"Clinical effectiveness and safety of erythropoietin‐stimulating agents for the treatment of low‐and intermediate‐1− risk myelodysplastic syndrome: a systematic …","googleId":"88ytR8ofm1EJ","googleLink":"https://onlinelibrary.wiley.com/doi/abs/10.1111/bjh.15707","googleCitationCount":19,"googleAuthor":"","doi":"10.1111/bjh.15707","elsevierAuthor":"Park S.","publicationName":"British Journal of Haematology","elsevierCoverDate":"2019-01-01","elsevierCoverDisplayDate":"January 2019","elsevierCitationCount":"13"},{"title":"Efficacy of venetoclax monotherapy in patients with relapsed chronic lymphocytic leukaemia in the post‐BCR inhibitor setting: a UK wide analysis","googleId":"-hyfXbRBb14J","googleLink":"https://onlinelibrary.wiley.com/doi/abs/10.1111/bjh.15802","googleCitationCount":24,"googleAuthor":"TA Eyre","doi":"10.1111/bjh.15802","elsevierAuthor":"Eyre T.A.","publicationName":"British Journal of Haematology","elsevierCoverDate":"2019-05-01","elsevierCoverDisplayDate":"May 2019","elsevierCitationCount":"16"},{"title":"Pembrolizumab with R‐CHOP in previously untreated diffuse large B‐cell lymphoma: potential for biomarker driven therapy","googleId":"lzDwmyBZxSYJ","googleLink":"https://onlinelibrary.wiley.com/doi/abs/10.1111/bjh.16494","googleCitationCount":15,"googleAuthor":"","doi":"10.1111/bjh.16494","elsevierAuthor":"Smith S.D.","publicationName":"British Journal of Haematology","elsevierCoverDate":"2020-06-01","elsevierCoverDisplayDate":"1 June 2020","elsevierCitationCount":"10"},{"title":"An open‐label phase 2 trial of entospletinib in indolent non‐Hodgkin lymphoma and mantle cell lymphoma","googleId":"uA5lgnLdqYMJ","googleLink":"https://onlinelibrary.wiley.com/doi/abs/10.1111/bjh.15552","googleCitationCount":23,"googleAuthor":"S Assouline","doi":"10.1111/bjh.15552","elsevierAuthor":"Andorsky D.J.","publicationName":"British Journal of Haematology","elsevierCoverDate":"2019-01-01","elsevierCoverDisplayDate":"January 2019","elsevierCitationCount":"19"},{"title":"Advances in understanding the molecular mechanisms that maintain normal haemostasis","googleId":"69izreRNPW0J","googleLink":"https://onlinelibrary.wiley.com/doi/abs/10.1111/bjh.15872","googleCitationCount":19,"googleAuthor":"JM O'Sullivan","doi":"10.1111/bjh.15872","elsevierAuthor":"O'Donnell J.S.","publicationName":"British Journal of Haematology","elsevierCoverDate":"2019-07-01","elsevierCoverDisplayDate":"July 2019","elsevierCitationCount":"9"},{"title":"Ten‐year survivors in AL amyloidosis: characteristics and treatment pattern","googleId":"-i8N25WH-kIJ","googleLink":"https://onlinelibrary.wiley.com/doi/abs/10.1111/bjh.16096","googleCitationCount":16,"googleAuthor":"E Muchtar","doi":"10.1111/bjh.16096","elsevierAuthor":"Muchtar E.","publicationName":"British Journal of Haematology","elsevierCoverDate":"2019-12-01","elsevierCoverDisplayDate":"1 December 2019","elsevierCitationCount":"12"},{"title":"The role of allogeneic stem cell transplantation in the management of acute myeloid leukaemia: a triumph of hope and experience","googleId":"zJasNgjT-7gJ","googleLink":"https://onlinelibrary.wiley.com/doi/abs/10.1111/bjh.16355","googleCitationCount":10,"googleAuthor":"J Loke","doi":"10.1111/bjh.16355","elsevierAuthor":"Loke J.","publicationName":"British Journal of Haematology","elsevierCoverDate":"2020-01-01","elsevierCoverDisplayDate":"1 January 2020","elsevierCitationCount":"6"},{"title":"Assessing the impact of lockdown: fresh challenges for the care of haematology patients in the COVID‐19 pandemic","googleId":"772aTacs6IkJ","googleLink":"https://onlinelibrary.wiley.com/doi/abs/10.1111/bjh.16782","googleCitationCount":13,"googleAuthor":"J Willan","doi":"10.1111/bjh.16782","elsevierAuthor":"Willan J.","publicationName":"British Journal of Haematology","elsevierCoverDate":"2020-06-01","elsevierCoverDisplayDate":"1 June 2020","elsevierCitationCount":"9"},{"title":"Advances in understanding the pathogenesis of graft‐versus‐host disease","googleId":"f_HpgFh1tyUJ","googleLink":"https://onlinelibrary.wiley.com/doi/abs/10.1111/bjh.16190","googleCitationCount":12,"googleAuthor":"R Zeiser","doi":"10.1111/bjh.16190","elsevierAuthor":"Zeiser R.","publicationName":"British Journal of Haematology","elsevierCoverDate":"2019-12-01","elsevierCoverDisplayDate":"1 December 2019","elsevierCitationCount":"5"},{"title":"Use of ixazomib, lenalidomide and dexamethasone in patients with relapsed amyloid light‐chain amyloidosis","googleId":"RvDXPUZ8h4YJ","googleLink":"https://onlinelibrary.wiley.com/doi/abs/10.1111/bjh.16401","googleCitationCount":10,"googleAuthor":"JD Gillmore","doi":"10.1111/bjh.16401","elsevierAuthor":"Cohen O.C.","publicationName":"British Journal of Haematology","elsevierCoverDate":"2020-05-01","elsevierCoverDisplayDate":"1 May 2020","elsevierCitationCount":"7"},{"title":"Haematological cancers and the risk of severe COVID‐19: Exploration and critical evaluation of the evidence to date","googleId":"XsEubFjKSGAJ","googleLink":"https://onlinelibrary.wiley.com/doi/abs/10.1111/bjh.16956","googleCitationCount":10,"googleAuthor":"","doi":"10.1111/bjh.16956","elsevierAuthor":"El-Sharkawi D.","publicationName":"British Journal of Haematology","elsevierCoverDate":"2020-08-01","elsevierCoverDisplayDate":"1 August 2020","elsevierCitationCount":"7"},{"title":"Characterization of a novel venetoclax resistance mutation (BCL2 Phe104Ile) observed in follicular lymphoma","googleId":"wU_ifpGrlxwJ","googleLink":"https://onlinelibrary.wiley.com/doi/abs/10.1111/bjh.16069","googleCitationCount":16,"googleAuthor":"RW Birkinshaw","doi":"10.1111/bjh.16069","elsevierAuthor":"Blombery P.","publicationName":"British Journal of Haematology","elsevierCoverDate":"2019-09-01","elsevierCoverDisplayDate":"1 September 2019","elsevierCitationCount":"11"},{"title":"Emerging therapies in sickle cell disease","googleId":"joGLCWxKg6UJ","googleLink":"https://onlinelibrary.wiley.com/doi/abs/10.1111/bjh.16504","googleCitationCount":7,"googleAuthor":"","doi":"10.1111/bjh.16504","elsevierAuthor":"Nardo-Marino A.","publicationName":"British Journal of Haematology","elsevierCoverDate":"2020-07-01","elsevierCoverDisplayDate":"1 July 2020","elsevierCitationCount":"4"},{"title":"Haemoglobin oxygen affinity in patients with severe COVID‐19 infection","googleId":"GO2kIh8bm8IJ","googleLink":"https://onlinelibrary.wiley.com/doi/abs/10.1111/bjh.16888","googleCitationCount":9,"googleAuthor":"","doi":"10.1111/bjh.16888","elsevierAuthor":"Daniel Y.","publicationName":"British Journal of Haematology","elsevierCoverDate":"2020-08-01","elsevierCoverDisplayDate":"1 August 2020","elsevierCitationCount":"8"},{"title":"Temporal changes in immune blood cell parameters in COVID‐19 infection and recovery from severe infection","googleId":"Aq6yuBwQJqwJ","googleLink":"https://onlinelibrary.wiley.com/doi/abs/10.1111/bjh.16847","googleCitationCount":12,"googleAuthor":"CYC Yip","doi":"10.1111/bjh.16847","elsevierAuthor":"Yip C.Y.C.","publicationName":"British Journal of Haematology","elsevierCoverDate":"2020-07-01","elsevierCoverDisplayDate":"1 July 2020","elsevierCitationCount":"9"},{"title":"COVID‐19 mortality in patients on anticoagulants and antiplatelet agents","googleId":"1uOHGROBrCkJ","googleLink":"https://onlinelibrary.wiley.com/doi/abs/10.1111/bjh.16968","googleCitationCount":13,"googleAuthor":"EE Ladikou","doi":"10.1111/bjh.16968","elsevierAuthor":"Sivaloganathan H.","publicationName":"British Journal of Haematology","elsevierCoverDate":"2020-08-01","elsevierCoverDisplayDate":"1 August 2020","elsevierCitationCount":"8"},{"title":"Monoclonal antibodies in the treatment of AL amyloidosis: co‐targetting the plasma cell clone and amyloid deposits","googleId":"tDQgqJCuPp8J","googleLink":"https://onlinelibrary.wiley.com/doi/abs/10.1111/bjh.16436","googleCitationCount":9,"googleAuthor":"","doi":"10.1111/bjh.16436","elsevierAuthor":"Popkova T.","publicationName":"British Journal of Haematology","elsevierCoverDate":"2020-04-01","elsevierCoverDisplayDate":"1 April 2020","elsevierCitationCount":"6"},{"title":"Romiplostim in adult patients with newly diagnosed or persistent immune thrombocytopenia (ITP) for up to 1 year and in those with chronic ITP for more than 1 year: a …","googleId":"pDwAdXkqiRAJ","googleLink":"https://onlinelibrary.wiley.com/doi/abs/10.1111/bjh.15803","googleCitationCount":16,"googleAuthor":"A Newland","doi":"10.1111/bjh.15803","elsevierAuthor":"Kuter D.J.","publicationName":"British Journal of Haematology","elsevierCoverDate":"2019-05-01","elsevierCoverDisplayDate":"May 2019","elsevierCitationCount":"12"},{"title":"Clinical significance of blue‐green neutrophil and monocyte cytoplasmic inclusions in SARS‐CoV‐2 positive critically ill patients","googleId":"HivgZODN0bQJ","googleLink":"https://onlinelibrary.wiley.com/doi/abs/10.1111/bjh.16882","googleCitationCount":10,"googleAuthor":"FN Emmons","doi":"10.1111/bjh.16882","elsevierAuthor":"Cantu M.D.","publicationName":"British Journal of Haematology","elsevierCoverDate":"2020-07-01","elsevierCoverDisplayDate":"1 July 2020","elsevierCitationCount":"7"},{"title":"Unexpected kinetics of anti‐SARS‐CoV‐2 total antibodies in two patients with chronic lymphocytic leukemia","googleId":"1AiZMvWAzm0J","googleLink":"https://onlinelibrary.wiley.com/doi/abs/10.1111/bjh.16954","googleCitationCount":10,"googleAuthor":"J Favresse","doi":"10.1111/bjh.16954","elsevierAuthor":"Favresse J.","publicationName":"British Journal of Haematology","elsevierCoverDate":"2020-08-01","elsevierCoverDisplayDate":"1 August 2020","elsevierCitationCount":"5"},{"title":"Mesenchymal stromal cells for acute graft‐versus‐host disease: response at 1 week predicts probability of survival","googleId":"XI8AaQ_Uq3AJ","googleLink":"https://onlinelibrary.wiley.com/doi/abs/10.1111/bjh.15749","googleCitationCount":18,"googleAuthor":"A Galleu","doi":"10.1111/bjh.15749","elsevierAuthor":"Galleu A.","publicationName":"British Journal of Haematology","elsevierCoverDate":"2019-04-01","elsevierCoverDisplayDate":"April 2019","elsevierCitationCount":"16"},{"title":"SMAC mimetics as potential cancer therapeutics in myeloid malignancies","googleId":"LVa_8ECDQx4J","googleLink":"https://onlinelibrary.wiley.com/doi/abs/10.1111/bjh.15829","googleCitationCount":15,"googleAuthor":"","doi":"10.1111/bjh.15829","elsevierAuthor":"Boddu P.","publicationName":"British Journal of Haematology","elsevierCoverDate":"2019-04-01","elsevierCoverDisplayDate":"April 2019","elsevierCitationCount":"11"},{"title":"Clinical characteristics, management and outcome of COVID‐19‐associated immune thrombocytopenia: a French multicentre series","googleId":"ncFxzkk34GAJ","googleLink":"https://onlinelibrary.wiley.com/doi/abs/10.1111/bjh.17024","googleCitationCount":12,"googleAuthor":"E Andres","doi":"10.1111/bjh.17024","elsevierAuthor":"Mahévas M.","publicationName":"British Journal of Haematology","elsevierCoverDate":"2020-08-01","elsevierCoverDisplayDate":"1 August 2020","elsevierCitationCount":"4"},{"title":"Prospects for achieving treatment‐free remission in chronic myeloid leukaemia","googleId":"ylObc_j4PXMJ","googleLink":"https://onlinelibrary.wiley.com/doi/abs/10.1111/bjh.16506","googleCitationCount":7,"googleAuthor":"G Saglio","doi":"10.1111/bjh.16506","elsevierAuthor":"Saglio G.","publicationName":"British Journal of Haematology","elsevierCoverDate":"2020-08-01","elsevierCoverDisplayDate":"1 August 2020","elsevierCitationCount":"4"},{"title":"Spanish Guidelines for the use of targeted deep sequencing in myelodysplastic syndromes and chronic myelomonocytic leukaemia","googleId":"-xqSPiYtTqcJ","googleLink":"https://onlinelibrary.wiley.com/doi/abs/10.1111/bjh.16175","googleCitationCount":9,"googleAuthor":"L Palomo","doi":"10.1111/bjh.16175","elsevierAuthor":"Palomo L.","publicationName":"British Journal of Haematology","elsevierCoverDate":"2020-03-01","elsevierCoverDisplayDate":"1 March 2020","elsevierCitationCount":"7"},{"title":"Pilot study investigating the effect of enteral and parenteral nutrition on the gastrointestinal microbiome post‐allogeneic transplantation","googleId":"dzaKc6-y-5EJ","googleLink":"https://onlinelibrary.wiley.com/doi/abs/10.1111/bjh.16218","googleCitationCount":12,"googleAuthor":"H Staudacher","doi":"10.1111/bjh.16218","elsevierAuthor":"Andersen S.","publicationName":"British Journal of Haematology","elsevierCoverDate":"2020-02-01","elsevierCoverDisplayDate":"1 February 2020","elsevierCitationCount":"8"},{"title":"How I treat children with haemophilia and inhibitors","googleId":"HDPE2q3jZksJ","googleLink":"https://onlinelibrary.wiley.com/doi/abs/10.1111/bjh.15942","googleCitationCount":16,"googleAuthor":"","doi":"10.1111/bjh.15942","elsevierAuthor":"Young G.","publicationName":"British Journal of Haematology","elsevierCoverDate":"2019-08-01","elsevierCoverDisplayDate":"August 2019","elsevierCitationCount":"11"},{"title":"New developments in von Willebrand disease","googleId":"vLbFf7swDSgJ","googleLink":"https://onlinelibrary.wiley.com/doi/abs/10.1111/bjh.16681","googleCitationCount":6,"googleAuthor":"H Fogarty","doi":"10.1111/bjh.16681","elsevierAuthor":"Fogarty H.","publicationName":"British Journal of Haematology","elsevierCoverDate":"2020-11-01","elsevierCoverDisplayDate":"1 November 2020","elsevierCitationCount":"4"},{"title":"Challenges in the management of patients with systemic light chain (AL) amyloidosis during the COVID‐19 pandemic","googleId":"mWvdwdI0qPcJ","googleLink":"https://onlinelibrary.wiley.com/doi/abs/10.1111/bjh.16898","googleCitationCount":6,"googleAuthor":"E Kastritis","doi":"10.1111/bjh.16898","elsevierAuthor":"Kastritis E.","publicationName":"British Journal of Haematology","elsevierCoverDate":"2020-08-01","elsevierCoverDisplayDate":"1 August 2020","elsevierCitationCount":"4"},{"title":"Reflection on passive immunotherapy in those who need most: some novel strategic arguments for obtaining safer therapeutic plasma or autologous antibodies from …","googleId":"mifnSjQtggIJ","googleLink":"https://onlinelibrary.wiley.com/doi/abs/10.1111/bjh.16814","googleCitationCount":12,"googleAuthor":"F Lanza","doi":"10.1111/bjh.16814","elsevierAuthor":"Lanza F.","publicationName":"British Journal of Haematology","elsevierCoverDate":"2020-07-01","elsevierCoverDisplayDate":"1 July 2020","elsevierCitationCount":"8"},{"title":"TARGET: a survey of real‐world management of chronic myeloid leukaemia across 33 countries","googleId":"hZskkjE3mBEJ","googleLink":"https://onlinelibrary.wiley.com/doi/abs/10.1111/bjh.16599","googleCitationCount":15,"googleAuthor":"V Mathews","doi":"10.1111/bjh.16599","elsevierAuthor":"Turkina A.","publicationName":"British Journal of Haematology","elsevierCoverDate":"2020-09-01","elsevierCoverDisplayDate":"1 September 2020","elsevierCitationCount":"7"},{"title":"Incidence, Risk Factors for and Outcomes of Transplant‐Associated Thrombotic Microangiopathy","googleId":"wLEf9VoKs6oJ","googleLink":"https://onlinelibrary.wiley.com/doi/abs/10.1111/bjh.16457","googleCitationCount":10,"googleAuthor":"N Epperla","doi":"10.1111/bjh.16457","elsevierAuthor":"Epperla N.","publicationName":"British Journal of Haematology","elsevierCoverDate":"2020-06-01","elsevierCoverDisplayDate":"1 June 2020","elsevierCitationCount":"5"},{"title":"Lenalidomide plus rituximab (R2) in previously untreated marginal zone lymphoma: subgroup analysis and long‐term follow‐up of an open‐label phase 2 trial","googleId":"nWGz5Smk-FcJ","googleLink":"https://onlinelibrary.wiley.com/doi/abs/10.1111/bjh.15843","googleCitationCount":14,"googleAuthor":"","doi":"10.1111/bjh.15843","elsevierAuthor":"Becnel M.R.","publicationName":"British Journal of Haematology","elsevierCoverDate":"2019-06-01","elsevierCoverDisplayDate":"June 2019","elsevierCitationCount":"13"},{"title":"How I manage children with Diamond‐Blackfan anaemia","googleId":"Dp3T8t5gzQ4J","googleLink":"https://onlinelibrary.wiley.com/doi/abs/10.1111/bjh.15701","googleCitationCount":16,"googleAuthor":"M Bierings","doi":"10.1111/bjh.15701","elsevierAuthor":"Bartels M.","publicationName":"British Journal of Haematology","elsevierCoverDate":"2019-01-01","elsevierCoverDisplayDate":"January 2019","elsevierCitationCount":"7"},{"title":"A novel simultaneous clot‐fibrinolysis waveform analysis for assessing fibrin formation and clot lysis in haemorrhagic disorders","googleId":"wGDyGkgGnCkJ","googleLink":"https://onlinelibrary.wiley.com/doi/abs/10.1111/bjh.16111","googleCitationCount":11,"googleAuthor":"","doi":"10.1111/bjh.16111","elsevierAuthor":"Nogami K.","publicationName":"British Journal of Haematology","elsevierCoverDate":"2019-11-01","elsevierCoverDisplayDate":"1 November 2019","elsevierCitationCount":"9"},{"title":"Advances in understanding the molecular mechanisms of venous thrombosis","googleId":"VcYrWC2nozUJ","googleLink":"https://onlinelibrary.wiley.com/doi/abs/10.1111/bjh.15869","googleCitationCount":13,"googleAuthor":"RJS Preston","doi":"10.1111/bjh.15869","elsevierAuthor":"Preston R.J.S.","publicationName":"British Journal of Haematology","elsevierCoverDate":"2019-07-01","elsevierCoverDisplayDate":"July 2019","elsevierCitationCount":"5"},{"title":"Concomitant haemorrhagic syndrome and recurrent extensive arterial thrombosis in a patient with COVID‐19 and acute promyelocytic leukaemia","googleId":"9XRYmEiba9gJ","googleLink":"https://onlinelibrary.wiley.com/doi/abs/10.1111/bjh.16768","googleCitationCount":9,"googleAuthor":"R Pop","doi":"10.1111/bjh.16768","elsevierAuthor":"Baldacini M.","publicationName":"British Journal of Haematology","elsevierCoverDate":"2020-06-01","elsevierCoverDisplayDate":"1 June 2020","elsevierCitationCount":"7"},{"title":"A left shift in the oxyhaemoglobin dissociation curve in patients with severe coronavirus disease 2019 (COVID‐19)","googleId":"PBG6qY6rESMJ","googleLink":"https://onlinelibrary.wiley.com/doi/abs/10.1111/bjh.17128","googleCitationCount":7,"googleAuthor":"F Formenti","doi":"10.1111/bjh.17128","elsevierAuthor":"Vogel D.J.","publicationName":"British Journal of Haematology","elsevierCoverDate":"2020-11-01","elsevierCoverDisplayDate":"1 November 2020","elsevierCitationCount":"5"},{"title":"Bone marrow characterization in sickle cell disease: inflammation and stress erythropoiesis lead to suboptimal CD34 recovery","googleId":"Fu6FQCFt0KkJ","googleLink":"https://onlinelibrary.wiley.com/doi/abs/10.1111/bjh.15902","googleCitationCount":13,"googleAuthor":"VM Dominical","doi":"10.1111/bjh.15902","elsevierAuthor":"Leonard A.","publicationName":"British Journal of Haematology","elsevierCoverDate":"2019-07-01","elsevierCoverDisplayDate":"July 2019","elsevierCitationCount":"7"},{"title":"Developing role of B cells in the pathogenesis and treatment of chronic GVHD","googleId":"ou9NVQKrkNMJ","googleLink":"https://onlinelibrary.wiley.com/doi/abs/10.1111/bjh.15719","googleCitationCount":16,"googleAuthor":"","doi":"10.1111/bjh.15719","elsevierAuthor":"Li X.","publicationName":"British Journal of Haematology","elsevierCoverDate":"2019-02-01","elsevierCoverDisplayDate":"Februaryy 2019","elsevierCitationCount":"9"},{"title":"Safety of switching from intravenous to subcutaneous rituximab during first‐line treatment of patients with non‐Hodgkin lymphoma: the Spanish population of the …","googleId":"rq1mo1gJBm8J","googleLink":"https://onlinelibrary.wiley.com/doi/abs/10.1111/bjh.16227","googleCitationCount":13,"googleAuthor":"","doi":"10.1111/bjh.16227","elsevierAuthor":"García-Muñoz R.","publicationName":"British Journal of Haematology","elsevierCoverDate":"2020-03-01","elsevierCoverDisplayDate":"1 March 2020","elsevierCitationCount":"6"},{"title":"Venetoclax and hypomethylating agents in TP53‐mutated acute myeloid leukaemia","googleId":"R7P2EJ8jCgsJ","googleLink":"https://onlinelibrary.wiley.com/doi/abs/10.1111/bjh.16166","googleCitationCount":13,"googleAuthor":"","doi":"10.1111/bjh.16166","elsevierAuthor":"Aldoss I.","publicationName":"British Journal of Haematology","elsevierCoverDate":"2019-10-01","elsevierCoverDisplayDate":"1 October 2019","elsevierCitationCount":"9"},{"title":"Comparison of MALDI‐TOF mass spectrometry analysis of peripheral blood and bone marrow‐based flow cytometry for tracking measurable residual disease in …","googleId":"iioxybjvh6UJ","googleLink":"https://onlinelibrary.wiley.com/doi/abs/10.1111/bjh.16443","googleCitationCount":11,"googleAuthor":"","doi":"10.1111/bjh.16443","elsevierAuthor":"Eveillard M.","publicationName":"British Journal of Haematology","elsevierCoverDate":"2020-06-01","elsevierCoverDisplayDate":"1 June 2020","elsevierCitationCount":"7"},{"title":"Clinical features, laboratory characteristics and outcomes of patients with renal versus cardiac light chain amyloidosis","googleId":"zgvnW5_x7WoJ","googleLink":"https://onlinelibrary.wiley.com/doi/abs/10.1111/bjh.15832","googleCitationCount":14,"googleAuthor":"S Sidana","doi":"10.1111/bjh.15832","elsevierAuthor":"Sidana S.","publicationName":"British Journal of Haematology","elsevierCoverDate":"2019-05-01","elsevierCoverDisplayDate":"May 2019","elsevierCitationCount":"7"},{"title":"Lymphoblastic lymphoma in children and adolescents: review of current challenges and future opportunities","googleId":"LbVoByk3EYUJ","googleLink":"https://onlinelibrary.wiley.com/doi/abs/10.1111/bjh.15793","googleCitationCount":15,"googleAuthor":"","doi":"10.1111/bjh.15793","elsevierAuthor":"Burkhardt B.","publicationName":"British Journal of Haematology","elsevierCoverDate":"2019-06-01","elsevierCoverDisplayDate":"June 2019","elsevierCitationCount":"9"},{"title":"Rapid screening of COVID‐19 patients using white blood cell scattergrams, a study on 381 patients","googleId":"WtqXyNBNlsgJ","googleLink":"https://onlinelibrary.wiley.com/doi/abs/10.1111/bjh.16943","googleCitationCount":7,"googleAuthor":"","doi":"10.1111/bjh.16943","elsevierAuthor":"Osman J.","publicationName":"British Journal of Haematology","elsevierCoverDate":"2020-09-01","elsevierCoverDisplayDate":"1 September 2020","elsevierCitationCount":"3"},{"title":"Thrombolysis restores perfusion in COVID‐19 hypoxia","googleId":"yQPtdAoJuXQJ","googleLink":"https://onlinelibrary.wiley.com/doi/abs/10.1111/bjh.17050","googleCitationCount":7,"googleAuthor":"","doi":"10.1111/bjh.17050","elsevierAuthor":"Arachchillage D.J.","publicationName":"British Journal of Haematology","elsevierCoverDate":"2020-09-01","elsevierCoverDisplayDate":"1 September 2020","elsevierCitationCount":"4"},{"title":"Carfilzomib is an effective upfront treatment in AL amyloidosis patients with peripheral and autonomic neuropathy","googleId":"ODEQOcplZKEJ","googleLink":"https://onlinelibrary.wiley.com/doi/abs/10.1111/bjh.16122","googleCitationCount":14,"googleAuthor":"","doi":"10.1111/bjh.16122","elsevierAuthor":"Manwani R.","publicationName":"British Journal of Haematology","elsevierCoverDate":"2019-12-01","elsevierCoverDisplayDate":"1 December 2019","elsevierCitationCount":"11"},{"title":"The proportion of patients with thrombocytopenia in three human-susceptible coronavirus infections: a systematic review and meta-analysis","googleId":"REg9Zr4_oxkJ","googleLink":"https://pubmed.ncbi.nlm.nih.gov/32285448/","googleCitationCount":9,"googleAuthor":"","doi":"10.1111/bjh.16655,","elsevierAuthor":"Zhou M.","publicationName":"British Journal of Haematology","elsevierCoverDate":"2020-05-01","elsevierCoverDisplayDate":"1 May 2020","elsevierCitationCount":"7"},{"title":"Outcome of a patient with refractory Hodgkin lymphoma on pembrolizumab, infected with SARS‐CoV‐2","googleId":"r3DMnb_ltFAJ","googleLink":"https://onlinelibrary.wiley.com/doi/abs/10.1111/bjh.16798","googleCitationCount":10,"googleAuthor":"","doi":"10.1111/bjh.16798","elsevierAuthor":"O'Kelly B.","publicationName":"British Journal of Haematology","elsevierCoverDate":"2020-07-01","elsevierCoverDisplayDate":"1 July 2020","elsevierCitationCount":"5"},{"title":"Atypical lymphocytes in peripheral blood of patients with COVID‐19","googleId":"aEMbT_bLBGkJ","googleLink":"https://onlinelibrary.wiley.com/doi/abs/10.1111/bjh.16848","googleCitationCount":8,"googleAuthor":"SE Weinberg","doi":"10.1111/bjh.16848","elsevierAuthor":"Weinberg S.E.","publicationName":"British Journal of Haematology","elsevierCoverDate":"2020-07-01","elsevierCoverDisplayDate":"1 July 2020","elsevierCitationCount":"7"},{"title":"Convalescent plasma for persisting Covid‐19 following therapeutic lymphocyte depletion: a report of rapid recovery","googleId":"QciwOTlYAAMJ","googleLink":"https://onlinelibrary.wiley.com/doi/abs/10.1111/bjh.16981","googleCitationCount":14,"googleAuthor":"E Clark","doi":"10.1111/bjh.16981","elsevierAuthor":"Clark E.","publicationName":"British Journal of Haematology","elsevierCoverDate":"2020-08-01","elsevierCoverDisplayDate":"1 August 2020","elsevierCitationCount":"4"},{"title":"Daratumumab in high‐risk relapsed/refractory multiple myeloma patients: adverse effect of chromosome 1q21 gain/amplification and GEP70 status on outcome","googleId":"2Kmu3ezRPwQJ","googleLink":"https://onlinelibrary.wiley.com/doi/abs/10.1111/bjh.16292","googleCitationCount":8,"googleAuthor":"M Mohan","doi":"10.1111/bjh.16292","elsevierAuthor":"Mohan M.","publicationName":"British Journal of Haematology","elsevierCoverDate":"2020-04-01","elsevierCoverDisplayDate":"1 April 2020","elsevierCitationCount":"5"},{"title":"How I manage patients with Wiskott Aldrich syndrome","googleId":"yT8O409qjF8J","googleLink":"https://onlinelibrary.wiley.com/doi/abs/10.1111/bjh.15831","googleCitationCount":15,"googleAuthor":"A Worth","doi":"10.1111/bjh.15831","elsevierAuthor":"Rivers E.","publicationName":"British Journal of Haematology","elsevierCoverDate":"2019-05-01","elsevierCoverDisplayDate":"May 2019","elsevierCitationCount":"7"},{"title":"Risk of molecular recurrence after tyrosine kinase inhibitor discontinuation in chronic myeloid leukaemia patients: a systematic review of literature with a meta …","googleId":"JYN-2uhpLAwJ","googleLink":"https://onlinelibrary.wiley.com/doi/abs/10.1111/bjh.16408","googleCitationCount":7,"googleAuthor":"","doi":"10.1111/bjh.16408","elsevierAuthor":"Dulucq S.","publicationName":"British Journal of Haematology","elsevierCoverDate":"2020-05-01","elsevierCoverDisplayDate":"1 May 2020","elsevierCitationCount":"4"},{"title":"Curative options for sickle cell disease: haploidentical stem cell transplantation or gene therapy?","googleId":"s_b9zE2Ap14J","googleLink":"https://onlinelibrary.wiley.com/doi/abs/10.1111/bjh.16437","googleCitationCount":8,"googleAuthor":"","doi":"10.1111/bjh.16437","elsevierAuthor":"Leonard A.","publicationName":"British Journal of Haematology","elsevierCoverDate":"2020-05-01","elsevierCoverDisplayDate":"1 May 2020","elsevierCitationCount":"7"},{"title":"How we manage adults with myelodysplastic syndrome","googleId":"x_8aXB_3cAwJ","googleLink":"https://onlinelibrary.wiley.com/doi/abs/10.1111/bjh.16206","googleCitationCount":12,"googleAuthor":"","doi":"10.1111/bjh.16206","elsevierAuthor":"Fenaux P.","publicationName":"British Journal of Haematology","elsevierCoverDate":"2020-06-01","elsevierCoverDisplayDate":"1 June 2020","elsevierCitationCount":"6"},{"title":"Efficacy and safety of prothrombin complex concentrate in patients treated with rivaroxaban or apixaban compared to warfarin presenting with major bleeding","googleId":"S5XUwpt-L0oJ","googleLink":"https://onlinelibrary.wiley.com/doi/abs/10.1111/bjh.15705","googleCitationCount":17,"googleAuthor":"","doi":"10.1111/bjh.15705","elsevierAuthor":"Arachchillage D.R.J.","publicationName":"British Journal of Haematology","elsevierCoverDate":"2019-03-01","elsevierCoverDisplayDate":"March 2019","elsevierCitationCount":"14"},{"title":"Phosphoglycerate dehydrogenase promotes proliferation and bortezomib resistance through increasing reduced glutathione synthesis in multiple myeloma","googleId":"V_oYANzurakJ","googleLink":"https://onlinelibrary.wiley.com/doi/abs/10.1111/bjh.16503","googleCitationCount":8,"googleAuthor":"","doi":"10.1111/bjh.16503","elsevierAuthor":"Wu X.","publicationName":"British Journal of Haematology","elsevierCoverDate":"2020-07-01","elsevierCoverDisplayDate":"1 July 2020","elsevierCitationCount":"5"},{"title":"Progress in the monitoring of direct oral anticoagulant therapy","googleId":"p1xKk7m7mHsJ","googleLink":"https://onlinelibrary.wiley.com/doi/abs/10.1111/bjh.15756","googleCitationCount":15,"googleAuthor":"JP Patel","doi":"10.1111/bjh.15756","elsevierAuthor":"Patel J.P.","publicationName":"British Journal of Haematology","elsevierCoverDate":"2019-03-01","elsevierCoverDisplayDate":"March 2019","elsevierCitationCount":"11"},{"title":"Longer treatment duration and history of osteoarticular symptoms predispose to tyrosine kinase inhibitor withdrawal syndrome","googleId":"CQnxJBt3igkJ","googleLink":"https://onlinelibrary.wiley.com/doi/abs/10.1111/bjh.16083","googleCitationCount":12,"googleAuthor":"P Rousselot","doi":"10.1111/bjh.16083","elsevierAuthor":"Berger M.G.","publicationName":"British Journal of Haematology","elsevierCoverDate":"2019-11-01","elsevierCoverDisplayDate":"1 November 2019","elsevierCitationCount":"11"},{"title":"COVID‐19 comorbidities, associated procoagulant extracellular vesicles and venous thromboembolisms: a possible link with ethnicity?","googleId":"aKpr-fhgjToJ","googleLink":"https://onlinelibrary.wiley.com/doi/abs/10.1111/bjh.17011","googleCitationCount":6,"googleAuthor":"J Inal","doi":"10.1111/bjh.17011","elsevierAuthor":"Inal J.","publicationName":"British Journal of Haematology","elsevierCoverDate":"2020-08-01","elsevierCoverDisplayDate":"1 August 2020","elsevierCitationCount":"4"},{"title":"Covid‐19 in bone marrow transplant recipients: reflecting on a single centre experience","googleId":"D1KiIXS6l-gJ","googleLink":"https://onlinelibrary.wiley.com/doi/abs/10.1111/bjh.16856","googleCitationCount":11,"googleAuthor":"","doi":"10.1111/bjh.16856","elsevierAuthor":"Kanellopoulos A.","publicationName":"British Journal of Haematology","elsevierCoverDate":"2020-07-01","elsevierCoverDisplayDate":"1 July 2020","elsevierCitationCount":"4"},{"title":"Minimal residual disease monitoring in early stage follicular lymphoma can predict prognosis and drive treatment with rituximab after radiotherapy","googleId":"ohvBucJpVsUJ","googleLink":"https://onlinelibrary.wiley.com/doi/abs/10.1111/bjh.16125","googleCitationCount":10,"googleAuthor":"A Pulsoni","doi":"10.1111/bjh.16125","elsevierAuthor":"Pulsoni A.","publicationName":"British Journal of Haematology","elsevierCoverDate":"2020-01-01","elsevierCoverDisplayDate":"1 January 2020","elsevierCitationCount":"8"},{"title":"Successful treatment‐free remission in chronic myeloid leukaemia and its association with reduced immune suppressors and increased natural killer cells","googleId":"wOvMtTH0vGYJ","googleLink":"https://onlinelibrary.wiley.com/doi/abs/10.1111/bjh.16718","googleCitationCount":8,"googleAuthor":"YD Irani","doi":"10.1111/bjh.16718","elsevierAuthor":"Irani Y.D.","publicationName":"British Journal of Haematology","elsevierCoverDate":"2020-11-01","elsevierCoverDisplayDate":"1 November 2020","elsevierCitationCount":"2"},{"title":"Allodepleted T‐cell immunotherapy after haploidentical haematopoietic stem cell transplantation without severe acute graft‐versus‐host disease (GVHD) in the …","googleId":"KHvm1kqWYLkJ","googleLink":"https://onlinelibrary.wiley.com/doi/abs/10.1111/bjh.15970","googleCitationCount":14,"googleAuthor":"DC Roy","doi":"10.1111/bjh.15970","elsevierAuthor":"Roy D.C.","publicationName":"British Journal of Haematology","elsevierCoverDate":"2019-01-01","elsevierCoverDisplayDate":"2019","elsevierCitationCount":"11"},{"title":"The treatment of older Hodgkin lymphoma patients","googleId":"KCyO48EdYjoJ","googleLink":"https://onlinelibrary.wiley.com/doi/abs/10.1111/bjh.15652","googleCitationCount":16,"googleAuthor":"","doi":"10.1111/bjh.15652","elsevierAuthor":"Böll B.","publicationName":"British Journal of Haematology","elsevierCoverDate":"2019-01-01","elsevierCoverDisplayDate":"January 2019","elsevierCitationCount":"6"},{"title":"Fatigue in children and adolescents with immune thrombocytopenia","googleId":"xJ1f7uJOPdIJ","googleLink":"https://onlinelibrary.wiley.com/doi/abs/10.1111/bjh.16751","googleCitationCount":5,"googleAuthor":"RJ Klaassen","doi":"10.1111/bjh.16751","elsevierAuthor":"Grace R.F.","publicationName":"British Journal of Haematology","elsevierCoverDate":"2020-10-01","elsevierCoverDisplayDate":"1 October 2020","elsevierCitationCount":"4"},{"title":"Secondary HLH is uncommon in severe COVID‐19","googleId":"K70RJInLH9sJ","googleLink":"https://onlinelibrary.wiley.com/doi/abs/10.1111/bjh.16934","googleCitationCount":10,"googleAuthor":"","doi":"10.1111/bjh.16934","elsevierAuthor":"Wood H.","publicationName":"British Journal of Haematology","elsevierCoverDate":"2020-09-01","elsevierCoverDisplayDate":"1 September 2020","elsevierCitationCount":"9"},{"title":"Prognostic implications of the microenvironment for follicular lymphoma under immunomodulation therapy","googleId":"QDmv-ywoztUJ","googleLink":"https://onlinelibrary.wiley.com/doi/abs/10.1111/bjh.16414","googleCitationCount":5,"googleAuthor":"A Tzankov","doi":"10.1111/bjh.16414","elsevierAuthor":"Menter T.","publicationName":"British Journal of Haematology","elsevierCoverDate":"2020-05-01","elsevierCoverDisplayDate":"1 May 2020","elsevierCitationCount":"4"},{"title":"Combined IL‐6 and JAK/STAT inhibition therapy in COVID‐19‐related sHLH, potential game changer","googleId":"4w6zXz9hmEIJ","googleLink":"https://onlinelibrary.wiley.com/doi/abs/10.1111/bjh.16966","googleCitationCount":8,"googleAuthor":"","doi":"10.1111/bjh.16966","elsevierAuthor":"Portsmore S.","publicationName":"British Journal of Haematology","elsevierCoverDate":"2020-08-01","elsevierCoverDisplayDate":"1 August 2020","elsevierCitationCount":"4"},{"title":"Philadelphia‐positive acute lymphoblastic leukaemia (ALL) in Italy during the COVID‐19 pandemic: a Campus ALL study","googleId":"yJm7-NrS3DkJ","googleLink":"https://onlinelibrary.wiley.com/doi/abs/10.1111/bjh.16758","googleCitationCount":8,"googleAuthor":"A Curti","doi":"10.1111/bjh.16758","elsevierAuthor":"Foà R.","publicationName":"British Journal of Haematology","elsevierCoverDate":"2020-07-01","elsevierCoverDisplayDate":"1 July 2020","elsevierCitationCount":"9"},{"title":"Acute myeloid leukaemia and the immune system: implications for immunotherapy","googleId":"8ViT_zPpId8J","googleLink":"https://onlinelibrary.wiley.com/doi/abs/10.1111/bjh.16310","googleCitationCount":8,"googleAuthor":"AJ Barrett","doi":"10.1111/bjh.16310","elsevierAuthor":"Barrett A.J.","publicationName":"British Journal of Haematology","elsevierCoverDate":"2020-01-01","elsevierCoverDisplayDate":"1 January 2020","elsevierCitationCount":"6"},{"title":"Platelet biology of the rapidly failing lung","googleId":"yrLcrBBx550J","googleLink":"https://onlinelibrary.wiley.com/doi/abs/10.1111/bjh.16315","googleCitationCount":10,"googleAuthor":"","doi":"10.1111/bjh.16315","elsevierAuthor":"Washington A.V.","publicationName":"British Journal of Haematology","elsevierCoverDate":"2020-03-01","elsevierCoverDisplayDate":"1 March 2020","elsevierCitationCount":"7"},{"title":"Advances in knowledge of inhibitor formation in severe haemophilia A","googleId":"Jwu6OPl9Sy4J","googleLink":"https://onlinelibrary.wiley.com/doi/abs/10.1111/bjh.16377","googleCitationCount":6,"googleAuthor":"","doi":"10.1111/bjh.16377","elsevierAuthor":"Cormier M.","publicationName":"British Journal of Haematology","elsevierCoverDate":"2020-04-01","elsevierCoverDisplayDate":"1 April 2020","elsevierCitationCount":"4"},{"title":"Early experience using salvage radiotherapy for relapsed/refractory non‐Hodgkin lymphomas after CD19 chimeric antigen receptor (CAR) T cell therapy","googleId":"3o3wtyEipkUJ","googleLink":"https://onlinelibrary.wiley.com/doi/abs/10.1111/bjh.16541","googleCitationCount":6,"googleAuthor":"BS Imber","doi":"10.1111/bjh.16541","elsevierAuthor":"Imber B.S.","publicationName":"British Journal of Haematology","elsevierCoverDate":"2020-07-01","elsevierCoverDisplayDate":"1 July 2020","elsevierCitationCount":"6"},{"title":"Prognostic value of indoleamine 2, 3 dioxygenase in patients with higher‐risk myelodysplastic syndromes treated with azacytidine","googleId":"XQ3WVwuHMwMJ","googleLink":"https://onlinelibrary.wiley.com/doi/abs/10.1111/bjh.16652","googleCitationCount":4,"googleAuthor":"","doi":"10.1111/bjh.16652","elsevierAuthor":"Müller-Thomas C.","publicationName":"British Journal of Haematology","elsevierCoverDate":"2020-08-01","elsevierCoverDisplayDate":"1 August 2020","elsevierCitationCount":"2"},{"title":"Maintenance rituximab or observation after frontline treatment with bendamustine‐rituximab for follicular lymphoma","googleId":"3kPJwvAzbyUJ","googleLink":"https://onlinelibrary.wiley.com/doi/abs/10.1111/bjh.15720","googleCitationCount":15,"googleAuthor":"","doi":"10.1111/bjh.15720","elsevierAuthor":"Hill B.","publicationName":"British Journal of Haematology","elsevierCoverDate":"2019-02-01","elsevierCoverDisplayDate":"Februaryy 2019","elsevierCitationCount":"10"},{"title":"Response‐adapted therapy for the treatment of children with newly diagnosed high risk Hodgkin lymphoma (AHOD0831): a report from the Children's Oncology Group","googleId":"QTSDVfQwm0cJ","googleLink":"https://onlinelibrary.wiley.com/doi/abs/10.1111/bjh.16014","googleCitationCount":11,"googleAuthor":"PD Cole","doi":"10.1111/bjh.16014","elsevierAuthor":"Kelly K.M.","publicationName":"British Journal of Haematology","elsevierCoverDate":"2019-10-01","elsevierCoverDisplayDate":"1 October 2019","elsevierCitationCount":"5"},{"title":"Novel therapeutic agents for relapsed classical Hodgkin lymphoma","googleId":"og6xvfEMeEIJ","googleLink":"https://onlinelibrary.wiley.com/doi/abs/10.1111/bjh.15695","googleCitationCount":15,"googleAuthor":"","doi":"10.1111/bjh.15695","elsevierAuthor":"von Keudell G.","publicationName":"British Journal of Haematology","elsevierCoverDate":"2019-01-01","elsevierCoverDisplayDate":"January 2019","elsevierCitationCount":"11"},{"title":"How we manage haemostasis during sepsis","googleId":"Vd0oSGwQBvIJ","googleLink":"https://onlinelibrary.wiley.com/doi/abs/10.1111/bjh.15821","googleCitationCount":12,"googleAuthor":"M Levi","doi":"10.1111/bjh.15821","elsevierAuthor":"Scully M.","publicationName":"British Journal of Haematology","elsevierCoverDate":"2019-04-01","elsevierCoverDisplayDate":"April 2019","elsevierCitationCount":"9"},{"title":"Checkpoint blockade treatment sensitises relapsed/refractory non‐Hodgkin lymphoma to subsequent therapy","googleId":"AAu6HWwYc7UJ","googleLink":"https://onlinelibrary.wiley.com/doi/abs/10.1111/bjh.16756","googleCitationCount":5,"googleAuthor":"","doi":"10.1111/bjh.16756","elsevierAuthor":"Carreau N.A.","publicationName":"British Journal of Haematology","elsevierCoverDate":"2020-10-01","elsevierCoverDisplayDate":"1 October 2020","elsevierCitationCount":"5"},{"title":"SIRT3 deacetylase activity confers chemoresistance in AML via regulation of mitochondrial oxidative phosphorylation","googleId":"XTs33tklL8oJ","googleLink":"https://onlinelibrary.wiley.com/doi/abs/10.1111/bjh.16044","googleCitationCount":9,"googleAuthor":"","doi":"10.1111/bjh.16044","elsevierAuthor":"","publicationName":"British Journal of Haematology","elsevierCoverDate":"2020-02-01","elsevierCoverDisplayDate":"1 February 2020","elsevierCitationCount":"0"},{"title":"Ruxolitinib for tocilizumab‐refractory severe COVID‐19 infection","googleId":"jVMU4lUm9P4J","googleLink":"https://onlinelibrary.wiley.com/doi/abs/10.1111/bjh.16979","googleCitationCount":9,"googleAuthor":"LB Cook","doi":"10.1111/bjh.16979","elsevierAuthor":"Innes A.J.","publicationName":"British Journal of Haematology","elsevierCoverDate":"2020-08-01","elsevierCoverDisplayDate":"1 August 2020","elsevierCitationCount":"5"},{"title":"Composite and sequential lymphoma between classical Hodgkin lymphoma and primary mediastinal lymphoma/diffuse large B‐cell lymphoma, a clinico‐pathological …","googleId":"lHUMvQOxtQwJ","googleLink":"https://onlinelibrary.wiley.com/doi/abs/10.1111/bjh.16331","googleCitationCount":5,"googleAuthor":"","doi":"10.1111/bjh.16331","elsevierAuthor":"Aussedat G.","publicationName":"British Journal of Haematology","elsevierCoverDate":"2020-04-01","elsevierCoverDisplayDate":"1 April 2020","elsevierCitationCount":"3"},{"title":"Routine sequencing in CLL has prognostic implications and provides new insight into pathogenesis and targeted treatments","googleId":"avgUWlKVZCoJ","googleLink":"https://onlinelibrary.wiley.com/doi/abs/10.1111/bjh.15877","googleCitationCount":10,"googleAuthor":"","doi":"10.1111/bjh.15877","elsevierAuthor":"Hu B.","publicationName":"British Journal of Haematology","elsevierCoverDate":"2019-06-01","elsevierCoverDisplayDate":"June 2019","elsevierCitationCount":"7"},{"title":"New prognosis score including absolute lymphocyte/monocyte ratio, red blood cell distribution width and beta‐2 microglobulin in patients with diffuse large B‐cell …","googleId":"Ru2LzApUqhQJ","googleLink":"https://onlinelibrary.wiley.com/doi/abs/10.1111/bjh.16263","googleCitationCount":8,"googleAuthor":"A Díaz‐López","doi":"10.1111/bjh.16263","elsevierAuthor":"Bento L.","publicationName":"British Journal of Haematology","elsevierCoverDate":"2020-03-01","elsevierCoverDisplayDate":"1 March 2020","elsevierCitationCount":"5"},{"title":"Haemophagocytosis in bone marrow aspirates in patients with COVID‐19","googleId":"tv06qH5UCMYJ","googleLink":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7307071/","googleCitationCount":8,"googleAuthor":"","doi":"10.1111/bjh.16860","elsevierAuthor":"Debliquis A.","publicationName":"British Journal of Haematology","elsevierCoverDate":"2020-07-01","elsevierCoverDisplayDate":"1 July 2020","elsevierCitationCount":"4"},{"title":"JAK1/2 pathway inhibition suppresses M2 polarization and overcomes resistance of myeloma to lenalidomide by reducing TRIB1, MUC1, CD44, CXCL12, and …","googleId":"UK8YMmiEQP4J","googleLink":"https://onlinelibrary.wiley.com/doi/abs/10.1111/bjh.16158","googleCitationCount":9,"googleAuthor":"H Chen","doi":"10.1111/bjh.16158","elsevierAuthor":"Chen H.","publicationName":"British Journal of Haematology","elsevierCoverDate":"2020-01-01","elsevierCoverDisplayDate":"1 January 2020","elsevierCitationCount":"8"},{"title":"Phase 1b trial of pembrolizumab monotherapy for relapsed/refractory multiple myeloma: KEYNOTE-013","googleId":"U-Xrgu3VKYwJ","googleLink":"https://pubmed.ncbi.nlm.nih.gov/30937889/?from_term=Posada+J&from_pos=5","googleCitationCount":18,"googleAuthor":"","doi":"10.1111/bjh.15888,","elsevierAuthor":"Ribrag V.","publicationName":"British Journal of Haematology","elsevierCoverDate":"2019-08-01","elsevierCoverDisplayDate":"August 2019","elsevierCitationCount":"15"},{"title":"Convalescent donor SARS‐COV‐2‐specific cytotoxic T lymphocyte infusion as a possible treatment option for COVID‐19 patients with severe disease has not …","googleId":"7cnYDY0RSYUJ","googleLink":"https://onlinelibrary.wiley.com/doi/abs/10.1111/bjh.16780","googleCitationCount":7,"googleAuthor":"","doi":"10.1111/bjh.16780","elsevierAuthor":"Hanley B.","publicationName":"British Journal of Haematology","elsevierCoverDate":"2020-06-01","elsevierCoverDisplayDate":"1 June 2020","elsevierCitationCount":"4"},{"title":"A diagnostic solution for haemostasis laboratories for patients taking direct oral anticoagulants using DOAC‐Remove","googleId":"shHAyeMjNbcJ","googleLink":"https://onlinelibrary.wiley.com/doi/abs/10.1111/bjh.16091","googleCitationCount":11,"googleAuthor":"S MacDonald","doi":"10.1111/bjh.16091","elsevierAuthor":"Cox-Morton S.","publicationName":"British Journal of Haematology","elsevierCoverDate":"2019-11-01","elsevierCoverDisplayDate":"1 November 2019","elsevierCitationCount":"10"},{"title":"Safety and efficacy of apixaban for routine thromboprophylaxis in myeloma patients treated with thalidomide‐and lenalidomide‐containing regimens","googleId":"x7w3vw5gJUEJ","googleLink":"https://onlinelibrary.wiley.com/doi/abs/10.1111/bjh.15392?af=R","googleCitationCount":20,"googleAuthor":"","doi":"10.1111/bjh.15392","elsevierAuthor":"Storrar N.P.F.","publicationName":"British Journal of Haematology","elsevierCoverDate":"2019-04-01","elsevierCoverDisplayDate":"April 2019","elsevierCitationCount":"13"},{"title":"Deferasirox reduces oxidative DNA damage in bone marrow cells from myelodysplastic patients and improves their differentiation capacity","googleId":"9fuqcShBCmoJ","googleLink":"https://onlinelibrary.wiley.com/doi/abs/10.1111/bjh.16013","googleCitationCount":11,"googleAuthor":"","doi":"10.1111/bjh.16013","elsevierAuthor":"Jiménez-Solas T.","publicationName":"British Journal of Haematology","elsevierCoverDate":"2019-10-01","elsevierCoverDisplayDate":"1 October 2019","elsevierCitationCount":"7"},{"title":"Utilizing a PLASMIC score‐based approach in the management of suspected immune thrombotic thrombocytopenic purpura: a cost minimization analysis within the …","googleId":"oNcS9U4nu3UJ","googleLink":"https://onlinelibrary.wiley.com/doi/abs/10.1111/bjh.15932","googleCitationCount":11,"googleAuthor":"BP Geisler","doi":"10.1111/bjh.15932","elsevierAuthor":"Upadhyay V.A.","publicationName":"British Journal of Haematology","elsevierCoverDate":"2019-08-01","elsevierCoverDisplayDate":"August 2019","elsevierCitationCount":"7"},{"title":"Haemophagocytic lymphohistiocytosis has variable time to onset following CD19 chimeric antigen receptor T cell therapy","googleId":"UKi9aJQ-G_cJ","googleLink":"https://onlinelibrary.wiley.com/doi/abs/10.1111/bjh.16155","googleCitationCount":11,"googleAuthor":"","doi":"10.1111/bjh.16155","elsevierAuthor":"Hashmi H.","publicationName":"British Journal of Haematology","elsevierCoverDate":"2019-10-01","elsevierCoverDisplayDate":"1 October 2019","elsevierCitationCount":"8"},{"title":"Varying presentations and favourable outcomes of COVID‐19 infection in children and young adults with sickle cell disease: an additional case series with …","googleId":"jvuZoN9F_tYJ","googleLink":"https://onlinelibrary.wiley.com/doi/abs/10.1111/bjh.17013","googleCitationCount":5,"googleAuthor":"","doi":"10.1111/bjh.17013","elsevierAuthor":"Appiah-Kubi A.","publicationName":"British Journal of Haematology","elsevierCoverDate":"2020-08-01","elsevierCoverDisplayDate":"1 August 2020","elsevierCitationCount":"3"},{"title":"Novel exomic rare variants associated with venous thrombosis","googleId":"t8Kyreybd_cJ","googleLink":"https://onlinelibrary.wiley.com/doi/abs/10.1111/bjh.16613","googleCitationCount":6,"googleAuthor":"","doi":"10.1111/bjh.16613","elsevierAuthor":"Deguchi H.","publicationName":"British Journal of Haematology","elsevierCoverDate":"2020-09-01","elsevierCoverDisplayDate":"1 September 2020","elsevierCitationCount":"2"},{"title":"Efficacy and safety of humanized anti‐CD19‐CAR‐T therapy following intensive lymphodepleting chemotherapy for refractory/relapsed B acute lymphoblastic …","googleId":"8FPxVgEoBhwJ","googleLink":"https://onlinelibrary.wiley.com/doi/abs/10.1111/bjh.16623","googleCitationCount":8,"googleAuthor":"","doi":"10.1111/bjh.16623","elsevierAuthor":"Wang J.","publicationName":"British Journal of Haematology","elsevierCoverDate":"2020-10-01","elsevierCoverDisplayDate":"1 October 2020","elsevierCitationCount":"4"},{"title":"Platelet and immune characteristics of immune thrombocytopaenia patients non‐responsive to therapy reveal severe immune dysregulation","googleId":"KKOKDJt8yFEJ","googleLink":"https://onlinelibrary.wiley.com/doi/abs/10.1111/bjh.16459","googleCitationCount":6,"googleAuthor":"","doi":"10.1111/bjh.16459","elsevierAuthor":"Monzón Manzano E.","publicationName":"British Journal of Haematology","elsevierCoverDate":"2020-06-01","elsevierCoverDisplayDate":"1 June 2020","elsevierCitationCount":"5"},{"title":"How I manage severe von Willebrand disease","googleId":"uYjfDmcHJX4J","googleLink":"https://onlinelibrary.wiley.com/doi/abs/10.1111/bjh.16186","googleCitationCount":10,"googleAuthor":"FWG Leebeek","doi":"10.1111/bjh.16186","elsevierAuthor":"Leebeek F.W.G.","publicationName":"British Journal of Haematology","elsevierCoverDate":"2019-11-01","elsevierCoverDisplayDate":"1 November 2019","elsevierCitationCount":"6"},{"title":"Targeted therapy paves the way for the cure of acute lymphoblastic leukaemia","googleId":"zRcqupDmydsJ","googleLink":"https://onlinelibrary.wiley.com/doi/abs/10.1111/bjh.16207","googleCitationCount":6,"googleAuthor":"H Rafei","doi":"10.1111/bjh.16207","elsevierAuthor":"Rafei H.","publicationName":"British Journal of Haematology","elsevierCoverDate":"2020-01-01","elsevierCoverDisplayDate":"1 January 2020","elsevierCitationCount":"7"},{"title":"Guidelines on the use of prophylactic factor replacement for children and adults with Haemophilia A and B","googleId":"RPHRKWOfAKgJ","googleLink":"http://www.ukhcdo.org/wp-content/uploads/2020/10/Guidelines-on-the-use-of-prophylactic-factor-replacement-for-children-and-adults-with-Haemophilia-A-and-B.-A-British-Society-for-Haematology-Guideline..pdf","googleCitationCount":5,"googleAuthor":""},{"title":"Minimal relapse risk and early normalization of survival for patients with Burkitt lymphoma treated with intensive immunochemotherapy: an international study of 264 …","googleId":"bboafGlqUVAJ","googleLink":"https://onlinelibrary.wiley.com/doi/abs/10.1111/bjh.16425","googleCitationCount":6,"googleAuthor":"LH Jakobsen","doi":"10.1111/bjh.16425","elsevierAuthor":"Jakobsen L.H.","publicationName":"British Journal of Haematology","elsevierCoverDate":"2020-05-01","elsevierCoverDisplayDate":"1 May 2020","elsevierCitationCount":"3"},{"title":"Risk of invasive pneumococcal disease in children with sickle cell disease in the era of conjugate vaccines: a systematic review of the literature","googleId":"XfcJSyYPZHAJ","googleLink":"https://onlinelibrary.wiley.com/doi/abs/10.1111/bjh.15846","googleCitationCount":10,"googleAuthor":"M Fallaha","doi":"10.1111/bjh.15846","elsevierAuthor":"Oligbu G.","publicationName":"British Journal of Haematology","elsevierCoverDate":"2019-05-01","elsevierCoverDisplayDate":"May 2019","elsevierCitationCount":"3"},{"title":"How we manage Bing–Neel syndrome","googleId":"EMhG_luSyfcJ","googleLink":"https://onlinelibrary.wiley.com/doi/abs/10.1111/bjh.16167","googleCitationCount":8,"googleAuthor":"JJ Castillo","doi":"10.1111/bjh.16167","elsevierAuthor":"Castillo J.J.","publicationName":"British Journal of Haematology","elsevierCoverDate":"2019-11-01","elsevierCoverDisplayDate":"1 November 2019","elsevierCitationCount":"5"},{"title":"The long and winding road to pathogen reduction of platelets, red blood cells and whole blood","googleId":"RUvYUUi0TiMJ","googleLink":"https://onlinelibrary.wiley.com/doi/abs/10.1111/bjh.16093","googleCitationCount":10,"googleAuthor":"P Rebulla","doi":"10.1111/bjh.16093","elsevierAuthor":"Rebulla P.","publicationName":"British Journal of Haematology","elsevierCoverDate":"2019-01-01","elsevierCoverDisplayDate":"2019","elsevierCitationCount":"7"},{"title":"Predictors of response to anti‐IL 6 monoclonal antibody therapy (siltuximab) in idiopathic multicentric Castleman disease: secondary analyses of phase II clinical trial …","googleId":"oAhqspMV5I0J","googleLink":"https://onlinelibrary.wiley.com/doi/abs/10.1111/bjh.15588","googleCitationCount":14,"googleAuthor":"DE Morra","doi":"10.1111/bjh.15588","elsevierAuthor":"Morra D.","publicationName":"British Journal of Haematology","elsevierCoverDate":"2019-01-01","elsevierCoverDisplayDate":"January 2019","elsevierCitationCount":"9"},{"title":"Guidelines on the use of irradiated blood components","googleId":"3uuwoHGGfi4J","googleLink":"http://medi-guide.meditool.cn/ymtpdf/92D57D3A-D529-9CBF-7037-4997F517C0D3.pdf","googleCitationCount":4,"googleAuthor":""},{"title":"Pomalidomide plus low‐dose dexamethasone in relapsed refractory multiple myeloma after lenalidomide treatment failure","googleId":"j1cwC7ncljkJ","googleLink":"https://onlinelibrary.wiley.com/doi/abs/10.1111/bjh.16213","googleCitationCount":10,"googleAuthor":"DS Siegel","doi":"10.1111/bjh.16213","elsevierAuthor":"Siegel D.S.","publicationName":"British Journal of Haematology","elsevierCoverDate":"2020-02-01","elsevierCoverDisplayDate":"1 February 2020","elsevierCitationCount":"5"},{"title":"Treatment and outcome of Unicentric Castleman disease: a retrospective analysis of 71 cases","googleId":"RXLn8Tf2VAkJ","googleLink":"https://onlinelibrary.wiley.com/doi/abs/10.1111/bjh.15921","googleCitationCount":11,"googleAuthor":"","doi":"10.1111/bjh.15921","elsevierAuthor":"Boutboul D.","publicationName":"British Journal of Haematology","elsevierCoverDate":"2019-07-01","elsevierCoverDisplayDate":"July 2019","elsevierCitationCount":"6"},{"title":"Daratumumab is effective in the relapsed or refractory systemic light‐chain amyloidosis but associated with high infection burden in a frail real‐life population","googleId":"NnnU0CHxqrwJ","googleLink":"https://onlinelibrary.wiley.com/doi/abs/10.1111/bjh.16282","googleCitationCount":9,"googleAuthor":"","doi":"10.1111/bjh.16282","elsevierAuthor":"Van de Wyngaert Z.","publicationName":"British Journal of Haematology","elsevierCoverDate":"2020-02-01","elsevierCoverDisplayDate":"1 February 2020","elsevierCitationCount":"7"},{"title":"Direct‐acting antiviral agents for hepatitis C virus‐mixed cryoglobulinaemia: dissociated virological and haematological responses","googleId":"F2LwYCZGt_4J","googleLink":"https://onlinelibrary.wiley.com/doi/abs/10.1111/bjh.17036","googleCitationCount":3,"googleAuthor":"","doi":"10.1111/bjh.17036","elsevierAuthor":"Pozzato G.","publicationName":"British Journal of Haematology","elsevierCoverDate":"2020-12-01","elsevierCoverDisplayDate":"December 2020","elsevierCitationCount":"1"},{"title":"Response duration and survival shorten after each relapse in patients with follicular lymphoma treated in the rituximab era","googleId":"Svzagw3BjoQJ","googleLink":"https://onlinelibrary.wiley.com/doi/abs/10.1111/bjh.15708","googleCitationCount":12,"googleAuthor":"A Rivas‐Delgado","doi":"10.1111/bjh.15708","elsevierAuthor":"Rivas-Delgado A.","publicationName":"British Journal of Haematology","elsevierCoverDate":"2019-03-01","elsevierCoverDisplayDate":"March 2019","elsevierCitationCount":"10"},{"title":"Prevalence of germline GATA2 and SAMD9/9L variants in paediatric haematological disorders with monosomy 7","googleId":"QRoXuSW-WeYJ","googleLink":"https://onlinelibrary.wiley.com/doi/abs/10.1111/bjh.17006","googleCitationCount":3,"googleAuthor":"H Shima","doi":"10.1111/bjh.17006","elsevierAuthor":"Yoshida M.","publicationName":"British Journal of Haematology","elsevierCoverDate":"2020-12-01","elsevierCoverDisplayDate":"December 2020","elsevierCitationCount":"2"},{"title":"The anti‐mitotic agents PTC‐028 and PTC596 display potent activity in pre‐clinical models of multiple myeloma but challenge the role of BMI‐1 as an essential …","googleId":"TXVeY3x4BZMJ","googleLink":"https://onlinelibrary.wiley.com/doi/abs/10.1111/bjh.16595","googleCitationCount":6,"googleAuthor":"","doi":"10.1111/bjh.16595","elsevierAuthor":"Bolomsky A.","publicationName":"British Journal of Haematology","elsevierCoverDate":"2020-09-01","elsevierCoverDisplayDate":"1 September 2020","elsevierCitationCount":"5"},{"title":"Transfusion strategies for major haemorrhage in trauma","googleId":"4fP0uLmSKwIJ","googleLink":"https://onlinelibrary.wiley.com/doi/abs/10.1111/bjh.15737","googleCitationCount":15,"googleAuthor":"R Davenport","doi":"10.1111/bjh.15737","elsevierCitationCount":0},{"title":"Hypomethylating agent alters the immune microenvironment in acute myeloid leukaemia (AML) and enhances the immunogenicity of a dendritic cell/AML vaccine","googleId":"0hW7VJPvunEJ","googleLink":"https://onlinelibrary.wiley.com/doi/abs/10.1111/bjh.15818","googleCitationCount":10,"googleAuthor":"MR Nahas","doi":"10.1111/bjh.15818","elsevierAuthor":"Nahas M.R.","publicationName":"British Journal of Haematology","elsevierCoverDate":"2019-05-01","elsevierCoverDisplayDate":"May 2019","elsevierCitationCount":"5"},{"title":"Blood component use in critical care in patients with COVID‐19 infection: a single‐centre experience","googleId":"20_Uew4zNoMJ","googleLink":"https://onlinelibrary.wiley.com/doi/abs/10.1111/bjh.17007","googleCitationCount":5,"googleAuthor":"","doi":"10.1111/bjh.17007","elsevierAuthor":"Doyle A.J.","publicationName":"British Journal of Haematology","elsevierCoverDate":"2020-11-01","elsevierCoverDisplayDate":"1 November 2020","elsevierCitationCount":"4"},{"title":"Covid‐19 and Myeloma: what are the implications for now and in the future?","googleId":"rKoiBQw9D1sJ","googleLink":"https://onlinelibrary.wiley.com/doi/abs/10.1111/bjh.16815","googleCitationCount":3,"googleAuthor":"J Mikhael","doi":"10.1111/bjh.16815","elsevierAuthor":"Freeman C.L.","publicationName":"British Journal of Haematology","elsevierCoverDate":"2020-07-01","elsevierCoverDisplayDate":"1 July 2020","elsevierCitationCount":"3"},{"title":"Association of gene mutations with time‐to‐first treatment in 384 treatment‐naive chronic lymphocytic leukaemia patients","googleId":"jWisfninbJMJ","googleLink":"https://onlinelibrary.wiley.com/doi/abs/10.1111/bjh.16042","googleCitationCount":10,"googleAuthor":"","doi":"10.1111/bjh.16042","elsevierAuthor":"Hu B.","publicationName":"British Journal of Haematology","elsevierCoverDate":"2019-11-01","elsevierCoverDisplayDate":"1 November 2019","elsevierCitationCount":"9"},{"title":"Pain and opioid use after reversal of sickle cell disease following HLA-matched sibling haematopoietic stem cell transplant","googleId":"AHRof22W10AJ","googleLink":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6541482/","googleCitationCount":21,"googleAuthor":""},{"title":"CCAAT enhancer binding protein alpha (CEBPA) biallelic acute myeloid leukaemia: cooperating lesions, molecular mechanisms and clinical relevance","googleId":"KwrI-NciBvAJ","googleLink":"https://onlinelibrary.wiley.com/doi/abs/10.1111/bjh.16534","googleCitationCount":3,"googleAuthor":"BT Porse","doi":"10.1111/bjh.16534","elsevierAuthor":"Wilhelmson A.S.","publicationName":"British Journal of Haematology","elsevierCoverDate":"2020-08-01","elsevierCoverDisplayDate":"1 August 2020","elsevierCitationCount":"1"},{"title":"Chimeric antigen receptor T‐cell therapy as a bridge to haematopoietic stem cell transplantation for refractory/relapsed B‐cell acute lymphoblastic leukemia","googleId":"9dzbScWa-X4J","googleLink":"https://onlinelibrary.wiley.com/doi/abs/10.1111/bjh.16339","googleCitationCount":6,"googleAuthor":"","doi":"10.1111/bjh.16339","elsevierAuthor":"Zhang Y.","publicationName":"British Journal of Haematology","elsevierCoverDate":"2020-04-01","elsevierCoverDisplayDate":"1 April 2020","elsevierCitationCount":"4"},{"title":"Association between hydroxycarbamide exposure and neurocognitive function in adolescents with sickle cell disease","googleId":"XwOz9dFt01kJ","googleLink":"https://onlinelibrary.wiley.com/doi/abs/10.1111/bjh.16519","googleCitationCount":4,"googleAuthor":"M Partanen","doi":"10.1111/bjh.16519","elsevierAuthor":"Partanen M.","publicationName":"British Journal of Haematology","elsevierCoverDate":"2020-06-01","elsevierCoverDisplayDate":"1 June 2020","elsevierCitationCount":"3"},{"title":"Presentation clinical, haematological and immunophenotypic features of 1081 patients with GPI‐deficient (paroxysmal nocturnal haemoglobinuria) cells detected by …","googleId":"GR6p7xcsOqkJ","googleLink":"https://onlinelibrary.wiley.com/doi/abs/10.1111/bjh.16427","googleCitationCount":4,"googleAuthor":"","doi":"10.1111/bjh.16427","elsevierAuthor":"Richards S.J.","publicationName":"British Journal of Haematology","elsevierCoverDate":"2020-06-01","elsevierCoverDisplayDate":"1 June 2020","elsevierCitationCount":"4"},{"title":"Outcomes of patients receiving direct oral anticoagulants for myeloproliferative neoplasm-associated venous thromboembolism in a large tertiary centre in the UK","googleId":"3-Vh7PCUO1AJ","googleLink":"https://pubmed.ncbi.nlm.nih.gov/32011726/","googleCitationCount":10,"googleAuthor":"","doi":"10.1111/bjh.16485,","elsevierAuthor":"Curto-Garcia N.","publicationName":"British Journal of Haematology","elsevierCoverDate":"2020-05-01","elsevierCoverDisplayDate":"1 May 2020","elsevierCitationCount":"6"},{"title":"Similar burden of type 2 diabetes among adult patients with sickle cell disease relative to African Americans in the US population: a six‐year population‐based cohort …","googleId":"GdtVGHunpy0J","googleLink":"https://onlinelibrary.wiley.com/doi/abs/10.1111/bjh.15773","googleCitationCount":11,"googleAuthor":"J Zhou","doi":"10.1111/bjh.15773","elsevierAuthor":"Zhou J.","publicationName":"British Journal of Haematology","elsevierCoverDate":"2019-04-01","elsevierCoverDisplayDate":"April 2019","elsevierCitationCount":"7"},{"title":"The Duffy antigen receptor for chemokines, ACKR1,– 'Jeanne DARC' of benign neutropenia","googleId":"ZcNdVE1qUNUJ","googleLink":"https://onlinelibrary.wiley.com/doi/abs/10.1111/bjh.15730","googleCitationCount":11,"googleAuthor":"","doi":"10.1111/bjh.15730","elsevierCitationCount":0},{"title":"Reevaluation of platelet function in chronic immune thrombocytopenia: impacts of platelet size, platelet‐associated anti‐αIIbβ3 antibodies and thrombopoietin receptor …","googleId":"tEEeIpGGh4MJ","googleLink":"https://onlinelibrary.wiley.com/doi/abs/10.1111/bjh.16439","googleCitationCount":3,"googleAuthor":"","doi":"10.1111/bjh.16439","elsevierAuthor":"Nishiura N.","publicationName":"British Journal of Haematology","elsevierCoverDate":"2020-05-01","elsevierCoverDisplayDate":"1 May 2020","elsevierCitationCount":"2"},{"title":"Epidemiology, outcome, targeted agents and immunotherapy in adolescent and young adult non‐Hodgkin and Hodgkin lymphoma","googleId":"ys59dGtjTv8J","googleLink":"https://onlinelibrary.wiley.com/doi/abs/10.1111/bjh.15789","googleCitationCount":11,"googleAuthor":"ML Metzger","doi":"10.1111/bjh.15789","elsevierAuthor":"Metzger M.L.","publicationName":"British Journal of Haematology","elsevierCoverDate":"2019-06-01","elsevierCoverDisplayDate":"June 2019","elsevierCitationCount":"9"},{"title":"Venetoclax induces rapid elimination of NPM1 mutant measurable residual disease in combination with low‐intensity chemotherapy in acute myeloid leukaemia","googleId":"KE_u2mfCs3MJ","googleLink":"https://onlinelibrary.wiley.com/doi/abs/10.1111/bjh.16722","googleCitationCount":7,"googleAuthor":"R Dillon","doi":"10.1111/bjh.16722","elsevierAuthor":"Tiong I.S.","publicationName":"British Journal of Haematology","elsevierCoverDate":"2020-01-01","elsevierCoverDisplayDate":"2020","elsevierCitationCount":"5"},{"title":"Long‐term data from a phase 3 study of radotinib versus imatinib in patients with newly diagnosed, chronic myeloid leukaemia in the chronic phase (RERISE)","googleId":"uMNdHmHdJQwJ","googleLink":"https://onlinelibrary.wiley.com/doi/abs/10.1111/bjh.16381","googleCitationCount":5,"googleAuthor":"","doi":"10.1111/bjh.16381","elsevierAuthor":"Do Y.R.","publicationName":"British Journal of Haematology","elsevierCoverDate":"2020-04-01","elsevierCoverDisplayDate":"1 April 2020","elsevierCitationCount":"2"},{"title":"Establishment of brain natriuretic peptide‐based criteria for evaluating cardiac response to treatment in light chain (AL) amyloidosis","googleId":"n8Aj71tNtrQJ","googleLink":"https://onlinelibrary.wiley.com/doi/abs/10.1111/bjh.16198","googleCitationCount":8,"googleAuthor":"","doi":"10.1111/bjh.16198","elsevierAuthor":"Lilleness B.","publicationName":"British Journal of Haematology","elsevierCoverDate":"2020-02-01","elsevierCoverDisplayDate":"1 February 2020","elsevierCitationCount":"8"},{"title":"Deficit of circulating CD19+CD24hiCD38hi regulatory B cells in severe aplastic anaemia","googleId":"nXFuCNl-XaIJ","googleLink":"https://onlinelibrary.wiley.com/doi/abs/10.1111/bjh.16651","googleCitationCount":5,"googleAuthor":"Y Zaimoku","doi":"10.1111/bjh.16651","elsevierAuthor":"Zaimoku Y.","publicationName":"British Journal of Haematology","elsevierCoverDate":"2020-08-01","elsevierCoverDisplayDate":"1 August 2020","elsevierCitationCount":"2"},{"title":"CoVID‐19 insights from transfusion medicine","googleId":"4wTs1NZk3JsJ","googleLink":"https://onlinelibrary.wiley.com/doi/abs/10.1111/bjh.17005","googleCitationCount":3,"googleAuthor":"","doi":"10.1111/bjh.17005","elsevierAuthor":"Flegel W.A.","publicationName":"British Journal of Haematology","elsevierCoverDate":"2020-09-01","elsevierCoverDisplayDate":"1 September 2020","elsevierCitationCount":"2"},{"title":"Bortezomib and dexamethasone, an original approach for treating multi‐refractory warm autoimmune haemolytic anaemia","googleId":"en4v_85REuQJ","googleLink":"https://onlinelibrary.wiley.com/doi/abs/10.1111/bjh.16009","googleCitationCount":10,"googleAuthor":"","doi":"10.1111/bjh.16009","elsevierAuthor":"Fadlallah J.","publicationName":"British Journal of Haematology","elsevierCoverDate":"2019-10-01","elsevierCoverDisplayDate":"1 October 2019","elsevierCitationCount":"6"},{"title":"Identification of relapse‐associated gene mutations by next‐generation sequencing in low‐risk acute myeloid leukaemia patients","googleId":"dClfvoaIDWgJ","googleLink":"https://onlinelibrary.wiley.com/doi/abs/10.1111/bjh.16420","googleCitationCount":3,"googleAuthor":"C Jiménez","doi":"10.1111/bjh.16420","elsevierAuthor":"Prieto-Conde M.I.","publicationName":"British Journal of Haematology","elsevierCoverDate":"2020-05-01","elsevierCoverDisplayDate":"1 May 2020","elsevierCitationCount":"2"},{"title":"Patient and physician preferences for first‐line treatment of classical Hodgkin lymphoma in Germany, France and the United Kingdom","googleId":"Ligh34I8XecJ","googleLink":"https://onlinelibrary.wiley.com/doi/abs/10.1111/bjh.15566","googleCitationCount":14,"googleAuthor":"","doi":"10.1111/bjh.15566","elsevierAuthor":"Bröckelmann P.J.","publicationName":"British Journal of Haematology","elsevierCoverDate":"2019-01-01","elsevierCoverDisplayDate":"January 2019","elsevierCitationCount":"7"},{"title":"Haemophilia and ageing","googleId":"xTNcZh3-dpkJ","googleLink":"https://onlinelibrary.wiley.com/doi/abs/10.1111/bjh.15745","googleCitationCount":11,"googleAuthor":"M Makris","doi":"10.1111/bjh.15745","elsevierAuthor":"Shapiro S.","publicationName":"British Journal of Haematology","elsevierCoverDate":"2019-03-01","elsevierCoverDisplayDate":"March 2019","elsevierCitationCount":"9"},{"title":"Genomic evolution of ibrutinib‐resistant clones in Waldenström macroglobulinaemia","googleId":"_2owRNeLJv0J","googleLink":"https://onlinelibrary.wiley.com/doi/abs/10.1111/bjh.16463","googleCitationCount":5,"googleAuthor":"C Jiménez","doi":"10.1111/bjh.16463","elsevierAuthor":"Jiménez C.","publicationName":"British Journal of Haematology","elsevierCoverDate":"2020-06-01","elsevierCoverDisplayDate":"1 June 2020","elsevierCitationCount":"4"},{"title":"The prevalence and significance of monoclonal gammopathy of undetermined significance in acute medical admissions","googleId":"72hB65lXCZMJ","googleLink":"https://onlinelibrary.wiley.com/doi/abs/10.1111/bjh.16487","googleCitationCount":5,"googleAuthor":"C Atkin","doi":"10.1111/bjh.16487","elsevierAuthor":"Atkin C.","publicationName":"British Journal of Haematology","elsevierCoverDate":"2020-06-01","elsevierCoverDisplayDate":"1 June 2020","elsevierCitationCount":"3"},{"title":"Risk of hospitalised bleeding in comparisons of oral anticoagulant options for the primary treatment of venous thromboembolism","googleId":"7hpzjKp1TOMJ","googleLink":"https://onlinelibrary.wiley.com/doi/abs/10.1111/bjh.15857","googleCitationCount":12,"googleAuthor":"PL Lutsey","doi":"10.1111/bjh.15857","elsevierAuthor":"Lutsey P.L.","publicationName":"British Journal of Haematology","elsevierCoverDate":"2019-06-01","elsevierCoverDisplayDate":"June 2019","elsevierCitationCount":"7"},{"title":"Impact of treatment variability and clinicopathological characteristics on survival in patients with Epstein‐Barr‐Virus positive diffuse large B cell lymphoma","googleId":"q1ARvSTnQ50J","googleLink":"https://onlinelibrary.wiley.com/doi/abs/10.1111/bjh.16342","googleCitationCount":4,"googleAuthor":"","doi":"10.1111/bjh.16342","elsevierAuthor":"Witte H.M.","publicationName":"British Journal of Haematology","elsevierCoverDate":"2020-04-01","elsevierCoverDisplayDate":"1 April 2020","elsevierCitationCount":"3"},{"title":"Outcomes of older patients with primary central nervous system lymphoma treated in routine clinical practice in the UK: methotrexate dose intensity correlates with …","googleId":"h1f9wzT-WcAJ","googleLink":"https://onlinelibrary.wiley.com/doi/abs/10.1111/bjh.16592","googleCitationCount":4,"googleAuthor":"N Martinez‐Calle","doi":"10.1111/bjh.16592","elsevierAuthor":"Martinez-Calle N.","publicationName":"British Journal of Haematology","elsevierCoverDate":"2020-08-01","elsevierCoverDisplayDate":"1 August 2020","elsevierCitationCount":"3"},{"title":"Ticagrelor does not impact patient‐reported pain in young adults with sickle cell disease: a multicentre, randomised phase II b study","googleId":"Vo6btw8UIyAJ","googleLink":"https://onlinelibrary.wiley.com/doi/abs/10.1111/bjh.15646","googleCitationCount":12,"googleAuthor":"","doi":"10.1111/bjh.15646","elsevierAuthor":"Kanter J.","publicationName":"British Journal of Haematology","elsevierCoverDate":"2019-01-01","elsevierCoverDisplayDate":"January 2019","elsevierCitationCount":"11"},{"title":"Identification of high-risk DUSP22-rearranged ALK-negative anaplastic large cell lymphoma.","googleId":"RGUOhacHz5sJ","googleLink":"https://europepmc.org/article/pmc/pmc7679007","googleCitationCount":16,"googleAuthor":""},{"title":"Sphingosine kinase‐2 is overexpressed in large granular lymphocyte leukaemia and promotes survival through Mcl‐1","googleId":"Zr046ZhLSs0J","googleLink":"https://onlinelibrary.wiley.com/doi/abs/10.1111/bjh.16530","googleCitationCount":4,"googleAuthor":"","doi":"10.1111/bjh.16530","elsevierAuthor":"LeBlanc F.R.","publicationName":"British Journal of Haematology","elsevierCoverDate":"2020-08-01","elsevierCoverDisplayDate":"1 August 2020","elsevierCitationCount":"3"},{"title":"No evidence of increased cerebrovascular involvement in adult neurologically‐asymptomatic β‐Thalassaemia. A multicentre multimodal magnetic resonance study","googleId":"PozBt0cxs2oJ","googleLink":"https://onlinelibrary.wiley.com/doi/abs/10.1111/bjh.15834","googleCitationCount":10,"googleAuthor":"I Tartaglione","doi":"10.1111/bjh.15834","elsevierAuthor":"Tartaglione I.","publicationName":"British Journal of Haematology","elsevierCoverDate":"2019-05-01","elsevierCoverDisplayDate":"May 2019","elsevierCitationCount":"9"},{"title":"The translational science of hodgkin lymphoma","googleId":"4xYNRtijNcgJ","googleLink":"https://onlinelibrary.wiley.com/doi/abs/10.1111/bjh.15658","googleCitationCount":11,"googleAuthor":"","doi":"10.1111/bjh.15658","elsevierAuthor":"Cirillo M.","publicationName":"British Journal of Haematology","elsevierCoverDate":"2019-01-01","elsevierCoverDisplayDate":"January 2019","elsevierCitationCount":"6"},{"title":"First‐line R‐CVP versus R‐CHOP induction immunochemotherapy for indolent lymphoma with rituximab maintenance. A multicentre, phase III randomized study by …","googleId":"--cvn5FVJPoJ","googleLink":"https://onlinelibrary.wiley.com/doi/abs/10.1111/bjh.16264","googleCitationCount":8,"googleAuthor":"","doi":"10.1111/bjh.16264","elsevierAuthor":"Walewski J.","publicationName":"British Journal of Haematology","elsevierCoverDate":"2020-03-01","elsevierCoverDisplayDate":"1 March 2020","elsevierCitationCount":"4"},{"title":"Safety and efficacy of eltrombopag plus pulsed dexamethasone as first‐line therapy for immune thrombocytopenia","googleId":"CtjWIcGBG14J","googleLink":"https://onlinelibrary.wiley.com/doi/abs/10.1111/bjh.16327","googleCitationCount":5,"googleAuthor":"","doi":"10.1111/bjh.16327","elsevierAuthor":"Zhang L.","publicationName":"British Journal of Haematology","elsevierCoverDate":"2020-04-01","elsevierCoverDisplayDate":"1 April 2020","elsevierCitationCount":"5"},{"title":"How we use molecular minimal residual disease (MRD) testing in acute myeloid leukaemia (AML)","googleId":"kstB1ymItS8J","googleLink":"https://onlinelibrary.wiley.com/doi/abs/10.1111/bjh.17185","googleCitationCount":2,"googleAuthor":"R Dillon","doi":"10.1111/bjh.17185","elsevierAuthor":"Dillon R.","publicationName":"British Journal of Haematology","elsevierCoverDate":"2020-01-01","elsevierCoverDisplayDate":"2020","elsevierCitationCount":"2"},{"title":"A randomised controlled trial of extended anticoagulation treatment versus standard treatment for the prevention of recurrent venous thromboembolism (VTE) and …","googleId":"030kQDO1SxwJ","googleLink":"https://onlinelibrary.wiley.com/doi/abs/10.1111/bjh.16275","googleCitationCount":5,"googleAuthor":"","doi":"10.1111/bjh.16275","elsevierCitationCount":0},{"title":"Kinetics of T‐cell subset reconstitution following treatment with bendamustine and rituximab for low‐grade lymphoproliferative disease: a population‐based analysis","googleId":"DaxwWB3Koc4J","googleLink":"https://onlinelibrary.wiley.com/doi/abs/10.1111/bjh.15722","googleCitationCount":10,"googleAuthor":"N Martínez‐Calle","doi":"10.1111/bjh.15722","elsevierAuthor":"Martínez-Calle N.","publicationName":"British Journal of Haematology","elsevierCoverDate":"2019-03-01","elsevierCoverDisplayDate":"March 2019","elsevierCitationCount":"8"},{"title":"Clonal haematopoiesis of indeterminate potential among cancer survivors exposed to myelotoxic chemotherapy","googleId":"8lfuzq_s4tcJ","googleLink":"https://onlinelibrary.wiley.com/doi/abs/10.1111/bjh.15861?af=R","googleCitationCount":11,"googleAuthor":"AJ Olszewski","doi":"10.1111/bjh.15861","elsevierAuthor":"Olszewski A.J.","publicationName":"British Journal of Haematology","elsevierCoverDate":"2019-08-01","elsevierCoverDisplayDate":"August 2019","elsevierCitationCount":"7"},{"title":"Impact of type of reduced‐intensity conditioning regimen on the outcomes of allogeneic haematopoietic cell transplantation in classical Hodgkin lymphoma","googleId":"1Ry5I7P7410J","googleLink":"https://onlinelibrary.wiley.com/doi/abs/10.1111/bjh.16664","googleCitationCount":5,"googleAuthor":"KW Ahn","doi":"10.1111/bjh.16664","elsevierAuthor":"Ahmed S.","publicationName":"British Journal of Haematology","elsevierCoverDate":"2020-08-01","elsevierCoverDisplayDate":"1 August 2020","elsevierCitationCount":"2"},{"title":"Shwachman‐Diamond syndrome with clonal interstitial deletion of the long arm of chromosome 20 in bone marrow: haematological features, prognosis and genomic …","googleId":"xPV__bOazukJ","googleLink":"https://onlinelibrary.wiley.com/doi/abs/10.1111/bjh.15729","googleCitationCount":11,"googleAuthor":"A Minelli","doi":"10.1111/bjh.15729","elsevierAuthor":"Valli R.","publicationName":"British Journal of Haematology","elsevierCoverDate":"2019-03-01","elsevierCoverDisplayDate":"March 2019","elsevierCitationCount":"8"},{"title":"T‐cell receptor sequencing demonstrates persistence of virus‐specific T cells after antiviral immunotherapy","googleId":"Ox1yU72Fjd0J","googleLink":"https://onlinelibrary.wiley.com/doi/abs/10.1111/bjh.16053","googleCitationCount":7,"googleAuthor":"","doi":"10.1111/bjh.16053","elsevierAuthor":"Keller M.D.","publicationName":"British Journal of Haematology","elsevierCoverDate":"2019-10-01","elsevierCoverDisplayDate":"1 October 2019","elsevierCitationCount":"6"},{"title":"The power and potential of integrated diagnostics in acute myeloid leukaemia","googleId":"BLEhJREHQQYJ","googleLink":"https://onlinelibrary.wiley.com/doi/abs/10.1111/bjh.16360","googleCitationCount":5,"googleAuthor":"","doi":"10.1111/bjh.16360","elsevierAuthor":"Haferlach T.","publicationName":"British Journal of Haematology","elsevierCoverDate":"2020-01-01","elsevierCoverDisplayDate":"1 January 2020","elsevierCitationCount":"2"},{"title":"The face of remission induction","googleId":"NXQQ8D1oPaYJ","googleLink":"https://onlinelibrary.wiley.com/doi/abs/10.1111/bjh.16353","googleCitationCount":4,"googleAuthor":"","doi":"10.1111/bjh.16353","elsevierAuthor":"Paul S.","publicationName":"British Journal of Haematology","elsevierCoverDate":"2020-01-01","elsevierCoverDisplayDate":"1 January 2020","elsevierCitationCount":"1"},{"title":"COVID‐19 in a patient with pre‐existing acute lymphoblastic leukaemia","googleId":"diNpMTjWJfsJ","googleLink":"https://onlinelibrary.wiley.com/doi/abs/10.1111/bjh.16799","googleCitationCount":5,"googleAuthor":"","doi":"10.1111/bjh.16799","elsevierAuthor":"Wu Y.","publicationName":"British Journal of Haematology","elsevierCoverDate":"2020-07-01","elsevierCoverDisplayDate":"1 July 2020","elsevierCitationCount":"4"},{"title":"More on:'COVID‐19 coagulopathy in Caucasian patients'","googleId":"OU688qjcgP0J","googleLink":"https://onlinelibrary.wiley.com/doi/abs/10.1111/bjh.16772","googleCitationCount":4,"googleAuthor":"M Marietta","doi":"10.1111/bjh.16772","elsevierAuthor":"Marietta M.","publicationName":"British Journal of Haematology","elsevierCoverDate":"2020-06-01","elsevierCoverDisplayDate":"1 June 2020","elsevierCitationCount":"4"},{"title":"Low burden of minimal residual disease prior to transplantation in children with very high risk acute lymphoblastic leukaemia: The NOPHO ALL 2008 experience","googleId":"G9Q1BNJASR8J","googleLink":"https://onlinelibrary.wiley.com/doi/abs/10.1111/bjh.15761","googleCitationCount":10,"googleAuthor":"M Ifversen","doi":"10.1111/bjh.15761","elsevierAuthor":"Ifversen M.","publicationName":"British Journal of Haematology","elsevierCoverDate":"2019-03-01","elsevierCoverDisplayDate":"March 2019","elsevierCitationCount":"7"},{"title":"Treatment efficacy for adult persistent immune thrombocytopenia: a systematic review and network meta‐analysis","googleId":"15EdbI4djusJ","googleLink":"https://onlinelibrary.wiley.com/doi/abs/10.1111/bjh.16161","googleCitationCount":8,"googleAuthor":"","doi":"10.1111/bjh.16161","elsevierAuthor":"Puavilai T.","publicationName":"British Journal of Haematology","elsevierCoverDate":"2020-02-01","elsevierCoverDisplayDate":"1 February 2020","elsevierCitationCount":"5"},{"title":"Challenges and opportunities in the assessment of measurable residual disease in multiple myeloma","googleId":"OQTTqQe-argJ","googleLink":"https://onlinelibrary.wiley.com/doi/abs/10.1111/bjh.16130","googleCitationCount":6,"googleAuthor":"S Bal","doi":"10.1111/bjh.16130","elsevierAuthor":"Bal S.","publicationName":"British Journal of Haematology","elsevierCoverDate":"2019-09-01","elsevierCoverDisplayDate":"1 September 2019","elsevierCitationCount":"5"},{"title":"Androgen derivatives improve blood counts and elongate telomere length in adult cryptic dyskeratosis congenita","googleId":"_mOTmgCa1REJ","googleLink":"https://onlinelibrary.wiley.com/doi/abs/10.1111/bjh.16997","googleCitationCount":3,"googleAuthor":"","doi":"10.1111/bjh.16997","elsevierAuthor":"Kirschner M.","publicationName":"British Journal of Haematology","elsevierCoverDate":"2020-01-01","elsevierCoverDisplayDate":"2020","elsevierCitationCount":"2"},{"title":"What is the appropriate anticoagulation strategy for thrombotic antiphospholipid syndrome?","googleId":"w1bKvcuK_7MJ","googleLink":"https://onlinelibrary.wiley.com/doi/abs/10.1111/bjh.16431","googleCitationCount":4,"googleAuthor":"","doi":"10.1111/bjh.16431","elsevierAuthor":"Arachchillage D.R.J.","publicationName":"British Journal of Haematology","elsevierCoverDate":"2020-04-01","elsevierCoverDisplayDate":"1 April 2020","elsevierCitationCount":"3"},{"title":"Genetic predisposition to PEG‐asparaginase hypersensitivity in children treated according to NOPHO ALL 2008","googleId":"yJbcLd8NV3IJ","googleLink":"https://onlinelibrary.wiley.com/doi/abs/10.1111/bjh.15660","googleCitationCount":11,"googleAuthor":"BO Wolthers","doi":"10.1111/bjh.15660","elsevierAuthor":"Højfeldt S.G.","publicationName":"British Journal of Haematology","elsevierCoverDate":"2019-02-01","elsevierCoverDisplayDate":"Februaryy 2019","elsevierCitationCount":"8"},{"title":"Which is more important for the selection of cord blood units for haematopoietic cell transplantation: the number of CD34-positive cells or total nucleated cells?","googleId":"C_MjIcs5DboJ","googleLink":"https://kyushu-u.pure.elsevier.com/en/publications/which-is-more-important-for-the-selection-of-cord-blood-units-for","googleCitationCount":14,"googleAuthor":"","doi":"10.1111/bjh.15418","elsevierAuthor":"Nakasone H.","publicationName":"British Journal of Haematology","elsevierCoverDate":"2019-04-01","elsevierCoverDisplayDate":"April 2019","elsevierCitationCount":"11"},{"title":"Methodological aspects of health‐related quality of life measurement and analysis in patients with multiple myeloma","googleId":"MkIxYKBB1M0J","googleLink":"https://onlinelibrary.wiley.com/doi/abs/10.1111/bjh.15759","googleCitationCount":11,"googleAuthor":"","doi":"10.1111/bjh.15759","elsevierAuthor":"Nielsen L.K.","publicationName":"British Journal of Haematology","elsevierCoverDate":"2019-04-01","elsevierCoverDisplayDate":"April 2019","elsevierCitationCount":"5"},{"title":"Genotype–phenotype correlation in children with hereditary spherocytosis","googleId":"hkqJ7P3wBsAJ","googleLink":"https://onlinelibrary.wiley.com/doi/abs/10.1111/bjh.16750","googleCitationCount":3,"googleAuthor":"","doi":"10.1111/bjh.16750","elsevierAuthor":"Tole S.","publicationName":"British Journal of Haematology","elsevierCoverDate":"2020-11-01","elsevierCoverDisplayDate":"1 November 2020","elsevierCitationCount":"2"},{"title":"Pharmacokinetic and pharmacodynamic effects of ravulizumab and eculizumab on complement component 5 in adults with paroxysmal nocturnal haemoglobinuria …","googleId":"HkGEqaXKrDkJ","googleLink":"https://onlinelibrary.wiley.com/doi/abs/10.1111/bjh.16711","googleCitationCount":4,"googleAuthor":"RA Brodsky","doi":"10.1111/bjh.16711","elsevierAuthor":"Peffault de Latour R.","publicationName":"British Journal of Haematology","elsevierCoverDate":"2020-11-01","elsevierCoverDisplayDate":"1 November 2020","elsevierCitationCount":"2"},{"title":"A journey through infectious risk associated with ruxolitinib","googleId":"qcoboy9BkGwJ","googleLink":"https://onlinelibrary.wiley.com/doi/abs/10.1111/bjh.16174","googleCitationCount":14,"googleAuthor":"","doi":"10.1111/bjh.16174","elsevierAuthor":"Sant’Antonio E.","publicationName":"British Journal of Haematology","elsevierCoverDate":"2019-11-01","elsevierCoverDisplayDate":"1 November 2019","elsevierCitationCount":"12"},{"title":"CD14+CD16+ monocytes are involved in daratumumab‐mediated myeloma cells killing and in anti‐CD47 therapeutic strategy","googleId":"ZCHeCh-4Ok0J","googleLink":"https://onlinelibrary.wiley.com/doi/abs/10.1111/bjh.16548","googleCitationCount":4,"googleAuthor":"","doi":"10.1111/bjh.16548","elsevierAuthor":"Storti P.","publicationName":"British Journal of Haematology","elsevierCoverDate":"2020-08-01","elsevierCoverDisplayDate":"1 August 2020","elsevierCitationCount":"1"},{"title":"Experience with ponatinib in paediatric patients with leukaemia","googleId":"5g0H-KaBX7cJ","googleLink":"https://onlinelibrary.wiley.com/doi/abs/10.1111/bjh.16338","googleCitationCount":5,"googleAuthor":"","doi":"10.1111/bjh.16338","elsevierAuthor":"Rossoff J.","publicationName":"British Journal of Haematology","elsevierCoverDate":"2020-04-01","elsevierCoverDisplayDate":"1 April 2020","elsevierCitationCount":"3"},{"title":"Mutation topography and risk stratification for de novo acute myeloid leukaemia with normal cytogenetics and no nucleophosmin 1 (NPM1) mutation or Fms‐like tyrosine kinase …","googleId":"jiiwMOhNHyoJ","googleLink":"https://onlinelibrary.wiley.com/doi/abs/10.1111/bjh.16526","googleCitationCount":3,"googleAuthor":"","doi":"10.1111/bjh.16526","elsevierAuthor":"Zhou Y.L.","publicationName":"British Journal of Haematology","elsevierCoverDate":"2020-07-01","elsevierCoverDisplayDate":"1 July 2020","elsevierCitationCount":"3"},{"title":"Emicizumab treatment and monitoring in a paediatric cohort: real‐world data","googleId":"V5k2dgVmrrcJ","googleLink":"https://onlinelibrary.wiley.com/doi/abs/10.1111/bjh.16964","googleCitationCount":5,"googleAuthor":"I Budnik","doi":"10.1111/bjh.16964","elsevierAuthor":"Barg A.A.","publicationName":"British Journal of Haematology","elsevierCoverDate":"2020-10-01","elsevierCoverDisplayDate":"1 October 2020","elsevierCitationCount":"3"},{"title":"The prevention of central nervous system relapse in diffuse large B‐cell lymphoma: a British Society for Haematology good practice paper","googleId":"dc5UIPYNKxsJ","googleLink":"https://onlinelibrary.wiley.com/doi/abs/10.1111/bjh.16866","googleCitationCount":5,"googleAuthor":"S Chaganti","doi":"10.1111/bjh.16866","elsevierAuthor":"McKay P.","publicationName":"British Journal of Haematology","elsevierCoverDate":"2020-09-01","elsevierCoverDisplayDate":"1 September 2020","elsevierCitationCount":"2"},{"title":"Aneuploidy in children with relapsed B‐cell precursor acute lymphoblastic leukaemia: clinical importance of detecting a hypodiploid origin of relapse","googleId":"BSZuy5p19WEJ","googleLink":"https://onlinelibrary.wiley.com/doi/abs/10.1111/bjh.15770","googleCitationCount":9,"googleAuthor":"MP Schroeder","doi":"10.1111/bjh.15770","elsevierCitationCount":0},{"title":"The new biology of PTCL‐NOS and AITL: current status and future clinical impact","googleId":"iISTDHlHcZQJ","googleLink":"https://onlinelibrary.wiley.com/doi/abs/10.1111/bjh.16428","googleCitationCount":5,"googleAuthor":"","doi":"10.1111/bjh.16428","elsevierAuthor":"Timmins M.A.","publicationName":"British Journal of Haematology","elsevierCoverDate":"2020-04-01","elsevierCoverDisplayDate":"1 April 2020","elsevierCitationCount":"3"},{"title":"Low‐dose lenalidomide maintenance after induction therapy in older patients with primary central nervous system lymphoma","googleId":"96BCSWvK8GUJ","googleLink":"https://onlinelibrary.wiley.com/doi/abs/10.1111/bjh.15787?af=R","googleCitationCount":14,"googleAuthor":"H Geng","doi":"10.1111/bjh.15787","elsevierAuthor":"Vu K.","publicationName":"British Journal of Haematology","elsevierCoverDate":"2019-07-01","elsevierCoverDisplayDate":"July 2019","elsevierCitationCount":"8"},{"title":"Prediction of the haemostatic effects of bypassing therapy using comprehensive coagulation assays in emicizumab prophylaxis‐treated haemophilia A patients with …","googleId":"Eszt1ppquloJ","googleLink":"https://onlinelibrary.wiley.com/doi/abs/10.1111/bjh.16574","googleCitationCount":5,"googleAuthor":"","doi":"10.1111/bjh.16574","elsevierAuthor":"Furukawa S.","publicationName":"British Journal of Haematology","elsevierCoverDate":"2020-09-01","elsevierCoverDisplayDate":"1 September 2020","elsevierCitationCount":"3"},{"title":"SARS‐CoV‐2: a new aetiology for atypical lymphocytes","googleId":"uPnqrF7vidQJ","googleLink":"https://onlinelibrary.wiley.com/doi/abs/10.1111/bjh.16730","googleCitationCount":11,"googleAuthor":"","doi":"10.1111/bjh.16730","elsevierAuthor":"Gérard D.","publicationName":"British Journal of Haematology","elsevierCoverDate":"2020-06-01","elsevierCoverDisplayDate":"1 June 2020","elsevierCitationCount":"8"},{"title":"Bendamustine plus rituximab in newly-diagnosed Waldenström macroglobulinaemia patients. A study on behalf of the French Innovative Leukaemia Organization …","googleId":"th1M6HxfTKcJ","googleLink":"https://pubmed.ncbi.nlm.nih.gov/30548257/?from_term=Chaoui+D&from_pos=6","googleCitationCount":13,"googleAuthor":"","doi":"10.1111/bjh.15718,","elsevierCitationCount":0},{"title":"Clinical outcomes of IDH2-mutated advanced-phase Ph-negative myeloproliferative neoplasms treated with enasidenib","googleId":"OpHtZlOp6AsJ","googleLink":"https://pubmed.ncbi.nlm.nih.gov/32358888/","googleCitationCount":6,"googleAuthor":"","doi":"10.1111/bjh.16709,","elsevierAuthor":"Patel A.A.","publicationName":"British Journal of Haematology","elsevierCoverDate":"2020-07-01","elsevierCoverDisplayDate":"1 July 2020","elsevierCitationCount":"6"},{"title":"p53 is associated with high‐risk and pinpoints TP53 missense mutations in mantle cell lymphoma","googleId":"N9tDxob5-mUJ","googleLink":"https://onlinelibrary.wiley.com/doi/abs/10.1111/bjh.17023","googleCitationCount":3,"googleAuthor":"","doi":"10.1111/bjh.17023","elsevierAuthor":"Rodrigues J.M.","publicationName":"British Journal of Haematology","elsevierCoverDate":"2020-12-01","elsevierCoverDisplayDate":"December 2020","elsevierCitationCount":"3"},{"title":"Infectious complications after post‐transplantation cyclophosphamide and anti‐thymocyte globulin‐based haploidentical stem cell transplantation","googleId":"gQAs7lQ7RZoJ","googleLink":"https://onlinelibrary.wiley.com/doi/abs/10.1111/bjh.16189","googleCitationCount":7,"googleAuthor":"R Mohty","doi":"10.1111/bjh.16189","elsevierCitationCount":0},{"title":"Phase 2 study of all‐oral ixazomib, cyclophosphamide and low‐dose dexamethasone for relapsed/refractory multiple myeloma","googleId":"Q1v9bk7mbyIJ","googleLink":"https://onlinelibrary.wiley.com/doi/abs/10.1111/bjh.15679","googleCitationCount":10,"googleAuthor":"SK Kumar","doi":"10.1111/bjh.15679","elsevierAuthor":"Kumar S.K.","publicationName":"British Journal of Haematology","elsevierCoverDate":"2019-02-01","elsevierCoverDisplayDate":"Februaryy 2019","elsevierCitationCount":"8"},{"title":"Allogeneic stem cell transplantation as part of front line therapy for Mantle cell lymphoma","googleId":"yHVmguqkMycJ","googleLink":"https://onlinelibrary.wiley.com/doi/abs/10.1111/bjh.15723","googleCitationCount":13,"googleAuthor":"G Cook","doi":"10.1111/bjh.15723","elsevierAuthor":"Rule S.","publicationName":"British Journal of Haematology","elsevierCoverDate":"2019-03-01","elsevierCoverDisplayDate":"March 2019","elsevierCitationCount":"9"},{"title":"A pilot trial of complement inhibition using eculizumab to overcome platelet transfusion refractoriness in human leukocyte antigen allo‐immunized patients","googleId":"K_335mkX8IcJ","googleLink":"https://onlinelibrary.wiley.com/doi/abs/10.1111/bjh.16385","googleCitationCount":4,"googleAuthor":"","doi":"10.1111/bjh.16385","elsevierAuthor":"Vo P.","publicationName":"British Journal of Haematology","elsevierCoverDate":"2020-05-01","elsevierCoverDisplayDate":"1 May 2020","elsevierCitationCount":"2"},{"title":"Outcome of children relapsing after first allogeneic haematopoietic stem cell transplantation for acute myeloid leukaemia: a retrospective I‐BFM analysis of 333 …","googleId":"3fCiX9csKs0J","googleLink":"https://onlinelibrary.wiley.com/doi/abs/10.1111/bjh.16441","googleCitationCount":5,"googleAuthor":"","doi":"10.1111/bjh.16441","elsevierCitationCount":0},{"title":"Long term outcomes in monoclonal gammopathy of renal significance","googleId":"IyEnBtPvE-IJ","googleLink":"https://onlinelibrary.wiley.com/doi/abs/10.1111/bjh.15987","googleCitationCount":10,"googleAuthor":"F Djebbari","doi":"10.1111/bjh.15987","elsevierCitationCount":0},{"title":"Anticoagulation prophylaxis reduces venous thromboembolism rate in adult acute lymphoblastic leukaemia treated with asparaginase‐based therapy","googleId":"NyaM03uHC5wJ","googleLink":"https://onlinelibrary.wiley.com/doi/abs/10.1111/bjh.16695","googleCitationCount":6,"googleAuthor":"R Chen","doi":"10.1111/bjh.16695","elsevierAuthor":"Sibai H.","publicationName":"British Journal of Haematology","elsevierCoverDate":"2020-12-01","elsevierCoverDisplayDate":"December 2020","elsevierCitationCount":"3"},{"title":"Variables affecting the presence of mesenchymal stromal cells in peripheral blood and their relationship with apheresis products","googleId":"RSfazypOyBcJ","googleLink":"https://onlinelibrary.wiley.com/doi/abs/10.1111/bjh.16412","googleCitationCount":5,"googleAuthor":"","doi":"10.1111/bjh.16412","elsevierAuthor":"Jain A.","publicationName":"British Journal of Haematology","elsevierCoverDate":"2020-05-01","elsevierCoverDisplayDate":"1 May 2020","elsevierCitationCount":"4"},{"title":"Remdesivir during induction chemotherapy for newly diagnosed paediatric acute lymphoblastic leukaemia with concomitant SARS‐CoV‐2 infection","googleId":"KezeewS4LUwJ","googleLink":"https://onlinelibrary.wiley.com/doi/abs/10.1111/bjh.17014","googleCitationCount":3,"googleAuthor":"","doi":"10.1111/bjh.17014","elsevierCitationCount":0},{"title":"How to address second and therapy‐related acute myelogenous leukaemia","googleId":"A8xa8FVPJE4J","googleLink":"https://onlinelibrary.wiley.com/doi/abs/10.1111/bjh.16354","googleCitationCount":6,"googleAuthor":"","doi":"10.1111/bjh.16354","elsevierAuthor":"Oliai C.","publicationName":"British Journal of Haematology","elsevierCoverDate":"2020-01-01","elsevierCoverDisplayDate":"1 January 2020","elsevierCitationCount":"4"},{"title":"Development of a core outcome set for myelodysplastic syndromes–a Delphi study from the EUMDS Registry Group","googleId":"8juTh0-ZeTsJ","googleLink":"https://onlinelibrary.wiley.com/doi/abs/10.1111/bjh.16654","googleCitationCount":2,"googleAuthor":"","doi":"10.1111/bjh.16654","elsevierAuthor":"Rochau U.","publicationName":"British Journal of Haematology","elsevierCoverDate":"2020-11-01","elsevierCoverDisplayDate":"1 November 2020","elsevierCitationCount":"2"},{"title":"Redefining the prognostic likelihood of chronic lymphocytic leukaemia patients with borderline percentage of immunoglobulin variable heavy chain region mutations","googleId":"makp3ooRaRUJ","googleLink":"https://onlinelibrary.wiley.com/doi/abs/10.1111/bjh.16434","googleCitationCount":3,"googleAuthor":"","doi":"10.1111/bjh.16434","elsevierAuthor":"Raponi S.","publicationName":"British Journal of Haematology","elsevierCoverDate":"2020-06-01","elsevierCoverDisplayDate":"1 June 2020","elsevierCitationCount":"1"},{"title":"Brentuximab vedotin for the treatment of patients with relapsed or refractory Hodgkin lymphoma after autologous stem cell transplantation","googleId":"buJLMpIq2MEJ","googleLink":"https://onlinelibrary.wiley.com/doi/abs/10.1111/bjh.16201","googleCitationCount":6,"googleAuthor":"","doi":"10.1111/bjh.16201","elsevierAuthor":"Kaloyannidis P.","publicationName":"British Journal of Haematology","elsevierCoverDate":"2020-02-01","elsevierCoverDisplayDate":"1 February 2020","elsevierCitationCount":"3"},{"title":"ASXL1 mutations, previous vascular complications and age at diagnosis predict survival in 85 WHO‐defined polycythaemia vera patients","googleId":"KfOr_TvsA18J","googleLink":"https://onlinelibrary.wiley.com/doi/abs/10.1111/bjh.16450","googleCitationCount":3,"googleAuthor":"","doi":"10.1111/bjh.16450","elsevierAuthor":"Andréasson B.","publicationName":"British Journal of Haematology","elsevierCoverDate":"2020-06-01","elsevierCoverDisplayDate":"1 June 2020","elsevierCitationCount":"2"},{"title":"Reactive lymphocytes in patients with Covid‐19","googleId":"3Ox2uCROvFoJ","googleLink":"https://onlinelibrary.wiley.com/doi/abs/10.1111/bjh.16690","googleCitationCount":11,"googleAuthor":"BE Fan","doi":"10.1111/bjh.16690","elsevierAuthor":"Chong V.C.L.","publicationName":"British Journal of Haematology","elsevierCoverDate":"2020-06-01","elsevierCoverDisplayDate":"1 June 2020","elsevierCitationCount":"5"},{"title":"Fungal infections in children with haematologic malignancies and stem cell transplant recipients","googleId":"in7rhsAJ690J","googleLink":"https://onlinelibrary.wiley.com/doi/abs/10.1111/bjh.16452","googleCitationCount":3,"googleAuthor":"AM Green","doi":"10.1111/bjh.16452","elsevierAuthor":"Otto W.R.","publicationName":"British Journal of Haematology","elsevierCoverDate":"2020-05-01","elsevierCoverDisplayDate":"1 May 2020","elsevierCitationCount":"2"},{"title":"Blood utilisation and transfusion reactions in adult patients transfused with conventional or pathogen‐reduced platelets","googleId":"cFwBOSi90_sJ","googleLink":"https://onlinelibrary.wiley.com/doi/abs/10.1111/bjh.16187","googleCitationCount":6,"googleAuthor":"B Bahar","doi":"10.1111/bjh.16187","elsevierAuthor":"Bahar B.","publicationName":"British Journal of Haematology","elsevierCoverDate":"2020-02-01","elsevierCoverDisplayDate":"1 February 2020","elsevierCitationCount":"6"},{"title":"The impact of SOCS1 mutations in diffuse large B‐cell lymphoma","googleId":"0cq2EiNEoOIJ","googleLink":"https://onlinelibrary.wiley.com/doi/abs/10.1111/bjh.16147","googleCitationCount":5,"googleAuthor":"JK Lennerz","doi":"10.1111/bjh.16147","elsevierAuthor":"Mellert K.","publicationName":"British Journal of Haematology","elsevierCoverDate":"2019-12-01","elsevierCoverDisplayDate":"1 December 2019","elsevierCitationCount":"4"},{"title":"No excess long‐term mortality in stage I‐IIA Hodgkin lymphoma patients treated with ABVD and limited field radiotherapy","googleId":"41QR0zKFoyoJ","googleLink":"https://onlinelibrary.wiley.com/doi/abs/10.1111/bjh.16232","googleCitationCount":6,"googleAuthor":"H Holte","doi":"10.1111/bjh.16232","elsevierAuthor":"Lagerlöf I.","publicationName":"British Journal of Haematology","elsevierCoverDate":"2020-03-01","elsevierCoverDisplayDate":"1 March 2020","elsevierCitationCount":"4"},{"title":"Multiple myeloma treatment patterns and clinical outcomes in the Latin America Haemato‐Oncology (HOLA) Observational Study, 2008–2016","googleId":"UiVepyPbWvAJ","googleLink":"https://onlinelibrary.wiley.com/doi/abs/10.1111/bjh.16124","googleCitationCount":6,"googleAuthor":"","doi":"10.1111/bjh.16124","elsevierAuthor":"de Moraes Hungria V.T.","publicationName":"British Journal of Haematology","elsevierCoverDate":"2020-02-01","elsevierCoverDisplayDate":"1 February 2020","elsevierCitationCount":"6"},{"title":"The role of transplantation in Hodgkin lymphoma","googleId":"WiWXw-F7o9QJ","googleLink":"https://onlinelibrary.wiley.com/doi/abs/10.1111/bjh.15639","googleCitationCount":13,"googleAuthor":"PL Zinzani","doi":"10.1111/bjh.15639","elsevierAuthor":"Broccoli A.","publicationName":"British Journal of Haematology","elsevierCoverDate":"2019-01-01","elsevierCoverDisplayDate":"January 2019","elsevierCitationCount":"6"},{"title":"CBFA2T3‐GLIS2‐positive acute myeloid leukaemia. A peculiar paediatric entity","googleId":"mKyJAp9Ide4J","googleLink":"https://onlinelibrary.wiley.com/doi/abs/10.1111/bjh.15725","googleCitationCount":12,"googleAuthor":"R Masetti","doi":"10.1111/bjh.15725","elsevierAuthor":"Masetti R.","publicationName":"British Journal of Haematology","elsevierCoverDate":"2019-02-01","elsevierCoverDisplayDate":"Februaryy 2019","elsevierCitationCount":"8"},{"title":"Pro‐inflammatory cytokines favor the emergence of ETV6‐RUNX1‐positive pre‐leukemic cells in a model of mesenchymal niche","googleId":"knix3q8nVuAJ","googleLink":"https://onlinelibrary.wiley.com/doi/abs/10.1111/bjh.16523","googleCitationCount":3,"googleAuthor":"L Beneforti","doi":"10.1111/bjh.16523","elsevierCitationCount":0},{"title":"Paediatric haematologists' attitudes regarding haematopoietic cell transplantation as treatment for sickle cell disease","googleId":"AFVYK9ChUwAJ","googleLink":"https://onlinelibrary.wiley.com/doi/abs/10.1111/bjh.16248","googleCitationCount":4,"googleAuthor":"NS Majhail","doi":"10.1111/bjh.16248","elsevierAuthor":"Stallings A.M.","publicationName":"British Journal of Haematology","elsevierCoverDate":"2020-03-01","elsevierCoverDisplayDate":"1 March 2020","elsevierCitationCount":"1"},{"title":"First‐line treatment in older patients with Hodgkin lymphoma: a Surveillance, Epidemiology, and End Results (SEER)‐Medicare population‐based study","googleId":"Qe1puM358tkJ","googleLink":"https://onlinelibrary.wiley.com/doi/abs/10.1111/bjh.16525","googleCitationCount":2,"googleAuthor":"","doi":"10.1111/bjh.16525","elsevierAuthor":"Rodday A.M.","publicationName":"British Journal of Haematology","elsevierCoverDate":"2020-07-01","elsevierCoverDisplayDate":"1 July 2020","elsevierCitationCount":"0"},{"title":"The prevalence and associated mortality of non‐anaemic iron deficiency in older adults: a 14 years observational cohort study","googleId":"eyHE2tBVvcQJ","googleLink":"https://onlinelibrary.wiley.com/doi/abs/10.1111/bjh.16409","googleCitationCount":6,"googleAuthor":"KEJ Philip","doi":"10.1111/bjh.16409","elsevierCitationCount":0},{"title":"Haematological management of major bleeding associated with direct oral anticoagulants–UK experience","googleId":"Ud2sqY53MaAJ","googleLink":"https://onlinelibrary.wiley.com/doi/abs/10.1111/bjh.15808","googleCitationCount":10,"googleAuthor":"L Green","doi":"10.1111/bjh.15808","elsevierAuthor":"Green L.","publicationName":"British Journal of Haematology","elsevierCoverDate":"2019-05-01","elsevierCoverDisplayDate":"May 2019","elsevierCitationCount":"8"},{"title":"Lenalidomide and pomalidomide potently interfere with induction of myeloid‐derived suppressor cells in multiple myeloma","googleId":"bBgvg69eNz0J","googleLink":"https://onlinelibrary.wiley.com/doi/abs/10.1111/bjh.16881","googleCitationCount":3,"googleAuthor":"","doi":"10.1111/bjh.16881","elsevierCitationCount":0},{"title":"Advances in cellular and humoral immunotherapy–implications for the treatment of poor risk childhood, adolescent, and young adult B‐cell non‐Hodgkin lymphoma","googleId":"LRnN55Oeeb4J","googleLink":"https://onlinelibrary.wiley.com/doi/abs/10.1111/bjh.15753","googleCitationCount":9,"googleAuthor":"","doi":"10.1111/bjh.15753","elsevierCitationCount":0},{"title":"Effect of renin‐angiotensin‐aldosterone system blocking agents on progression of glomerulopathy in sickle cell disease","googleId":"ilBuyCepmQkJ","googleLink":"https://onlinelibrary.wiley.com/doi/abs/10.1111/bjh.15651","googleCitationCount":11,"googleAuthor":"P Maitra","doi":"10.1111/bjh.15651","elsevierAuthor":"Thrower A.","publicationName":"British Journal of Haematology","elsevierCoverDate":"2019-01-01","elsevierCoverDisplayDate":"January 2019","elsevierCitationCount":"7"},{"title":"Phase I dose-escalation trial investigating volasertib as monotherapy or in combination with cytarabine in patients with relapsed/refractory acute myeloid …","googleId":"inJeh289jGQJ","googleLink":"http://orca.cf.ac.uk/123126/1/OTTMANN%2C%20Oliver%20-%20Phase%20I%20dose-escalation%20trial%20investi.pdf","googleCitationCount":14,"googleAuthor":"C Müller-Tidow"},{"title":"Amustaline‐glutathione pathogen‐reduced red blood cell concentrates for transfusion‐dependent thalassaemia","googleId":"XN1K16zCafIJ","googleLink":"https://onlinelibrary.wiley.com/doi/abs/10.1111/bjh.15963","googleCitationCount":9,"googleAuthor":"A Piga","doi":"10.1111/bjh.15963","elsevierAuthor":"Aydinok Y.","publicationName":"British Journal of Haematology","elsevierCoverDate":"2019-01-01","elsevierCoverDisplayDate":"2019","elsevierCitationCount":"4"},{"title":"Acute lymphoblastic leukaemia patients treated with PEGasparaginase develop antibodies to PEG and the succinate linker","googleId":"QanZAM3X50sJ","googleLink":"https://onlinelibrary.wiley.com/doi/abs/10.1111/bjh.16254","googleCitationCount":4,"googleAuthor":"","doi":"10.1111/bjh.16254","elsevierCitationCount":0},{"title":"Analysis of the clinical impact of NPM1 mutant allele burden in a large cohort of younger adult patients with acute myeloid leukaemia","googleId":"cWb3FgLtfpEJ","googleLink":"https://onlinelibrary.wiley.com/doi/abs/10.1111/bjh.16239","googleCitationCount":6,"googleAuthor":"RK Hills","doi":"10.1111/bjh.16239","elsevierAuthor":"Linch D.C.","publicationName":"British Journal of Haematology","elsevierCoverDate":"2020-03-01","elsevierCoverDisplayDate":"1 March 2020","elsevierCitationCount":"4"},{"title":"Improved survival for adolescents and young adults with Hodgkin lymphoma and continued high survival for children in the Netherlands: a population‐based study …","googleId":"qOUpZl3oZXwJ","googleLink":"https://onlinelibrary.wiley.com/doi/abs/10.1111/bjh.16491","googleCitationCount":3,"googleAuthor":"","doi":"10.1111/bjh.16491","elsevierAuthor":"Reedijk A.M.J.","publicationName":"British Journal of Haematology","elsevierCoverDate":"2020-06-01","elsevierCoverDisplayDate":"1 June 2020","elsevierCitationCount":"2"},{"title":"Abnormal concentration of porphyrins in serum from COVID‐19 patients","googleId":"CvoRPxJzDm4J","googleLink":"https://onlinelibrary.wiley.com/doi/abs/10.1111/bjh.17060","googleCitationCount":3,"googleAuthor":"C Bruzzone","doi":"10.1111/bjh.17060","elsevierAuthor":"San Juan I.","publicationName":"British Journal of Haematology","elsevierCoverDate":"2020-09-01","elsevierCoverDisplayDate":"1 September 2020","elsevierCitationCount":"1"},{"title":"AML through the prism of molecular genetics","googleId":"7PKSw7uBVbAJ","googleLink":"https://onlinelibrary.wiley.com/doi/abs/10.1111/bjh.16356","googleCitationCount":6,"googleAuthor":"A Rio‐Machin","doi":"10.1111/bjh.16356","elsevierAuthor":"Charrot S.","publicationName":"British Journal of Haematology","elsevierCoverDate":"2020-01-01","elsevierCoverDisplayDate":"1 January 2020","elsevierCitationCount":"2"},{"title":"Triage tool for the rationing of blood for massively bleeding patients during a severe national blood shortage: guidance from the National Blood Transfusion …","googleId":"LOKzkR9PDSYJ","googleLink":"https://onlinelibrary.wiley.com/doi/abs/10.1111/bjh.16736","googleCitationCount":4,"googleAuthor":"L Green","doi":"10.1111/bjh.16736","elsevierAuthor":"Doughty H.","publicationName":"British Journal of Haematology","elsevierCoverDate":"2020-11-01","elsevierCoverDisplayDate":"1 November 2020","elsevierCitationCount":"3"},{"title":"Real‐world data on safety and efficacy of venetoclax‐based regimens in relapsed/refractory t (11; 14) multiple myeloma","googleId":"pyfKLnvOnXsJ","googleLink":"https://onlinelibrary.wiley.com/doi/abs/10.1111/bjh.16454","googleCitationCount":8,"googleAuthor":"R Chakraborty","doi":"10.1111/bjh.16454","elsevierAuthor":"Basali D.","publicationName":"British Journal of Haematology","elsevierCoverDate":"2020-06-01","elsevierCoverDisplayDate":"1 June 2020","elsevierCitationCount":"5"},{"title":"A 24‐year experience of autologous stem cell transplantation for light chain amyloidosis patients in the United Kingdom","googleId":"vJnbHD5fPJUJ","googleLink":"https://onlinelibrary.wiley.com/doi/abs/10.1111/bjh.16143","googleCitationCount":10,"googleAuthor":"","doi":"10.1111/bjh.16143","elsevierAuthor":"Sharpley F.A.","publicationName":"British Journal of Haematology","elsevierCoverDate":"2019-12-01","elsevierCoverDisplayDate":"1 December 2019","elsevierCitationCount":"8"},{"title":"Frequent false‐negative FIP1L1‐PDGFRA FISH analyses of bone marrow samples from clonal eosinophilia at diagnosis","googleId":"YaUj4mq-hMgJ","googleLink":"https://onlinelibrary.wiley.com/doi/abs/10.1111/bjh.16340","googleCitationCount":5,"googleAuthor":"","doi":"10.1111/bjh.16340","elsevierAuthor":"Olsson-Arvidsson L.","publicationName":"British Journal of Haematology","elsevierCoverDate":"2020-03-01","elsevierCoverDisplayDate":"1 March 2020","elsevierCitationCount":"5"},{"title":"Checkpoint inhibitors in AML: are we there yet?","googleId":"T6-EGge0kCoJ","googleLink":"https://onlinelibrary.wiley.com/doi/abs/10.1111/bjh.16358","googleCitationCount":4,"googleAuthor":"A Ghosh","doi":"10.1111/bjh.16358","elsevierAuthor":"Ghosh A.","publicationName":"British Journal of Haematology","elsevierCoverDate":"2020-01-01","elsevierCoverDisplayDate":"1 January 2020","elsevierCitationCount":"2"},{"title":"Heterogeneity in reporting venous thromboembolic phenotypes in COVID‐19: methodological issues and clinical implications","googleId":"jiHKNkqPW2UJ","googleLink":"https://onlinelibrary.wiley.com/doi/abs/10.1111/bjh.16993","googleCitationCount":5,"googleAuthor":"A Kollias","doi":"10.1111/bjh.16993","elsevierAuthor":"Kollias A.","publicationName":"British Journal of Haematology","elsevierCoverDate":"2020-08-01","elsevierCoverDisplayDate":"1 August 2020","elsevierCitationCount":"4"},{"title":"Mesenchymal stem cells gene signature in high‐risk myeloma bone marrow linked to suppression of distinct IGFBP2‐expressing small adipocytes","googleId":"ErPM4yIwcBIJ","googleLink":"https://onlinelibrary.wiley.com/doi/abs/10.1111/bjh.15669","googleCitationCount":10,"googleAuthor":"SJ Mehdi","doi":"10.1111/bjh.15669","elsevierAuthor":"Mehdi S.J.","publicationName":"British Journal of Haematology","elsevierCoverDate":"2019-02-01","elsevierCoverDisplayDate":"Februaryy 2019","elsevierCitationCount":"6"},{"title":"DPEP1 expression promotes proliferation and survival of leukaemia cells and correlates with relapse in adults with common B cell acute lymphoblastic leukaemia","googleId":"k52KnSdRBzoJ","googleLink":"https://onlinelibrary.wiley.com/doi/abs/10.1111/bjh.16505","googleCitationCount":2,"googleAuthor":"RP Gale","doi":"10.1111/bjh.16505","elsevierAuthor":"Zhang J.M.","publicationName":"British Journal of Haematology","elsevierCoverDate":"2020-07-01","elsevierCoverDisplayDate":"1 July 2020","elsevierCitationCount":"1"},{"title":"Life expectancy of follicular lymphoma patients in complete response at 30 months is similar to that of the Spanish general population","googleId":"_4fRxyIuZ-EJ","googleLink":"https://onlinelibrary.wiley.com/doi/abs/10.1111/bjh.15805","googleCitationCount":9,"googleAuthor":"L Magnano","doi":"10.1111/bjh.15805","elsevierAuthor":"Magnano L.","publicationName":"British Journal of Haematology","elsevierCoverDate":"2019-05-01","elsevierCoverDisplayDate":"May 2019","elsevierCitationCount":"7"},{"title":"Next‐generation sequencing for measurable residual disease detection in acute myeloid leukaemia","googleId":"W5EaY9GhkwQJ","googleLink":"https://onlinelibrary.wiley.com/doi/abs/10.1111/bjh.16362","googleCitationCount":4,"googleAuthor":"J Ghannam","doi":"10.1111/bjh.16362","elsevierAuthor":"Ghannam J.","publicationName":"British Journal of Haematology","elsevierCoverDate":"2020-01-01","elsevierCoverDisplayDate":"1 January 2020","elsevierCitationCount":"1"},{"title":"Modified diagnostic criteria, grading classification and newly elucidated pathophysiology of hepatic SOS/VOD after haematopoietic cell transplantation","googleId":"ut3R6iFUtIkJ","googleLink":"https://onlinelibrary.wiley.com/doi/abs/10.1111/bjh.16557","googleCitationCount":4,"googleAuthor":"","doi":"10.1111/bjh.16557","elsevierAuthor":"Cairo M.S.","publicationName":"British Journal of Haematology","elsevierCoverDate":"2020-09-01","elsevierCoverDisplayDate":"1 September 2020","elsevierCitationCount":"1"},{"title":"Clinical outcome and prognostic factors of patients with Richter syndrome: real‐world study of the Spanish Chronic Lymphocytic Leukemia Study Group (GELLC)","googleId":"lctj2-S-A_8J","googleLink":"https://onlinelibrary.wiley.com/doi/abs/10.1111/bjh.16748","googleCitationCount":5,"googleAuthor":"J Delgado","doi":"10.1111/bjh.16748","elsevierAuthor":"Abrisqueta P.","publicationName":"British Journal of Haematology","elsevierCoverDate":"2020-09-01","elsevierCoverDisplayDate":"1 September 2020","elsevierCitationCount":"2"},{"title":"Long‐term survivors of childhood, adolescent and young adult non‐Hodgkin lymphoma","googleId":"PXh7WGi7uHwJ","googleLink":"https://onlinelibrary.wiley.com/doi/abs/10.1111/bjh.15775","googleCitationCount":9,"googleAuthor":"","doi":"10.1111/bjh.15775","elsevierAuthor":"Ehrhardt M.J.","publicationName":"British Journal of Haematology","elsevierCoverDate":"2019-06-01","elsevierCoverDisplayDate":"June 2019","elsevierCitationCount":"5"},{"title":"Molecular and clinical features of myeloid neoplasms with somatic DDX41 mutations","googleId":"dit2Xt01vn4J","googleLink":"https://onlinelibrary.wiley.com/doi/abs/10.1111/bjh.16668","googleCitationCount":3,"googleAuthor":"","doi":"10.1111/bjh.16668","elsevierAuthor":"Qu S.","publicationName":"British Journal of Haematology","elsevierCoverDate":"2020-01-01","elsevierCoverDisplayDate":"2020","elsevierCitationCount":"0"},{"title":"Chronic medical conditions and late effects following non‐Hodgkin lymphoma in HIV‐uninfected and HIV‐infected adolescents and young adults: a population‐based …","googleId":"VidOFfV4vXIJ","googleLink":"https://onlinelibrary.wiley.com/doi/abs/10.1111/bjh.16539","googleCitationCount":2,"googleAuthor":"","doi":"10.1111/bjh.16539","elsevierAuthor":"Abrahão R.","publicationName":"British Journal of Haematology","elsevierCoverDate":"2020-08-01","elsevierCoverDisplayDate":"1 August 2020","elsevierCitationCount":"1"},{"title":"Comparison of effects of midostaurin, crenolanib, quizartinib, gilteritinib, sorafenib and BLU‐285 on oncogenic mutants of KIT, CBL and FLT3 in haematological …","googleId":"S0bP3TyZtigJ","googleLink":"https://onlinelibrary.wiley.com/doi/abs/10.1111/bjh.16092","googleCitationCount":8,"googleAuthor":"","doi":"10.1111/bjh.16092","elsevierAuthor":"Weisberg E.","publicationName":"British Journal of Haematology","elsevierCoverDate":"2019-11-01","elsevierCoverDisplayDate":"1 November 2019","elsevierCitationCount":"6"},{"title":"Primary prevention of venous thromboembolism with apixaban for multiple myeloma patients receiving immunomodulatory agents","googleId":"PIf509p2LO4J","googleLink":"https://onlinelibrary.wiley.com/doi/abs/10.1111/bjh.16653","googleCitationCount":3,"googleAuthor":"","doi":"10.1111/bjh.16653","elsevierAuthor":"Cornell R.F.","publicationName":"British Journal of Haematology","elsevierCoverDate":"2020-08-01","elsevierCoverDisplayDate":"1 August 2020","elsevierCitationCount":"2"},{"title":"Mature B‐NHL in children, adolescents and young adults: current therapeutic approach and emerging treatment strategies","googleId":"2oCk6p00_UUJ","googleLink":"https://onlinelibrary.wiley.com/doi/abs/10.1111/bjh.15734","googleCitationCount":7,"googleAuthor":"","doi":"10.1111/bjh.15734","elsevierAuthor":"Egan G.","publicationName":"British Journal of Haematology","elsevierCoverDate":"2019-06-01","elsevierCoverDisplayDate":"June 2019","elsevierCitationCount":"8"},{"title":"Failure of rituximab is associated with a poor outcome in diffuse large B cell lymphoma‐type post‐transplant lymphoproliferative disorder","googleId":"JjY9S-lSWd0J","googleLink":"https://onlinelibrary.wiley.com/doi/abs/10.1111/bjh.16304","googleCitationCount":4,"googleAuthor":"Z Liu","doi":"10.1111/bjh.16304","elsevierAuthor":"Jain M.D.","publicationName":"British Journal of Haematology","elsevierCoverDate":"2020-04-01","elsevierCoverDisplayDate":"1 April 2020","elsevierCitationCount":"3"},{"title":"Bortezomib maintenance after R‐CHOP, cytarabine and autologous stem cell transplantation in newly diagnosed patients with mantle cell lymphoma, results of a …","googleId":"x7xMtWKY4LsJ","googleLink":"https://onlinelibrary.wiley.com/doi/abs/10.1111/bjh.16567","googleCitationCount":3,"googleAuthor":"JM Zijlstra","doi":"10.1111/bjh.16567","elsevierAuthor":"Doorduijn J.K.","publicationName":"British Journal of Haematology","elsevierCoverDate":"2020-08-01","elsevierCoverDisplayDate":"1 August 2020","elsevierCitationCount":"3"},{"title":"Single and combined BTK and PI3Kδ inhibition with acalabrutinib and ACP‐319 in pre‐clinical models of aggressive lymphomas","googleId":"_K5xYSkdAXMJ","googleLink":"https://onlinelibrary.wiley.com/doi/abs/10.1111/bjh.16118","googleCitationCount":5,"googleAuthor":"F Spriano","doi":"10.1111/bjh.16118","elsevierAuthor":"Spriano F.","publicationName":"British Journal of Haematology","elsevierCoverDate":"2019-12-01","elsevierCoverDisplayDate":"1 December 2019","elsevierCitationCount":"3"},{"title":"Immunoglobulin heavy variable somatic hyper mutation status in chronic lymphocytic leukaemia: on the threshold of a new era?","googleId":"8BsTHa4tqwsJ","googleLink":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7318593/","googleCitationCount":3,"googleAuthor":"","doi":"10.1111/bjh.16480","elsevierAuthor":"Langerak A.W.","publicationName":"British Journal of Haematology","elsevierCoverDate":"2020-06-01","elsevierCoverDisplayDate":"1 June 2020","elsevierCitationCount":"1"},{"title":"Evaluation of the PIK3 pathway in peripheral T‐cell lymphoma and NK/T‐cell lymphoma","googleId":"8p8UceJRJwIJ","googleLink":"https://onlinelibrary.wiley.com/doi/abs/10.1111/bjh.16435","googleCitationCount":4,"googleAuthor":"D Huang","doi":"10.1111/bjh.16435","elsevierAuthor":"Huang D.","publicationName":"British Journal of Haematology","elsevierCoverDate":"2020-05-01","elsevierCoverDisplayDate":"1 May 2020","elsevierCitationCount":"2"},{"title":"Clonal hierarchy of main molecular lesions in acute myeloid leukaemia","googleId":"V5UmzraEOZcJ","googleLink":"https://onlinelibrary.wiley.com/doi/abs/10.1111/bjh.16341","googleCitationCount":5,"googleAuthor":"","doi":"10.1111/bjh.16341","elsevierAuthor":"Herudkova Z.","publicationName":"British Journal of Haematology","elsevierCoverDate":"2020-08-01","elsevierCoverDisplayDate":"1 August 2020","elsevierCitationCount":"3"},{"title":"Impact of age, sex, ethnicity, socio‐economic deprivation and novel pharmaceuticals on the overall survival of patients with multiple myeloma in New Zealand","googleId":"wF1z4_9zHAIJ","googleLink":"https://onlinelibrary.wiley.com/doi/abs/10.1111/bjh.16238","googleCitationCount":4,"googleAuthor":"RJ Milne","doi":"10.1111/bjh.16238","elsevierAuthor":"Chan H.S.H.","publicationName":"British Journal of Haematology","elsevierCoverDate":"2020-03-01","elsevierCoverDisplayDate":"1 March 2020","elsevierCitationCount":"4"},{"title":"Interleukin‐1 receptor‐associated kinase 4 inhibitor interrupts toll‐like receptor signalling and sensitizes chronic lymphocytic leukaemia cells to apoptosis","googleId":"sbFpCtYItb4J","googleLink":"https://onlinelibrary.wiley.com/doi/abs/10.1111/bjh.16386","googleCitationCount":2,"googleAuthor":"","doi":"10.1111/bjh.16386","elsevierAuthor":"Delvecchio V.S.","publicationName":"British Journal of Haematology","elsevierCoverDate":"2020-05-01","elsevierCoverDisplayDate":"1 May 2020","elsevierCitationCount":"2"},{"title":"Monoclonal gammopathy and serum immunoglobulin levels as prognostic factors in chronic lymphocytic leukaemia","googleId":"w9TF0aeZDB8J","googleLink":"https://onlinelibrary.wiley.com/doi/abs/10.1111/bjh.16975","googleCitationCount":3,"googleAuthor":"","doi":"10.1111/bjh.16975","elsevierAuthor":"Corbingi A.","publicationName":"British Journal of Haematology","elsevierCoverDate":"2020-09-01","elsevierCoverDisplayDate":"1 September 2020","elsevierCitationCount":"1"},{"title":"Second‐line treatment trends and long‐term outcomes of 392 children with chronic immune thrombocytopenic purpura: the French experience over the past 25 years","googleId":"QzLPc7G7xooJ","googleLink":"https://onlinelibrary.wiley.com/doi/abs/10.1111/bjh.16448","googleCitationCount":2,"googleAuthor":"","doi":"10.1111/bjh.16448","elsevierAuthor":"Ducassou S.","publicationName":"British Journal of Haematology","elsevierCoverDate":"2020-06-01","elsevierCoverDisplayDate":"1 June 2020","elsevierCitationCount":"1"},{"title":"Transformed mucosa‐associated lymphoid tissue lymphomas: A single institution retrospective study including polymerase chain reaction‐based clonality analysis","googleId":"3ClPP8HH5NYJ","googleLink":"https://onlinelibrary.wiley.com/doi/abs/10.1111/bjh.15953","googleCitationCount":6,"googleAuthor":"","doi":"10.1111/bjh.15953","elsevierAuthor":"Kiesewetter B.","publicationName":"British Journal of Haematology","elsevierCoverDate":"2019-08-01","elsevierCoverDisplayDate":"August 2019","elsevierCitationCount":"4"},{"title":"Human leukocyte antigen (HLA) class I antibodies and transfusion support in paediatric HLA‐matched haematopoietic cell transplant for sickle cell disease","googleId":"DE0GJL3ZqusJ","googleLink":"https://onlinelibrary.wiley.com/doi/abs/10.1111/bjh.16298","googleCitationCount":4,"googleAuthor":"","doi":"10.1111/bjh.16298","elsevierAuthor":"Nickel R.S.","publicationName":"British Journal of Haematology","elsevierCoverDate":"2020-04-01","elsevierCoverDisplayDate":"1 April 2020","elsevierCitationCount":"4"},{"title":"Fatigue, executive function and psychological effects in children with immune thrombocytopenia: a cross‐sectional study","googleId":"l86vf6xpqVkJ","googleLink":"https://onlinelibrary.wiley.com/doi/abs/10.1111/bjh.16387","googleCitationCount":2,"googleAuthor":"","doi":"10.1111/bjh.16387","elsevierAuthor":"Towner S.","publicationName":"British Journal of Haematology","elsevierCoverDate":"2020-05-01","elsevierCoverDisplayDate":"1 May 2020","elsevierCitationCount":"2"},{"title":"Estimating a normal reference range for serum B‐cell maturation antigen levels for multiple myeloma patients","googleId":"l90tUajMxloJ","googleLink":"https://onlinelibrary.wiley.com/doi/abs/10.1111/bjh.16673","googleCitationCount":3,"googleAuthor":"","doi":"10.1111/bjh.16673","elsevierAuthor":"Jew S.","publicationName":"British Journal of Haematology","elsevierCoverDate":"2020-01-01","elsevierCoverDisplayDate":"2020","elsevierCitationCount":"3"},{"title":"Influence of donor type, stem cell source and conditioning on outcomes after haploidentical transplant for lymphoma–a LWP‐EBMT study","googleId":"Z-8cvL4sdoIJ","googleLink":"https://onlinelibrary.wiley.com/doi/abs/10.1111/bjh.16182","googleCitationCount":6,"googleAuthor":"","doi":"10.1111/bjh.16182","elsevierAuthor":"Bazarbachi A.","publicationName":"British Journal of Haematology","elsevierCoverDate":"2020-03-01","elsevierCoverDisplayDate":"1 March 2020","elsevierCitationCount":"6"},{"title":"Allogeneic stem cell transplantation in AML with t(6;9)(p23;q34);DEK‐NUP214 shows a favourable outcome when performed in first complete remission","googleId":"yoYasFNOnP0J","googleLink":"https://onlinelibrary.wiley.com/doi/abs/10.1111/bjh.16433","googleCitationCount":4,"googleAuthor":"","doi":"10.1111/bjh.16433","elsevierAuthor":"","publicationName":"British Journal of Haematology","elsevierCoverDate":"2021-01-01","elsevierCoverDisplayDate":"January 2021","elsevierCitationCount":"0"},{"title":"Molecular mechanisms for thrombosis risk in Black people: a role in excess mortality from COVID‐19","googleId":"b45xGhhZsU0J","googleLink":"https://onlinelibrary.wiley.com/doi/abs/10.1111/bjh.16869","googleCitationCount":5,"googleAuthor":"","doi":"10.1111/bjh.16869","elsevierAuthor":"Ramasamy R.","publicationName":"British Journal of Haematology","elsevierCoverDate":"2020-07-01","elsevierCoverDisplayDate":"1 July 2020","elsevierCitationCount":"3"},{"title":"Patients aged less than 3 years with acute myeloid leukaemia characterize a molecularly and clinically distinct subgroup","googleId":"TsXXF_67c7QJ","googleLink":"https://onlinelibrary.wiley.com/doi/abs/10.1111/bjh.16203","googleCitationCount":6,"googleAuthor":"","doi":"10.1111/bjh.16203","elsevierAuthor":"Hara Y.","publicationName":"British Journal of Haematology","elsevierCoverDate":"2020-02-01","elsevierCoverDisplayDate":"1 February 2020","elsevierCitationCount":"2"},{"title":"Treatment of relapsed/refractory paediatric aggressive B‐cell non‐Hodgkin lymphoma","googleId":"TKwiuntVLhwJ","googleLink":"https://onlinelibrary.wiley.com/doi/abs/10.1111/bjh.16461","googleCitationCount":2,"googleAuthor":"","doi":"10.1111/bjh.16461","elsevierAuthor":"Moleti M.L.","publicationName":"British Journal of Haematology","elsevierCoverDate":"2020-06-01","elsevierCoverDisplayDate":"1 June 2020","elsevierCitationCount":"1"},{"title":"The Wee1 kinase inhibitor MK1775 suppresses cell growth, attenuates stemness and synergises with bortezomib in multiple myeloma","googleId":"V2NCfIMpbfcJ","googleLink":"https://onlinelibrary.wiley.com/doi/abs/10.1111/bjh.16614","googleCitationCount":2,"googleAuthor":"","doi":"10.1111/bjh.16614","elsevierAuthor":"Liang L.","publicationName":"British Journal of Haematology","elsevierCoverDate":"2020-10-01","elsevierCoverDisplayDate":"1 October 2020","elsevierCitationCount":"1"},{"title":"Sustained treatment‐free remission in chronic myeloid leukaemia is associated with an increased frequency of innate CD8 (+) T‐cells","googleId":"RvEekaP14gEJ","googleLink":"https://onlinelibrary.wiley.com/doi/abs/10.1111/bjh.15858","googleCitationCount":7,"googleAuthor":"","doi":"10.1111/bjh.15858","elsevierAuthor":"Cayssials E.","publicationName":"British Journal of Haematology","elsevierCoverDate":"2019-07-01","elsevierCoverDisplayDate":"July 2019","elsevierCitationCount":"6"},{"title":"Incorporating acalabrutinib, a selective next‐generation Bruton tyrosine kinase inhibitor, into clinical practice for the treatment of haematological malignancies","googleId":"Z_ZpyUvEqoMJ","googleLink":"https://onlinelibrary.wiley.com/doi/abs/10.1111/bjh.17184","googleCitationCount":5,"googleAuthor":"","doi":"10.1111/bjh.17184","elsevierAuthor":"Danilov A.V.","publicationName":"British Journal of Haematology","elsevierCoverDate":"2020-01-01","elsevierCoverDisplayDate":"2020","elsevierCitationCount":"2"},{"title":"Three-year outcomes with brentuximab vedotin plus bendamustine as first salvage therapy in relapsed or refractory Hodgkin lymphoma","googleId":"DTf-bJ7rdBsJ","googleLink":"https://mayoclinic.pure.elsevier.com/en/publications/three-year-outcomes-with-brentuximab-vedotin-plus-bendamustine-as","googleCitationCount":3,"googleAuthor":"","doi":"10.1111/bjh.16499","elsevierAuthor":"LaCasce A.S.","publicationName":"British Journal of Haematology","elsevierCoverDate":"2020-05-01","elsevierCoverDisplayDate":"1 May 2020","elsevierCitationCount":"3"},{"title":"Immune thrombocytopenia flare with mild COVID‐19 infection in pregnancy: A case report","googleId":"fZHp3k8Sz0gJ","googleLink":"https://onlinelibrary.wiley.com/doi/abs/10.1111/bjh.16928","googleCitationCount":4,"googleAuthor":"","doi":"10.1111/bjh.16928","elsevierAuthor":"Nesr G.","publicationName":"British Journal of Haematology","elsevierCoverDate":"2020-08-01","elsevierCoverDisplayDate":"1 August 2020","elsevierCitationCount":"3"},{"title":"Early T precursor acute lymphoblastic leukaemia/lymphoma shows differential immunophenotypic characteristics including frequent CD33 expression and in vitro …","googleId":"HB9UoXEbZMYJ","googleLink":"https://onlinelibrary.wiley.com/doi/abs/10.1111/bjh.15960","googleCitationCount":6,"googleAuthor":"","doi":"10.1111/bjh.15960","elsevierAuthor":"Khogeer H.","publicationName":"British Journal of Haematology","elsevierCoverDate":"2019-01-01","elsevierCoverDisplayDate":"2019","elsevierCitationCount":"5"},{"title":"Outcome of CARE: a 6‐year national registry of acquired haemophilia A in China","googleId":"Zc9imEHb6fUJ","googleLink":"https://onlinelibrary.wiley.com/doi/abs/10.1111/bjh.16128","googleCitationCount":5,"googleAuthor":"","doi":"10.1111/bjh.16128","elsevierAuthor":"Sun B.","publicationName":"British Journal of Haematology","elsevierCoverDate":"2019-12-01","elsevierCoverDisplayDate":"1 December 2019","elsevierCitationCount":"4"},{"title":"Distinctive and common features of moderate aplastic anaemia","googleId":"ILNDFcz0OOYJ","googleLink":"https://onlinelibrary.wiley.com/doi/abs/10.1111/bjh.16460","googleCitationCount":2,"googleAuthor":"","doi":"10.1111/bjh.16460","elsevierAuthor":"Patel B.J.","publicationName":"British Journal of Haematology","elsevierCoverDate":"2020-06-01","elsevierCoverDisplayDate":"1 June 2020","elsevierCitationCount":"2"},{"title":"Bleeding and bruising in Osteogenesis Imperfecta: International Society on Thrombosis and Haemostasis bleeding assessment tool and haemostasis laboratory …","googleId":"DLbwJeSGK_QJ","googleLink":"https://onlinelibrary.wiley.com/doi/abs/10.1111/bjh.16097","googleCitationCount":7,"googleAuthor":"","doi":"10.1111/bjh.16097","elsevierAuthor":"Gooijer K.","publicationName":"British Journal of Haematology","elsevierCoverDate":"2019-11-01","elsevierCoverDisplayDate":"1 November 2019","elsevierCitationCount":"3"},{"title":"Excellent outcomes in children and adolescents with CNS+ Burkitt lymphoma or other mature B‐NHL using only intrathecal and systemic chemoimmunotherapy …","googleId":"soGeHOisZtsJ","googleLink":"https://onlinelibrary.wiley.com/doi/abs/10.1111/bjh.15520?","googleCitationCount":11,"googleAuthor":"","doi":"10.1111/bjh.15520","elsevierAuthor":"Frazer J.K.","publicationName":"British Journal of Haematology","elsevierCoverDate":"2019-04-01","elsevierCoverDisplayDate":"April 2019","elsevierCitationCount":"9"},{"title":"Pre‐transplant short telomeres are associated with high mortality risk after unrelated donor haematopoietic cell transplant for severe aplastic anaemia","googleId":"jTruCPoPGkkJ","googleLink":"https://onlinelibrary.wiley.com/doi/abs/10.1111/bjh.16153","googleCitationCount":4,"googleAuthor":"Y Wang","doi":"10.1111/bjh.16153","elsevierAuthor":"Wang Y.","publicationName":"British Journal of Haematology","elsevierCoverDate":"2020-01-01","elsevierCoverDisplayDate":"1 January 2020","elsevierCitationCount":"3"},{"title":"Second primary malignancy in myelofibrosis patients treated with ruxolitinib","googleId":"2w9bAZKTYvsJ","googleLink":"https://onlinelibrary.wiley.com/doi/abs/10.1111/bjh.17192","googleCitationCount":4,"googleAuthor":"N Polverelli","doi":"10.1111/bjh.17192","elsevierAuthor":"Polverelli N.","publicationName":"British Journal of Haematology","elsevierCoverDate":"2020-01-01","elsevierCoverDisplayDate":"2020","elsevierCitationCount":"1"},{"title":"Autoimmune conditions and primary central nervous system lymphoma risk among older adults","googleId":"RuZErt4oBggJ","googleLink":"https://onlinelibrary.wiley.com/doi/abs/10.1111/bjh.16222","googleCitationCount":4,"googleAuthor":"P Mahale","doi":"10.1111/bjh.16222","elsevierAuthor":"Mahale P.","publicationName":"British Journal of Haematology","elsevierCoverDate":"2020-02-01","elsevierCoverDisplayDate":"1 February 2020","elsevierCitationCount":"2"},{"title":"FLA-IDA salvage chemotherapy combined with a seven-day course of venetoclax (FLAVIDA) in patients with relapsed/refractory acute leukaemia","googleId":"H97vnN96IFYJ","googleLink":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7116720/","googleCitationCount":5,"googleAuthor":""},{"title":"From bench to bedside: The past, present and future of therapy for systemic paediatric ALCL, ALK+","googleId":"8YRX6-hWIlUJ","googleLink":"https://onlinelibrary.wiley.com/doi/abs/10.1111/bjh.15763","googleCitationCount":8,"googleAuthor":"","doi":"10.1111/bjh.15763","elsevierAuthor":"Larose H.","publicationName":"British Journal of Haematology","elsevierCoverDate":"2019-06-01","elsevierCoverDisplayDate":"June 2019","elsevierCitationCount":"4"},{"title":"Enduring efficacy and tolerability of daratumumab in combination with lenalidomide and dexamethasone in patients with relapsed or relapsed/refractory multiple …","googleId":"-oZ_xw4Zi2YJ","googleLink":"https://pubmed.ncbi.nlm.nih.gov/30931524/","googleCitationCount":8,"googleAuthor":"T Plesner","doi":"10.1111/bjh.15879,","elsevierAuthor":"Plesner T.","publicationName":"British Journal of Haematology","elsevierCoverDate":"2019-08-01","elsevierCoverDisplayDate":"August 2019","elsevierCitationCount":"6"},{"title":"G‐CSF administration prior to donor lymphocyte apheresis promotes anti‐leukaemic effects in allogeneic HCT patients","googleId":"K8upFTM4pXoJ","googleLink":"https://onlinelibrary.wiley.com/doi/abs/10.1111/bjh.15881","googleCitationCount":6,"googleAuthor":"","doi":"10.1111/bjh.15881","elsevierAuthor":"Schneidawind C.","publicationName":"British Journal of Haematology","elsevierCoverDate":"2019-07-01","elsevierCoverDisplayDate":"July 2019","elsevierCitationCount":"3"},{"title":"Intermittent granulocyte maturation arrest, hypocellular bone marrow, and episodic normal neutrophil count can be associated with SRP54 mutations causing …","googleId":"IhzzkQ6E9swJ","googleLink":"https://pubmed.ncbi.nlm.nih.gov/32196641/","googleCitationCount":4,"googleAuthor":"","doi":"10.1111/bjh.16585,","elsevierAuthor":"Saettini F.","publicationName":"British Journal of Haematology","elsevierCoverDate":"2020-05-01","elsevierCoverDisplayDate":"1 May 2020","elsevierCitationCount":"3"},{"title":"FAS‐mediated apoptosis impairment in patients with ALPS/ALPS‐like phenotype carrying variants on CASP10 gene","googleId":"7BwThGR5bhcJ","googleLink":"https://onlinelibrary.wiley.com/doi/abs/10.1111/bjh.16098","googleCitationCount":7,"googleAuthor":"","doi":"10.1111/bjh.16098","elsevierAuthor":"Miano M.","publicationName":"British Journal of Haematology","elsevierCoverDate":"2019-11-01","elsevierCoverDisplayDate":"1 November 2019","elsevierCitationCount":"5"},{"title":"Clinical and biological features of paediatric acute myeloid leukaemia (AML) with primary induction failure in the Japanese Paediatric Leukaemia/Lymphoma Study …","googleId":"P1orXyTp0xYJ","googleLink":"https://onlinelibrary.wiley.com/doi/abs/10.1111/bjh.15799","googleCitationCount":7,"googleAuthor":"","doi":"10.1111/bjh.15799","elsevierAuthor":"Miyamura T.","publicationName":"British Journal of Haematology","elsevierCoverDate":"2019-04-01","elsevierCoverDisplayDate":"April 2019","elsevierCitationCount":"5"},{"title":"Fostamatinib is an effective second‐line therapy in patients with immune thrombocytopenia","googleId":"If-4sSGCQuAJ","googleLink":"https://onlinelibrary.wiley.com/doi/abs/10.1111/bjh.16959","googleCitationCount":3,"googleAuthor":"N Cooper","doi":"10.1111/bjh.16959","elsevierAuthor":"Boccia R.","publicationName":"British Journal of Haematology","elsevierCoverDate":"2020-09-01","elsevierCoverDisplayDate":"1 September 2020","elsevierCitationCount":"1"},{"title":"Regulation of iron homeostasis through the erythroferrone‐hepcidin axis in sickle cell disease","googleId":"T2IR0ZeCvrMJ","googleLink":"https://onlinelibrary.wiley.com/doi/abs/10.1111/bjh.16498","googleCitationCount":2,"googleAuthor":"AA Mangaonkar","doi":"10.1111/bjh.16498","elsevierAuthor":"Mangaonkar A.A.","publicationName":"British Journal of Haematology","elsevierCoverDate":"2020-06-01","elsevierCoverDisplayDate":"1 June 2020","elsevierCitationCount":"2"},{"title":"GDF11 contributes to hepatic hepcidin (HAMP) inhibition through SMURF1‐mediated BMP‐SMAD signalling suppression","googleId":"Ga8zru6mECAJ","googleLink":"https://onlinelibrary.wiley.com/doi/abs/10.1111/bjh.16156","googleCitationCount":4,"googleAuthor":"","doi":"10.1111/bjh.16156","elsevierAuthor":"Fang Z.","publicationName":"British Journal of Haematology","elsevierCoverDate":"2020-01-01","elsevierCoverDisplayDate":"1 January 2020","elsevierCitationCount":"4"},{"title":"Substratification of patients with newly diagnosed standard‐risk multiple myeloma","googleId":"3kcq3wec3QsJ","googleLink":"https://onlinelibrary.wiley.com/doi/abs/10.1111/bjh.15800","googleCitationCount":6,"googleAuthor":"M Binder","doi":"10.1111/bjh.15800","elsevierAuthor":"Binder M.","publicationName":"British Journal of Haematology","elsevierCoverDate":"2019-04-01","elsevierCoverDisplayDate":"April 2019","elsevierCitationCount":"3"},{"title":"Position paper on International Collaboration for Transfusion Medicine (ICTM) Guideline 'Red blood cell specifications for patients with hemoglobinopathies: a …","googleId":"AAKmGaXexIwJ","googleLink":"https://onlinelibrary.wiley.com/doi/abs/10.1111/bjh.16405","googleCitationCount":3,"googleAuthor":"","doi":"10.1111/bjh.16405","elsevierAuthor":"Trompeter S.","publicationName":"British Journal of Haematology","elsevierCoverDate":"2020-05-01","elsevierCoverDisplayDate":"1 May 2020","elsevierCitationCount":"3"},{"title":"Multicentre retrospective study of intravascular large B‐cell lymphoma treated at academic institutions within the United States","googleId":"yd5ZyYY_5B4J","googleLink":"https://onlinelibrary.wiley.com/doi/abs/10.1111/bjh.15923","googleCitationCount":6,"googleAuthor":"E Roberts","doi":"10.1111/bjh.15923","elsevierAuthor":"Geer M.","publicationName":"British Journal of Haematology","elsevierCoverDate":"2019-07-01","elsevierCoverDisplayDate":"July 2019","elsevierCitationCount":"4"},{"title":"Midostaurin abrogates CD 33‐directed Uni CAR and CD 33‐CD 3 bispecific antibody therapy in acute myeloid leukaemia","googleId":"jftqVoTJjCUJ","googleLink":"https://onlinelibrary.wiley.com/doi/abs/10.1111/bjh.15975","googleCitationCount":7,"googleAuthor":"C Arndt","doi":"10.1111/bjh.15975","elsevierAuthor":"Fasslrinner F.","publicationName":"British Journal of Haematology","elsevierCoverDate":"2019-01-01","elsevierCoverDisplayDate":"2019","elsevierCitationCount":"7"},{"title":"Hydroxycarbamide treatment in children with Sickle Cell Anaemia is associated with more intact white matter integrity: a quantitative MRI study","googleId":"3IzQEavIj54J","googleLink":"https://onlinelibrary.wiley.com/doi/abs/10.1111/bjh.16063","googleCitationCount":5,"googleAuthor":"","doi":"10.1111/bjh.16063","elsevierAuthor":"Kapustin D.","publicationName":"British Journal of Haematology","elsevierCoverDate":"2019-10-01","elsevierCoverDisplayDate":"1 October 2019","elsevierCitationCount":"4"},{"title":"Blood cell counts and lymphocyte subsets of patients admitted during the COVID‐19 pandemic: a prospective cohort study","googleId":"MukmKmNTmBkJ","googleLink":"https://onlinelibrary.wiley.com/doi/abs/10.1111/bjh.16983","googleCitationCount":2,"googleAuthor":"","doi":"10.1111/bjh.16983","elsevierAuthor":"Hengeveld P.J.","publicationName":"British Journal of Haematology","elsevierCoverDate":"2020-08-01","elsevierCoverDisplayDate":"1 August 2020","elsevierCitationCount":"1"},{"title":"Genotype/Phenotype correlations of childhood‐onset congenital sideroblastic anaemia in a European cohort","googleId":"jLpNrOcQTgEJ","googleLink":"https://onlinelibrary.wiley.com/doi/abs/10.1111/bjh.16100","googleCitationCount":4,"googleAuthor":"","doi":"10.1111/bjh.16100","elsevierAuthor":"Fouquet C.","publicationName":"British Journal of Haematology","elsevierCoverDate":"2019-11-01","elsevierCoverDisplayDate":"1 November 2019","elsevierCitationCount":"3"},{"title":"Second allogeneic stem cell transplantation in patients with acute lymphoblastic leukaemia: a study on behalf of the Acute Leukaemia Working Party of the European …","googleId":"_QxBRem46t4J","googleLink":"https://onlinelibrary.wiley.com/doi/abs/10.1111/bjh.15973","googleCitationCount":5,"googleAuthor":"A Nagler","doi":"10.1111/bjh.15973","elsevierAuthor":"Nagler A.","publicationName":"British Journal of Haematology","elsevierCoverDate":"2019-01-01","elsevierCoverDisplayDate":"2019","elsevierCitationCount":"5"},{"title":"Impact of Fc gamma receptor polymorphisms on efficacy and safety of daratumumab in relapsed/refractory multiple myeloma","googleId":"i14qR3ZeikMJ","googleLink":"https://pubmed.ncbi.nlm.nih.gov/29411874/","googleCitationCount":13,"googleAuthor":"NWCJ van de Donk","doi":"10.1111/bjh.15122,","elsevierAuthor":"van de Donk N.","publicationName":"British Journal of Haematology","elsevierCoverDate":"2019-02-01","elsevierCoverDisplayDate":"Februaryy 2019","elsevierCitationCount":"8"},{"title":"CAR‐T TREK through the lymphoma universe, to boldly go where no other therapy has gone before","googleId":"fjYuyxKGGGcJ","googleLink":"https://onlinelibrary.wiley.com/doi/abs/10.1111/bjh.17191","googleCitationCount":1,"googleAuthor":"","doi":"10.1111/bjh.17191","elsevierAuthor":"Ghilardi G.","publicationName":"British Journal of Haematology","elsevierCoverDate":"2020-01-01","elsevierCoverDisplayDate":"2020","elsevierCitationCount":"0"},{"title":"Mature outcomes and prognostic indices in diffuse large B‐cell lymphoma in Malawi: a prospective cohort","googleId":"dSWz578HvVsJ","googleLink":"https://onlinelibrary.wiley.com/doi/abs/10.1111/bjh.15625","googleCitationCount":10,"googleAuthor":"MS Painschab","doi":"10.1111/bjh.15625","elsevierAuthor":"Painschab M.S.","publicationName":"British Journal of Haematology","elsevierCoverDate":"2019-02-01","elsevierCoverDisplayDate":"Februaryy 2019","elsevierCitationCount":"9"},{"title":"Conquest of COVID‐19. Publish it to death?","googleId":"OJAe77nQbAcJ","googleLink":"https://onlinelibrary.wiley.com/doi/abs/10.1111/bjh.16905","googleCitationCount":5,"googleAuthor":"RP Gale","doi":"10.1111/bjh.16905","elsevierAuthor":"Gale R.P.","publicationName":"British Journal of Haematology","elsevierCoverDate":"2020-08-01","elsevierCoverDisplayDate":"1 August 2020","elsevierCitationCount":"4"},{"title":"TUBB 1 dysfunction in inherited thrombocytopenia causes genome instability","googleId":"74QUWoI4FKoJ","googleLink":"https://onlinelibrary.wiley.com/doi/abs/10.1111/bjh.15835","googleCitationCount":5,"googleAuthor":"","doi":"10.1111/bjh.15835","elsevierAuthor":"Matsumura T.","publicationName":"British Journal of Haematology","elsevierCoverDate":"2019-06-01","elsevierCoverDisplayDate":"June 2019","elsevierCitationCount":"5"},{"title":"Transfusion errors—can they be eliminated?","googleId":"_Z85rqHl-WIJ","googleLink":"https://onlinelibrary.wiley.com/doi/abs/10.1111/bjh.16256","googleCitationCount":3,"googleAuthor":"","doi":"10.1111/bjh.16256","elsevierAuthor":"Bolton-Maggs P.H.B.","publicationName":"British Journal of Haematology","elsevierCoverDate":"2020-04-01","elsevierCoverDisplayDate":"1 April 2020","elsevierCitationCount":"2"},{"title":"Acute myeloid leukemia with NPM1 mutation and favorable European LeukemiaNet category: outcome after preemptive intervention based on measurable residual …","googleId":"80bd101KNL0J","googleLink":"https://onlinelibrary.wiley.com/doi/abs/10.1111/bjh.16857","googleCitationCount":3,"googleAuthor":"G Oñate","doi":"10.1111/bjh.16857","elsevierAuthor":"Bataller A.","publicationName":"British Journal of Haematology","elsevierCoverDate":"2020-10-01","elsevierCoverDisplayDate":"1 October 2020","elsevierCitationCount":"2"},{"title":"Splenectomy in childhood for non‐malignant haematologic disorders–long‐term follow‐up shows minimal adverse effects","googleId":"YTg3B9udnxkJ","googleLink":"https://onlinelibrary.wiley.com/doi/abs/10.1111/bjh.16657","googleCitationCount":2,"googleAuthor":"","doi":"10.1111/bjh.16657","elsevierAuthor":"Yacobovich J.","publicationName":"British Journal of Haematology","elsevierCoverDate":"2020-09-01","elsevierCoverDisplayDate":"1 September 2020","elsevierCitationCount":"2"},{"title":"Trends in the prevalence, incidence and survival of non‐Hodgkin lymphoma subtypes during the 21st century–a Swedish lymphoma register study","googleId":"DUU4QTnJZNgJ","googleLink":"https://onlinelibrary.wiley.com/doi/abs/10.1111/bjh.16489","googleCitationCount":2,"googleAuthor":"I Glimelius","doi":"10.1111/bjh.16489","elsevierAuthor":"Ekberg S.","publicationName":"British Journal of Haematology","elsevierCoverDate":"2020-06-01","elsevierCoverDisplayDate":"1 June 2020","elsevierCitationCount":"0"},{"title":"Hepatitis E virus infection after haploidentical haematopoietic stem cell transplantation: incidence and clinical course","googleId":"CAtS5Y2xvhIJ","googleLink":"https://onlinelibrary.wiley.com/doi/abs/10.1111/bjh.15672","googleCitationCount":8,"googleAuthor":"","doi":"10.1111/bjh.15672","elsevierAuthor":"Tang F.F.","publicationName":"British Journal of Haematology","elsevierCoverDate":"2019-03-01","elsevierCoverDisplayDate":"March 2019","elsevierCitationCount":"6"},{"title":"COVID‐19 infection in patients on anti‐complement therapy: The Leeds National Paroxysmal Nocturnal Haemoglobinuria service experience","googleId":"QLm5YuAEuvkJ","googleLink":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7537165/","googleCitationCount":2,"googleAuthor":"","doi":"10.1111/bjh.17097","elsevierAuthor":"Pike A.","publicationName":"British Journal of Haematology","elsevierCoverDate":"2020-10-01","elsevierCoverDisplayDate":"1 October 2020","elsevierCitationCount":"2"},{"title":"Serum soluble VSIG4 as a surrogate marker for the diagnosis of lymphoma‐associated hemophagocytic lymphohistiocytosis","googleId":"xu-mbOCsk28J","googleLink":"https://onlinelibrary.wiley.com/doi/abs/10.1111/bjh.16299","googleCitationCount":2,"googleAuthor":"","doi":"10.1111/bjh.16299","elsevierAuthor":"Yuan S.","publicationName":"British Journal of Haematology","elsevierCoverDate":"2020-04-01","elsevierCoverDisplayDate":"1 April 2020","elsevierCitationCount":"2"},{"title":"Hydroxycarbamide exposure and ovarian reserve in women with sickle cell disease in the Multicenter Study of Hydroxycarbamide","googleId":"FlxU8tbhk0QJ","googleLink":"https://onlinelibrary.wiley.com/doi/abs/10.1111/bjh.16976","googleCitationCount":2,"googleAuthor":"S Hussain","doi":"10.1111/bjh.16976","elsevierAuthor":"Pecker L.H.","publicationName":"British Journal of Haematology","elsevierCoverDate":"2020-12-01","elsevierCoverDisplayDate":"December 2020","elsevierCitationCount":"0"},{"title":"L‐DEP regimen salvage therapy for paediatric patients with refractory Epstein‐Barr virus‐associated haemophagocytic lymphohistiocytosis","googleId":"qnM0xNYVEoMJ","googleLink":"https://onlinelibrary.wiley.com/doi/abs/10.1111/bjh.16861","googleCitationCount":4,"googleAuthor":"","doi":"10.1111/bjh.16861","elsevierAuthor":"Zhao Y.","publicationName":"British Journal of Haematology","elsevierCoverDate":"2020-11-01","elsevierCoverDisplayDate":"1 November 2020","elsevierCitationCount":"2"},{"title":"Outcome of transformed follicular lymphoma worsens according to the timing of transformation and to the number of previous therapies. A retrospective multicenter …","googleId":"aeFUUgoNOioJ","googleLink":"https://onlinelibrary.wiley.com/doi/abs/10.1111/bjh.15816","googleCitationCount":8,"googleAuthor":"","doi":"10.1111/bjh.15816","elsevierAuthor":"Rusconi C.","publicationName":"British Journal of Haematology","elsevierCoverDate":"2019-05-01","elsevierCoverDisplayDate":"May 2019","elsevierCitationCount":"6"},{"title":"Radiation exposure and longitudinal changes in peripheral monocytes over 50 years: the Adult Health Study of atomic‐bomb survivors","googleId":"nbXrtW0KU6MJ","googleLink":"https://onlinelibrary.wiley.com/doi/abs/10.1111/bjh.15750","googleCitationCount":8,"googleAuthor":"B French","doi":"10.1111/bjh.15750","elsevierAuthor":"Yoshida K.","publicationName":"British Journal of Haematology","elsevierCoverDate":"2019-04-01","elsevierCoverDisplayDate":"April 2019","elsevierCitationCount":"5"},{"title":"Evaluation of the impact of cachexia on clinical outcomes in aggressive lymphoma","googleId":"l46yhqPJYowJ","googleLink":"https://onlinelibrary.wiley.com/doi/abs/10.1111/bjh.15889","googleCitationCount":5,"googleAuthor":"","doi":"10.1111/bjh.15889","elsevierAuthor":"Burkart M.","publicationName":"British Journal of Haematology","elsevierCoverDate":"2019-07-01","elsevierCoverDisplayDate":"July 2019","elsevierCitationCount":"5"},{"title":"Early relapse after high‐dose melphalan autologous stem cell transplant predicts inferior survival and is associated with high disease burden and genetically high‐risk …","googleId":"UMiLEKUXG6QJ","googleLink":"https://onlinelibrary.wiley.com/doi/abs/10.1111/bjh.16793","googleCitationCount":3,"googleAuthor":"","doi":"10.1111/bjh.16793","elsevierAuthor":"Bygrave C.","publicationName":"British Journal of Haematology","elsevierCoverDate":"2020-01-01","elsevierCoverDisplayDate":"2020","elsevierCitationCount":"2"},{"title":"Pregnancy in sickle cell trait: what we do and don't know","googleId":"f1fYo3i4DOQJ","googleLink":"https://onlinelibrary.wiley.com/doi/abs/10.1111/bjh.16518","googleCitationCount":3,"googleAuthor":"S Wilson","doi":"10.1111/bjh.16518","elsevierAuthor":"Wilson S.","publicationName":"British Journal of Haematology","elsevierCoverDate":"2020-08-01","elsevierCoverDisplayDate":"1 August 2020","elsevierCitationCount":"0"},{"title":"Correction of Bcl‐x splicing improves responses to imatinib in chronic myeloid leukaemia cells and mouse models","googleId":"bvN3uvSFd0wJ","googleLink":"https://onlinelibrary.wiley.com/doi/abs/10.1111/bjh.16472","googleCitationCount":2,"googleAuthor":"","doi":"10.1111/bjh.16472","elsevierAuthor":"Zhang J.","publicationName":"British Journal of Haematology","elsevierCoverDate":"2020-06-01","elsevierCoverDisplayDate":"1 June 2020","elsevierCitationCount":"2"},{"title":"Saposin C is a frequent target of paraproteins in Gaucher disease‐associated MGUS/multiple myeloma","googleId":"XJFsgolWi0AJ","googleLink":"https://onlinelibrary.wiley.com/doi/abs/10.1111/bjh.15659","googleCitationCount":7,"googleAuthor":"","doi":"10.1111/bjh.15659","elsevierAuthor":"Preuss K.","publicationName":"British Journal of Haematology","elsevierCoverDate":"2019-02-01","elsevierCoverDisplayDate":"Februaryy 2019","elsevierCitationCount":"7"},{"title":"Validation of the MCL 35 gene expression proliferation assay in randomized trials of the European Mantle Cell Lymphoma Network","googleId":"RRrpLMx4jdMJ","googleLink":"https://onlinelibrary.wiley.com/doi/abs/10.1111/bjh.15519","googleCitationCount":10,"googleAuthor":"","doi":"10.1111/bjh.15519","elsevierAuthor":"Rauert-Wunderlich H.","publicationName":"British Journal of Haematology","elsevierCoverDate":"2019-02-01","elsevierCoverDisplayDate":"Februaryy 2019","elsevierCitationCount":"5"},{"title":"How I treat advanced Hodgkin lymphoma—a global view","googleId":"gJk-1djVvWIJ","googleLink":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7116450/","googleCitationCount":1,"googleAuthor":"K David"},{"title":"A British Society for Haematology Guideline on the diagnosis and management of chronic myeloid leukaemia","googleId":"z1GkjXrT3fQJ","googleLink":"http://csrpsp.com/Management/Common/KindEditor/attached/file/20200805/20200805155045_5247.pdf","googleCitationCount":2,"googleAuthor":"J Apperley"},{"title":"Delaying haematopoietic stem cell transplantation in children with viral respiratory infections reduces transplant‐related mortality","googleId":"7N3buMl-orQJ","googleLink":"https://onlinelibrary.wiley.com/doi/abs/10.1111/bjh.16216","googleCitationCount":4,"googleAuthor":"G Ottaviano","doi":"10.1111/bjh.16216","elsevierAuthor":"Ottaviano G.","publicationName":"British Journal of Haematology","elsevierCoverDate":"2020-02-01","elsevierCoverDisplayDate":"1 February 2020","elsevierCitationCount":"3"},{"title":"The role of high‐dose melphalan with autologous stem‐cell transplant in multiple myeloma: is it time for a paradigm shift?","googleId":"RifuHT5BW-sJ","googleLink":"https://onlinelibrary.wiley.com/doi/abs/10.1111/bjh.16764","googleCitationCount":1,"googleAuthor":"","doi":"10.1111/bjh.16764","elsevierAuthor":"Kazandjian D.","publicationName":"British Journal of Haematology","elsevierCoverDate":"2020-12-01","elsevierCoverDisplayDate":"December 2020","elsevierCitationCount":"1"},{"title":"TBET‐expressing Th1 CD4+ T cells accumulate in chronic lymphocytic leukaemia without affecting disease progression in Eµ‐TCL1 mice","googleId":"jJYBbv7QeaEJ","googleLink":"https://onlinelibrary.wiley.com/doi/abs/10.1111/bjh.16316","googleCitationCount":4,"googleAuthor":"BS Hanna","doi":"10.1111/bjh.16316","elsevierAuthor":"Roessner P.M.","publicationName":"British Journal of Haematology","elsevierCoverDate":"2020-04-01","elsevierCoverDisplayDate":"1 April 2020","elsevierCitationCount":"3"},{"title":"Immune off‐target effects of Brentuximab Vedotin in relapsed/refractory Hodgkin Lymphoma","googleId":"yMYirMuUfMgJ","googleLink":"https://onlinelibrary.wiley.com/doi/abs/10.1111/bjh.15801","googleCitationCount":6,"googleAuthor":"","doi":"10.1111/bjh.15801","elsevierAuthor":"Romano A.","publicationName":"British Journal of Haematology","elsevierCoverDate":"2019-05-01","elsevierCoverDisplayDate":"May 2019","elsevierCitationCount":"5"},{"title":"MYD88 p.(L265P) detection on cell-free DNA in liquid biopsies of patients with primary central nervous system lymphoma","googleId":"2e8vMF9S4gQJ","googleLink":"https://pubmed.ncbi.nlm.nih.gov/30408153/","googleCitationCount":11,"googleAuthor":"","doi":"10.1111/bjh.15674,","elsevierAuthor":"Hiemcke-Jiwa L.S.","publicationName":"British Journal of Haematology","elsevierCoverDate":"2019-06-01","elsevierCoverDisplayDate":"June 2019","elsevierCitationCount":"4"},{"title":"Lycorine targets multiple myeloma stem cell‐like cells by inhibition of Wnt/β‐catenin pathway","googleId":"G46j5vteL0YJ","googleLink":"https://onlinelibrary.wiley.com/doi/abs/10.1111/bjh.16477","googleCitationCount":1,"googleAuthor":"","doi":"10.1111/bjh.16477","elsevierAuthor":"Wang H.","publicationName":"British Journal of Haematology","elsevierCoverDate":"2020-06-01","elsevierCoverDisplayDate":"1 June 2020","elsevierCitationCount":"1"},{"title":"A phase 1/2, open-label, dose-escalation study of midostaurin in children with relapsed or refractory acute leukaemia","googleId":"LCH0ZM96UlQJ","googleLink":"https://pubmed.ncbi.nlm.nih.gov/30203832/","googleCitationCount":12,"googleAuthor":"","doi":"10.1111/bjh.15593,","elsevierAuthor":"Zwaan C.M.","publicationName":"British Journal of Haematology","elsevierCoverDate":"2019-05-01","elsevierCoverDisplayDate":"May 2019","elsevierCitationCount":"6"},{"title":"A synonymous GATA2 variant underlying familial myeloid malignancy with striking intrafamilial phenotypic variability","googleId":"mPRCM0xwrhoJ","googleLink":"https://pubmed.ncbi.nlm.nih.gov/32488879/","googleCitationCount":4,"googleAuthor":"AL Brown","doi":"10.1111/bjh.16819,","elsevierAuthor":"Fox L.C.","publicationName":"British Journal of Haematology","elsevierCoverDate":"2020-09-01","elsevierCoverDisplayDate":"1 September 2020","elsevierCitationCount":"4"},{"title":"Closing the survivorship gap in children and adolescents with Hodgkin lymphoma","googleId":"Sv2e9TxJjVwJ","googleLink":"https://onlinelibrary.wiley.com/doi/abs/10.1111/bjh.16197","googleCitationCount":4,"googleAuthor":"","doi":"10.1111/bjh.16197","elsevierAuthor":"Castellino S.M.","publicationName":"British Journal of Haematology","elsevierCoverDate":"2019-12-01","elsevierCoverDisplayDate":"1 December 2019","elsevierCitationCount":"2"},{"title":"Ibrutinib for central nervous system lymphoma: the Australasian Lymphoma Alliance/MD Anderson Cancer Center experience","googleId":"Hn49stzp6OUJ","googleLink":"https://onlinelibrary.wiley.com/doi/abs/10.1111/bjh.16946","googleCitationCount":2,"googleAuthor":"","doi":"10.1111/bjh.16946","elsevierAuthor":"Lewis K.L.","publicationName":"British Journal of Haematology","elsevierCoverDate":"2020-01-01","elsevierCoverDisplayDate":"2020","elsevierCitationCount":"0"},{"title":"Developments beyond blood group serology in the genomics era","googleId":"FgUI5LAC-HIJ","googleLink":"https://onlinelibrary.wiley.com/doi/abs/10.1111/bjh.15747","googleCitationCount":7,"googleAuthor":"CA Hyland","doi":"10.1111/bjh.15747","elsevierAuthor":"Hyland C.A.","publicationName":"British Journal of Haematology","elsevierCoverDate":"2019-03-01","elsevierCoverDisplayDate":"March 2019","elsevierCitationCount":"4"},{"title":"A 20‐year long term experience of the Italian Diamond‐Blackfan Anaemia Registry: RPS and RPL genes, different faces of the same disease?","googleId":"b_dLp2AXqFAJ","googleLink":"https://onlinelibrary.wiley.com/doi/abs/10.1111/bjh.16508","googleCitationCount":2,"googleAuthor":"","doi":"10.1111/bjh.16508","elsevierAuthor":"Quarello P.","publicationName":"British Journal of Haematology","elsevierCoverDate":"2020-07-01","elsevierCoverDisplayDate":"1 July 2020","elsevierCitationCount":"2"},{"title":"Single‐agent daratumumab in patients with relapsed and refractory multiple myeloma requiring dialysis: results of a Spanish retrospective, multicentre study","googleId":"rVjvO5TsBQ8J","googleLink":"https://onlinelibrary.wiley.com/doi/abs/10.1111/bjh.16286","googleCitationCount":4,"googleAuthor":"","doi":"10.1111/bjh.16286","elsevierAuthor":"Cejalvo M.J.","publicationName":"British Journal of Haematology","elsevierCoverDate":"2020-09-01","elsevierCoverDisplayDate":"1 September 2020","elsevierCitationCount":"3"},{"title":"Risk of secondary haematological malignancies in patients with follicular lymphoma: an analysis of 1028 patients treated in the rituximab era","googleId":"y0KiSFXs0DwJ","googleLink":"https://onlinelibrary.wiley.com/doi/abs/10.1111/bjh.16090","googleCitationCount":5,"googleAuthor":"","doi":"10.1111/bjh.16090","elsevierAuthor":"Prusila R.E.I.","publicationName":"British Journal of Haematology","elsevierCoverDate":"2019-11-01","elsevierCoverDisplayDate":"1 November 2019","elsevierCitationCount":"4"},{"title":"Second-line and subsequent therapy and outcomes for follicular lymphoma in the United States: data from the observational National LymphoCare Study","googleId":"-ngwROPNkr0J","googleLink":"https://pubmed.ncbi.nlm.nih.gov/29611177/","googleCitationCount":15,"googleAuthor":"","doi":"10.1111/bjh.15149,","elsevierAuthor":"Link B.K.","publicationName":"British Journal of Haematology","elsevierCoverDate":"2019-02-01","elsevierCoverDisplayDate":"Februaryy 2019","elsevierCitationCount":"8"},{"title":"Potential influence of concomitant chemotherapy on CXCR4 expression in receptor directed endoradiotherapy","googleId":"nQ41Kz1s8QAJ","googleLink":"https://pubmed.ncbi.nlm.nih.gov/29363736/","googleCitationCount":14,"googleAuthor":"","doi":"10.1111/bjh.15096,","elsevierAuthor":"Lapa C.","publicationName":"British Journal of Haematology","elsevierCoverDate":"2019-02-01","elsevierCoverDisplayDate":"Februaryy 2019","elsevierCitationCount":"8"},{"title":"Major surgery management in patients with haemophilia A and inhibitors on emicizumab prophylaxis without global coagulation monitoring","googleId":"zT7zlii2_t0J","googleLink":"https://pubmed.ncbi.nlm.nih.gov/32087028/","googleCitationCount":4,"googleAuthor":"","doi":"10.1111/bjh.16512,","elsevierAuthor":"Biron-Andreani C.","publicationName":"British Journal of Haematology","elsevierCoverDate":"2020-05-01","elsevierCoverDisplayDate":"1 May 2020","elsevierCitationCount":"2"},{"title":"The derived neutrophil‐to‐lymphocyte ratio is an independent prognostic factor in patients with angioimmunoblastic T‐cell lymphoma","googleId":"aOhGwymIFQUJ","googleLink":"https://onlinelibrary.wiley.com/doi/abs/10.1111/bjh.16447","googleCitationCount":3,"googleAuthor":"","doi":"10.1111/bjh.16447","elsevierAuthor":"Hong H.","publicationName":"British Journal of Haematology","elsevierCoverDate":"2020-06-01","elsevierCoverDisplayDate":"1 June 2020","elsevierCitationCount":"2"},{"title":"Pixantrone plus rituximab versus gemcitabine plus rituximab in patients with relapsed aggressive B‐cell non‐Hodgkin lymphoma not eligible for stem cell …","googleId":"srwc5ikGqZQJ","googleLink":"https://onlinelibrary.wiley.com/doi/abs/10.1111/bjh.16255","googleCitationCount":4,"googleAuthor":"","doi":"10.1111/bjh.16255","elsevierAuthor":"Pettengell R.","publicationName":"British Journal of Haematology","elsevierCoverDate":"2020-01-01","elsevierCoverDisplayDate":"1 January 2020","elsevierCitationCount":"2"},{"title":"F cell numbers are associated with an X‐linked genetic polymorphism and correlate with haematological parameters in patients with sickle cell disease","googleId":"NwGmBG7R2jIJ","googleLink":"https://onlinelibrary.wiley.com/doi/abs/10.1111/bjh.17102","googleCitationCount":2,"googleAuthor":"S Nkya","doi":"10.1111/bjh.17102","elsevierAuthor":"Urio F.","publicationName":"British Journal of Haematology","elsevierCoverDate":"2020-12-01","elsevierCoverDisplayDate":"December 2020","elsevierCitationCount":"1"},{"title":"Validation of the UK myeloma research alliance risk profile, a new clinical prediction model for outcome in patients with newly diagnosed multiple myeloma not eligible …","googleId":"5q1pjevmlpIJ","googleLink":"https://onlinelibrary.wiley.com/doi/abs/10.1111/bjh.16806","googleCitationCount":2,"googleAuthor":"","doi":"10.1111/bjh.16806","elsevierAuthor":"Redder L.","publicationName":"British Journal of Haematology","elsevierCoverDate":"2020-01-01","elsevierCoverDisplayDate":"2020","elsevierCitationCount":"2"},{"title":"Novel prognostic scoring system for autologous hematopoietic cell transplantation in multiple myeloma","googleId":"ypkcJ0jdATQJ","googleLink":"https://onlinelibrary.wiley.com/doi/abs/10.1111/bjh.16987","googleCitationCount":1,"googleAuthor":"B Dhakal","doi":"10.1111/bjh.16987","elsevierAuthor":"Dhakal B.","publicationName":"British Journal of Haematology","elsevierCoverDate":"2020-11-01","elsevierCoverDisplayDate":"1 November 2020","elsevierCitationCount":"1"},{"title":"PML/RARA inhibits expression of HSP 90 and its target AKT","googleId":"HKWVJgN7Ol4J","googleLink":"https://onlinelibrary.wiley.com/doi/abs/10.1111/bjh.15715","googleCitationCount":6,"googleAuthor":"","doi":"10.1111/bjh.15715","elsevierAuthor":"Piredda M.L.","publicationName":"British Journal of Haematology","elsevierCoverDate":"2019-03-01","elsevierCoverDisplayDate":"March 2019","elsevierCitationCount":"5"},{"title":"Development and validation of a novel risk stratification algorithm for relapsed multiple myeloma","googleId":"xpMOyUP2exsJ","googleLink":"https://onlinelibrary.wiley.com/doi/abs/10.1111/bjh.16105","googleCitationCount":4,"googleAuthor":"M Delforge","doi":"10.1111/bjh.16105","elsevierAuthor":"Hájek R.","publicationName":"British Journal of Haematology","elsevierCoverDate":"2019-11-01","elsevierCoverDisplayDate":"1 November 2019","elsevierCitationCount":"2"},{"title":"Extended experience with a non‐cytotoxic DNMT1‐targeting regimen of decitabine to treat myeloid malignancies","googleId":"XYpPq3lYP-IJ","googleLink":"https://onlinelibrary.wiley.com/doi/abs/10.1111/bjh.16281","googleCitationCount":4,"googleAuthor":"H Awada","doi":"10.1111/bjh.16281","elsevierAuthor":"Awada H.","publicationName":"British Journal of Haematology","elsevierCoverDate":"2020-03-01","elsevierCoverDisplayDate":"1 March 2020","elsevierCitationCount":"2"},{"title":"Identification of genetic biomarkers for alloimmunization in sickle cell disease","googleId":"m49pf4teTZEJ","googleLink":"https://onlinelibrary.wiley.com/doi/abs/10.1111/bjh.15998","googleCitationCount":5,"googleAuthor":"","doi":"10.1111/bjh.15998","elsevierAuthor":"Meinderts S.M.","publicationName":"British Journal of Haematology","elsevierCoverDate":"2019-09-01","elsevierCoverDisplayDate":"1 September 2019","elsevierCitationCount":"2"},{"title":"High tumour plasma cell infiltration reflects an important microenvironmental component in classic Hodgkin lymphoma linked to presence of B‐symptoms","googleId":"bmE9dhU0FnMJ","googleLink":"https://onlinelibrary.wiley.com/doi/abs/10.1111/bjh.15703","googleCitationCount":8,"googleAuthor":"","doi":"10.1111/bjh.15703","elsevierAuthor":"Gholiha A.","publicationName":"British Journal of Haematology","elsevierCoverDate":"2019-01-01","elsevierCoverDisplayDate":"January 2019","elsevierCitationCount":"6"},{"title":"Energy metabolism and drug response in myeloid leukaemic stem cells","googleId":"WnxVlItF4wAJ","googleLink":"https://onlinelibrary.wiley.com/doi/abs/10.1111/bjh.16074","googleCitationCount":3,"googleAuthor":"AE Bencomo‐Alvarez","doi":"10.1111/bjh.16074","elsevierAuthor":"Bencomo-Alvarez A.E.","publicationName":"British Journal of Haematology","elsevierCoverDate":"2019-01-01","elsevierCoverDisplayDate":"2019","elsevierCitationCount":"3"},{"title":"Potential roles of artificial intelligence learning and faecal immunochemical testing for prioritisation of colonoscopy in anaemia","googleId":"ik2qYMm5MJYJ","googleLink":"https://onlinelibrary.wiley.com/doi/abs/10.1111/bjh.15776","googleCitationCount":8,"googleAuthor":"RM Ayling","doi":"10.1111/bjh.15776","elsevierAuthor":"Ayling R.M.","publicationName":"British Journal of Haematology","elsevierCoverDate":"2019-04-01","elsevierCoverDisplayDate":"April 2019","elsevierCitationCount":"7"},{"title":"Daratumumab and dexamethasone is safe and effective for triple refractory myeloma patients: final results of the IFM 2014‐04 (Etoile du Nord) trial","googleId":"bfeMkjkRdbUJ","googleLink":"https://onlinelibrary.wiley.com/doi/abs/10.1111/bjh.16059","googleCitationCount":7,"googleAuthor":"","doi":"10.1111/bjh.16059","elsevierAuthor":"Boyle E.M.","publicationName":"British Journal of Haematology","elsevierCoverDate":"2019-11-01","elsevierCoverDisplayDate":"1 November 2019","elsevierCitationCount":"7"},{"title":"Blinatumomab and inotuzumab for B cell precursor acute lymphoblastic leukaemia in children: a retrospective study from the Leukemia Working Group of the Spanish …","googleId":"lfuiWnhaeIoJ","googleLink":"https://onlinelibrary.wiley.com/doi/abs/10.1111/bjh.16647","googleCitationCount":2,"googleAuthor":"","doi":"10.1111/bjh.16647","elsevierAuthor":"Fuster J.L.","publicationName":"British Journal of Haematology","elsevierCoverDate":"2020-09-01","elsevierCoverDisplayDate":"1 September 2020","elsevierCitationCount":"2"},{"title":"Graft‐versus‐host disease and graft‐versus‐leukaemia effects in secondary acute myeloid leukaemia: a retrospective, multicentre registry analysis from the Acute …","googleId":"YZIGkYZMXvAJ","googleLink":"https://onlinelibrary.wiley.com/doi/abs/10.1111/bjh.16185","googleCitationCount":3,"googleAuthor":"F Baron","doi":"10.1111/bjh.16185","elsevierAuthor":"Baron F.","publicationName":"British Journal of Haematology","elsevierCoverDate":"2020-02-01","elsevierCoverDisplayDate":"1 February 2020","elsevierCitationCount":"2"},{"title":"Understanding how older age drives decision‐making and outcome in Immune Thrombocytopenia. A single centre study on 465 adult patients","googleId":"E43S3UW1hMIJ","googleLink":"https://onlinelibrary.wiley.com/doi/abs/10.1111/bjh.15668","googleCitationCount":7,"googleAuthor":"L Catani","doi":"10.1111/bjh.15668","elsevierAuthor":"Palandri F.","publicationName":"British Journal of Haematology","elsevierCoverDate":"2019-02-01","elsevierCoverDisplayDate":"Februaryy 2019","elsevierCitationCount":"6"},{"title":"Progressive multifocal leukoencephalopathy in patients with follicular lymphoma treated with bendamustine plus rituximab followed by rituximab maintenance","googleId":"F6ftIP4SZawJ","googleLink":"https://pubmed.ncbi.nlm.nih.gov/32150646/","googleCitationCount":3,"googleAuthor":"","doi":"10.1111/bjh.16563,","elsevierAuthor":"D’Alò F.","publicationName":"British Journal of Haematology","elsevierCoverDate":"2020-05-01","elsevierCoverDisplayDate":"1 May 2020","elsevierCitationCount":"2"},{"title":"Clinical relevance of pulmonary vasculature involvement in sickle cell disease","googleId":"pxtaUz1l6c4J","googleLink":"https://onlinelibrary.wiley.com/doi/abs/10.1111/bjh.15795","googleCitationCount":6,"googleAuthor":"","doi":"10.1111/bjh.15795","elsevierAuthor":"Carstens G.R.","publicationName":"British Journal of Haematology","elsevierCoverDate":"2019-04-01","elsevierCoverDisplayDate":"April 2019","elsevierCitationCount":"3"},{"title":"Platelets in myeloproliferative neoplasms have a distinct transcript signature in the presence of marrow fibrosis","googleId":"W02Hc5bB12AJ","googleLink":"https://onlinelibrary.wiley.com/doi/abs/10.1111/bjh.16152","googleCitationCount":3,"googleAuthor":"BB Guo","doi":"10.1111/bjh.16152","elsevierAuthor":"Guo B.B.","publicationName":"British Journal of Haematology","elsevierCoverDate":"2020-01-01","elsevierCoverDisplayDate":"1 January 2020","elsevierCitationCount":"2"},{"title":"Rosuvastatin use increases plasma fibrinolytic potential: a randomised clinical trial","googleId":"WF6pnKn8KbcJ","googleLink":"https://onlinelibrary.wiley.com/doi/abs/10.1111/bjh.16648","googleCitationCount":2,"googleAuthor":"","doi":"10.1111/bjh.16648","elsevierAuthor":"Schol-Gelok S.","publicationName":"British Journal of Haematology","elsevierCoverDate":"2020-09-01","elsevierCoverDisplayDate":"1 September 2020","elsevierCitationCount":"2"},{"title":"What do we know about duodenal‐type follicular lymphoma? From pathological definition to treatment options","googleId":"qZyOvL9o1uoJ","googleLink":"https://onlinelibrary.wiley.com/doi/abs/10.1111/bjh.16348","googleCitationCount":3,"googleAuthor":"G Collins","doi":"10.1111/bjh.16348","elsevierAuthor":"Duffles Amarante G.","publicationName":"British Journal of Haematology","elsevierCoverDate":"2020-03-01","elsevierCoverDisplayDate":"1 March 2020","elsevierCitationCount":"1"},{"title":"Requirement for etoposide in the initial treatment of Epstein‐Barr virus–associated haemophagocytic lymphohistiocytosis","googleId":"Lw2RnzirQqYJ","googleLink":"https://onlinelibrary.wiley.com/doi/abs/10.1111/bjh.15988","googleCitationCount":5,"googleAuthor":"","doi":"10.1111/bjh.15988","elsevierAuthor":"Song Y.","publicationName":"British Journal of Haematology","elsevierCoverDate":"2019-01-01","elsevierCoverDisplayDate":"2019","elsevierCitationCount":"3"},{"title":"Endothelial cell function and endothelial‐related disorders following haematopoietic cell transplantation","googleId":"2Hj4nBke3RcJ","googleLink":"https://onlinelibrary.wiley.com/doi/abs/10.1111/bjh.16621","googleCitationCount":2,"googleAuthor":"","doi":"10.1111/bjh.16621","elsevierAuthor":"Hildebrandt G.C.","publicationName":"British Journal of Haematology","elsevierCoverDate":"2020-08-01","elsevierCoverDisplayDate":"1 August 2020","elsevierCitationCount":"2"},{"title":"Disordered serum erythroferrone and hepcidin levels as indicators of the spontaneous abortion occurrence during early pregnancy in humans","googleId":"qcMnvD2wsuwJ","googleLink":"https://onlinelibrary.wiley.com/doi/abs/10.1111/bjh.17049","googleCitationCount":1,"googleAuthor":"","doi":"10.1111/bjh.17049","elsevierAuthor":"Wei S.","publicationName":"British Journal of Haematology","elsevierCoverDate":"2021-02-01","elsevierCoverDisplayDate":"February 2021","elsevierCitationCount":"0"},{"title":"Poor outcomes for double‐hit lymphoma patients treated with curative‐intent second‐line immunochemotherapy following failure of intensive front‐line …","googleId":"j0A72IfgUVwJ","googleLink":"https://onlinelibrary.wiley.com/doi/abs/10.1111/bjh.16319","googleCitationCount":3,"googleAuthor":"DA Bond","doi":"10.1111/bjh.16319","elsevierAuthor":"Landsburg D.J.","publicationName":"British Journal of Haematology","elsevierCoverDate":"2020-04-01","elsevierCoverDisplayDate":"1 April 2020","elsevierCitationCount":"2"},{"title":"Phase I/II study of dasatinib and exploratory genomic analysis in relapsed or refractory non‐Hodgkin lymphoma","googleId":"uzwJPHJQls4J","googleLink":"https://onlinelibrary.wiley.com/doi/abs/10.1111/bjh.15702","googleCitationCount":9,"googleAuthor":"JM Umakanthan","doi":"10.1111/bjh.15702","elsevierAuthor":"Umakanthan J.M.","publicationName":"British Journal of Haematology","elsevierCoverDate":"2019-03-01","elsevierCoverDisplayDate":"March 2019","elsevierCitationCount":"5"},{"title":"Circulating dendritic cells deficiencies as a new biomarker in classical Hodgkin lymphoma","googleId":"IbwuR14Qpl4J","googleLink":"https://onlinelibrary.wiley.com/doi/abs/10.1111/bjh.15676","googleCitationCount":6,"googleAuthor":"","doi":"10.1111/bjh.15676","elsevierAuthor":"Galati D.","publicationName":"British Journal of Haematology","elsevierCoverDate":"2019-02-01","elsevierCoverDisplayDate":"Februaryy 2019","elsevierCitationCount":"5"},{"title":"Management of COVID‐19‐related paediatric blood samples in a clinical haematology laboratory","googleId":"uTBAbW7JnLkJ","googleLink":"https://onlinelibrary.wiley.com/doi/abs/10.1111/bjh.16721","googleCitationCount":3,"googleAuthor":"JCM Lam","doi":"10.1111/bjh.16721","elsevierAuthor":"Lam J.C.M.","publicationName":"British Journal of Haematology","elsevierCoverDate":"2020-06-01","elsevierCoverDisplayDate":"1 June 2020","elsevierCitationCount":"2"},{"title":"Interim thymus and activation regulated chemokine versus interim 18F‐fluorodeoxyglucose positron‐emission tomography in classical Hodgkin lymphoma response …","googleId":"tXoLMeE1PnkJ","googleLink":"https://onlinelibrary.wiley.com/doi/abs/10.1111/bjh.16514","googleCitationCount":2,"googleAuthor":"WJ Plattel","doi":"10.1111/bjh.16514","elsevierAuthor":"Plattel W.J.","publicationName":"British Journal of Haematology","elsevierCoverDate":"2020-07-01","elsevierCoverDisplayDate":"1 July 2020","elsevierCitationCount":"2"},{"title":"Effect of low or high doses of low‐molecular‐weight heparin on thrombin generation and other haemostasis parameters in critically ill patients with COVID‐19","googleId":"OGRCLHXdmckJ","googleLink":"https://onlinelibrary.wiley.com/doi/abs/10.1111/bjh.17003","googleCitationCount":2,"googleAuthor":"F Alessandri","doi":"10.1111/bjh.17003","elsevierAuthor":"Chistolini A.","publicationName":"British Journal of Haematology","elsevierCoverDate":"2020-08-01","elsevierCoverDisplayDate":"1 August 2020","elsevierCitationCount":"3"},{"title":"SARS‐CoV‐2 persistence and non‐protective immunity in infected haematological patients","googleId":"F9GU0yazlbMJ","googleLink":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7753427/","googleCitationCount":1,"googleAuthor":"K Akinosoglou","doi":"10.1111/bjh.17212","elsevierAuthor":"Akinosoglou K.","publicationName":"British Journal of Haematology","elsevierCoverDate":"2021-01-01","elsevierCoverDisplayDate":"January 2021","elsevierCitationCount":"0"},{"title":"Safety, feasibility and preliminary efficacy of single agent combretastatin A1 diphosphate (OXi4503) in patients with relapsed or refractory acute myeloid leukemia or …","googleId":"bwUpK7LpqxkJ","googleLink":"https://pubmed.ncbi.nlm.nih.gov/32236943/","googleCitationCount":3,"googleAuthor":"CR Cogle","doi":"10.1111/bjh.16629,","elsevierAuthor":"Cogle C.R.","publicationName":"British Journal of Haematology","elsevierCoverDate":"2020-06-01","elsevierCoverDisplayDate":"1 June 2020","elsevierCitationCount":"2"},{"title":"Late relapse in patients with diffuse large B‐cell lymphoma: impact of rituximab on their incidence and outcome","googleId":"PXvnUSJ3YuoJ","googleLink":"https://onlinelibrary.wiley.com/doi/abs/10.1111/bjh.16106","googleCitationCount":4,"googleAuthor":"","doi":"10.1111/bjh.16106","elsevierAuthor":"Vannata B.","publicationName":"British Journal of Haematology","elsevierCoverDate":"2019-11-01","elsevierCoverDisplayDate":"1 November 2019","elsevierCitationCount":"3"},{"title":"The impact of cytogenetics on duration of response and overall survival in patients with relapsed multiple myeloma (long‐term follow‐up results from BSBMT/UKMF …","googleId":"cdWf1mJpyoEJ","googleLink":"https://onlinelibrary.wiley.com/doi/abs/10.1111/bjh.15782","googleCitationCount":10,"googleAuthor":"G Cook","doi":"10.1111/bjh.15782","elsevierAuthor":"Cook G.","publicationName":"British Journal of Haematology","elsevierCoverDate":"2019-05-01","elsevierCoverDisplayDate":"May 2019","elsevierCitationCount":"5"},{"title":"Editorial comment: variables affecting the presence of mesenchymal stromal cells in the peripheral blood and their relationship with apheresis product","googleId":"TP5-vu01ffEJ","googleLink":"https://www.pace-h2020.eu/documents/publications/PACE_2020_MOLL_BJH_EDITORIAL_Circulating_MSCs.pdf","googleCitationCount":2,"googleAuthor":"G Moll"},{"title":"Development of a prognostic model for overall survival in multiple myeloma using the Connect® MM Patient Registry","googleId":"JxMZIzd0-QkJ","googleLink":"https://onlinelibrary.wiley.com/doi/abs/10.1111/bjh.16139","googleCitationCount":4,"googleAuthor":"","doi":"10.1111/bjh.16139","elsevierAuthor":"Terebelo H.R.","publicationName":"British Journal of Haematology","elsevierCoverDate":"2019-12-01","elsevierCoverDisplayDate":"1 December 2019","elsevierCitationCount":"1"},{"title":"Follow-up of a randomised phase II study of chemotherapy alone or in combination with mogamulizumab in newly diagnosed aggressive adult T-cell leukaemia …","googleId":"6KhdB-MxjQIJ","googleLink":"https://kyushu-u.pure.elsevier.com/en/publications/follow-up-of-a-randomised-phase-ii-study-of-chemotherapy-alone-or","googleCitationCount":11,"googleAuthor":"","doi":"10.1111/bjh.15123","elsevierAuthor":"Ishida T.","publicationName":"British Journal of Haematology","elsevierCoverDate":"2019-02-01","elsevierCoverDisplayDate":"Februaryy 2019","elsevierCitationCount":"11"},{"title":"Androgen therapy in inherited bone marrow failure syndromes: Analysis from the Canadian Inherited Marrow Failure Registry","googleId":"phf-ymu4O7MJ","googleLink":"https://onlinelibrary.wiley.com/doi/abs/10.1111/bjh.16445","googleCitationCount":3,"googleAuthor":"","doi":"10.1111/bjh.16445","elsevierAuthor":"Català A.","publicationName":"British Journal of Haematology","elsevierCoverDate":"2020-06-01","elsevierCoverDisplayDate":"1 June 2020","elsevierCitationCount":"2"},{"title":"Modern principles in the management of nodular lymphocyte‐predominant Hodgkin lymphoma","googleId":"Wxk8fIAZ0poJ","googleLink":"https://onlinelibrary.wiley.com/doi/abs/10.1111/bjh.15616","googleCitationCount":8,"googleAuthor":"G Varma","doi":"10.1111/bjh.15616","elsevierAuthor":"Spinner M.A.","publicationName":"British Journal of Haematology","elsevierCoverDate":"2019-01-01","elsevierCoverDisplayDate":"January 2019","elsevierCitationCount":"6"},{"title":"Real‐world non‐interventional long‐term post‐authorisation safety study of ruxolitinib in myelofibrosis","googleId":"d14wtXSv0I0J","googleLink":"https://onlinelibrary.wiley.com/doi/abs/10.1111/bjh.16729","googleCitationCount":1,"googleAuthor":"R Greil","doi":"10.1111/bjh.16729","elsevierAuthor":"Barraco F.","publicationName":"British Journal of Haematology","elsevierCoverDate":"2020-12-01","elsevierCoverDisplayDate":"December 2020","elsevierCitationCount":"1"},{"title":"Homocysteine is associated with severity of microvasculopathy in sickle cell disease patients","googleId":"3XXLOmwy0XIJ","googleLink":"https://onlinelibrary.wiley.com/doi/abs/10.1111/bjh.16618","googleCitationCount":1,"googleAuthor":"JW Miller","doi":"10.1111/bjh.16618","elsevierAuthor":"Samarron S.L.","publicationName":"British Journal of Haematology","elsevierCoverDate":"2020-08-01","elsevierCoverDisplayDate":"1 August 2020","elsevierCitationCount":"1"},{"title":"Brain functional impairment in beta‐thalassaemia: the cognitive profile in Italian neurologically asymptomatic adult patients in comparison to the reported literature","googleId":"l_tsZiCNodsJ","googleLink":"https://onlinelibrary.wiley.com/doi/abs/10.1111/bjh.15959","googleCitationCount":6,"googleAuthor":"I Tartaglione","doi":"10.1111/bjh.15959","elsevierAuthor":"Tartaglione I.","publicationName":"British Journal of Haematology","elsevierCoverDate":"2019-01-01","elsevierCoverDisplayDate":"2019","elsevierCitationCount":"6"},{"title":"CD70‐silenced dendritic cells induce immune tolerance in immune thrombocytopenia patients","googleId":"7GWZSM2Vz8kJ","googleLink":"https://onlinelibrary.wiley.com/doi/abs/10.1111/bjh.16689","googleCitationCount":1,"googleAuthor":"","doi":"10.1111/bjh.16689","elsevierAuthor":"Zhang X.","publicationName":"British Journal of Haematology","elsevierCoverDate":"2020-11-01","elsevierCoverDisplayDate":"1 November 2020","elsevierCitationCount":"0"},{"title":"Molecular pathogenesis of chronic lymphocytic leukaemia","googleId":"jawohXKlIsYJ","googleLink":"https://onlinelibrary.wiley.com/doi/abs/10.1111/bjh.16102","googleCitationCount":5,"googleAuthor":"K Crassini","doi":"10.1111/bjh.16102","elsevierAuthor":"Crassini K.","publicationName":"British Journal of Haematology","elsevierCoverDate":"2019-01-01","elsevierCoverDisplayDate":"2019","elsevierCitationCount":"3"},{"title":"SET alpha and SET beta mRNA isoforms in chronic lymphocytic leukaemia","googleId":"d4H6rxuUHc8J","googleLink":"https://onlinelibrary.wiley.com/doi/abs/10.1111/bjh.15677","googleCitationCount":8,"googleAuthor":"","doi":"10.1111/bjh.15677","elsevierAuthor":"Brander D.M.","publicationName":"British Journal of Haematology","elsevierCoverDate":"2019-02-01","elsevierCoverDisplayDate":"Februaryy 2019","elsevierCitationCount":"7"},{"title":"Treatment of acute leukaemia in adult Jehovah's Witnesses","googleId":"oBRvDzg3LPsJ","googleLink":"https://onlinelibrary.wiley.com/doi/abs/10.1111/bjh.16284","googleCitationCount":2,"googleAuthor":"","doi":"10.1111/bjh.16284","elsevierAuthor":"El Chaer F.","publicationName":"British Journal of Haematology","elsevierCoverDate":"2020-09-01","elsevierCoverDisplayDate":"1 September 2020","elsevierCitationCount":"1"},{"title":"Prophylactic donor lymphocyte infusions after haploidentical haematopoietic stem cell transplantation for high risk haematological malignancies: a retrospective …","googleId":"T72tyeChzkAJ","googleLink":"https://onlinelibrary.wiley.com/doi/abs/10.1111/bjh.15544?af=R","googleCitationCount":9,"googleAuthor":"L Castagna","doi":"10.1111/bjh.15544","elsevierAuthor":"Cauchois R.","publicationName":"British Journal of Haematology","elsevierCoverDate":"2019-05-01","elsevierCoverDisplayDate":"May 2019","elsevierCitationCount":"6"},{"title":"Pembrolizumab in relapsed or refractory Richter syndrome","googleId":"2EHcmw1PZpwJ","googleLink":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7496875/","googleCitationCount":2,"googleAuthor":"","doi":"10.1111/bjh.16762","elsevierAuthor":"Armand P.","publicationName":"British Journal of Haematology","elsevierCoverDate":"2020-07-01","elsevierCoverDisplayDate":"1 July 2020","elsevierCitationCount":"1"},{"title":"NICE NG89 recommendations for extended pharmacological thromboprophylaxis-is it justified and is it cost effective: a rebuttal from the British Society for …","googleId":"RpfCY0THResJ","googleLink":"http://www.repository.uhblibrary.co.uk/id/eprint/3280","googleCitationCount":6,"googleAuthor":"","doi":"10.1111/bjh.16007","elsevierAuthor":"Lester W.","publicationName":"British Journal of Haematology","elsevierCoverDate":"2019-01-01","elsevierCoverDisplayDate":"2019","elsevierCitationCount":"2"},{"title":"The natural course of pregnancies in women with primary atypical haemolytic uraemic syndrome and asymptomatic relatives","googleId":"VbyaH4hPE_MJ","googleLink":"https://onlinelibrary.wiley.com/doi/abs/10.1111/bjh.16626","googleCitationCount":2,"googleAuthor":"","doi":"10.1111/bjh.16626","elsevierAuthor":"Timmermans S.A.M.E.G.","publicationName":"British Journal of Haematology","elsevierCoverDate":"2020-08-01","elsevierCoverDisplayDate":"1 August 2020","elsevierCitationCount":"1"},{"title":"Management of anaemia in pre‐term infants","googleId":"9Ujpa1o0XCEJ","googleLink":"https://onlinelibrary.wiley.com/doi/abs/10.1111/bjh.16233","googleCitationCount":3,"googleAuthor":"","doi":"10.1111/bjh.16233","elsevierAuthor":"Saito-Benz M.","publicationName":"British Journal of Haematology","elsevierCoverDate":"2020-02-01","elsevierCoverDisplayDate":"1 February 2020","elsevierCitationCount":"1"},{"title":"Comorbidities and sex differences in causes of death among mantle cell lymphoma patients–A nationwide population‐based cohort study","googleId":"8RQFTWTFG5sJ","googleLink":"https://onlinelibrary.wiley.com/doi/abs/10.1111/bjh.16317","googleCitationCount":4,"googleAuthor":"I Glimelius","doi":"10.1111/bjh.16317","elsevierAuthor":"Glimelius I.","publicationName":"British Journal of Haematology","elsevierCoverDate":"2020-04-01","elsevierCoverDisplayDate":"1 April 2020","elsevierCitationCount":"3"},{"title":"FAS mutations are an uncommon cause of immune thrombocytopenia in children and adults without additional features of immunodeficiency","googleId":"29LWjtecg3EJ","googleLink":"https://discovery.ucl.ac.uk/id/eprint/10104696/1/Vandrovcova_FAS%20manuscript.pdf","googleCitationCount":5,"googleAuthor":"J Vandrovcova"},{"title":"Serum brain‐derived neurotrophic factor (BDNF) concentration predicts polyneuropathy and overall survival in multiple myeloma patients","googleId":"yuG6YUXUCaYJ","googleLink":"https://onlinelibrary.wiley.com/doi/abs/10.1111/bjh.16862","googleCitationCount":2,"googleAuthor":"","doi":"10.1111/bjh.16862","elsevierAuthor":"Szudy-Szczyrek A.","publicationName":"British Journal of Haematology","elsevierCoverDate":"2020-10-01","elsevierCoverDisplayDate":"1 October 2020","elsevierCitationCount":"1"},{"title":"The joint effect of genetic risk factors and different types of combined oral contraceptives on venous thrombosis risk","googleId":"S1t0OCdVDSkJ","googleLink":"https://onlinelibrary.wiley.com/doi/abs/10.1111/bjh.16666","googleCitationCount":1,"googleAuthor":"S le Cessie","doi":"10.1111/bjh.16666","elsevierAuthor":"Khialani D.","publicationName":"British Journal of Haematology","elsevierCoverDate":"2020-10-01","elsevierCoverDisplayDate":"1 October 2020","elsevierCitationCount":"2"},{"title":"Longitudinal sequencing of RUNX1 familial platelet disorder: new insights into genetic mechanisms of transformation to myeloid malignancies","googleId":"ekzO5NgXNEYJ","googleLink":"https://onlinelibrary.wiley.com/doi/abs/10.1111/bjh.15990","googleCitationCount":5,"googleAuthor":"","doi":"10.1111/bjh.15990","elsevierAuthor":"Duarte B.K.L.","publicationName":"British Journal of Haematology","elsevierCoverDate":"2019-01-01","elsevierCoverDisplayDate":"2019","elsevierCitationCount":"2"},{"title":"Large granular lymphocytic leukaemia after solid organ and haematopoietic stem cell transplantation","googleId":"DCF7vHe3NPQJ","googleLink":"https://onlinelibrary.wiley.com/doi/abs/10.1111/bjh.16336","googleCitationCount":2,"googleAuthor":"H Awada","doi":"10.1111/bjh.16336","elsevierAuthor":"Awada H.","publicationName":"British Journal of Haematology","elsevierCoverDate":"2020-04-01","elsevierCoverDisplayDate":"1 April 2020","elsevierCitationCount":"0"},{"title":"Mean platelet counts are relatively decreased with malaria but relatively increased with endemic Burkitt Lymphoma in Uganda, Tanzania, and Kenya","googleId":"rtGfntDcvZwJ","googleLink":"https://onlinelibrary.wiley.com/doi/abs/10.1111/bjh.16700","googleCitationCount":1,"googleAuthor":"S Peprah","doi":"10.1111/bjh.16700","elsevierAuthor":"Peprah S.","publicationName":"British Journal of Haematology","elsevierCoverDate":"2020-09-01","elsevierCoverDisplayDate":"1 September 2020","elsevierCitationCount":"1"},{"title":"Switching from dispersible to film coated tablet formulation of deferasirox improves hemoglobin levels and transfusional interval in patients with transfusion-dependent …","googleId":"o1CGxtPLUD0J","googleLink":"https://pubmed.ncbi.nlm.nih.gov/32119115/","googleCitationCount":4,"googleAuthor":"","doi":"10.1111/bjh.16468,","elsevierAuthor":"Quarta A.","publicationName":"British Journal of Haematology","elsevierCoverDate":"2020-04-01","elsevierCoverDisplayDate":"1 April 2020","elsevierCitationCount":"0"},{"title":"The use of artificial neural network analysis can improve the risk‐stratification of patients presenting with suspected deep vein thrombosis","googleId":"B0ZdpkwWBFoJ","googleLink":"https://onlinelibrary.wiley.com/doi/abs/10.1111/bjh.15780","googleCitationCount":6,"googleAuthor":"J Willan","doi":"10.1111/bjh.15780","elsevierAuthor":"Willan J.","publicationName":"British Journal of Haematology","elsevierCoverDate":"2019-04-01","elsevierCoverDisplayDate":"April 2019","elsevierCitationCount":"4"},{"title":"C1 esterase inhibitor and the contact system in COVID‐19","googleId":"VYuovm1XOIYJ","googleLink":"https://onlinelibrary.wiley.com/doi/abs/10.1111/bjh.16938","googleCitationCount":1,"googleAuthor":"TM Thomson","doi":"10.1111/bjh.16938","elsevierAuthor":"Thomson T.M.","publicationName":"British Journal of Haematology","elsevierCoverDate":"2020-08-01","elsevierCoverDisplayDate":"1 August 2020","elsevierCitationCount":"2"},{"title":"Rituximab and reduced‐intensity chemotherapy in children and adolescents with mature B‐cell lymphoma: interim results for 231 patients enrolled in the second …","googleId":"-CeN-z6s0tgJ","googleLink":"https://onlinelibrary.wiley.com/doi/abs/10.1111/bjh.15944","googleCitationCount":5,"googleAuthor":"","doi":"10.1111/bjh.15944","elsevierAuthor":"Maschan A.","publicationName":"British Journal of Haematology","elsevierCoverDate":"2019-08-01","elsevierCoverDisplayDate":"August 2019","elsevierCitationCount":"3"},{"title":"Clinical proof of concept for a safe and effective NF-κB-targeting strategy in multiple myeloma","googleId":"fe3kCGLLZHsJ","googleLink":"https://pubmed.ncbi.nlm.nih.gov/30255568/","googleCitationCount":8,"googleAuthor":"D D'Andrea","doi":"10.1111/bjh.15569,","elsevierAuthor":"Tornatore L.","publicationName":"British Journal of Haematology","elsevierCoverDate":"2019-05-01","elsevierCoverDisplayDate":"May 2019","elsevierCitationCount":"7"},{"title":"Identification of essential exported Plasmodium falciparum protein kinases in malaria‐infected red blood cells","googleId":"PpTItQsgdRoJ","googleLink":"https://onlinelibrary.wiley.com/doi/abs/10.1111/bjh.16219","googleCitationCount":5,"googleAuthor":"G Siddiqui","doi":"10.1111/bjh.16219","elsevierAuthor":"Siddiqui G.","publicationName":"British Journal of Haematology","elsevierCoverDate":"2020-03-01","elsevierCoverDisplayDate":"1 March 2020","elsevierCitationCount":"2"},{"title":"Integrated stress response and immune cell infiltration in an ibrutinib-refractory mantle cell lymphoma patient following ONC201 treatment","googleId":"caYWpgC1GHQJ","googleLink":"https://pubmed.ncbi.nlm.nih.gov/29740811/","googleCitationCount":9,"googleAuthor":"R Tarapore","doi":"10.1111/bjh.15271,","elsevierAuthor":"Romaguera J.E.","publicationName":"British Journal of Haematology","elsevierCoverDate":"2019-04-01","elsevierCoverDisplayDate":"April 2019","elsevierCitationCount":"5"},{"title":"Down the Rabbit‐Hole of blood groups and COVID‐19","googleId":"tyQRlZYG34cJ","googleLink":"https://onlinelibrary.wiley.com/doi/abs/10.1111/bjh.17059","googleCitationCount":3,"googleAuthor":"","doi":"10.1111/bjh.17059","elsevierAuthor":"Takagi H.","publicationName":"British Journal of Haematology","elsevierCoverDate":"2020-09-01","elsevierCoverDisplayDate":"1 September 2020","elsevierCitationCount":"0"},{"title":"Forging ahead or moving back: dilemmas and disappointments of novel agents for myeloproliferative neoplasms","googleId":"zuW4vDgxdYAJ","googleLink":"https://onlinelibrary.wiley.com/doi/abs/10.1111/bjh.16573","googleCitationCount":2,"googleAuthor":"","doi":"10.1111/bjh.16573","elsevierAuthor":"McLornan D.P.","publicationName":"British Journal of Haematology","elsevierCoverDate":"2020-10-01","elsevierCoverDisplayDate":"1 October 2020","elsevierCitationCount":"2"},{"title":"Detection of measurable residual disease may better predict outcomes than mutations based on next‐generation sequencing in acute myeloid leukaemia with biallelic …","googleId":"bsfg2tAM5M8J","googleLink":"https://onlinelibrary.wiley.com/doi/abs/10.1111/bjh.16535","googleCitationCount":1,"googleAuthor":"","doi":"10.1111/bjh.16535","elsevierAuthor":"Wang J.","publicationName":"British Journal of Haematology","elsevierCoverDate":"2020-08-01","elsevierCoverDisplayDate":"1 August 2020","elsevierCitationCount":"1"},{"title":"The clinical and pathological panoply of systemic mastocytosis","googleId":"SdTeJXgdwpMJ","googleLink":"https://onlinelibrary.wiley.com/doi/abs/10.1111/bjh.16288","googleCitationCount":2,"googleAuthor":"A Green","doi":"10.1111/bjh.16288","elsevierAuthor":"Radia D.H.","publicationName":"British Journal of Haematology","elsevierCoverDate":"2020-03-01","elsevierCoverDisplayDate":"1 March 2020","elsevierCitationCount":"1"},{"title":"Novel targeted therapeutic agents for the treatment of childhood, adolescent and young adult non‐Hodgkin lymphoma","googleId":"_44sBiwi4icJ","googleLink":"https://onlinelibrary.wiley.com/doi/abs/10.1111/bjh.15783","googleCitationCount":5,"googleAuthor":"MJ Barth","doi":"10.1111/bjh.15783","elsevierAuthor":"Barth M.J.","publicationName":"British Journal of Haematology","elsevierCoverDate":"2019-06-01","elsevierCoverDisplayDate":"June 2019","elsevierCitationCount":"4"},{"title":"Early mortality benefit with COVID‐19 convalescent plasma: a matched control study","googleId":"wWjdHsLDS5cJ","googleLink":"https://onlinelibrary.wiley.com/doi/abs/10.1111/bjh.17272","googleCitationCount":2,"googleAuthor":"AZ Hettinger","doi":"10.1111/bjh.17272","elsevierAuthor":"Shenoy A.G.","publicationName":"British Journal of Haematology","elsevierCoverDate":"2021-01-01","elsevierCoverDisplayDate":"2021","elsevierCitationCount":"0"},{"title":"Concomitant Erdheim‐Chester disease and chronic myelomonocytic leukaemia: genomic insights into a common clonal origin","googleId":"jj7D1qLeWOQJ","googleLink":"https://onlinelibrary.wiley.com/doi/abs/10.1111/bjh.16177","googleCitationCount":5,"googleAuthor":"G Goyal","doi":"10.1111/bjh.16177","elsevierAuthor":"Goyal G.","publicationName":"British Journal of Haematology","elsevierCoverDate":"2019-10-01","elsevierCoverDisplayDate":"1 October 2019","elsevierCitationCount":"5"},{"title":"Attention, response inhibition and brain event‐related potential alterations in adults with beta‐thalassaemia major","googleId":"U8BWNwmnDpAJ","googleLink":"https://onlinelibrary.wiley.com/doi/abs/10.1111/bjh.15957","googleCitationCount":3,"googleAuthor":"A Koren","doi":"10.1111/bjh.15957","elsevierAuthor":"Raz S.","publicationName":"British Journal of Haematology","elsevierCoverDate":"2019-01-01","elsevierCoverDisplayDate":"2019","elsevierCitationCount":"1"},{"title":"High‐fluorescent lymphocytes are increased in patients with COVID‐19","googleId":"OxILaLh4B_8J","googleLink":"https://onlinelibrary.wiley.com/doi/abs/10.1111/bjh.16867","googleCitationCount":2,"googleAuthor":"","doi":"10.1111/bjh.16867","elsevierAuthor":"Wang Z.","publicationName":"British Journal of Haematology","elsevierCoverDate":"2020-07-01","elsevierCoverDisplayDate":"1 July 2020","elsevierCitationCount":"2"},{"title":"Changes in neurocognitive function and central nervous system structure in childhood acute lymphoblastic leukaemia survivors after treatment: a meta‐analysis","googleId":"6jc_ASrbbLgJ","googleLink":"https://onlinelibrary.wiley.com/doi/abs/10.1111/bjh.16279","googleCitationCount":4,"googleAuthor":"","doi":"10.1111/bjh.16279","elsevierAuthor":"Zhou C.","publicationName":"British Journal of Haematology","elsevierCoverDate":"2020-03-01","elsevierCoverDisplayDate":"1 March 2020","elsevierCitationCount":"3"},{"title":"Results of successive EORTC‐CLG 58 881 and 58 951 trials in paediatric T‐cell acute lymphoblastic leukaemia (ALL)","googleId":"2YrwbEAOh6AJ","googleLink":"https://onlinelibrary.wiley.com/doi/abs/10.1111/bjh.15983","googleCitationCount":5,"googleAuthor":"","doi":"10.1111/bjh.15983","elsevierAuthor":"Hofmans M.","publicationName":"British Journal of Haematology","elsevierCoverDate":"2019-01-01","elsevierCoverDisplayDate":"2019","elsevierCitationCount":"4"},{"title":"Optimizing outcomes for children with non‐Hodgkin lymphoma in low‐and middle‐income countries by early correct diagnosis, reducing toxic death and preventing …","googleId":"VxJVx6YFBxwJ","googleLink":"https://onlinelibrary.wiley.com/doi/abs/10.1111/bjh.15785","googleCitationCount":5,"googleAuthor":"CG Lam","doi":"10.1111/bjh.15785","elsevierAuthor":"Chantada G.","publicationName":"British Journal of Haematology","elsevierCoverDate":"2019-06-01","elsevierCoverDisplayDate":"June 2019","elsevierCitationCount":"3"},{"title":"Autologous stem cell transplantation for untreated transformed indolent B‐cell lymphoma in first remission: an international, multi‐centre propensity‐score‐matched …","googleId":"KdFwfcXE3p4J","googleLink":"https://onlinelibrary.wiley.com/doi/abs/10.1111/bjh.17072","googleCitationCount":1,"googleAuthor":"KJ Lim","doi":"10.1111/bjh.17072","elsevierAuthor":"Chin C.K.","publicationName":"British Journal of Haematology","elsevierCoverDate":"2020-12-01","elsevierCoverDisplayDate":"December 2020","elsevierCitationCount":"1"},{"title":"Incidence and outcomes of heparin‐induced thrombocytopenia in solid malignancy: an analysis of the National Inpatient Sample Database","googleId":"B0NJHVosEDMJ","googleLink":"https://onlinelibrary.wiley.com/doi/abs/10.1111/bjh.16400","googleCitationCount":3,"googleAuthor":"R Kumar","doi":"10.1111/bjh.16400","elsevierAuthor":"Kumar R.","publicationName":"British Journal of Haematology","elsevierCoverDate":"2020-05-01","elsevierCoverDisplayDate":"1 May 2020","elsevierCitationCount":"1"},{"title":"GATA2 deficiency and haematopoietic stem cell transplantation: challenges for the clinical practitioner","googleId":"DUzXAKUKXwYJ","googleLink":"https://onlinelibrary.wiley.com/doi/abs/10.1111/bjh.16247","googleCitationCount":9,"googleAuthor":"","doi":"10.1111/bjh.16247","elsevierAuthor":"Bogaert D.J.","publicationName":"British Journal of Haematology","elsevierCoverDate":"2020-03-01","elsevierCoverDisplayDate":"1 March 2020","elsevierCitationCount":"6"},{"title":"Single‐cell oxygen saturation imaging shows that gas exchange by red blood cells is not impaired in COVID‐19 patients","googleId":"4nnePGInXSoJ","googleLink":"https://onlinelibrary.wiley.com/doi/abs/10.1111/bjh.17025","googleCitationCount":1,"googleAuthor":"KC Park","doi":"10.1111/bjh.17025","elsevierAuthor":"Park K.C.","publicationName":"British Journal of Haematology","elsevierCoverDate":"2020-08-01","elsevierCoverDisplayDate":"1 August 2020","elsevierCitationCount":"1"},{"title":"MYD 88 L265P mutations identify a prognostic gene expression signature and a pathway for targeted inhibition in CLL","googleId":"XBeAmsdqtAcJ","googleLink":"https://onlinelibrary.wiley.com/doi/abs/10.1111/bjh.15714","googleCitationCount":6,"googleAuthor":"JL Klitgaard","doi":"10.1111/bjh.15714","elsevierAuthor":"Improgo M.R.","publicationName":"British Journal of Haematology","elsevierCoverDate":"2019-03-01","elsevierCoverDisplayDate":"March 2019","elsevierCitationCount":"6"},{"title":"Childhood, adolescent and young adult non‐Hodgkin lymphoma: current perspectives","googleId":"2FY4GYbiZhAJ","googleLink":"https://onlinelibrary.wiley.com/doi/abs/10.1111/bjh.15764","googleCitationCount":5,"googleAuthor":"","doi":"10.1111/bjh.15764","elsevierAuthor":"Cairo M.S.","publicationName":"British Journal of Haematology","elsevierCoverDate":"2019-06-01","elsevierCoverDisplayDate":"June 2019","elsevierCitationCount":"2"},{"title":"Characteristics of graft‐versus‐host disease occurring after alemtuzumab‐containing allogeneic stem cell transplants: incidence, organ involvement, risk factors and …","googleId":"XTAG02-pZJcJ","googleLink":"https://onlinelibrary.wiley.com/doi/abs/10.1111/bjh.16200","googleCitationCount":2,"googleAuthor":"C Craddock","doi":"10.1111/bjh.16200","elsevierAuthor":"Finazzi M.C.","publicationName":"British Journal of Haematology","elsevierCoverDate":"2020-02-01","elsevierCoverDisplayDate":"1 February 2020","elsevierCitationCount":"2"},{"title":"Maternal antibodies against paternal class I human leukocyte antigens are not associated with foetal and neonatal alloimmune thrombocytopenia","googleId":"K00SmHddhnoJ","googleLink":"https://onlinelibrary.wiley.com/doi/abs/10.1111/bjh.16419","googleCitationCount":1,"googleAuthor":"","doi":"10.1111/bjh.16419","elsevierAuthor":"Sachs U.J.","publicationName":"British Journal of Haematology","elsevierCoverDate":"2020-05-01","elsevierCoverDisplayDate":"1 May 2020","elsevierCitationCount":"1"},{"title":"Daratumumab‐based therapy for patients with monoclonal gammopathy of renal significance","googleId":"DvioqFwgm80J","googleLink":"https://onlinelibrary.wiley.com/doi/abs/10.1111/bjh.17052","googleCitationCount":3,"googleAuthor":"E Kastritis","doi":"10.1111/bjh.17052","elsevierAuthor":"Kastritis E.","publicationName":"British Journal of Haematology","elsevierCoverDate":"2020-01-01","elsevierCoverDisplayDate":"2020","elsevierCitationCount":"0"},{"title":"Current considerations in AYA Hodgkin lymphoma","googleId":"RerGUA5NtqwJ","googleLink":"https://onlinelibrary.wiley.com/doi/abs/10.1111/bjh.15640","googleCitationCount":6,"googleAuthor":"","doi":"10.1111/bjh.15640","elsevierAuthor":"Crombie J.","publicationName":"British Journal of Haematology","elsevierCoverDate":"2019-01-01","elsevierCoverDisplayDate":"January 2019","elsevierCitationCount":"1"},{"title":"How I manage patients with follicular lymphoma","googleId":"g6maO5ta1UwJ","googleLink":"https://onlinelibrary.wiley.com/doi/abs/10.1111/bjh.16011","googleCitationCount":3,"googleAuthor":"","doi":"10.1111/bjh.16011","elsevierAuthor":"Casulo C.","publicationName":"British Journal of Haematology","elsevierCoverDate":"2019-01-01","elsevierCoverDisplayDate":"2019","elsevierCitationCount":"1"},{"title":"Factor VIII: the protein, cloning its gene, synthetic factor and now–35 years later–gene therapy; what happened in between?","googleId":"MvsqKalJveQJ","googleLink":"https://onlinelibrary.wiley.com/doi/abs/10.1111/bjh.16311","googleCitationCount":2,"googleAuthor":"EGD Tuddenham","doi":"10.1111/bjh.16311","elsevierAuthor":"Ling G.","publicationName":"British Journal of Haematology","elsevierCoverDate":"2020-05-01","elsevierCoverDisplayDate":"1 May 2020","elsevierCitationCount":"2"},{"title":"The combination of ibrutinib and rituximab demonstrates activity in first‐line follicular lymphoma","googleId":"nTIBUXQ8qVUJ","googleLink":"https://onlinelibrary.wiley.com/doi/abs/10.1111/bjh.16424","googleCitationCount":2,"googleAuthor":"","doi":"10.1111/bjh.16424","elsevierAuthor":"Fowler N.H.","publicationName":"British Journal of Haematology","elsevierCoverDate":"2020-05-01","elsevierCoverDisplayDate":"1 May 2020","elsevierCitationCount":"2"},{"title":"Essential thrombocythaemia treated with recombinant interferon:'real world'United Kingdom referral centre experience","googleId":"5RlnfZD2XTIJ","googleLink":"https://onlinelibrary.wiley.com/doi/abs/10.1111/bjh.15968","googleCitationCount":4,"googleAuthor":"","doi":"10.1111/bjh.15968","elsevierAuthor":"Desterro J.","publicationName":"British Journal of Haematology","elsevierCoverDate":"2019-01-01","elsevierCoverDisplayDate":"2019","elsevierCitationCount":"1"},{"title":"Next generation sequencing redefines a triple negative essential thrombocythaemia as double-positive with rare mutations on JAK2 V617 and MPL W515 hotspots","googleId":"YgjRNB3tLHAJ","googleLink":"https://pubmed.ncbi.nlm.nih.gov/31087331/","googleCitationCount":5,"googleAuthor":"","doi":"10.1111/bjh.15954,","elsevierAuthor":"Beucher A.","publicationName":"British Journal of Haematology","elsevierCoverDate":"2019-01-01","elsevierCoverDisplayDate":"2019","elsevierCitationCount":"1"},{"title":"Headache: an important symptom possibly linked to white matter lesions in thalassaemia","googleId":"G0EHfPFWJ3kJ","googleLink":"https://onlinelibrary.wiley.com/doi/abs/10.1111/bjh.15825","googleCitationCount":4,"googleAuthor":"A Premawardhena","doi":"10.1111/bjh.15825","elsevierAuthor":"Premawardhena A.","publicationName":"British Journal of Haematology","elsevierCoverDate":"2019-05-01","elsevierCoverDisplayDate":"May 2019","elsevierCitationCount":"4"},{"title":"Management of vaso‐occlusive episodes in the day hospital decreases admissions in children with sickle cell disease","googleId":"heSEecnLekgJ","googleLink":"https://onlinelibrary.wiley.com/doi/abs/10.1111/bjh.16002","googleCitationCount":3,"googleAuthor":"","doi":"10.1111/bjh.16002","elsevierAuthor":"Karkoska K.","publicationName":"British Journal of Haematology","elsevierCoverDate":"2019-09-01","elsevierCoverDisplayDate":"1 September 2019","elsevierCitationCount":"1"},{"title":"Administration of immunoglobulin G-degrading enzyme of Streptococcus pyogenes (IdeS) for persistent anti-ADAMTS13 antibodies in patients with thrombotic …","googleId":"hcEVjWCOdSQJ","googleLink":"https://pubmed.ncbi.nlm.nih.gov/30488420/","googleCitationCount":7,"googleAuthor":"C Vendramin","doi":"10.1111/bjh.15706,","elsevierAuthor":"Stubbs M.J.","publicationName":"British Journal of Haematology","elsevierCoverDate":"2019-07-01","elsevierCoverDisplayDate":"July 2019","elsevierCitationCount":"3"},{"title":"Ibrutinib in patients with relapsed/refractory central nervous system lymphoma: A retrospective single-centre analysis","googleId":"Bl_0N8QOmQIJ","googleLink":"https://pubmed.ncbi.nlm.nih.gov/32452526/","googleCitationCount":3,"googleAuthor":"","doi":"10.1111/bjh.16759,","elsevierAuthor":"Lauer E.M.","publicationName":"British Journal of Haematology","elsevierCoverDate":"2020-07-01","elsevierCoverDisplayDate":"1 July 2020","elsevierCitationCount":"2"},{"title":"Revisiting CLEC 12A as leukaemic stem cell marker in AML: highlighting the necessity of precision diagnostics in patients eligible for targeted therapy","googleId":"Kopzeiq1IAEJ","googleLink":"https://onlinelibrary.wiley.com/doi/abs/10.1111/bjh.15711","googleCitationCount":5,"googleAuthor":"","doi":"10.1111/bjh.15711","elsevierAuthor":"Bill M.","publicationName":"British Journal of Haematology","elsevierCoverDate":"2019-03-01","elsevierCoverDisplayDate":"March 2019","elsevierCitationCount":"4"},{"title":"Adjuvant tyrosine kinase inhibitor therapy improves outcome for children and adolescents with acute lymphoblastic leukaemia who have an ABL‐class fusion","googleId":"dnUfUyuyiRsJ","googleLink":"https://onlinelibrary.wiley.com/doi/abs/10.1111/bjh.17093","googleCitationCount":1,"googleAuthor":"AV Moorman","doi":"10.1111/bjh.17093","elsevierAuthor":"Moorman A.V.","publicationName":"British Journal of Haematology","elsevierCoverDate":"2020-12-01","elsevierCoverDisplayDate":"December 2020","elsevierCitationCount":"1"},{"title":"Ibrutinib provides favourable survival outcomes in patients with comorbidities versus established therapies","googleId":"MbJNzlVMCvAJ","googleLink":"https://www.researchgate.net/profile/Thorsten_Graef/publication/331015534_Ibrutinib_provides_favourable_survival_outcomes_in_patients_with_comorbidities_versus_established_therapies/links/5d260cd4458515c11c23faaa/Ibrutinib-provides-favourable-survival-outcomes-in-patients-with-comorbidities-versus-established-therapies.pdf","googleCitationCount":5,"googleAuthor":"JA Burger"},{"title":"Congenital factor XIII deficiency: comprehensive overview of the FranceCoag cohort","googleId":"UsJJsHukxJUJ","googleLink":"https://onlinelibrary.wiley.com/doi/abs/10.1111/bjh.16133","googleCitationCount":4,"googleAuthor":"","doi":"10.1111/bjh.16133","elsevierAuthor":"Bouttefroy S.","publicationName":"British Journal of Haematology","elsevierCoverDate":"2020-01-01","elsevierCoverDisplayDate":"1 January 2020","elsevierCitationCount":"1"},{"title":"Inotuzumab ozogamicin compassionate use for French paediatric patients with relapsed or refractory CD22-positive B-cell acute lymphoblastic leukaemia","googleId":"LmgLjcy2DzkJ","googleLink":"https://pubmed.ncbi.nlm.nih.gov/32424837/","googleCitationCount":4,"googleAuthor":"","doi":"10.1111/bjh.16732,","elsevierAuthor":"Calvo C.","publicationName":"British Journal of Haematology","elsevierCoverDate":"2020-07-01","elsevierCoverDisplayDate":"1 July 2020","elsevierCitationCount":"2"},{"title":"Assessment of romiplostim immunogenicity in adult patients in clinical trials and in a global postmarketing registry","googleId":"vKgydthwFagJ","googleLink":"https://onlinelibrary.wiley.com/doi/abs/10.1111/bjh.16658","googleCitationCount":1,"googleAuthor":"","doi":"10.1111/bjh.16658","elsevierAuthor":"Mytych D.T.","publicationName":"British Journal of Haematology","elsevierCoverDate":"2020-09-01","elsevierCoverDisplayDate":"1 September 2020","elsevierCitationCount":"1"},{"title":"Selinexor-based regimens for the treatment of myeloma refractory to chimeric antigen receptor T cell therapy","googleId":"hh9itn4xCToJ","googleLink":"https://pubmed.ncbi.nlm.nih.gov/32124443/","googleCitationCount":2,"googleAuthor":"","doi":"10.1111/bjh.16550,","elsevierAuthor":"Chari A.","publicationName":"British Journal of Haematology","elsevierCoverDate":"2020-05-01","elsevierCoverDisplayDate":"1 May 2020","elsevierCitationCount":"1"},{"title":"Prevalence and correlates of growth failure in young African patients with sickle cell disease","googleId":"nyuctskoEPkJ","googleLink":"https://onlinelibrary.wiley.com/doi/abs/10.1111/bjh.15638","googleCitationCount":5,"googleAuthor":"L Alexandre‐Heymann","doi":"10.1111/bjh.15638","elsevierAuthor":"Alexandre-Heymann L.","publicationName":"British Journal of Haematology","elsevierCoverDate":"2019-01-01","elsevierCoverDisplayDate":"January 2019","elsevierCitationCount":"2"},{"title":"IgM paraprotein‐associated peripheral neuropathy: small CD20‐positive B‐cell clones may predict a monoclonal gammopathy of neurological significance and …","googleId":"MDMFZ5jN1bYJ","googleLink":"https://onlinelibrary.wiley.com/doi/abs/10.1111/bjh.16210","googleCitationCount":4,"googleAuthor":"","doi":"10.1111/bjh.16210","elsevierAuthor":"Chen L.Y.","publicationName":"British Journal of Haematology","elsevierCoverDate":"2020-02-01","elsevierCoverDisplayDate":"1 February 2020","elsevierCitationCount":"1"},{"title":"Increased ferritin levels in non‐transfusion‐dependent β°‐thalassaemia/HbE are associated with reduced CXCR2 expression and neutrophil migration","googleId":"aqLKfnS6yCwJ","googleLink":"https://onlinelibrary.wiley.com/doi/abs/10.1111/bjh.16295","googleCitationCount":2,"googleAuthor":"","doi":"10.1111/bjh.16295","elsevierAuthor":"Thiengtavor C.","publicationName":"British Journal of Haematology","elsevierCoverDate":"2020-04-01","elsevierCoverDisplayDate":"1 April 2020","elsevierCitationCount":"2"},{"title":"Filanesib in combination with pomalidomide and dexamethasone in refractory MM patients: safety and efficacy, and association with alpha 1‐acid glycoprotein (AAG) …","googleId":"UUDoScEHsHsJ","googleLink":"https://onlinelibrary.wiley.com/doi/abs/10.1111/bjh.16788","googleCitationCount":1,"googleAuthor":"EM Ocio","doi":"10.1111/bjh.16788","elsevierAuthor":"Ocio E.M.","publicationName":"British Journal of Haematology","elsevierCoverDate":"2021-02-01","elsevierCoverDisplayDate":"February 2021","elsevierCitationCount":"1"},{"title":"Blood counts in adult and elderly individuals: defining the norms over eight decades of life","googleId":"_5Rah_My_3IJ","googleLink":"https://onlinelibrary.wiley.com/doi/abs/10.1111/bjh.16430","googleCitationCount":1,"googleAuthor":"","doi":"10.1111/bjh.16430","elsevierAuthor":"","publicationName":"British Journal of Haematology","elsevierCoverDate":"2020-07-01","elsevierCoverDisplayDate":"1 July 2020","elsevierCitationCount":"0"},{"title":"Successful treatment of a PNH patient non‐responsive to eculizumab with the novel complement C5 inhibitor coversin (nomacopan)","googleId":"yZoPX6Zy9doJ","googleLink":"https://www.researchgate.net/profile/Miles-Nunn/publication/337952750_Successful_treatment_of_a_PNH_patient_non-responsive_to_eculizumab_with_the_novel_complement_C5_inhibitor_coversin_nomacopan/links/5f047b37458515505091d127/Successful-treatment-of-a-PNH-patient-non-responsive-to-eculizumab-with-the-novel-complement-C5-inhibitor-coversin-nomacopan.pdf","googleCitationCount":4,"googleAuthor":"S Schols"},{"title":"Serum profiling identifies ibrutinib as a treatment option for young adults with B‐cell acute lymphoblastic leukaemia","googleId":"QX8npYlN9SAJ","googleLink":"https://onlinelibrary.wiley.com/doi/abs/10.1111/bjh.16407","googleCitationCount":1,"googleAuthor":"","doi":"10.1111/bjh.16407","elsevierAuthor":"Jordaens S.","publicationName":"British Journal of Haematology","elsevierCoverDate":"2020-05-01","elsevierCoverDisplayDate":"1 May 2020","elsevierCitationCount":"2"},{"title":"Cumulative outcome of pre‐implantation genetic diagnosis for sickle cell disease: a 5‐year review","googleId":"gTyun9yJoh0J","googleLink":"https://onlinelibrary.wiley.com/doi/abs/10.1111/bjh.16930","googleCitationCount":1,"googleAuthor":"S Vali","doi":"10.1111/bjh.16930","elsevierAuthor":"Vali S.","publicationName":"British Journal of Haematology","elsevierCoverDate":"2020-12-01","elsevierCoverDisplayDate":"December 2020","elsevierCitationCount":"0"},{"title":"S100A16 suppresses the growth and survival of leukaemia cells and correlates with relapse and relapse free survival in adults with Philadelphia chromosome …","googleId":"jBkYDYYrW20J","googleLink":"https://onlinelibrary.wiley.com/doi/abs/10.1111/bjh.15878","googleCitationCount":3,"googleAuthor":"","doi":"10.1111/bjh.15878","elsevierAuthor":"Zhang J.","publicationName":"British Journal of Haematology","elsevierCoverDate":"2019-06-01","elsevierCoverDisplayDate":"June 2019","elsevierCitationCount":"2"},{"title":"Use of PD‐1 (PDCD 1) inhibitors for the treatment of Richter syndrome: experience at a single academic centre","googleId":"20jON3PPk3wJ","googleLink":"https://onlinelibrary.wiley.com/doi/abs/10.1111/bjh.15508?af=R","googleCitationCount":9,"googleAuthor":"","doi":"10.1111/bjh.15508","elsevierAuthor":"Rogers K.A.","publicationName":"British Journal of Haematology","elsevierCoverDate":"2019-04-01","elsevierCoverDisplayDate":"April 2019","elsevierCitationCount":"6"},{"title":"Early intracranial haemorrhages in acute promyelocytic leukaemia: analysis of neuroradiological and clinico‐biological parameters","googleId":"Avds2bKlNVkJ","googleLink":"https://onlinelibrary.wiley.com/doi/abs/10.1111/bjh.17018","googleCitationCount":1,"googleAuthor":"C Gurnari","doi":"10.1111/bjh.17018","elsevierAuthor":"Gurnari C.","publicationName":"British Journal of Haematology","elsevierCoverDate":"2020-01-01","elsevierCoverDisplayDate":"2020","elsevierCitationCount":"1"},{"title":"High-level Induction of Fetal Haemoglobin by Pomalidomide in β-thalassaemia/HbE Erythroid Progenitor Cells","googleId":"rXdVAtrmrY0J","googleLink":"https://pubmed.ncbi.nlm.nih.gov/32358840/","googleCitationCount":3,"googleAuthor":"","doi":"10.1111/bjh.16670,","elsevierCitationCount":0},{"title":"Product type and the risk of inhibitor development in nonsevere haemophilia A patients: a case‒control study","googleId":"wXcjlqPvE5oJ","googleLink":"https://onlinelibrary.wiley.com/doi/abs/10.1111/bjh.16490","googleCitationCount":1,"googleAuthor":"","doi":"10.1111/bjh.16490","elsevierAuthor":"van Velzen A.S.","publicationName":"British Journal of Haematology","elsevierCoverDate":"2020-06-01","elsevierCoverDisplayDate":"1 June 2020","elsevierCitationCount":"0"},{"title":"Aetiology and outcomes of secondary myelofibrosis occurring in the context of inherited platelet disorders: A single institutional study of four patients","googleId":"_WzufGiBSzkJ","googleLink":"https://mayoclinic.pure.elsevier.com/en/publications/aetiology-and-outcomes-of-secondary-myelofibrosis-occurring-in-th","googleCitationCount":2,"googleAuthor":"A Ferrer","doi":"10.1111/bjh.16897","elsevierAuthor":"Saliba A.N.","publicationName":"British Journal of Haematology","elsevierCoverDate":"2020-09-01","elsevierCoverDisplayDate":"1 September 2020","elsevierCitationCount":"2"},{"title":"Impact of primary disease on outcome after allogeneic stem cell transplantation for transformed secondary acute leukaemia","googleId":"Nf7J8Ozr0EQJ","googleLink":"https://onlinelibrary.wiley.com/doi/abs/10.1111/bjh.15819","googleCitationCount":4,"googleAuthor":"N Kröger","doi":"10.1111/bjh.15819","elsevierAuthor":"Kröger N.","publicationName":"British Journal of Haematology","elsevierCoverDate":"2019-05-01","elsevierCoverDisplayDate":"May 2019","elsevierCitationCount":"3"},{"title":"Comparison of Rituximab originator (MabThera) to biosimilar (Truxima) in patients with immune‐mediated thrombotic thrombocytopenic purpura","googleId":"mkQy5ex6p2oJ","googleLink":"https://onlinelibrary.wiley.com/doi/abs/10.1111/bjh.15874","googleCitationCount":5,"googleAuthor":"","doi":"10.1111/bjh.15874","elsevierAuthor":"Stubbs M.J.","publicationName":"British Journal of Haematology","elsevierCoverDate":"2019-06-01","elsevierCoverDisplayDate":"June 2019","elsevierCitationCount":"4"},{"title":"A risk‐stratification model based on the initial concentration of the serum monoclonal protein and MYD88 mutation status identifies a subset of patients with IgM …","googleId":"wpaTn_fYyHgJ","googleLink":"https://onlinelibrary.wiley.com/doi/abs/10.1111/bjh.16086","googleCitationCount":5,"googleAuthor":"M Varettoni","doi":"10.1111/bjh.16086","elsevierAuthor":"Varettoni M.","publicationName":"British Journal of Haematology","elsevierCoverDate":"2019-11-01","elsevierCoverDisplayDate":"1 November 2019","elsevierCitationCount":"5"},{"title":"Extended follow‐up and the feasibility of Panobinostat maintenance for patients with Relapsed Multiple Myeloma treated with Bortezomib, Thalidomide …","googleId":"ATYvHMA8vXgJ","googleLink":"http://eprints.whiterose.ac.uk/134841/","googleCitationCount":7,"googleAuthor":"","doi":"10.1111/bjh.15551.","elsevierAuthor":"Popat R.","publicationName":"British Journal of Haematology","elsevierCoverDate":"2019-05-01","elsevierCoverDisplayDate":"May 2019","elsevierCitationCount":"5"},{"title":"Superior survival of unmanipulated haploidentical haematopoietic stem cell transplantation compared with intensive chemotherapy as post‐remission treatment for …","googleId":"okH1YXe85rIJ","googleLink":"https://onlinelibrary.wiley.com/doi/abs/10.1111/bjh.16226","googleCitationCount":2,"googleAuthor":"","doi":"10.1111/bjh.16226","elsevierAuthor":"Xue Y.j.","publicationName":"British Journal of Haematology","elsevierCoverDate":"2020-03-01","elsevierCoverDisplayDate":"1 March 2020","elsevierCitationCount":"2"},{"title":"Chronic lymphocytic leukaemia: the role of T cells in a B cell disease","googleId":"_1W1hhMQfWoJ","googleLink":"https://onlinelibrary.wiley.com/doi/abs/10.1111/bjh.15918","googleCitationCount":4,"googleAuthor":"","doi":"10.1111/bjh.15918","elsevierAuthor":"Man S.","publicationName":"British Journal of Haematology","elsevierCoverDate":"2019-07-01","elsevierCoverDisplayDate":"July 2019","elsevierCitationCount":"1"},{"title":"Optimising the value of immunomodulatory drugs during induction and maintenance in transplant ineligible patients with newly diagnosed multiple myeloma: results …","googleId":"jLhrN3AW9tIJ","googleLink":"https://onlinelibrary.wiley.com/doi/abs/10.1111/bjh.16945","googleCitationCount":1,"googleAuthor":"","doi":"10.1111/bjh.16945","elsevierAuthor":"Jackson G.H.","publicationName":"British Journal of Haematology","elsevierCoverDate":"2020-01-01","elsevierCoverDisplayDate":"2020","elsevierCitationCount":"0"},{"title":"Baseline dysmegakaryopoiesis in inherited thrombocytopenia/platelet disorder with predisposition to haematological malignancies","googleId":"tAAqUlVGgKEJ","googleLink":"https://pubmed.ncbi.nlm.nih.gov/32103500/","googleCitationCount":2,"googleAuthor":"","doi":"10.1111/bjh.16543,","elsevierAuthor":"Fournier E.","publicationName":"British Journal of Haematology","elsevierCoverDate":"2020-05-01","elsevierCoverDisplayDate":"1 May 2020","elsevierCitationCount":"2"},{"title":"Adoptive donor immunity protects against resolved hepatitis B virus reactivation after allogeneic haematopoietic stem cell transplantation in the world's largest …","googleId":"G8GYytfg5DEJ","googleLink":"https://onlinelibrary.wiley.com/doi/abs/10.1111/bjh.15884","googleCitationCount":5,"googleAuthor":"","doi":"10.1111/bjh.15884","elsevierAuthor":"Liu J.H.","publicationName":"British Journal of Haematology","elsevierCoverDate":"2019-07-01","elsevierCoverDisplayDate":"July 2019","elsevierCitationCount":"1"},{"title":"Normalization of serum B‐cell maturation antigen levels predicts overall survival among multiple myeloma patients starting treatment","googleId":"ggegafwPCYYJ","googleLink":"https://onlinelibrary.wiley.com/doi/abs/10.1111/bjh.16752","googleCitationCount":1,"googleAuthor":"","doi":"10.1111/bjh.16752","elsevierAuthor":"Jew S.","publicationName":"British Journal of Haematology","elsevierCoverDate":"2021-01-01","elsevierCoverDisplayDate":"January 2021","elsevierCitationCount":"0"},{"title":"Long‐term overall‐and progression‐free survival after pentostatin, cyclophosphamide and rituximab therapy for indolent non‐Hodgkin lymphoma","googleId":"mPXI9PY9YUQJ","googleLink":"https://onlinelibrary.wiley.com/doi/abs/10.1111/bjh.15814","googleCitationCount":4,"googleAuthor":"","doi":"10.1111/bjh.15814","elsevierCitationCount":0},{"title":"The prognostic effect of smoking status on intensively treated acute myeloid leukaemia–A Danish nationwide cohort study","googleId":"GHQiGlgvpcsJ","googleLink":"https://onlinelibrary.wiley.com/doi/abs/10.1111/bjh.16667","googleCitationCount":1,"googleAuthor":"LB Nielsen","doi":"10.1111/bjh.16667","elsevierAuthor":"Kristensen D.","publicationName":"British Journal of Haematology","elsevierCoverDate":"2020-07-01","elsevierCoverDisplayDate":"1 July 2020","elsevierCitationCount":"1"},{"title":"Determinants of low‐quality warfarin anticoagulation in patients with mechanical prosthetic heart valves. The nationwide PLECTRUM study","googleId":"f_i120YdUbIJ","googleLink":"https://onlinelibrary.wiley.com/doi/abs/10.1111/bjh.16528","googleCitationCount":2,"googleAuthor":"D Pastori","doi":"10.1111/bjh.16528","elsevierAuthor":"Pastori D.","publicationName":"British Journal of Haematology","elsevierCoverDate":"2020-08-01","elsevierCoverDisplayDate":"1 August 2020","elsevierCitationCount":"1"},{"title":"Development and validation of a prediction model (AHC) for early identification of refractory thrombotic thrombocytopenic purpura using nationally representative data","googleId":"m-Yi2zs0i8kJ","googleLink":"https://onlinelibrary.wiley.com/doi/abs/10.1111/bjh.16767","googleCitationCount":1,"googleAuthor":"","doi":"10.1111/bjh.16767","elsevierAuthor":"Gui R.Y.","publicationName":"British Journal of Haematology","elsevierCoverDate":"2020-10-01","elsevierCoverDisplayDate":"1 October 2020","elsevierCitationCount":"1"},{"title":"The National VTE Exemplar Centres Network response to implementation of updated NICE guidance: venous thromboembolism in over 16s: reducing the risk of …","googleId":"O6ZqTSUGM7QJ","googleLink":"https://pubmed.ncbi.nlm.nih.gov/31168834/","googleCitationCount":5,"googleAuthor":"","doi":"10.1111/bjh.16010,","elsevierAuthor":"Gee E.","publicationName":"British Journal of Haematology","elsevierCoverDate":"2019-01-01","elsevierCoverDisplayDate":"2019","elsevierCitationCount":"4"},{"title":"Impact of Ruxolitinib on Myelofibrosis Patients Post Allogeneic Stem Cell Transplant---A Pilot Study","googleId":"eN7pX551tiMJ","googleLink":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6706301/","googleCitationCount":4,"googleAuthor":""},{"title":"Pre‐treatment metabolic tumour volume and total lesion glycolysis are superior to conventional positron‐emission tomography/computed tomography variables for …","googleId":"bDO3qJIcL_4J","googleLink":"https://onlinelibrary.wiley.com/doi/abs/10.1111/bjh.16633","googleCitationCount":2,"googleAuthor":"","doi":"10.1111/bjh.16633","elsevierAuthor":"Terao T.","publicationName":"British Journal of Haematology","elsevierCoverDate":"2020-10-01","elsevierCoverDisplayDate":"1 October 2020","elsevierCitationCount":"2"},{"title":"Neuro‐meningeal relapse in anaplastic large‐cell lymphoma: incidence, risk factors and prognosis–a report from the European intergroup for childhood non‐Hodgkin …","googleId":"KMvnGcrV4YUJ","googleLink":"https://onlinelibrary.wiley.com/doi/abs/10.1111/bjh.16755","googleCitationCount":1,"googleAuthor":"","doi":"10.1111/bjh.16755","elsevierAuthor":"Del Baldo G.","publicationName":"British Journal of Haematology","elsevierCoverDate":"2020-01-01","elsevierCoverDisplayDate":"2020","elsevierCitationCount":"1"},{"title":"Impact of metformin use on the outcomes of newly diagnosed diffuse large B‐cell lymphoma and follicular lymphoma","googleId":"4TcRpmkzXIMJ","googleLink":"https://onlinelibrary.wiley.com/doi/abs/10.1111/bjh.15997","googleCitationCount":3,"googleAuthor":"Y Wang","doi":"10.1111/bjh.15997","elsevierAuthor":"Wang Y.","publicationName":"British Journal of Haematology","elsevierCoverDate":"2019-09-01","elsevierCoverDisplayDate":"1 September 2019","elsevierCitationCount":"2"},{"title":"Negative CD19 expression is associated with inferior relapse‐free survival in children with RUNX1‐RUNX1T1–positive acute myeloid leukaemia: results from the …","googleId":"6ajhmwCxRTkJ","googleLink":"https://onlinelibrary.wiley.com/doi/abs/10.1111/bjh.16080","googleCitationCount":4,"googleAuthor":"","doi":"10.1111/bjh.16080","elsevierAuthor":"Sakamoto K.","publicationName":"British Journal of Haematology","elsevierCoverDate":"2019-11-01","elsevierCoverDisplayDate":"1 November 2019","elsevierCitationCount":"2"},{"title":"Frontline management of nodular lymphocyte predominant Hodgkin lymphoma-a retrospective UK multicentre study","googleId":"oaWB84m0LB4J","googleLink":"https://pubmed.ncbi.nlm.nih.gov/31344253/","googleCitationCount":4,"googleAuthor":"T Bagguley","doi":"10.1111/bjh.16109,","elsevierAuthor":"Wilson M.R.","publicationName":"British Journal of Haematology","elsevierCoverDate":"2019-09-01","elsevierCoverDisplayDate":"1 September 2019","elsevierCitationCount":"4"},{"title":"NF‐E2 mutation as a novel cause for inherited thrombocytopenia","googleId":"qzYALUIaKmkJ","googleLink":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7187305/","googleCitationCount":2,"googleAuthor":"","doi":"10.1111/bjh.16438","elsevierAuthor":"Luk A.D.W.","publicationName":"British Journal of Haematology","elsevierCoverDate":"2020-04-01","elsevierCoverDisplayDate":"1 April 2020","elsevierCitationCount":"1"},{"title":"TP53 mutations are associated with mutated MYD88 and CXCR4, and confer an adverse outcome in Waldenström macroglobulinaemia","googleId":"JExaoOfwmyEJ","googleLink":"https://onlinelibrary.wiley.com/doi/abs/10.1111/bjh.15560","googleCitationCount":10,"googleAuthor":"","doi":"10.1111/bjh.15560","elsevierAuthor":"Gustine J.","publicationName":"British Journal of Haematology","elsevierCoverDate":"2019-01-01","elsevierCoverDisplayDate":"January 2019","elsevierCitationCount":"6"},{"title":"PU.1 subcellular localization in acute myeloid leukaemia with mutated NPM1","googleId":"L6VZchSTxUgJ","googleLink":"https://www.researchgate.net/profile/Lorenzo_Brunetti2/publication/337500380_PU1_subcellular_localization_in_acute_myeloid_leukaemia_with_mutated_NPM1/links/5e2f560e4585152d156eff6e/PU1-subcellular-localization-in-acute-myeloid-leukaemia-with-mutated-NPM1.pdf","googleCitationCount":3,"googleAuthor":"C Betti"},{"title":"Daratumumab, pomalidomide and dexamethasone combination therapy in daratumumab and/or pomalidomide refractory multiple myeloma","googleId":"uvuYNJuCQLYJ","googleLink":"https://pubmed.ncbi.nlm.nih.gov/30536372/","googleCitationCount":6,"googleAuthor":"MJ Hussain","doi":"10.1111/bjh.15716,","elsevierAuthor":"Hussain M.J.","publicationName":"British Journal of Haematology","elsevierCoverDate":"2019-07-01","elsevierCoverDisplayDate":"July 2019","elsevierCitationCount":"3"},{"title":"Incorporation of thiotepa in a reduced intensity conditioning regimen may improve engraftment after transplant for HLH","googleId":"cm9pcCt7-mcJ","googleLink":"https://pubmed.ncbi.nlm.nih.gov/31989587/","googleCitationCount":3,"googleAuthor":"O Eckstein","doi":"10.1111/bjh.16370,","elsevierAuthor":"Naik S.","publicationName":"British Journal of Haematology","elsevierCoverDate":"2020-03-01","elsevierCoverDisplayDate":"1 March 2020","elsevierCitationCount":"2"},{"title":"Treosulfan conditioning for allogeneic transplantation in multiple myeloma-improved overall survival in first line haematopoietic stem cell transplantation-a large …","googleId":"D_gUO9yc9FYJ","googleLink":"https://pubmed.ncbi.nlm.nih.gov/32301111/","googleCitationCount":2,"googleAuthor":"C Gran","doi":"10.1111/bjh.16642,","elsevierAuthor":"Gran C.","publicationName":"British Journal of Haematology","elsevierCoverDate":"2020-06-01","elsevierCoverDisplayDate":"1 June 2020","elsevierCitationCount":"1"},{"title":"Frequent methylation of the tumour suppressor miR‐1258 targeting PDL1: implication in multiple myeloma‐specific cytotoxicity and prognostification","googleId":"VhtrLnJeCLoJ","googleLink":"https://onlinelibrary.wiley.com/doi/abs/10.1111/bjh.16517","googleCitationCount":3,"googleAuthor":"LQ Wang","doi":"10.1111/bjh.16517","elsevierAuthor":"Wang L.Q.","publicationName":"British Journal of Haematology","elsevierCoverDate":"2020-07-01","elsevierCoverDisplayDate":"1 July 2020","elsevierCitationCount":"2"},{"title":"Prevalence and survival of smouldering Waldenström macroglobulinaemia in the United States","googleId":"73aV_ouaOwkJ","googleLink":"https://onlinelibrary.wiley.com/doi/abs/10.1111/bjh.15201?af=R","googleCitationCount":11,"googleAuthor":"PA Pophali","doi":"10.1111/bjh.15201","elsevierAuthor":"Pophali P.A.","publicationName":"British Journal of Haematology","elsevierCoverDate":"2019-03-01","elsevierCoverDisplayDate":"March 2019","elsevierCitationCount":"7"},{"title":"Emergency response to radiological and nuclear accidents and incidents","googleId":"ehoyVYaDjukJ","googleLink":"https://onlinelibrary.wiley.com/doi/abs/10.1111/bjh.16138","googleCitationCount":3,"googleAuthor":"RP Gale","doi":"10.1111/bjh.16138","elsevierAuthor":"Gale R.","publicationName":"British Journal of Haematology","elsevierCoverDate":"2019-01-01","elsevierCoverDisplayDate":"2019","elsevierCitationCount":"2"},{"title":"Cyclin D1 expression and novel mutational findings in Rosai‐Dorfman disease","googleId":"t0ZEDfMhr_wJ","googleLink":"https://onlinelibrary.wiley.com/doi/abs/10.1111/bjh.16006","googleCitationCount":3,"googleAuthor":"E Baraban","doi":"10.1111/bjh.16006","elsevierAuthor":"Baraban E.","publicationName":"British Journal of Haematology","elsevierCoverDate":"2019-09-01","elsevierCoverDisplayDate":"1 September 2019","elsevierCitationCount":"2"},{"title":"Induction therapy with the MATRix regimen in patients with newly diagnosed primary diffuse large B‐cell lymphoma of the central nervous system–an international …","googleId":"7OQzJ1HjgTIJ","googleLink":"https://onlinelibrary.wiley.com/doi/abs/10.1111/bjh.16451","googleCitationCount":2,"googleAuthor":"E Schorb","doi":"10.1111/bjh.16451","elsevierAuthor":"Schorb E.","publicationName":"British Journal of Haematology","elsevierCoverDate":"2020-06-01","elsevierCoverDisplayDate":"1 June 2020","elsevierCitationCount":"3"},{"title":"Primary therapy and survival among patients with nodular lymphocyte‐predominant Hodgkin lymphoma: a population‐based analysis in the Netherlands, 1993–2016","googleId":"FVKwB4o3kxUJ","googleLink":"https://onlinelibrary.wiley.com/doi/abs/10.1111/bjh.16290","googleCitationCount":3,"googleAuthor":"JM Zijlstra","doi":"10.1111/bjh.16290","elsevierAuthor":"Posthuma H.L.A.","publicationName":"British Journal of Haematology","elsevierCoverDate":"2020-04-01","elsevierCoverDisplayDate":"1 April 2020","elsevierCitationCount":"3"},{"title":"Building Canadian capacity for CAR-T cells in relapsed/refractory acute lymphoblastic leukaemia: a retrospective cohort study","googleId":"H4ZuHwObIgUJ","googleLink":"https://pubmed.ncbi.nlm.nih.gov/32688454/","googleCitationCount":1,"googleAuthor":"J Montroy","doi":"10.1111/bjh.16940,","elsevierAuthor":"Khalife R.","publicationName":"British Journal of Haematology","elsevierCoverDate":"2020-10-01","elsevierCoverDisplayDate":"1 October 2020","elsevierCitationCount":"1"},{"title":"Fatigue and cognitive impairment in immune thrombocytopenic purpura remain stable over time: short report from a longitudinal study","googleId":"U5862DKtIgsJ","googleLink":"https://onlinelibrary.wiley.com/doi/abs/10.1111/bjh.15993","googleCitationCount":3,"googleAuthor":"","doi":"10.1111/bjh.15993","elsevierAuthor":"Mitchell E.","publicationName":"British Journal of Haematology","elsevierCoverDate":"2019-01-01","elsevierCoverDisplayDate":"2019","elsevierCitationCount":"2"},{"title":"The risk of bleeding in patients receiving ibrutinib combined with novel direct oral anticoagulants","googleId":"885HP9hYwzUJ","googleLink":"https://pubmed.ncbi.nlm.nih.gov/32150642/","googleCitationCount":2,"googleAuthor":"O Bairey","doi":"10.1111/bjh.16422,","elsevierAuthor":"Raz M.A.","publicationName":"British Journal of Haematology","elsevierCoverDate":"2020-04-01","elsevierCoverDisplayDate":"1 April 2020","elsevierCitationCount":"1"},{"title":"Comparison of efficacy from two different dosing regimens of bortezomib: an exposure–response analysis","googleId":"jlGOAWMhkIcJ","googleLink":"https://onlinelibrary.wiley.com/doi/abs/10.1111/bjh.16446","googleCitationCount":2,"googleAuthor":"","doi":"10.1111/bjh.16446","elsevierAuthor":"Parasrampuria D.A.","publicationName":"British Journal of Haematology","elsevierCoverDate":"2020-06-01","elsevierCoverDisplayDate":"1 June 2020","elsevierCitationCount":"1"},{"title":"Characterisation and prognostic impact of immunoparesis in relapsed multiple myeloma","googleId":"qF0Rtt-HS2QJ","googleLink":"https://onlinelibrary.wiley.com/doi/abs/10.1111/bjh.16488","googleCitationCount":1,"googleAuthor":"R Chakraborty","doi":"10.1111/bjh.16488","elsevierAuthor":"Chakraborty R.","publicationName":"British Journal of Haematology","elsevierCoverDate":"2020-06-01","elsevierCoverDisplayDate":"1 June 2020","elsevierCitationCount":"1"},{"title":"A phase III randomized, multicentre, double blind, active controlled trial to compare the efficacy and safety of two different anagrelide formulations in patients with …","googleId":"UjwMMm68XmcJ","googleLink":"https://onlinelibrary.wiley.com/doi/abs/10.1111/bjh.15824","googleCitationCount":3,"googleAuthor":"","doi":"10.1111/bjh.15824","elsevierAuthor":"Gisslinger H.","publicationName":"British Journal of Haematology","elsevierCoverDate":"2019-05-01","elsevierCoverDisplayDate":"May 2019","elsevierCitationCount":"2"},{"title":"Unravelling the suboptimal response of TP53‐mutated chronic lymphocytic leukaemia to ibrutinib","googleId":"migqJdLWGuUJ","googleLink":"https://onlinelibrary.wiley.com/doi/abs/10.1111/bjh.15613","googleCitationCount":6,"googleAuthor":"A Guarini","doi":"10.1111/bjh.15613","elsevierAuthor":"Guarini A.","publicationName":"British Journal of Haematology","elsevierCoverDate":"2019-02-01","elsevierCoverDisplayDate":"Februaryy 2019","elsevierCitationCount":"3"},{"title":"Cell‐of‐origin in diffuse large B‐cell lymphoma: findings from the UK's population‐based Haematological Malignancy Research Network","googleId":"x-6BIDvCbyIJ","googleLink":"http://eprints.whiterose.ac.uk/139582/","googleCitationCount":6,"googleAuthor":"S Lacy","doi":"10.1111/bjh.15619.","elsevierAuthor":"Painter D.","publicationName":"British Journal of Haematology","elsevierCoverDate":"2019-05-01","elsevierCoverDisplayDate":"May 2019","elsevierCitationCount":"5"},{"title":"Stand‐alone intrathecal central nervous system (CNS) prophylaxis provide unclear benefit in reducing CNS relapse risk in elderly DLBCL patients treated with R …","googleId":"vzngRw2iIcgJ","googleLink":"https://onlinelibrary.wiley.com/doi/abs/10.1111/bjh.16070","googleCitationCount":6,"googleAuthor":"TA Eyre","doi":"10.1111/bjh.16070","elsevierAuthor":"Eyre T.A.","publicationName":"British Journal of Haematology","elsevierCoverDate":"2019-10-01","elsevierCoverDisplayDate":"1 October 2019","elsevierCitationCount":"4"},{"title":"The poor prognosis of low hypodiploidy in adults with B‐cell precursor acute lymphoblastic leukaemia is restricted to older adults and elderly patients","googleId":"FAxetC6t9TAJ","googleLink":"https://onlinelibrary.wiley.com/doi/abs/10.1111/bjh.15887","googleCitationCount":4,"googleAuthor":"J Ribera","doi":"10.1111/bjh.15887","elsevierAuthor":"Ribera J.","publicationName":"British Journal of Haematology","elsevierCoverDate":"2019-07-01","elsevierCoverDisplayDate":"July 2019","elsevierCitationCount":"2"},{"title":"The links of hepcidin and erythropoietin in the interplay of inflammation and iron deficiency in a large observational study of rheumatoid arthritis","googleId":"8faBT2UfZo4J","googleLink":"https://onlinelibrary.wiley.com/doi/abs/10.1111/bjh.15895","googleCitationCount":3,"googleAuthor":"AB Leichtle","doi":"10.1111/bjh.15895","elsevierAuthor":"Scholz G.A.","publicationName":"British Journal of Haematology","elsevierCoverDate":"2019-07-01","elsevierCoverDisplayDate":"July 2019","elsevierCitationCount":"3"},{"title":"Choosing between continuing vitamin K antagonists (VKA) or switching to a direct oral anticoagulant in currently well‐controlled patients on VKA for atrial fibrillation: a …","googleId":"wQHtpJpDLosJ","googleLink":"https://onlinelibrary.wiley.com/doi/abs/10.1111/bjh.15856?af=R","googleCitationCount":5,"googleAuthor":"JHA van Miert","doi":"10.1111/bjh.15856","elsevierCitationCount":0},{"title":"Difficulty distinguishing essential thrombocythaemia from polycythaemia vera in children with JAK2 V617F‐positive myeloproliferative neoplasms","googleId":"HNec0bfKgCEJ","googleLink":"https://onlinelibrary.wiley.com/doi/abs/10.1111/bjh.15386?af=R","googleCitationCount":7,"googleAuthor":"M Al‐Kawaaz","doi":"10.1111/bjh.15386","elsevierAuthor":"Kucine N.","publicationName":"British Journal of Haematology","elsevierCoverDate":"2019-04-01","elsevierCoverDisplayDate":"April 2019","elsevierCitationCount":"5"},{"title":"The effectiveness of ibrutinib in chronic lymphocytic leukaemia: a nationwide, population-based study in the Netherlands","googleId":"KCV9WAfqe7wJ","googleLink":"https://repub.eur.nl/pub/124452/Repub_124452.pdf","googleCitationCount":2,"googleAuthor":"MD Levin"},{"title":"Acute myeloid leukaemia niche regulates response to L‐asparaginase","googleId":"B5utsY32FUIJ","googleLink":"https://onlinelibrary.wiley.com/doi/abs/10.1111/bjh.15920","googleCitationCount":5,"googleAuthor":"","doi":"10.1111/bjh.15920","elsevierAuthor":"Michelozzi I.M.","publicationName":"British journal of haematology","elsevierCoverDate":"2019-08-01","elsevierCoverDisplayDate":"1 August 2019","elsevierCitationCount":"3"},{"title":"Longitudinal minimal residual disease (MRD) evaluation in acute myeloid leukaemia with NPM1 mutation: from definition of molecular relapse to MRD‐driven …","googleId":"dC4gHdl7kNMJ","googleLink":"https://onlinelibrary.wiley.com/doi/abs/10.1111/bjh.16116","googleCitationCount":3,"googleAuthor":"F Guolo","doi":"10.1111/bjh.16116","elsevierAuthor":"Guolo F.","publicationName":"British Journal of Haematology","elsevierCoverDate":"2019-09-01","elsevierCoverDisplayDate":"1 September 2019","elsevierCitationCount":"3"},{"title":"T memory stem cells after allogeneic haematopoietic cell transplantation: unique long‐term kinetics and influence of chronic graft‐versus‐host disease","googleId":"wHMY78MrJf8J","googleLink":"https://onlinelibrary.wiley.com/doi/abs/10.1111/bjh.15995","googleCitationCount":3,"googleAuthor":"","doi":"10.1111/bjh.15995","elsevierAuthor":"Jimbo K.","publicationName":"British Journal of Haematology","elsevierCoverDate":"2019-09-01","elsevierCoverDisplayDate":"1 September 2019","elsevierCitationCount":"3"},{"title":"Response to erythropoiesis-stimulating agents in patients with WHO-defined myelodysplastic syndrome/myeloproliferative neoplasm with ring sideroblasts and …","googleId":"o47xSdzaGgMJ","googleLink":"https://mayoclinic.pure.elsevier.com/en/publications/response-to-erythropoiesis-stimulating-agents-in-patients-with-wh","googleCitationCount":1,"googleAuthor":"AA Mangaonkar","doi":"10.1111/bjh.16515","elsevierCitationCount":0},{"title":"In chronic lymphocytic leukaemia, SLAMF1 deregulation is associated with genomic complexity and independently predicts a worse outcome","googleId":"xziiV2-J-WIJ","googleLink":"https://onlinelibrary.wiley.com/doi/abs/10.1111/bjh.16865","googleCitationCount":1,"googleAuthor":"GM Rigolin","doi":"10.1111/bjh.16865","elsevierAuthor":"Rigolin G.M.","publicationName":"British Journal of Haematology","elsevierCoverDate":"2020-01-01","elsevierCoverDisplayDate":"2020","elsevierCitationCount":"1"},{"title":"Phase 2 multicentre study of single‐agent ofatumumab in previously untreated follicular lymphoma: CALGB 50901 (Alliance)","googleId":"EPeLXKk7J7QJ","googleLink":"https://onlinelibrary.wiley.com/doi/abs/10.1111/bjh.15768","googleCitationCount":4,"googleAuthor":"","doi":"10.1111/bjh.15768","elsevierAuthor":"Rosenbaum C.A.","publicationName":"British Journal of Haematology","elsevierCoverDate":"2019-04-01","elsevierCoverDisplayDate":"April 2019","elsevierCitationCount":"3"},{"title":"A decade with whole exome sequencing in haematology","googleId":"_XGLI8QvZ9YJ","googleLink":"https://onlinelibrary.wiley.com/doi/abs/10.1111/bjh.16249","googleCitationCount":2,"googleAuthor":"MC Hansen","doi":"10.1111/bjh.16249","elsevierAuthor":"Hansen M.C.","publicationName":"British Journal of Haematology","elsevierCoverDate":"2020-02-01","elsevierCoverDisplayDate":"1 February 2020","elsevierCitationCount":"2"},{"title":"High prevalence of the natural Asn89Asp mutation in the GP1BB gene associated with Bernard–Soulier syndrome in French patients from the genetic isolate of …","googleId":"e8bxk1w89BwJ","googleLink":"https://onlinelibrary.wiley.com/doi/abs/10.1111/bjh.16479","googleCitationCount":2,"googleAuthor":"M Fiore","doi":"10.1111/bjh.16479","elsevierAuthor":"Fiore M.","publicationName":"British Journal of Haematology","elsevierCoverDate":"2020-05-01","elsevierCoverDisplayDate":"1 May 2020","elsevierCitationCount":"1"},{"title":"Minimal residual disease analysis in childhood mature B-cell leukaemia/lymphoma treated with AIEOP LNH-97 protocol with/without anti-CD20 administration","googleId":"9HUk-z7UlMUJ","googleLink":"https://pubmed.ncbi.nlm.nih.gov/32080837/","googleCitationCount":2,"googleAuthor":"L Mussolin","doi":"10.1111/bjh.16531,","elsevierAuthor":"Mussolin L.","publicationName":"British Journal of Haematology","elsevierCoverDate":"2020-05-01","elsevierCoverDisplayDate":"1 May 2020","elsevierCitationCount":"1"},{"title":"Comparison of the clinical phenotype and haematological course of siblings with Fanconi anaemia","googleId":"D_e5AyzH0s4J","googleLink":"https://onlinelibrary.wiley.com/doi/abs/10.1111/bjh.17061","googleCitationCount":1,"googleAuthor":"M Jung","doi":"10.1111/bjh.17061","elsevierAuthor":"Jung M.","publicationName":"British Journal of Haematology","elsevierCoverDate":"2020-01-01","elsevierCoverDisplayDate":"2020","elsevierCitationCount":"1"},{"title":"The evolving role of next generation sequencing in myelodysplastic syndromes","googleId":"c2V49KnYUgsJ","googleLink":"https://onlinelibrary.wiley.com/doi/abs/10.1111/bjh.16212","googleCitationCount":2,"googleAuthor":"","doi":"10.1111/bjh.16212","elsevierAuthor":"Spaulding T.P.","publicationName":"British Journal of Haematology","elsevierCoverDate":"2020-01-01","elsevierCoverDisplayDate":"1 January 2020","elsevierCitationCount":"1"},{"title":"Increased frequency of CD4+PD‐1+HLA‐DR+ T cells is associated with disease progression in CLL","googleId":"-cgbSb6fCkYJ","googleLink":"https://onlinelibrary.wiley.com/doi/abs/10.1111/bjh.16260","googleCitationCount":3,"googleAuthor":"R Hills","doi":"10.1111/bjh.16260","elsevierAuthor":"Elston L.","publicationName":"British Journal of Haematology","elsevierCoverDate":"2020-03-01","elsevierCoverDisplayDate":"1 March 2020","elsevierCitationCount":"3"},{"title":"The role of anti‐complement factor H antibodies in the development of atypical haemolytic uremic syndrome: a possible contribution to abnormality of platelet function","googleId":"5zuhqF8iS9UJ","googleLink":"https://onlinelibrary.wiley.com/doi/abs/10.1111/bjh.16297","googleCitationCount":2,"googleAuthor":"","doi":"10.1111/bjh.16297","elsevierAuthor":"Fujisawa M.","publicationName":"British Journal of Haematology","elsevierCoverDate":"2020-04-01","elsevierCoverDisplayDate":"1 April 2020","elsevierCitationCount":"0"},{"title":"Practical management of tumour lysis syndrome in venetoclax‐treated patients with chronic lymphocytic leukaemia","googleId":"imVLxZw3_YEJ","googleLink":"https://onlinelibrary.wiley.com/doi/abs/10.1111/bjh.16345","googleCitationCount":2,"googleAuthor":"JG Gribben","doi":"10.1111/bjh.16345","elsevierAuthor":"Gribben J.G.","publicationName":"British Journal of Haematology","elsevierCoverDate":"2020-03-01","elsevierCoverDisplayDate":"1 March 2020","elsevierCitationCount":"3"},{"title":"Historical review: a history of the British Journal of Haematology","googleId":"ddiLPRh1-uYJ","googleLink":"https://onlinelibrary.wiley.com/doi/abs/10.1111/bjh.17160","googleCitationCount":1,"googleAuthor":"","doi":"10.1111/bjh.17160","elsevierAuthor":"Bain B.J.","publicationName":"British Journal of Haematology","elsevierCoverDate":"2020-11-01","elsevierCoverDisplayDate":"November 2020","elsevierCitationCount":"1"},{"title":"A five‐year follow‐up of untreated patients with chronic lymphocytic leukaemia treated with ofatumumab and chlorambucil: final analysis of the Complement 1 phase 3 …","googleId":"ioI7NfG-LIMJ","googleLink":"https://onlinelibrary.wiley.com/doi/abs/10.1111/bjh.16625","googleCitationCount":2,"googleAuthor":"F Offner","doi":"10.1111/bjh.16625","elsevierAuthor":"Offner F.","publicationName":"British Journal of Haematology","elsevierCoverDate":"2020-09-01","elsevierCoverDisplayDate":"1 September 2020","elsevierCitationCount":"0"},{"title":"Co‐morbidities and mortality associated with transfusion‐dependent beta‐thalassaemia in patients in England: a 10‐year retrospective cohort analysis","googleId":"_3AzA1aiINIJ","googleLink":"https://onlinelibrary.wiley.com/doi/abs/10.1111/bjh.17091","googleCitationCount":1,"googleAuthor":"","doi":"10.1111/bjh.17091","elsevierAuthor":"Jobanputra M.","publicationName":"British Journal of Haematology","elsevierCoverDate":"2020-12-01","elsevierCoverDisplayDate":"December 2020","elsevierCitationCount":"1"},{"title":"DNA damage corrects the aberrant cytoplasmic localisation of nucleophosmin in NPM1 mutated acute myeloid leukaemia","googleId":"OwPu9UR8fZQJ","googleLink":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6617782/","googleCitationCount":4,"googleAuthor":"HMH Qutob","doi":"10.1111/bjh.15823","elsevierAuthor":"Bailey G.D.","publicationName":"British Journal of Haematology","elsevierCoverDate":"2019-07-01","elsevierCoverDisplayDate":"July 2019","elsevierCitationCount":"3"},{"title":"Iron overload in congenital haemolytic anaemias: role of hepcidin and cytokines and predictive value of ferritin and transferrin saturation","googleId":"ZJIEds5aSB4J","googleLink":"https://onlinelibrary.wiley.com/doi/abs/10.1111/bjh.15811","googleCitationCount":3,"googleAuthor":"","doi":"10.1111/bjh.15811","elsevierAuthor":"Barcellini W.","publicationName":"British Journal of Haematology","elsevierCoverDate":"2019-05-01","elsevierCoverDisplayDate":"May 2019","elsevierCitationCount":"3"},{"title":"P-selectin plays a role in haem-induced acute lung injury in sickle mice.","googleId":"zlWMAHBKjIUJ","googleLink":"https://europepmc.org/articles/pmc6860014/bin/nihms1011173-supplement-supp_figs1.pdf","googleCitationCount":5,"googleAuthor":"","doi":"10.1111/bjh.15807","elsevierAuthor":"Ghosh S.","publicationName":"British Journal of Haematology","elsevierCoverDate":"2019-07-01","elsevierCoverDisplayDate":"July 2019","elsevierCitationCount":"4"},{"title":"The effects of hydroxycarbamide on the plasma proteome of children with sickle cell anaemia","googleId":"300SSCWuZp0J","googleLink":"https://onlinelibrary.wiley.com/doi/abs/10.1111/bjh.15996","googleCitationCount":4,"googleAuthor":"S Menzel","doi":"10.1111/bjh.15996","elsevierAuthor":"Brewin J.","publicationName":"British Journal of Haematology","elsevierCoverDate":"2019-09-01","elsevierCoverDisplayDate":"1 September 2019","elsevierCitationCount":"3"},{"title":"Efficacy of venetoclax in combination with azacitidine followed by haploidentical transplantation in refractory acute myeloid leukaemia and mixed phenotype acute …","googleId":"1yqAYhJH5roJ","googleLink":"https://pubmed.ncbi.nlm.nih.gov/32242923/","googleCitationCount":2,"googleAuthor":"","doi":"10.1111/bjh.16622,","elsevierAuthor":"Wu X.","publicationName":"British Journal of Haematology","elsevierCoverDate":"2020-06-01","elsevierCoverDisplayDate":"1 June 2020","elsevierCitationCount":"1"},{"title":"Tolerance to arsenic trioxide combined with all-trans-retinoic acid in children with acute promyelocytic leukaemia in France","googleId":"08FzOof994AJ","googleLink":"https://pubmed.ncbi.nlm.nih.gov/31808943/","googleCitationCount":4,"googleAuthor":"A Petit","doi":"10.1111/bjh.16364,","elsevierAuthor":"Garcia Spezza E.","publicationName":"British Journal of Haematology","elsevierCoverDate":"2020-01-01","elsevierCoverDisplayDate":"1 January 2020","elsevierCitationCount":"2"},{"title":"PET‐adapted therapy after three cycles of ABVD for all stages of Hodgkin lymphoma: results of the GATLA LH‐05 trial","googleId":"9-ik8yDISsYJ","googleLink":"https://onlinelibrary.wiley.com/doi/abs/10.1111/bjh.15838","googleCitationCount":5,"googleAuthor":"","doi":"10.1111/bjh.15838","elsevierAuthor":"Pavlovsky A.","publicationName":"British Journal of Haematology","elsevierCoverDate":"2019-06-01","elsevierCoverDisplayDate":"June 2019","elsevierCitationCount":"3"},{"title":"An alpha‐defensin gene single nucleotide polymorphism modulates the gut microbiota and may alter the risk of acute graft‐versus‐host disease","googleId":"x3bqBiQbkEcJ","googleLink":"https://onlinelibrary.wiley.com/doi/abs/10.1111/bjh.16458","googleCitationCount":1,"googleAuthor":"A Herman","doi":"10.1111/bjh.16458","elsevierAuthor":"Rashidi A.","publicationName":"British Journal of Haematology","elsevierCoverDate":"2020-06-01","elsevierCoverDisplayDate":"1 June 2020","elsevierCitationCount":"1"},{"title":"Low risk of Pneumocystis jirovecii pneumonia and invasive aspergillosis in patients with Waldenström macroglobulinaemia on ibrutinib","googleId":"tY0aNpuM4_UJ","googleLink":"https://pubmed.ncbi.nlm.nih.gov/30460682/","googleCitationCount":7,"googleAuthor":"MP Cheng","doi":"10.1111/bjh.15627,","elsevierAuthor":"Cheng M.","publicationName":"British Journal of Haematology","elsevierCoverDate":"2019-05-01","elsevierCoverDisplayDate":"May 2019","elsevierCitationCount":"5"},{"title":"Characterising the risk of hepatitis E virus infection in haematological malignancies: a UK prospective prevalence study","googleId":"8yMc-0HHEzsJ","googleLink":"https://discovery.ucl.ac.uk/id/eprint/10073858/1/Fox_Final%20draft%20HEV%20paper.pdf","googleCitationCount":6,"googleAuthor":"S Ijaz"},{"title":"Successful remission induction therapy with gilteritinib in a patient with de novo FLT3‐mutated acute myeloid leukaemia and severe COVID‐19","googleId":"UmV-w2kqBtwJ","googleLink":"https://onlinelibrary.wiley.com/doi/abs/10.1111/bjh.16962","googleCitationCount":2,"googleAuthor":"","doi":"10.1111/bjh.16962","elsevierCitationCount":0},{"title":"Real-world data on treatment patterns and outcomes of hypomethylating therapy in patients with newly diagnosed acute myeloid leukaemia aged≥ 60 years","googleId":"rXqQXKFDZBgJ","googleLink":"https://pubmed.ncbi.nlm.nih.gov/32103493/","googleCitationCount":3,"googleAuthor":"A Österroos","doi":"10.1111/bjh.16410,","elsevierAuthor":"Österroos A.","publicationName":"British Journal of Haematology","elsevierCoverDate":"2020-04-01","elsevierCoverDisplayDate":"1 April 2020","elsevierCitationCount":"2"},{"title":"Evolution of platelet function in adult patients with chronic immune thrombocytopenia on romiplostim treatment","googleId":"fuq7YuL9grkJ","googleLink":"https://elibrary.ru/item.asp?id=41617308","googleCitationCount":3,"googleAuthor":""},{"title":"Managing the front‐line treatment for diffuse large B cell lymphoma and high‐grade B cell lymphoma during the COVID‐19 outbreak","googleId":"dm9F6T4TEwsJ","googleLink":"https://onlinelibrary.wiley.com/doi/abs/10.1111/bjh.17066","googleCitationCount":2,"googleAuthor":"","doi":"10.1111/bjh.17066","elsevierAuthor":"de la Cruz-Benito B.","publicationName":"British Journal of Haematology","elsevierCoverDate":"2020-11-01","elsevierCoverDisplayDate":"1 November 2020","elsevierCitationCount":"1"},{"title":"Venous and arterial thrombosis in patients with haematological malignancy during treatment with ibrutinib.","googleId":"-mFstFlkoaIJ","googleLink":"https://europepmc.org/article/pmc/pmc6819220","googleCitationCount":4,"googleAuthor":"SA Bhat"},{"title":"Evolution of multiple myeloma treatment practices in Europe from 2014 to 2016","googleId":"DzOLN-DKGT4J","googleLink":"https://discovery.ucl.ac.uk/id/eprint/10064984/1/Yong_Accepted_Patient%20chart%20audit%202014vs2016_letter_11Sept2018.pdf","googleCitationCount":5,"googleAuthor":""},{"title":"Concerns about how to use established minimal residual disease (MRD) monitoring in the treatment of NPM1‐mutant AML following reduced intensity …","googleId":"63wtdqXdyzEJ","googleLink":"https://www.researchgate.net/profile/Richard_Burt5/publication/342613287_Concerns_about_how_to_use_established_minimal_residual_disease_MRD_monitoring_in_the_treatment_of_NPM1_-mutant_AML_following_reduced_intensity_chemotherapy_protocols_for_AML_given_as_a_result_of_the_C/links/5eff10e3458515505087a62c/Concerns-about-how-to-use-established-minimal-residual-disease-MRD-monitoring-in-the-treatment-of-NPM1-mutant-AML-following-reduced-intensity-chemotherapy-protocols-for-AML-given-as-a-result-of-the-C.pdf","googleCitationCount":1,"googleAuthor":""},{"title":"Annotation: travel and thrombosis","googleId":"FC61BERleaQJ","googleLink":"https://onlinelibrary.wiley.com/doi/abs/10.1111/bjh.16120","googleCitationCount":2,"googleAuthor":"","doi":"10.1111/bjh.16120","elsevierAuthor":"Czuprynska J.","publicationName":"British Journal of Haematology","elsevierCoverDate":"2020-03-01","elsevierCoverDisplayDate":"1 March 2020","elsevierCitationCount":"0"},{"title":"Novel Illumina‐based next generation sequencing approach with one‐round amplification provides early and reliable detection of BCR‐ABL1 kinase domain …","googleId":"nx6jdsb73REJ","googleLink":"https://onlinelibrary.wiley.com/doi/abs/10.1111/bjh.16382","googleCitationCount":1,"googleAuthor":"","doi":"10.1111/bjh.16382","elsevierAuthor":"Romzova M.","publicationName":"British Journal of Haematology","elsevierCoverDate":"2020-05-01","elsevierCoverDisplayDate":"1 May 2020","elsevierCitationCount":"1"},{"title":"Protein phosphatase, Mg2+/Mn2+‐dependent 1D (PPM1D) mutations in haematological cancer","googleId":"vbRFZQXlq8cJ","googleLink":"https://onlinelibrary.wiley.com/doi/abs/10.1111/bjh.17120","googleCitationCount":0,"googleAuthor":"S Husby","doi":"10.1111/bjh.17120","elsevierAuthor":"Husby S.","publicationName":"British Journal of Haematology","elsevierCoverDate":"2020-01-01","elsevierCoverDisplayDate":"2020","elsevierCitationCount":"0"},{"title":"The pyruvate kinase (PK) to hexokinase enzyme activity ratio and erythrocyte PK protein level in the diagnosis and phenotype of PK deficiency","googleId":"4trMHq_8-igJ","googleLink":"https://onlinelibrary.wiley.com/doi/abs/10.1111/bjh.16724","googleCitationCount":2,"googleAuthor":"H Al‐Samkari","doi":"10.1111/bjh.16724","elsevierAuthor":"Al-Samkari H.","publicationName":"British Journal of Haematology","elsevierCoverDate":"2020-01-01","elsevierCoverDisplayDate":"2020","elsevierCitationCount":"1"},{"title":"A case series of Monoclonal Gammopathy of Undetermined Significance and COVID‐19","googleId":"foh2IFG1FXAJ","googleLink":"https://onlinelibrary.wiley.com/doi/abs/10.1111/bjh.16906","googleCitationCount":2,"googleAuthor":"JD Gonzalez‐Lugo","doi":"10.1111/bjh.16906","elsevierAuthor":"Gonzalez-Lugo J.D.","publicationName":"British Journal of Haematology","elsevierCoverDate":"2020-08-01","elsevierCoverDisplayDate":"1 August 2020","elsevierCitationCount":"2"},{"title":"The incidence of invasive fungal infections in children, adolescents and young adults with acute lymphoblastic leukaemia/lymphoma treated with the Ukall 2011 …","googleId":"MSTi3jx9XV8J","googleLink":"https://onlinelibrary.wiley.com/doi/abs/10.1111/bjh.15798?af=R","googleCitationCount":4,"googleAuthor":"","doi":"10.1111/bjh.15798","elsevierAuthor":"O'Reilly M.A.","publicationName":"British Journal of Haematology","elsevierCoverDate":"2019-07-01","elsevierCoverDisplayDate":"July 2019","elsevierCitationCount":"4"},{"title":"Induction response criteria in acute myeloid leukaemia: implications of a flow cytometric measurable residual disease negative test in refractory adults","googleId":"YYTNxJH34xAJ","googleLink":"https://pubmed.ncbi.nlm.nih.gov/30520018/","googleCitationCount":5,"googleAuthor":"RK Hills","doi":"10.1111/bjh.15698,","elsevierAuthor":"Freeman S.D.","publicationName":"British Journal of Haematology","elsevierCoverDate":"2019-07-01","elsevierCoverDisplayDate":"July 2019","elsevierCitationCount":"3"},{"title":"Efficacy of R‐BAC in relapsed, refractory mantle cell lymphoma post BTK inhibitor therapy","googleId":"LnUX09kw6nsJ","googleLink":"https://onlinelibrary.wiley.com/doi/abs/10.1111/bjh.16416","googleCitationCount":9,"googleAuthor":"C Visco","doi":"10.1111/bjh.16416","elsevierAuthor":"McCulloch R.","publicationName":"British Journal of Haematology","elsevierCoverDate":"2020-05-01","elsevierCoverDisplayDate":"1 May 2020","elsevierCitationCount":"8"},{"title":"Peripheral blood blast rate of clearance is an independent predictor of clinical response and outcomes in acute myeloid leukaemia","googleId":"2v9g3_TAiQ8J","googleLink":"https://onlinelibrary.wiley.com/doi/abs/10.1111/bjh.16261","googleCitationCount":2,"googleAuthor":"","doi":"10.1111/bjh.16261","elsevierAuthor":"Holtzman N.G.","publicationName":"British Journal of Haematology","elsevierCoverDate":"2020-03-01","elsevierCoverDisplayDate":"1 March 2020","elsevierCitationCount":"2"},{"title":"In trans early mosaic mutational escape and novel phenotypic features of germline SAMD9 mutation","googleId":"dP50_4hwTP4J","googleLink":"https://pubmed.ncbi.nlm.nih.gov/31900929/","googleCitationCount":2,"googleAuthor":"","doi":"10.1111/bjh.16322,","elsevierAuthor":"Hockings C.","publicationName":"British Journal of Haematology","elsevierCoverDate":"2020-02-01","elsevierCoverDisplayDate":"1 February 2020","elsevierCitationCount":"1"},{"title":"Predictive impact of circulating microRNA‐193a‐5p on early relapse after autologous stem cell transplantation in patients with multiple myeloma","googleId":"MdTeps5Jr1UJ","googleLink":"https://onlinelibrary.wiley.com/doi/abs/10.1111/bjh.16413","googleCitationCount":1,"googleAuthor":"","doi":"10.1111/bjh.16413","elsevierAuthor":"Park S.S.","publicationName":"British Journal of Haematology","elsevierCoverDate":"2020-05-01","elsevierCoverDisplayDate":"1 May 2020","elsevierCitationCount":"0"},{"title":"Venetoclax for chronic lymphocytic leukaemia patients who progress after more than one B‐cell receptor pathway inhibitor","googleId":"lGxU6RdKnSEJ","googleLink":"https://www.ncbi.nlm.nih.gov/pmc/articles/pmc6587980/","googleCitationCount":5,"googleAuthor":"JC Byrd","doi":"10.1111/bjh.15666","elsevierAuthor":"Wierda W.G.","publicationName":"British Journal of Haematology","elsevierCoverDate":"2019-06-01","elsevierCoverDisplayDate":"June 2019","elsevierCitationCount":"3"},{"title":"Survival and specific outcome of sickle cell disease patients after renal transplantation","googleId":"dzq0Z6JaQkMJ","googleLink":"https://onlinelibrary.wiley.com/doi/abs/10.1111/bjh.16113","googleCitationCount":3,"googleAuthor":"","doi":"10.1111/bjh.16113","elsevierAuthor":"Gérardin C.","publicationName":"British Journal of Haematology","elsevierCoverDate":"2019-12-01","elsevierCoverDisplayDate":"1 December 2019","elsevierCitationCount":"2"},{"title":"Prognostic impact of interim positron emission tomography in mantle cell lymphoma patients treated with frontline R‐CHOP","googleId":"U4KnSjHa-rMJ","googleLink":"https://onlinelibrary.wiley.com/doi/abs/10.1111/bjh.16257","googleCitationCount":2,"googleAuthor":"","doi":"10.1111/bjh.16257","elsevierAuthor":"Jeon Y.W.","publicationName":"British Journal of Haematology","elsevierCoverDate":"2020-03-01","elsevierCoverDisplayDate":"1 March 2020","elsevierCitationCount":"2"},{"title":"A risk stratification for systemic immunoglobulin light‐chain amyloidosis with renal involvement","googleId":"6T335kALoA0J","googleLink":"https://onlinelibrary.wiley.com/doi/abs/10.1111/bjh.16112","googleCitationCount":2,"googleAuthor":"","doi":"10.1111/bjh.16112","elsevierAuthor":"Li T.","publicationName":"British Journal of Haematology","elsevierCoverDate":"2019-11-01","elsevierCoverDisplayDate":"1 November 2019","elsevierCitationCount":"2"},{"title":"A Toll‐like receptor 2 genetic variant modulates occurrence of bacterial infections in patients with sickle cell disease","googleId":"M8ODKYfw0eAJ","googleLink":"https://onlinelibrary.wiley.com/doi/abs/10.1111/bjh.15875","googleCitationCount":3,"googleAuthor":"V Rocha","doi":"10.1111/bjh.15875","elsevierAuthor":"Tozatto-Maio K.","publicationName":"British Journal of Haematology","elsevierCoverDate":"2019-06-01","elsevierCoverDisplayDate":"June 2019","elsevierCitationCount":"2"},{"title":"Successful treatment of chronic myelomonocytic leukaemia with hydroxycarbamide in a patient presenting with acute hypoxic respiratory failure due to COVID‐19 …","googleId":"7yl6nmpDjJQJ","googleLink":"https://onlinelibrary.wiley.com/doi/abs/10.1111/bjh.16978","googleCitationCount":2,"googleAuthor":"A Cumpstey","doi":"10.1111/bjh.16978","elsevierAuthor":"Chopra J.","publicationName":"British Journal of Haematology","elsevierCoverDate":"2020-08-01","elsevierCoverDisplayDate":"1 August 2020","elsevierCitationCount":"2"},{"title":"Knockout of von Willebrand factor in Zebrafish by CRISPR/Cas9 mutagenesis.","googleId":"puW9G_fmRRwJ","googleLink":"https://europepmc.org/articles/pmc6679758/bin/nihms1019648-supplement-supp_info.doc","googleCitationCount":4,"googleAuthor":"N Iyer","doi":"10.1111/bjh.15910","elsevierAuthor":"Iyer N.","publicationName":"British Journal of Haematology","elsevierCoverDate":"2019-01-01","elsevierCoverDisplayDate":"2019","elsevierCitationCount":"4"},{"title":"Combinatorial ixazomib and belinostat therapy induces NFE2L2‐dependent apoptosis in Hodgkin and T‐cell lymphoma","googleId":"zh1_1yoj6iUJ","googleLink":"https://onlinelibrary.wiley.com/doi/abs/10.1111/bjh.16160","googleCitationCount":2,"googleAuthor":"JT McDonald","doi":"10.1111/bjh.16160","elsevierAuthor":"Passero F.C.","publicationName":"British Journal of Haematology","elsevierCoverDate":"2020-01-01","elsevierCoverDisplayDate":"1 January 2020","elsevierCitationCount":"2"},{"title":"Differential expression of long non‐coding RNA s are related to proliferation and histological diversity in follicular lymphomas","googleId":"vSCwDlmgnVYJ","googleLink":"https://onlinelibrary.wiley.com/doi/abs/10.1111/bjh.15656","googleCitationCount":4,"googleAuthor":"A Roisman","doi":"10.1111/bjh.15656","elsevierAuthor":"Roisman A.","publicationName":"British Journal of Haematology","elsevierCoverDate":"2019-02-01","elsevierCoverDisplayDate":"Februaryy 2019","elsevierCitationCount":"4"},{"title":"90 Y-ibritumomab tiuxetan in patients with extra-nodal marginal zone B-cell lymphoma of mucosa-associated lymphoid tissue (MALT lymphoma)-The Zeno Study","googleId":"mhQpKgPUzxkJ","googleLink":"https://pubmed.ncbi.nlm.nih.gov/31944265/","googleCitationCount":2,"googleAuthor":"","doi":"10.1111/bjh.16404,","elsevierAuthor":"Lolli G.","publicationName":"British Journal of Haematology","elsevierCoverDate":"2020-04-01","elsevierCoverDisplayDate":"1 April 2020","elsevierCitationCount":"2"},{"title":"Bendamustine as part of conditioning of autologous stem cell transplantation in patients with aggressive lymphoma: a phase 2 study from the GELTAMO group","googleId":"YiBS6TWDI3wJ","googleLink":"https://onlinelibrary.wiley.com/doi/abs/10.1111/bjh.15713","googleCitationCount":5,"googleAuthor":"","doi":"10.1111/bjh.15713","elsevierAuthor":"Redondo A.M.","publicationName":"British Journal of Haematology","elsevierCoverDate":"2019-03-01","elsevierCoverDisplayDate":"March 2019","elsevierCitationCount":"5"},{"title":"Blastic transformation of BCR-ABL1 positive chronic myeloid leukaemia through acquisition of CBFB-MYH11 and mutant KIT","googleId":"vrP8QP4UoKsJ","googleLink":"https://pubmed.ncbi.nlm.nih.gov/32579287/","googleCitationCount":2,"googleAuthor":"K Shoumariyeh","doi":"10.1111/bjh.16904,","elsevierAuthor":"Shoumariyeh K.","publicationName":"British Journal of Haematology","elsevierCoverDate":"2020-09-01","elsevierCoverDisplayDate":"1 September 2020","elsevierCitationCount":"1"},{"title":"Managing venous thromboembolic risk in women undergoing spontaneous or induced early pregnancy loss: a consensus statement from the British Society of …","googleId":"XVr-oxHppoMJ","googleLink":"https://onlinelibrary.wiley.com/doi/abs/10.1111/bjh.16496","googleCitationCount":1,"googleAuthor":"CN Bagot","doi":"10.1111/bjh.16496","elsevierAuthor":"Bagot C.N.","publicationName":"British Journal of Haematology","elsevierCoverDate":"2020-07-01","elsevierCoverDisplayDate":"1 July 2020","elsevierCitationCount":"1"},{"title":"Doxorubicin, vinblastine, dacarbazine and lenalidomide for older Hodgkin lymphoma patients: final results of a German Hodgkin Study Group (GHSG) phase‐I trial","googleId":"_6rMv5d27YEJ","googleLink":"https://onlinelibrary.wiley.com/doi/abs/10.1111/bjh.15741","googleCitationCount":5,"googleAuthor":"","doi":"10.1111/bjh.15741","elsevierAuthor":"Böll B.","publicationName":"British Journal of Haematology","elsevierCoverDate":"2019-04-01","elsevierCoverDisplayDate":"April 2019","elsevierCitationCount":"6"},{"title":"Efficacy and safety of a bortezomib and reduced‐intensity cytarabine‐based protocol, TMC ALLR1, for relapsed childhood ALL in India","googleId":"vidDH_gmQxkJ","googleLink":"https://onlinelibrary.wiley.com/doi/abs/10.1111/bjh.16005","googleCitationCount":3,"googleAuthor":"","doi":"10.1111/bjh.16005","elsevierAuthor":"Roy P.","publicationName":"British Journal of Haematology","elsevierCoverDate":"2019-09-01","elsevierCoverDisplayDate":"1 September 2019","elsevierCitationCount":"3"},{"title":"Genetic analysis of Diffuse Large B‐cell Lymphoma occurring in cases with antecedent Waldenström Macroglobulinaemia reveals different patterns of clonal evolution","googleId":"coca1OiNcUIJ","googleLink":"https://onlinelibrary.wiley.com/doi/abs/10.1111/bjh.15610?","googleCitationCount":6,"googleAuthor":"","doi":"10.1111/bjh.15610","elsevierAuthor":"Talaulikar D.","publicationName":"British Journal of Haematology","elsevierCoverDate":"2019-05-01","elsevierCoverDisplayDate":"May 2019","elsevierCitationCount":"2"},{"title":"Impact of germline CTC1 alterations on telomere length in acquired bone marrow failure","googleId":"bA12dFNhL6oJ","googleLink":"https://onlinelibrary.wiley.com/doi/abs/10.1111/bjh.15862","googleCitationCount":3,"googleAuthor":"CM Kerr","doi":"10.1111/bjh.15862","elsevierAuthor":"Shen W.","publicationName":"British Journal of Haematology","elsevierCoverDate":"2019-06-01","elsevierCoverDisplayDate":"June 2019","elsevierCitationCount":"1"},{"title":"Upregulation of AKR1C1 in mesenchymal stromal cells promotes the survival of acute myeloid leukaemia cells","googleId":"wAcUJEMTbmMJ","googleLink":"https://onlinelibrary.wiley.com/doi/abs/10.1111/bjh.16253","googleCitationCount":1,"googleAuthor":"","doi":"10.1111/bjh.16253","elsevierAuthor":"Jiang Y.","publicationName":"British Journal of Haematology","elsevierCoverDate":"2020-05-01","elsevierCoverDisplayDate":"1 May 2020","elsevierCitationCount":"1"},{"title":"Transfusion demand in COVID‐19 patients from the Korean population: a nationwide study in South Korea","googleId":"-DqvbF9DHggJ","googleLink":"https://onlinelibrary.wiley.com/doi/abs/10.1111/bjh.17030","googleCitationCount":1,"googleAuthor":"","doi":"10.1111/bjh.17030","elsevierAuthor":"Rim J.H.","publicationName":"British Journal of Haematology","elsevierCoverDate":"2020-09-01","elsevierCoverDisplayDate":"1 September 2020","elsevierCitationCount":"0"},{"title":"Health‐related quality of life in children with chronic immune thrombocytopenia treated with eltrombopag in the PETIT study","googleId":"N4orzYgqdQIJ","googleLink":"https://onlinelibrary.wiley.com/doi/abs/10.1111/bjh.15732","googleCitationCount":5,"googleAuthor":"","doi":"10.1111/bjh.15732","elsevierAuthor":"Grainger J.D.","publicationName":"British Journal of Haematology","elsevierCoverDate":"2019-04-01","elsevierCoverDisplayDate":"April 2019","elsevierCitationCount":"5"},{"title":"Rapid decline in estimated glomerular filtration rate is common in adults with sickle cell disease and associated with increased mortality","googleId":"oMIm95_S8dQJ","googleLink":"https://onlinelibrary.wiley.com/doi/abs/10.1111/bjh.16003","googleCitationCount":4,"googleAuthor":"Q Zhou","doi":"10.1111/bjh.16003","elsevierAuthor":"Derebail V.K.","publicationName":"British Journal of Haematology","elsevierCoverDate":"2019-09-01","elsevierCoverDisplayDate":"1 September 2019","elsevierCitationCount":"2"},{"title":"Acute promyelocytic leukaemia lying under the mask of COVID‐19‐a diagnostic and therapeutic conundrum","googleId":"tOpAXX3P9EgJ","googleLink":"https://onlinelibrary.wiley.com/doi/abs/10.1111/bjh.16864","googleCitationCount":2,"googleAuthor":"","doi":"10.1111/bjh.16864","elsevierAuthor":"Farmer I.","publicationName":"British Journal of Haematology","elsevierCoverDate":"2020-08-01","elsevierCoverDisplayDate":"1 August 2020","elsevierCitationCount":"2"},{"title":"The 5‐year follow‐up of a real‐world observational study of patients in the United Kingdom and Ireland receiving ibrutinib for relapsed/refractory mantle cell lymphoma","googleId":"kmXXxkRwZJEJ","googleLink":"https://onlinelibrary.wiley.com/doi/abs/10.1111/bjh.16739","googleCitationCount":1,"googleAuthor":"","doi":"10.1111/bjh.16739","elsevierAuthor":"Tucker D.","publicationName":"British Journal of Haematology","elsevierCoverDate":"2020-01-01","elsevierCoverDisplayDate":"2020","elsevierCitationCount":"1"},{"title":"Cause‐specific mortality in individuals with lymphoplasmacytic lymphoma/Waldenström macroglobulinaemia, 2000–2016","googleId":"MrFj1s3UEtAJ","googleLink":"https://onlinelibrary.wiley.com/doi/abs/10.1111/bjh.16492","googleCitationCount":2,"googleAuthor":"","doi":"10.1111/bjh.16492","elsevierAuthor":"Dalal N.H.","publicationName":"British Journal of Haematology","elsevierCoverDate":"2020-06-01","elsevierCoverDisplayDate":"1 June 2020","elsevierCitationCount":"0"},{"title":"Idelalisib-rituximab induces durable remissions in TP53 disrupted B-PLL but results in significant toxicity: updated results of the UK-wide compassionate use …","googleId":"4eryAiC7-jYJ","googleLink":"http://heft-test.eprints-hosting.org/id/eprint/2777/","googleCitationCount":8,"googleAuthor":"TA Eyre"},{"title":"Antenatal screening for haemoglobinopathies: current status, barriers and ethics","googleId":"xUf69mf4Ew4J","googleLink":"https://onlinelibrary.wiley.com/doi/abs/10.1111/bjh.16188","googleCitationCount":2,"googleAuthor":"S Chakravorty","doi":"10.1111/bjh.16188","elsevierAuthor":"Chakravorty S.","publicationName":"British Journal of Haematology","elsevierCoverDate":"2019-11-01","elsevierCoverDisplayDate":"1 November 2019","elsevierCitationCount":"0"},{"title":"Focal skeletal FDG uptake indicates poor prognosis in cHL regardless of extent and first‐line chemotherapy","googleId":"_-60H6LOl2IJ","googleLink":"https://onlinelibrary.wiley.com/doi/abs/10.1111/bjh.15933","googleCitationCount":4,"googleAuthor":"LC Gormsen","doi":"10.1111/bjh.15933","elsevierAuthor":"Pedersen M.A.","publicationName":"British Journal of Haematology","elsevierCoverDate":"2019-08-01","elsevierCoverDisplayDate":"August 2019","elsevierCitationCount":"3"},{"title":"Genome‐wide linkage analysis and whole‐exome sequencing identifies an ITGA2B mutation in a family with thrombocytopenia","googleId":"MnlvbRO3cR8J","googleLink":"https://onlinelibrary.wiley.com/doi/abs/10.1111/bjh.15961","googleCitationCount":2,"googleAuthor":"AB Ozel","doi":"10.1111/bjh.15961","elsevierAuthor":"Khoriaty R.","publicationName":"British Journal of Haematology","elsevierCoverDate":"2019-01-01","elsevierCoverDisplayDate":"2019","elsevierCitationCount":"0"},{"title":"TP53 mutations and relevance of expression of TP53 pathway genes in paediatric acute myeloid leukaemia","googleId":"wXKap2HF2TkJ","googleLink":"https://onlinelibrary.wiley.com/doi/abs/10.1111/bjh.16229","googleCitationCount":2,"googleAuthor":"DGJ Cucchi","doi":"10.1111/bjh.16229","elsevierAuthor":"Cucchi D.G.J.","publicationName":"British Journal of Haematology","elsevierCoverDate":"2020-03-01","elsevierCoverDisplayDate":"1 March 2020","elsevierCitationCount":"2"},{"title":"Histopathological evidence for macrophage activation driving post‐transfusion hyperhaemolysis syndrome","googleId":"f_xV429oxJkJ","googleLink":"https://onlinelibrary.wiley.com/doi/abs/10.1111/bjh.15925","googleCitationCount":3,"googleAuthor":"","doi":"10.1111/bjh.15925","elsevierAuthor":"Win N.","publicationName":"British Journal of Haematology","elsevierCoverDate":"2019-08-01","elsevierCoverDisplayDate":"August 2019","elsevierCitationCount":"3"},{"title":"Predicting anaemia and transfusion dependency in severe alloimmune haemolytic disease of the fetus and newborn in the first 3 months after birth","googleId":"-oa2B_bQAjkJ","googleLink":"https://onlinelibrary.wiley.com/doi/abs/10.1111/bjh.15962","googleCitationCount":4,"googleAuthor":"RA Middelburg","doi":"10.1111/bjh.15962","elsevierAuthor":"Ree I.M.C.","publicationName":"British Journal of Haematology","elsevierCoverDate":"2019-01-01","elsevierCoverDisplayDate":"2019","elsevierCitationCount":"4"},{"title":"Primary analysis of JUMP, a phase 3b, expanded‐access study evaluating the safety and efficacy of ruxolitinib in patients with myelofibrosis, including those with low …","googleId":"wpj1JmwiD8cJ","googleLink":"https://onlinelibrary.wiley.com/doi/abs/10.1111/bjh.16462","googleCitationCount":7,"googleAuthor":"","doi":"10.1111/bjh.16462","elsevierAuthor":"Al-Ali H.K.","publicationName":"British Journal of Haematology","elsevierCoverDate":"2020-06-01","elsevierCoverDisplayDate":"1 June 2020","elsevierCitationCount":"5"},{"title":"Debate: Should the dose or duration of anticoagulants for the prevention of venous thrombosis be increased in patients with COVID‐19 while we are awaiting …","googleId":"ZKWwJe04cAkJ","googleLink":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7753713/","googleCitationCount":0,"googleAuthor":"","doi":"10.1111/bjh.17241","elsevierAuthor":"Gomez K.","publicationName":"British Journal of Haematology","elsevierCoverDate":"2021-02-01","elsevierCoverDisplayDate":"February 2021","elsevierCitationCount":"0"},{"title":"Spontaneous regression of a plasmablastic lymphoma with MYC rearrangement","googleId":"U_Hlb6fJWQgJ","googleLink":"https://pubmed.ncbi.nlm.nih.gov/31257571/","googleCitationCount":4,"googleAuthor":"S Stilgenbauer","doi":"10.1111/bjh.16082,","elsevierAuthor":"Yordanova K.","publicationName":"British Journal of Haematology","elsevierCoverDate":"2019-09-01","elsevierCoverDisplayDate":"1 September 2019","elsevierCitationCount":"1"},{"title":"Interleukin‐6 blockade treatment for COVID‐19 associated cytokine release syndrome in a patient with poorly controlled chronic myeloid leukaemia","googleId":"94VIm45iIqEJ","googleLink":"https://onlinelibrary.wiley.com/doi/abs/10.1111/bjh.16901","googleCitationCount":1,"googleAuthor":"","doi":"10.1111/bjh.16901","elsevierAuthor":"Ranger A.","publicationName":"British Journal of Haematology","elsevierCoverDate":"2020-08-01","elsevierCoverDisplayDate":"1 August 2020","elsevierCitationCount":"1"},{"title":"CAR‐T cell therapy in paediatric acute lymphoblastic leukaemia–past, present and future","googleId":"wISKN4rLprQJ","googleLink":"https://onlinelibrary.wiley.com/doi/abs/10.1111/bjh.17153","googleCitationCount":0,"googleAuthor":"","doi":"10.1111/bjh.17153","elsevierAuthor":"Rogosic S.","publicationName":"British Journal of Haematology","elsevierCoverDate":"2020-11-01","elsevierCoverDisplayDate":"November 2020","elsevierCitationCount":"0"},{"title":"Comparison of the NCCN-IPI, the IPI and PIT scores as prognostic tools in peripheral T-cell lymphomas.","googleId":"0s3Jvj_JHewJ","googleLink":"https://europepmc.org/article/pmc/pmc7046310","googleCitationCount":5,"googleAuthor":"MJ Maurer"},{"title":"Essential role of PTPN11 mutation in enhanced haematopoietic differentiation potential of induced pluripotent stem cells of juvenile myelomonocytic leukaemia","googleId":"233FBgC4-tsJ","googleLink":"https://onlinelibrary.wiley.com/doi/abs/10.1111/bjh.16060","googleCitationCount":2,"googleAuthor":"","doi":"10.1111/bjh.16060","elsevierAuthor":"Shigemura T.","publicationName":"British Journal of Haematology","elsevierCoverDate":"2019-10-01","elsevierCoverDisplayDate":"1 October 2019","elsevierCitationCount":"2"},{"title":"A Phase II study of selinexor plus cytarabine and idarubicin in patients with relapsed/refractory acute myeloid leukaemia","googleId":"f_soccFS-gUJ","googleLink":"https://pubmed.ncbi.nlm.nih.gov/32515072/","googleCitationCount":1,"googleAuthor":"","doi":"10.1111/bjh.16804,","elsevierAuthor":"Fiedler W.","publicationName":"British Journal of Haematology","elsevierCoverDate":"2020-08-01","elsevierCoverDisplayDate":"1 August 2020","elsevierCitationCount":"1"},{"title":"The role of plasma exchange in the management of autoimmune disorders","googleId":"9AEC3wXqLm0J","googleLink":"https://onlinelibrary.wiley.com/doi/abs/10.1111/bjh.15903","googleCitationCount":4,"googleAuthor":"","doi":"10.1111/bjh.15903","elsevierAuthor":"Zanatta E.","publicationName":"British Journal of Haematology","elsevierCoverDate":"2019-07-01","elsevierCoverDisplayDate":"July 2019","elsevierCitationCount":"1"},{"title":"Bortezomib, cyclophosphamide, dexamethasone versus lenalidomide, cyclophosphamide, dexamethasone in multiple myeloma patients at first relapse","googleId":"wk20JuKbwUwJ","googleLink":"https://onlinelibrary.wiley.com/doi/abs/10.1111/bjh.16287","googleCitationCount":3,"googleAuthor":"V Montefusco","doi":"10.1111/bjh.16287","elsevierAuthor":"Montefusco V.","publicationName":"British Journal of Haematology","elsevierCoverDate":"2020-03-01","elsevierCoverDisplayDate":"1 March 2020","elsevierCitationCount":"2"},{"title":"The effect on lymphocyte subsets of decreasing/stopping tyrosine kinase inhibitor therapy in chronic myeloid leukaemia: data from the DESTINY trial","googleId":"OIwSOKu_3SQJ","googleLink":"https://pubmed.ncbi.nlm.nih.gov/30408160/","googleCitationCount":5,"googleAuthor":"","doi":"10.1111/bjh.15629,","elsevierAuthor":"Austin G.M.","publicationName":"British Journal of Haematology","elsevierCoverDate":"2019-05-01","elsevierCoverDisplayDate":"May 2019","elsevierCitationCount":"4"},{"title":"The changing therapeutic landscape, burden of disease, and unmet needs in patients with cutaneous T‐cell lymphoma","googleId":"TI7B0CnXHIEJ","googleLink":"https://onlinelibrary.wiley.com/doi/abs/10.1111/bjh.17117","googleCitationCount":0,"googleAuthor":"M Bagot","doi":"10.1111/bjh.17117","elsevierAuthor":"Scarisbrick J.J.","publicationName":"British Journal of Haematology","elsevierCoverDate":"2020-01-01","elsevierCoverDisplayDate":"2020","elsevierCitationCount":"0"},{"title":"A novel non‐invasive prenatal sickle cell disease test for all at‐risk pregnancies","googleId":"Xrlq9XK48A0J","googleLink":"https://onlinelibrary.wiley.com/doi/abs/10.1111/bjh.16529","googleCitationCount":4,"googleAuthor":"","doi":"10.1111/bjh.16529","elsevierAuthor":"van Campen J.","publicationName":"British Journal of Haematology","elsevierCoverDate":"2020-07-01","elsevierCoverDisplayDate":"1 July 2020","elsevierCitationCount":"2"},{"title":"Novel ADA2 mutation presenting with neutropenia, lymphopenia and bone marrow failure in patients with deficiency in adenosine deaminase 2 (DADA2)","googleId":"tPdpQ96BhwkJ","googleLink":"https://pubmed.ncbi.nlm.nih.gov/30924144/?from_term=Ghurye+R&from_pos=4","googleCitationCount":4,"googleAuthor":"","doi":"10.1111/bjh.15896,","elsevierAuthor":"Ghurye R.R.","publicationName":"British Journal of Haematology","elsevierCoverDate":"2019-08-01","elsevierCoverDisplayDate":"August 2019","elsevierCitationCount":"2"},{"title":"Gains of EPOR and ERG genes in adult erythroleukaemia","googleId":"AIVCPoLNToUJ","googleLink":"https://pubmed.ncbi.nlm.nih.gov/32227335/","googleCitationCount":2,"googleAuthor":"J Adélaïde","doi":"10.1111/bjh.16586,","elsevierAuthor":"Adélaïde J.","publicationName":"British Journal of Haematology","elsevierCoverDate":"2020-05-01","elsevierCoverDisplayDate":"1 May 2020","elsevierCitationCount":"0"},{"title":"Current status of umbilical cord blood transplantation in children","googleId":"kBdewrAAF2gJ","googleLink":"https://onlinelibrary.wiley.com/doi/abs/10.1111/bjh.16107","googleCitationCount":2,"googleAuthor":"","doi":"10.1111/bjh.16107","elsevierAuthor":"Gabelli M.","publicationName":"British Journal of Haematology","elsevierCoverDate":"2020-09-01","elsevierCoverDisplayDate":"1 September 2020","elsevierCitationCount":"0"},{"title":"Dissecting the role of the CXCL12/CXCR4 axis in acute myeloid leukaemia","googleId":"D6_qf9w689UJ","googleLink":"https://onlinelibrary.wiley.com/doi/abs/10.1111/bjh.16456","googleCitationCount":1,"googleAuthor":"EE Ladikou","doi":"10.1111/bjh.16456","elsevierAuthor":"Ladikou E.E.","publicationName":"British Journal of Haematology","elsevierCoverDate":"2020-06-01","elsevierCoverDisplayDate":"1 June 2020","elsevierCitationCount":"1"},{"title":"Early minimal residual disease assessment after AML induction with fludarabine, cytarabine and idarubicin (FLAI) provides the most useful prognostic information","googleId":"_cqPVgwYV7cJ","googleLink":"https://pubmed.ncbi.nlm.nih.gov/29359798/","googleCitationCount":9,"googleAuthor":"P Minetto","doi":"10.1111/bjh.15106,","elsevierAuthor":"Minetto P.","publicationName":"British Journal of Haematology","elsevierCoverDate":"2019-02-01","elsevierCoverDisplayDate":"Februaryy 2019","elsevierCitationCount":"5"},{"title":"Doubling rituximab in high‐risk patients with aggressive B‐cell lymphoma‐results of the DENSE‐R‐Mega CHOEP trial","googleId":"lqoRT0bf1g8J","googleLink":"https://onlinelibrary.wiley.com/doi/abs/10.1111/bjh.15710","googleCitationCount":4,"googleAuthor":"","doi":"10.1111/bjh.15710","elsevierAuthor":"Friedrichs B.","publicationName":"British Journal of Haematology","elsevierCoverDate":"2019-03-01","elsevierCoverDisplayDate":"March 2019","elsevierCitationCount":"3"},{"title":"Low levels of von Willebrand markers associate with high serum IgM levels and improve with response to therapy, in patients with Waldenström macroglobulinaemia","googleId":"J5NbGGezn5gJ","googleLink":"https://onlinelibrary.wiley.com/doi/abs/10.1111/bjh.15200?","googleCitationCount":7,"googleAuthor":"JJ Castillo","doi":"10.1111/bjh.15200","elsevierAuthor":"Castillo J.J.","publicationName":"British Journal of Haematology","elsevierCoverDate":"2019-03-01","elsevierCoverDisplayDate":"March 2019","elsevierCitationCount":"6"},{"title":"Successful prevention and screening strategies for COVID‐19: focus on patients with haematologic diseases","googleId":"d_z-H5xCShkJ","googleLink":"https://onlinelibrary.wiley.com/doi/abs/10.1111/bjh.16818","googleCitationCount":3,"googleAuthor":"","doi":"10.1111/bjh.16818","elsevierAuthor":"Cho S.Y.","publicationName":"British Journal of Haematology","elsevierCoverDate":"2020-07-01","elsevierCoverDisplayDate":"1 July 2020","elsevierCitationCount":"2"},{"title":"Evaluating sixty years of UK trials research in acute myeloid leukaemia: lessons for trial design, past, present and future","googleId":"YRm-8fbj_78J","googleLink":"https://onlinelibrary.wiley.com/doi/abs/10.1111/bjh.16357","googleCitationCount":1,"googleAuthor":"RK Hills","doi":"10.1111/bjh.16357","elsevierAuthor":"Hills R.K.","publicationName":"British Journal of Haematology","elsevierCoverDate":"2020-01-01","elsevierCoverDisplayDate":"1 January 2020","elsevierCitationCount":"0"},{"title":"The miR-17~ 92 cluster activates mTORC1 in mantle cell lymphoma by targeting multiple regulators in the STK11/AMPK/TSC/mTOR pathway","googleId":"20pxAgbgdZ0J","googleLink":"https://pubmed.ncbi.nlm.nih.gov/30198569/","googleCitationCount":5,"googleAuthor":"C Jiang","doi":"10.1111/bjh.15591,","elsevierAuthor":"Jiang C.","publicationName":"British Journal of Haematology","elsevierCoverDate":"2019-05-01","elsevierCoverDisplayDate":"May 2019","elsevierCitationCount":"4"},{"title":"Impaired immune responses to herpesviruses and microbial ligands in patients with Mono MAC","googleId":"A2JiKYqRgy4J","googleLink":"https://onlinelibrary.wiley.com/doi/abs/10.1111/bjh.15947","googleCitationCount":2,"googleAuthor":"","doi":"10.1111/bjh.15947","elsevierAuthor":"Mardahl M.","publicationName":"British Journal of Haematology","elsevierCoverDate":"2019-08-01","elsevierCoverDisplayDate":"August 2019","elsevierCitationCount":"2"},{"title":"Phase 1–2 study of vorinostat (SAHA), cladribine and rituximab (SCR) in relapsed B‐cell non‐Hodgkin lymphoma and previously untreated mantle cell lymphoma","googleId":"-XpVK3ojW_YJ","googleLink":"https://onlinelibrary.wiley.com/doi/abs/10.1111/bjh.16008","googleCitationCount":6,"googleAuthor":"","doi":"10.1111/bjh.16008","elsevierAuthor":"Spurgeon S.E.","publicationName":"British Journal of Haematology","elsevierCoverDate":"2019-09-01","elsevierCoverDisplayDate":"1 September 2019","elsevierCitationCount":"9"},{"title":"Cerebral MRI findings predict the risk of cognitive impairment in thrombotic thrombocytopenic purpura","googleId":"CbKHiv0S-8oJ","googleLink":"https://onlinelibrary.wiley.com/doi/abs/10.1111/bjh.17126","googleCitationCount":1,"googleAuthor":"","doi":"10.1111/bjh.17126","elsevierAuthor":"Alwan F.","publicationName":"British Journal of Haematology","elsevierCoverDate":"2020-12-01","elsevierCoverDisplayDate":"December 2020","elsevierCitationCount":"0"},{"title":"Type 2 diabetes in adults with sickle cell disease: can we dive deeper?","googleId":"8fn3VD-tCMkJ","googleLink":"https://europepmc.org/article/med/31066026","googleCitationCount":3,"googleAuthor":"P Connes"},{"title":"Male gender is an independent predictor for worse survival and relapse in a large, consecutive cohort of elderly DLBCL patients treated with R‐CHOP","googleId":"mxwYtEiNc_4J","googleLink":"https://ora.ox.ac.uk/objects/uuid:216010ed-9e4a-440f-bb4b-6ebf3255810f/download_file?file_format=pdf&safe_filename=Letter%2520to%2520BJH%2520Male%2520gender%2520is%2520an%2520independent%2520predictor%2520for%2520worse%2520progression%2520Revision.pdf&type_of_work=Journal+article","googleCitationCount":4,"googleAuthor":"T Eyre"},{"title":"Immunomodulatory and clinical effects of daratumumab in T-cell acute lymphoblastic leukaemia","googleId":"uGIQ9yVaE7IJ","googleLink":"https://pubmed.ncbi.nlm.nih.gov/32686081/","googleCitationCount":1,"googleAuthor":"M Cerrano","doi":"10.1111/bjh.16960,","elsevierAuthor":"Cerrano M.","publicationName":"British Journal of Haematology","elsevierCoverDate":"2020-10-01","elsevierCoverDisplayDate":"1 October 2020","elsevierCitationCount":"1"},{"title":"Mutational profile and haematological response to iron chelation in myelodysplastic syndromes (MDS)","googleId":"sPHfszjBC6gJ","googleLink":"https://pubmed.ncbi.nlm.nih.gov/30407614/","googleCitationCount":5,"googleAuthor":"P Niscola","doi":"10.1111/bjh.15655,","elsevierAuthor":"Fabiani E.","publicationName":"British Journal of Haematology","elsevierCoverDate":"2019-06-01","elsevierCoverDisplayDate":"June 2019","elsevierCitationCount":"4"},{"title":"Bendamustine for patients with indolent B cell lymphoproliferative malignancies including chronic lymphocytic leukaemia–an updated meta‐analysis","googleId":"JsqyFp1DU68J","googleLink":"https://onlinelibrary.wiley.com/doi/abs/10.1111/bjh.15901","googleCitationCount":2,"googleAuthor":"","doi":"10.1111/bjh.15901","elsevierAuthor":"Vidal L.","publicationName":"British Journal of Haematology","elsevierCoverDate":"2019-07-01","elsevierCoverDisplayDate":"July 2019","elsevierCitationCount":"1"},{"title":"The chronic myeloid leukaemia story in the United Kingdom since 1960","googleId":"n6Y8JCusYM0J","googleLink":"https://onlinelibrary.wiley.com/doi/abs/10.1111/bjh.17149","googleCitationCount":0,"googleAuthor":"","doi":"10.1111/bjh.17149","elsevierAuthor":"Clark R.E.","publicationName":"British Journal of Haematology","elsevierCoverDate":"2020-11-01","elsevierCoverDisplayDate":"November 2020","elsevierCitationCount":"0"},{"title":"Controversies in the use of new bone‐modifying therapies in multiple myeloma","googleId":"Bi6CyFtpKtcJ","googleLink":"https://onlinelibrary.wiley.com/doi/abs/10.1111/bjh.17256","googleCitationCount":0,"googleAuthor":"E Terpos","doi":"10.1111/bjh.17256","elsevierAuthor":"Terpos E.","publicationName":"British Journal of Haematology","elsevierCoverDate":"2020-01-01","elsevierCoverDisplayDate":"2020","elsevierCitationCount":"0"},{"title":"Genomic data in prognostic models—what is lost in translation? The case of deletion 17p and mutant TP53 in chronic lymphocytic leukaemia","googleId":"kXIm_ZVadMsJ","googleLink":"https://onlinelibrary.wiley.com/doi/abs/10.1111/bjh.15827","googleCitationCount":2,"googleAuthor":"B Sadikovic","doi":"10.1111/bjh.15827","elsevierAuthor":"Chin-Yee B.","publicationName":"British Journal of Haematology","elsevierCoverDate":"2020-03-01","elsevierCoverDisplayDate":"1 March 2020","elsevierCitationCount":"1"},{"title":"High‐throughput sequencing of T‐cell receptor alpha chain clonal rearrangements at the DNA level in lymphoid malignancies","googleId":"dlp6BtRmrqMJ","googleLink":"https://onlinelibrary.wiley.com/doi/abs/10.1111/bjh.16230","googleCitationCount":1,"googleAuthor":"","doi":"10.1111/bjh.16230","elsevierAuthor":"Komkov A.","publicationName":"British Journal of Haematology","elsevierCoverDate":"2020-03-01","elsevierCoverDisplayDate":"1 March 2020","elsevierCitationCount":"1"},{"title":"Tumour debulking and reduction in predicted risk of tumour lysis syndrome with single-agent ibrutinib in patients with chronic lymphocytic leukaemia","googleId":"yTxbSaWxGWgJ","googleLink":"https://elibrary.ru/item.asp?id=38922572","googleCitationCount":3,"googleAuthor":"JA Burger"},{"title":"FANCD2 and HES1 suppress inflammation‐induced PPARɣ to prevent haematopoietic stem cell exhaustion","googleId":"MrS90ZwaKakJ","googleLink":"https://onlinelibrary.wiley.com/doi/abs/10.1111/bjh.17230","googleCitationCount":0,"googleAuthor":"","doi":"10.1111/bjh.17230","elsevierAuthor":"Wu L.","publicationName":"British Journal of Haematology","elsevierCoverDate":"2021-02-01","elsevierCoverDisplayDate":"February 2021","elsevierCitationCount":"0"},{"title":"Chimeric antigen receptor (CAR) natural killer (NK)‐cell therapy: leveraging the power of innate immunity","googleId":"VBFaW3egjX0J","googleLink":"https://onlinelibrary.wiley.com/doi/abs/10.1111/bjh.17186","googleCitationCount":0,"googleAuthor":"H Rafei","doi":"10.1111/bjh.17186","elsevierAuthor":"Rafei H.","publicationName":"British Journal of Haematology","elsevierCoverDate":"2020-01-01","elsevierCoverDisplayDate":"2020","elsevierCitationCount":"0"},{"title":"Addressing the conundrum of male predominance in mantle cell lymphoma using androgen receptor blockade","googleId":"nKSLSVUetywJ","googleLink":"https://pubmed.ncbi.nlm.nih.gov/32567674/","googleCitationCount":1,"googleAuthor":"","doi":"10.1111/bjh.16902,","elsevierAuthor":"Chow V.A.","publicationName":"British Journal of Haematology","elsevierCoverDate":"2020-09-01","elsevierCoverDisplayDate":"1 September 2020","elsevierCitationCount":"0"},{"title":"NPM1 mutation with DNMT3A wild type defines a subgroup of MDS with particularly favourable outcomes after decitabine therapy","googleId":"bAzNFmR62wYJ","googleLink":"https://pubmed.ncbi.nlm.nih.gov/32266961/","googleCitationCount":1,"googleAuthor":"","doi":"10.1111/bjh.16628,","elsevierAuthor":"Wu L.","publicationName":"British Journal of Haematology","elsevierCoverDate":"2020-06-01","elsevierCoverDisplayDate":"1 June 2020","elsevierCitationCount":"1"},{"title":"Identification of sphingosine kinase 1 as a therapeutic target in B‐lineage acute lymphoblastic leukaemia","googleId":"MiFUceB0gP8J","googleLink":"https://www.researchgate.net/profile/Alexander_Lewis6/publication/322664295_Identification_of_sphingosine_kinase_1_as_a_therapeutic_target_in_B-lineage_acute_lymphoblastic_leukaemia/links/5c859eeb458515831f9aa3af/Identification-of-sphingosine-kinase-1-as-a-therapeutic-target-in-B-lineage-acute-lymphoblastic-leukaemia.pdf","googleCitationCount":7,"googleAuthor":"CT Wallington‐Beddoe"},{"title":"Focus on monoclonal antibodies targeting B‐cell maturation antigen (BCMA) in multiple myeloma: update 2020","googleId":"31eMHJqZlfQJ","googleLink":"https://onlinelibrary.wiley.com/doi/abs/10.1111/bjh.17235","googleCitationCount":1,"googleAuthor":"","doi":"10.1111/bjh.17235","elsevierAuthor":"Demel I.","publicationName":"British Journal of Haematology","elsevierCoverDate":"2020-01-01","elsevierCoverDisplayDate":"2020","elsevierCitationCount":"0"},{"title":"Prognostic scoring systems and comorbidities in chronic myelomonocytic leukaemia: a nationwide population‐based study","googleId":"YA1X4ljdMbMJ","googleLink":"https://onlinelibrary.wiley.com/doi/abs/10.1111/bjh.16790","googleCitationCount":0,"googleAuthor":"","doi":"10.1111/bjh.16790","elsevierAuthor":"Moreno Berggren D.","publicationName":"British Journal of Haematology","elsevierCoverDate":"2021-02-01","elsevierCoverDisplayDate":"February 2021","elsevierCitationCount":"0"},{"title":"How we treat older patients with acute myeloid leukaemia","googleId":"3T0QmCZy6xsJ","googleLink":"https://onlinelibrary.wiley.com/doi/abs/10.1111/bjh.16701","googleCitationCount":0,"googleAuthor":"Y Ofran","doi":"10.1111/bjh.16701","elsevierAuthor":"Frisch A.","publicationName":"British Journal of Haematology","elsevierCoverDate":"2020-12-01","elsevierCoverDisplayDate":"December 2020","elsevierCitationCount":"0"},{"title":"Nilotinib efficacy, safety, adherence and impact on quality of life in newly diagnosed patients with chronic myeloid leukaemia in chronic phase: a prospective …","googleId":"amixVITLU24J","googleLink":"https://onlinelibrary.wiley.com/doi/abs/10.1111/bjh.16145","googleCitationCount":1,"googleAuthor":"","doi":"10.1111/bjh.16145","elsevierAuthor":"Huguet F.","publicationName":"British Journal of Haematology","elsevierCoverDate":"2019-12-01","elsevierCoverDisplayDate":"1 December 2019","elsevierCitationCount":"1"},{"title":"Thalassaemia intermedia caused by coinheritance of a β‐thalassaemia mutation and a de novo duplication of α‐globin genes in the paternal allele","googleId":"Je6tDof07TAJ","googleLink":"https://onlinelibrary.wiley.com/doi/abs/10.1111/bjh.15958","googleCitationCount":2,"googleAuthor":"","doi":"10.1111/bjh.15958","elsevierAuthor":"Pang D.","publicationName":"British Journal of Haematology","elsevierCoverDate":"2019-01-01","elsevierCoverDisplayDate":"2019","elsevierCitationCount":"1"},{"title":"The expression levels of long non‐coding RNA KIAA0125 are associated with distinct clinical and biological features in myelodysplastic syndromes","googleId":"BYUiexjiRtMJ","googleLink":"https://onlinelibrary.wiley.com/doi/abs/10.1111/bjh.17231","googleCitationCount":0,"googleAuthor":"CL Hsu","doi":"10.1111/bjh.17231","elsevierAuthor":"Hung S.Y.","publicationName":"British Journal of Haematology","elsevierCoverDate":"2021-02-01","elsevierCoverDisplayDate":"February 2021","elsevierCitationCount":"0"},{"title":"Smoking impairs molecular response, and reduces overall survival in patients with chronic myeloproliferative neoplasms: A retrospective cohort study","googleId":"UE0UMci-k_4J","googleLink":"https://onlinelibrary.wiley.com/doi/abs/10.1111/bjh.17130","googleCitationCount":0,"googleAuthor":"","doi":"10.1111/bjh.17130","elsevierAuthor":"Sørensen A.L.","publicationName":"British Journal of Haematology","elsevierCoverDate":"2020-01-01","elsevierCoverDisplayDate":"2020","elsevierCitationCount":"0"},{"title":"Gene therapy for primary immunodeficiencies","googleId":"A0MyHBCXDBsJ","googleLink":"https://onlinelibrary.wiley.com/doi/abs/10.1111/bjh.17269","googleCitationCount":0,"googleAuthor":"","doi":"10.1111/bjh.17269","elsevierAuthor":"Fox T.A.","publicationName":"British Journal of Haematology","elsevierCoverDate":"2020-01-01","elsevierCoverDisplayDate":"2020","elsevierCitationCount":"0"},{"title":"Phase II trial of single‐agent panobinostat consolidation improves responses after sub‐optimal transplant outcomes in multiple myeloma","googleId":"jWQLSiQpSJwJ","googleLink":"https://onlinelibrary.wiley.com/doi/abs/10.1111/bjh.17080","googleCitationCount":1,"googleAuthor":"S Mithraprabhu","doi":"10.1111/bjh.17080","elsevierAuthor":"Mithraprabhu S.","publicationName":"British Journal of Haematology","elsevierCoverDate":"2020-01-01","elsevierCoverDisplayDate":"2020","elsevierCitationCount":"1"},{"title":"Incorporation of somatic panels for the detection of haematopoietic transformation in children and young adults with leukaemia predisposition syndromes and with …","googleId":"hUjg2XvMnLIJ","googleLink":"https://onlinelibrary.wiley.com/doi/abs/10.1111/bjh.17285","googleCitationCount":0,"googleAuthor":"","doi":"10.1111/bjh.17285","elsevierAuthor":"Noy-Lotan S.","publicationName":"British Journal of Haematology","elsevierCoverDate":"2020-01-01","elsevierCoverDisplayDate":"2020","elsevierCitationCount":"0"},{"title":"Two independent consecutive lymphoma cases carry an identical MYD88 mutation but differ in their IGVH rearrangement","googleId":"58XJm9F85JIJ","googleLink":"https://pubmed.ncbi.nlm.nih.gov/32578872/","googleCitationCount":1,"googleAuthor":"","doi":"10.1111/bjh.16917,","elsevierAuthor":"Prieto-Torres L.","publicationName":"British Journal of Haematology","elsevierCoverDate":"2020-09-01","elsevierCoverDisplayDate":"1 September 2020","elsevierCitationCount":"1"},{"title":"Sickle cell trait and renal disease among African American US Army soldiers","googleId":"yCXSx-l3EAAJ","googleLink":"https://onlinelibrary.wiley.com/doi/abs/10.1111/bjh.15820","googleCitationCount":4,"googleAuthor":"J Hu","doi":"10.1111/bjh.15820","elsevierAuthor":"Hu J.","publicationName":"British Journal of Haematology","elsevierCoverDate":"2019-05-01","elsevierCoverDisplayDate":"May 2019","elsevierCitationCount":"2"},{"title":"Real world data as a key element in precision medicine for lymphoid malignancies: potentials and pitfalls","googleId":"GP0Ek4lirxIJ","googleLink":"https://onlinelibrary.wiley.com/doi/abs/10.1111/bjh.15965","googleCitationCount":2,"googleAuthor":"TC El‐Galaly","doi":"10.1111/bjh.15965","elsevierAuthor":"El-Galaly T.C.","publicationName":"British Journal of Haematology","elsevierCoverDate":"2019-08-01","elsevierCoverDisplayDate":"August 2019","elsevierCitationCount":"1"},{"title":"Diagnostic deep-targeted next-generation sequencing assessment of TP53 gene mutations in multiple myeloma from the whole bone marrow","googleId":"pGyoA671cDcJ","googleLink":"https://pubmed.ncbi.nlm.nih.gov/32130732/","googleCitationCount":2,"googleAuthor":"","doi":"10.1111/bjh.16547,","elsevierAuthor":"Petrackova A.","publicationName":"British Journal of Haematology","elsevierCoverDate":"2020-05-01","elsevierCoverDisplayDate":"1 May 2020","elsevierCitationCount":"2"},{"title":"The simplified follicular lymphoma PRIMA‐prognostic index is useful in patients with first‐line chemo‐free rituximab‐based therapy","googleId":"wI_SX7d-3WEJ","googleLink":"https://onlinelibrary.wiley.com/doi/abs/10.1111/bjh.16692","googleCitationCount":1,"googleAuthor":"H Holte","doi":"10.1111/bjh.16692","elsevierAuthor":"Kimby E.","publicationName":"British Journal of Haematology","elsevierCoverDate":"2020-12-01","elsevierCoverDisplayDate":"December 2020","elsevierCitationCount":"0"},{"title":"Noonan syndrome-associated myeloproliferative disorder with somatically acquired monosomy 7: impact on clinical decision making","googleId":"xIlK8qOCVXcJ","googleLink":"https://pubmed.ncbi.nlm.nih.gov/31617209/","googleCitationCount":6,"googleAuthor":"","doi":"10.1111/bjh.16191,","elsevierAuthor":"Hofmans M.","publicationName":"British Journal of Haematology","elsevierCoverDate":"2019-11-01","elsevierCoverDisplayDate":"1 November 2019","elsevierCitationCount":"3"},{"title":"Evolution or revolution in multiple myeloma therapy and the role of the UK","googleId":"H8AWDnpGgcgJ","googleLink":"https://onlinelibrary.wiley.com/doi/abs/10.1111/bjh.17148","googleCitationCount":0,"googleAuthor":"G Cook","doi":"10.1111/bjh.17148","elsevierAuthor":"Cook G.","publicationName":"British Journal of Haematology","elsevierCoverDate":"2020-11-01","elsevierCoverDisplayDate":"November 2020","elsevierCitationCount":"0"},{"title":"Risk of hepatitis B reactivation is controllable in patients with B-cell lymphoma receiving anti-CD19 CAR T cell therapy","googleId":"C82XKECgLAAJ","googleLink":"https://pubmed.ncbi.nlm.nih.gov/32671820/","googleCitationCount":1,"googleAuthor":"","doi":"10.1111/bjh.16951,","elsevierAuthor":"Liu W.","publicationName":"British Journal of Haematology","elsevierCoverDate":"2020-10-01","elsevierCoverDisplayDate":"1 October 2020","elsevierCitationCount":"2"},{"title":"Holding on to the Matutes score while dropping FMC7: new opportunity from standardised approaches in multiparameter flow cytometry","googleId":"PE4-sdTiXx4J","googleLink":"https://pubmed.ncbi.nlm.nih.gov/32557566/","googleCitationCount":1,"googleAuthor":"","doi":"10.1111/bjh.16870,","elsevierAuthor":"Zhu J.","publicationName":"British Journal of Haematology","elsevierCoverDate":"2020-08-01","elsevierCoverDisplayDate":"1 August 2020","elsevierCitationCount":"1"},{"title":"Anthropometric factors and risk of myeloid leukaemias and myelodysplastic syndromes: a prospective study and meta‐analysis","googleId":"m-RZvtxyjIkJ","googleLink":"https://onlinelibrary.wiley.com/doi/abs/10.1111/bjh.15904","googleCitationCount":1,"googleAuthor":"LR Teras","doi":"10.1111/bjh.15904","elsevierAuthor":"Teras L.R.","publicationName":"British Journal of Haematology","elsevierCoverDate":"2019-07-01","elsevierCoverDisplayDate":"July 2019","elsevierCitationCount":"1"},{"title":"Longitudinal follow‐up of patients with thalassaemia intermedia who started transfusion therapy in adulthood: a cohort study","googleId":"7klITXrL7n0J","googleLink":"https://onlinelibrary.wiley.com/doi/abs/10.1111/bjh.16753","googleCitationCount":1,"googleAuthor":"P Ricchi","doi":"10.1111/bjh.16753","elsevierAuthor":"Ricchi P.","publicationName":"British Journal of Haematology","elsevierCoverDate":"2020-10-01","elsevierCoverDisplayDate":"1 October 2020","elsevierCitationCount":"1"},{"title":"6q deletion in Waldenström macroglobulinaemia negatively affects time to transformation and survival","googleId":"8k4IIZONDrUJ","googleLink":"https://onlinelibrary.wiley.com/doi/abs/10.1111/bjh.17028","googleCitationCount":1,"googleAuthor":"I Dogliotti","doi":"10.1111/bjh.17028","elsevierAuthor":"García-Sanz R.","publicationName":"British Journal of Haematology","elsevierCoverDate":"2020-01-01","elsevierCoverDisplayDate":"2020","elsevierCitationCount":"0"},{"title":"Haemophilia, the journey in search of a cure. 1960–2020","googleId":"XCslmBtrMusJ","googleLink":"https://onlinelibrary.wiley.com/doi/abs/10.1111/bjh.17155","googleCitationCount":0,"googleAuthor":"EGD Tuddenham","doi":"10.1111/bjh.17155","elsevierAuthor":"Nathwani A.C.","publicationName":"British Journal of Haematology","elsevierCoverDate":"2020-11-01","elsevierCoverDisplayDate":"November 2020","elsevierCitationCount":"0"},{"title":"Prognostic significance of mutation profile at diagnosis and mutation persistence during disease remission in adult acute myeloid leukaemia patients","googleId":"uc3RDcZIio8J","googleLink":"https://onlinelibrary.wiley.com/doi/abs/10.1111/bjh.15916","googleCitationCount":3,"googleAuthor":"","doi":"10.1111/bjh.15916","elsevierAuthor":"Folta A.","publicationName":"British Journal of Haematology","elsevierCoverDate":"2019-07-01","elsevierCoverDisplayDate":"July 2019","elsevierCitationCount":"2"},{"title":"Clinical characteristics and outcomes among 2347 patients aged≥ 85 years with major lymphoma subtypes: a Nordic Lymphoma Group study","googleId":"ktbobjW75o4J","googleLink":"https://onlinelibrary.wiley.com/doi/abs/10.1111/bjh.17250","googleCitationCount":0,"googleAuthor":"S Eloranta","doi":"10.1111/bjh.17250","elsevierAuthor":"Wästerlid T.","publicationName":"British Journal of Haematology","elsevierCoverDate":"2021-02-01","elsevierCoverDisplayDate":"February 2021","elsevierCitationCount":"0"},{"title":"Emergencies in haematology: tumour lysis syndrome","googleId":"gSLk_4CCz7YJ","googleLink":"https://onlinelibrary.wiley.com/doi/abs/10.1111/bjh.16278","googleCitationCount":1,"googleAuthor":"","doi":"10.1111/bjh.16278","elsevierAuthor":"Durani U.","publicationName":"British Journal of Haematology","elsevierCoverDate":"2020-02-01","elsevierCoverDisplayDate":"1 February 2020","elsevierCitationCount":"0"},{"title":"Paroxysmal nocturnal haemoglobinuria (PNH): novel therapies for an ancient disease","googleId":"ySkvQvWVBN8J","googleLink":"https://onlinelibrary.wiley.com/doi/abs/10.1111/bjh.17147","googleCitationCount":0,"googleAuthor":"L Luzzatto","doi":"10.1111/bjh.17147","elsevierAuthor":"Luzzatto L.","publicationName":"British Journal of Haematology","elsevierCoverDate":"2020-11-01","elsevierCoverDisplayDate":"November 2020","elsevierCitationCount":"0"},{"title":"Impaired cellular and humoral immunity is a feature of Diamond‐Blackfan anaemia; experience of 107 unselected cases in the United Kingdom","googleId":"9SXxvDakCOEJ","googleLink":"https://onlinelibrary.wiley.com/doi/abs/10.1111/bjh.15915","googleCitationCount":3,"googleAuthor":"D Iskander","doi":"10.1111/bjh.15915","elsevierAuthor":"Iskander D.","publicationName":"British Journal of Haematology","elsevierCoverDate":"2019-07-01","elsevierCoverDisplayDate":"July 2019","elsevierCitationCount":"3"},{"title":"Vibration Controlled Transient Elastography (Fibroscan®) in sickle cell liver disease‐could we strike while the liver is hard?","googleId":"GLqtZS17x3QJ","googleLink":"https://onlinelibrary.wiley.com/doi/abs/10.1111/bjh.16047","googleCitationCount":2,"googleAuthor":"D Sharma","doi":"10.1111/bjh.16047","elsevierAuthor":"Ben Yakov G.","publicationName":"British Journal of Haematology","elsevierCoverDate":"2019-10-01","elsevierCoverDisplayDate":"1 October 2019","elsevierCitationCount":"1"},{"title":"Therapeutic recommendations for early stage Hodgkin lymphomas","googleId":"0QVJdnPEKlIJ","googleLink":"https://onlinelibrary.wiley.com/doi/abs/10.1111/bjh.15623","googleCitationCount":4,"googleAuthor":"","doi":"10.1111/bjh.15623","elsevierAuthor":"Depaus J.","publicationName":"British Journal of Haematology","elsevierCoverDate":"2019-01-01","elsevierCoverDisplayDate":"January 2019","elsevierCitationCount":"2"},{"title":"Benefits of risk‐adapted and mould‐specific antifungal prophylaxis in childhood leukaemia","googleId":"g12PHsgWz4AJ","googleLink":"https://onlinelibrary.wiley.com/doi/abs/10.1111/bjh.16931","googleCitationCount":0,"googleAuthor":"","doi":"10.1111/bjh.16931","elsevierAuthor":"Meryk A.","publicationName":"British Journal of Haematology","elsevierCoverDate":"2020-12-01","elsevierCoverDisplayDate":"December 2020","elsevierCitationCount":"0"},{"title":"Improvements in outcome of childhood acute lymphoblastic leukaemia (ALL) in the UK–a success story of modern medicine through successive UKALL trials and …","googleId":"6cuZLpfEtp4J","googleLink":"https://onlinelibrary.wiley.com/doi/abs/10.1111/bjh.17162","googleCitationCount":0,"googleAuthor":"J Bartram","doi":"10.1111/bjh.17162","elsevierAuthor":"Bartram J.","publicationName":"British Journal of Haematology","elsevierCoverDate":"2020-11-01","elsevierCoverDisplayDate":"November 2020","elsevierCitationCount":"0"},{"title":"Antibody‐based immunotherapy for treatment of immunoglobulin light‐chain amyloidosis","googleId":"e9cDhXfGszwJ","googleLink":"https://onlinelibrary.wiley.com/doi/abs/10.1111/bjh.16697","googleCitationCount":1,"googleAuthor":"","doi":"10.1111/bjh.16697","elsevierAuthor":"Parrondo R.D.","publicationName":"British Journal of Haematology","elsevierCoverDate":"2020-12-01","elsevierCoverDisplayDate":"December 2020","elsevierCitationCount":"0"},{"title":"Whole exome sequencing discloses heterozygous variants in the DNAJC21 and EFL1 genes but not in SRP54 in 6 out of 16 patients with Shwachman-Diamond …","googleId":"9kHXWWDIhkkJ","googleLink":"https://pubmed.ncbi.nlm.nih.gov/30198570/","googleCitationCount":5,"googleAuthor":"J Morini","doi":"10.1111/bjh.15594,","elsevierAuthor":"Morini J.","publicationName":"British Journal of Haematology","elsevierCoverDate":"2019-05-01","elsevierCoverDisplayDate":"May 2019","elsevierCitationCount":"4"},{"title":"Anaplastic large cell lymphoma in human immunodeficiency virus‐infected people and solid organ transplant recipients","googleId":"82z741bDHyIJ","googleLink":"https://onlinelibrary.wiley.com/doi/abs/10.1111/bjh.16778","googleCitationCount":0,"googleAuthor":"P Mahale","doi":"10.1111/bjh.16778","elsevierAuthor":"Mahale P.","publicationName":"British Journal of Haematology","elsevierCoverDate":"2021-02-01","elsevierCoverDisplayDate":"February 2021","elsevierCitationCount":"0"},{"title":"Low‐density lipoprotein receptor (LDLR) is an independent adverse prognostic factor in acute myeloid leukaemia","googleId":"YBJOu03qrvEJ","googleLink":"https://onlinelibrary.wiley.com/doi/abs/10.1111/bjh.16853","googleCitationCount":0,"googleAuthor":"","doi":"10.1111/bjh.16853","elsevierAuthor":"Floeth M.","publicationName":"British Journal of Haematology","elsevierCoverDate":"2021-02-01","elsevierCoverDisplayDate":"February 2021","elsevierCitationCount":"0"},{"title":"The epidemiology of amyloidosis in Queensland, Australia","googleId":"B0EQcP9n70sJ","googleLink":"https://onlinelibrary.wiley.com/doi/abs/10.1111/bjh.16000","googleCitationCount":2,"googleAuthor":"DSA McLeod","doi":"10.1111/bjh.16000","elsevierAuthor":"Wisniowski B.","publicationName":"British Journal of Haematology","elsevierCoverDate":"2019-09-01","elsevierCoverDisplayDate":"1 September 2019","elsevierCitationCount":"0"},{"title":"Venetoclax as a single agent and in combination with PI3K-MTOR1/2 kinase inhibitors against ibrutinib sensitive and resistant mantle cell lymphoma (MCL)","googleId":"kOVgSC44ML8J","googleLink":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6066460/","googleCitationCount":6,"googleAuthor":"X Zhao"},{"title":"Target capture next-generation sequencing in non-inversion haemophilia: an alternative approach","googleId":"dxZZ001RxC8J","googleLink":"https://pubmed.ncbi.nlm.nih.gov/32190902/","googleCitationCount":1,"googleAuthor":"","doi":"10.1111/bjh.16584,","elsevierAuthor":"Li Q.","publicationName":"British Journal of Haematology","elsevierCoverDate":"2020-05-01","elsevierCoverDisplayDate":"1 May 2020","elsevierCitationCount":"1"},{"title":"Class 1 HDAC and HDAC6 inhibition inversely regulates CD38 induction in myeloma cells via interferon-α and ATRA","googleId":"ulULdYLErRoJ","googleLink":"https://okayama.pure.elsevier.com/en/publications/class-1-hdac-and-hdac6-inhibition-inversely-regulates-cd38-induct","googleCitationCount":4,"googleAuthor":"A Bat-Erdene","doi":"10.1111/bjh.15673","elsevierAuthor":"Bat-Erdene A.","publicationName":"British Journal of Haematology","elsevierCoverDate":"2019-06-01","elsevierCoverDisplayDate":"June 2019","elsevierCitationCount":"1"},{"title":"A new case of heterozygous variant of the GP1BB gene responsible for macrothrombocytopenia","googleId":"tq_SmBZud8UJ","googleLink":"https://pubmed.ncbi.nlm.nih.gov/30609015/","googleCitationCount":4,"googleAuthor":"","doi":"10.1111/bjh.15739,","elsevierAuthor":"Babuty A.","publicationName":"British Journal of Haematology","elsevierCoverDate":"2019-07-01","elsevierCoverDisplayDate":"July 2019","elsevierCitationCount":"3"},{"title":"Inherited predisposition to haematopoietic malignancies: overcoming barriers and exploring opportunities","googleId":"0bjXw1Bs3n0J","googleLink":"https://onlinelibrary.wiley.com/doi/abs/10.1111/bjh.17247","googleCitationCount":0,"googleAuthor":"AM Trottier","doi":"10.1111/bjh.17247","elsevierAuthor":"Trottier A.M.","publicationName":"British Journal of Haematology","elsevierCoverDate":"2020-01-01","elsevierCoverDisplayDate":"2020","elsevierCitationCount":"0"},{"title":"Genomic analysis of multiple myeloma using targeted capture sequencing in the Japanese cohort","googleId":"xM7JaHUXZlkJ","googleLink":"https://onlinelibrary.wiley.com/doi/abs/10.1111/bjh.16720","googleCitationCount":0,"googleAuthor":"","doi":"10.1111/bjh.16720","elsevierAuthor":"Kanamori T.","publicationName":"British Journal of Haematology","elsevierCoverDate":"2020-12-01","elsevierCoverDisplayDate":"December 2020","elsevierCitationCount":"0"},{"title":"High-throughput analysis revealed the unique immunoglobulin gene rearrangements in plasmacytoma-like post-transplant lymphoproliferative disorder","googleId":"EaHJCFMMK9cJ","googleLink":"https://pubmed.ncbi.nlm.nih.gov/32191347/","googleCitationCount":1,"googleAuthor":"","doi":"10.1111/bjh.16583,","elsevierAuthor":"Hoshino A.","publicationName":"British Journal of Haematology","elsevierCoverDate":"2020-05-01","elsevierCoverDisplayDate":"1 May 2020","elsevierCitationCount":"1"},{"title":"Physiological and pathophysiological mechanisms of hepcidin regulation: clinical implications for iron disorders","googleId":"UVcP75jJynQJ","googleLink":"https://onlinelibrary.wiley.com/doi/abs/10.1111/bjh.17252","googleCitationCount":0,"googleAuthor":"","doi":"10.1111/bjh.17252","elsevierAuthor":"Xu Y.","publicationName":"British Journal of Haematology","elsevierCoverDate":"2020-01-01","elsevierCoverDisplayDate":"2020","elsevierCitationCount":"0"},{"title":"IDO in MDS/AML disease progression and its role in resistance to azacitidine: a potential new drug target?","googleId":"vMcLjtBoBIkJ","googleLink":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7496607/","googleCitationCount":0,"googleAuthor":"R Greil","doi":"10.1111/bjh.16710","elsevierAuthor":"Leisch M.","publicationName":"British Journal of Haematology","elsevierCoverDate":"2020-08-01","elsevierCoverDisplayDate":"1 August 2020","elsevierCitationCount":"0"},{"title":"Developments over the last 60 years in diffuse large B‐cell lymphomas","googleId":"OWSIZGQInoQJ","googleLink":"https://onlinelibrary.wiley.com/doi/abs/10.1111/bjh.17154","googleCitationCount":0,"googleAuthor":"","doi":"10.1111/bjh.17154","elsevierAuthor":"Linch D.","publicationName":"British Journal of Haematology","elsevierCoverDate":"2020-11-01","elsevierCoverDisplayDate":"November 2020","elsevierCitationCount":"0"},{"title":"A cross‐sectional, case‐control study of intracranial arterial wall thickness and complete blood count measures in sickle cell disease","googleId":"gM5v8yVK1JoJ","googleLink":"https://onlinelibrary.wiley.com/doi/abs/10.1111/bjh.17262","googleCitationCount":0,"googleAuthor":"LC Jordan","doi":"10.1111/bjh.17262","elsevierAuthor":"Yuan S.","publicationName":"British Journal of Haematology","elsevierCoverDate":"2020-01-01","elsevierCoverDisplayDate":"2020","elsevierCitationCount":"0"},{"title":"Clonal tracking of haematopoietic cells: insights and clinical implications","googleId":"_UJPRK8xWxsJ","googleLink":"https://onlinelibrary.wiley.com/doi/abs/10.1111/bjh.17175","googleCitationCount":0,"googleAuthor":"C Wu","doi":"10.1111/bjh.17175","elsevierAuthor":"Cordes S.","publicationName":"British Journal of Haematology","elsevierCoverDate":"2020-01-01","elsevierCoverDisplayDate":"2020","elsevierCitationCount":"0"},{"title":"Long‐term follow‐up of children with risk organ‐negative Langerhans cell histiocytosis after 2‐chlorodeoxyadenosine treatment","googleId":"mpFfv442vgkJ","googleLink":"https://onlinelibrary.wiley.com/doi/abs/10.1111/bjh.16944","googleCitationCount":1,"googleAuthor":"","doi":"10.1111/bjh.16944","elsevierAuthor":"Barkaoui M.A.","publicationName":"British Journal of Haematology","elsevierCoverDate":"2020-12-01","elsevierCoverDisplayDate":"December 2020","elsevierCitationCount":"0"},{"title":"Low urinary levels of angiotensin-converting enzyme 2 may contribute to albuminuria in children with sickle cell anaemia","googleId":"WJFdPj9Vh_gJ","googleLink":"https://pubmed.ncbi.nlm.nih.gov/29974954/","googleCitationCount":5,"googleAuthor":"ÉLM Vieira","doi":"10.1111/bjh.15439,","elsevierAuthor":"Belisário A.R.","publicationName":"British Journal of Haematology","elsevierCoverDate":"2019-04-01","elsevierCoverDisplayDate":"April 2019","elsevierCitationCount":"4"},{"title":"Novel mutations in SPTA1 and SPTB identified by whole exome sequencing in eight Thai families with hereditary pyropoikilocytosis presenting with severe fetal and …","googleId":"05tZTKZUSDoJ","googleLink":"https://pubmed.ncbi.nlm.nih.gov/30198572/","googleCitationCount":5,"googleAuthor":"","doi":"10.1111/bjh.15559,","elsevierAuthor":"Ittiwut C.","publicationName":"British Journal of Haematology","elsevierCoverDate":"2019-05-01","elsevierCoverDisplayDate":"May 2019","elsevierCitationCount":"4"},{"title":"JAK2 exon 12 mutation in myelodysplastic/myeloproliferative neoplasm with ring sideroblasts and thrombocytosis: Not an exclusive mutation to polycythaemia vera","googleId":"sXWqe3L0tQ4J","googleLink":"https://pubmed.ncbi.nlm.nih.gov/31418453/","googleCitationCount":2,"googleAuthor":"","doi":"10.1111/bjh.16146,","elsevierAuthor":"Inano T.","publicationName":"British Journal of Haematology","elsevierCoverDate":"2019-10-01","elsevierCoverDisplayDate":"1 October 2019","elsevierCitationCount":"3"},{"title":"Validation of a simplified international prognostic score (IPS‐3) in patients with advanced‐stage classic Hodgkin lymphoma","googleId":"URB0Lw33GM4J","googleLink":"https://onlinelibrary.wiley.com/doi/abs/10.1111/bjh.16293","googleCitationCount":2,"googleAuthor":"DG Lee","doi":"10.1111/bjh.16293","elsevierAuthor":"Hayden A.R.","publicationName":"British Journal of Haematology","elsevierCoverDate":"2020-04-01","elsevierCoverDisplayDate":"1 April 2020","elsevierCitationCount":"2"},{"title":"Distinct mutational pattern of myelodysplastic syndromes with and without 5q-treated with lenalidomide","googleId":"IXwk9YYdPicJ","googleLink":"https://pubmed.ncbi.nlm.nih.gov/32147816/","googleCitationCount":1,"googleAuthor":"L Palomo","doi":"10.1111/bjh.16558,","elsevierAuthor":"Adema V.","publicationName":"British Journal of Haematology","elsevierCoverDate":"2020-05-01","elsevierCoverDisplayDate":"1 May 2020","elsevierCitationCount":"1"},{"title":"Impact of genotype in relapsed and refractory acute myeloid leukaemia patients treated with clofarabine and cytarabine: a retrospective study","googleId":"NYzK9AGEFTAJ","googleLink":"https://onlinelibrary.wiley.com/doi/abs/10.1111/bjh.16045","googleCitationCount":2,"googleAuthor":"","doi":"10.1111/bjh.16045","elsevierAuthor":"Mondesir J.","publicationName":"British Journal of Haematology","elsevierCoverDate":"2019-10-01","elsevierCoverDisplayDate":"1 October 2019","elsevierCitationCount":"1"},{"title":"Histiocytic sarcoma arising in patient with history of clonally‐related germ cell tumour and myelodysplastic syndrome","googleId":"CIEbipmYRdwJ","googleLink":"https://onlinelibrary.wiley.com/doi/abs/10.1111/bjh.16372","googleCitationCount":3,"googleAuthor":"H Tashkandi","doi":"10.1111/bjh.16372","elsevierAuthor":"Tashkandi H.","publicationName":"British Journal of Haematology","elsevierCoverDate":"2020-01-01","elsevierCoverDisplayDate":"2020","elsevierCitationCount":"1"},{"title":"Bleeding signs due to acquired von Willebrand syndrome at diagnosis of chronic myeloid leukaemia in children","googleId":"UtRmcd3t5v8J","googleLink":"https://onlinelibrary.wiley.com/doi/abs/10.1111/bjh.16241","googleCitationCount":2,"googleAuthor":"F Paul","doi":"10.1111/bjh.16241","elsevierAuthor":"Knöfler R.","publicationName":"British Journal of Haematology","elsevierCoverDate":"2020-03-01","elsevierCoverDisplayDate":"1 March 2020","elsevierCitationCount":"0"},{"title":"Current treatment paradigms for advanced stage Hodgkin lymphoma","googleId":"tsLV9ZK9PpsJ","googleLink":"https://onlinelibrary.wiley.com/doi/abs/10.1111/bjh.15622","googleCitationCount":3,"googleAuthor":"PWM Johnson","doi":"10.1111/bjh.15622","elsevierAuthor":"Longley J.","publicationName":"British Journal of Haematology","elsevierCoverDate":"2019-01-01","elsevierCoverDisplayDate":"January 2019","elsevierCitationCount":"2"},{"title":"Haemolysis in sickle cell anaemia: effects of polymorphisms in α-globin gene regulatory elements","googleId":"X1tIpHvhMKoJ","googleLink":"https://www.ncbi.nlm.nih.gov/pmc/articles/pmc6606385/","googleCitationCount":3,"googleAuthor":"JN Milton"},{"title":"Iron Through the Prism of Haematology","googleId":"VI8ViH0udGMJ","googleLink":"https://onlinelibrary.wiley.com/doi/abs/10.1111/bjh.17164","googleCitationCount":0,"googleAuthor":"","doi":"10.1111/bjh.17164","elsevierAuthor":"Porter J.B.","publicationName":"British Journal of Haematology","elsevierCoverDate":"2020-11-01","elsevierCoverDisplayDate":"November 2020","elsevierCitationCount":"0"},{"title":"Cardiac expression of HMOX1 and PGF in sickle cell mice and haem‐treated wild type mice dominates organ expression profiles via Nrf2 (Nfe2l2)","googleId":"vSsgGy-tI9wJ","googleLink":"https://onlinelibrary.wiley.com/doi/abs/10.1111/bjh.16129","googleCitationCount":2,"googleAuthor":"OT Gbotosho","doi":"10.1111/bjh.16129","elsevierAuthor":"Gbotosho O.T.","publicationName":"British Journal of Haematology","elsevierCoverDate":"2019-12-01","elsevierCoverDisplayDate":"1 December 2019","elsevierCitationCount":"1"},{"title":"Characteristics of patients with myelodysplastic syndrome with balanced translocations","googleId":"75YhiNCijlAJ","googleLink":"https://pubmed.ncbi.nlm.nih.gov/32181489/","googleCitationCount":1,"googleAuthor":"MV Shah","doi":"10.1111/bjh.16551,","elsevierAuthor":"Joshi M.","publicationName":"British Journal of Haematology","elsevierCoverDate":"2020-07-01","elsevierCoverDisplayDate":"1 July 2020","elsevierCitationCount":"1"},{"title":"The spectrum of splenic complications in patients with sickle cell disease in Africa: a systematic review","googleId":"b_eh5OmnlOEJ","googleLink":"https://onlinelibrary.wiley.com/doi/abs/10.1111/bjh.17179","googleCitationCount":0,"googleAuthor":"A Adekile","doi":"10.1111/bjh.17179","elsevierAuthor":"Ladu A.I.","publicationName":"British Journal of Haematology","elsevierCoverDate":"2020-01-01","elsevierCoverDisplayDate":"2020","elsevierCitationCount":"0"},{"title":"A phase II study of addition of pracinostat to a hypomethylating agent in patients with myelodysplastic syndromes who have not responded to previous …","googleId":"51-2QO8IlmsJ","googleLink":"https://onlinelibrary.wiley.com/doi/abs/10.1111/bjh.16173","googleCitationCount":1,"googleAuthor":"FF Yalniz","doi":"10.1111/bjh.16173","elsevierAuthor":"Yalniz F.F.","publicationName":"British Journal of Haematology","elsevierCoverDate":"2020-02-01","elsevierCoverDisplayDate":"1 February 2020","elsevierCitationCount":"1"},{"title":"Hairy Cell Leukaemia: From Hairy Beginnings to a BRAF New World","googleId":"zqoOz1n35wMJ","googleLink":"https://onlinelibrary.wiley.com/doi/abs/10.1111/bjh.17158","googleCitationCount":0,"googleAuthor":"","doi":"10.1111/bjh.17158","elsevierAuthor":"Dearden C.","publicationName":"British Journal of Haematology","elsevierCoverDate":"2020-11-01","elsevierCoverDisplayDate":"November 2020","elsevierCitationCount":"0"},{"title":"CD52‐negative T cells predict acute graft‐versus‐host disease after an alemtuzumab‐based conditioning regimen","googleId":"tZ5ysOJWfeoJ","googleLink":"https://onlinelibrary.wiley.com/doi/abs/10.1111/bjh.16706","googleCitationCount":0,"googleAuthor":"","doi":"10.1111/bjh.16706","elsevierAuthor":"Woelfinger P.","publicationName":"British Journal of Haematology","elsevierCoverDate":"2020-10-01","elsevierCoverDisplayDate":"1 October 2020","elsevierCitationCount":"0"},{"title":"Unexpected low expression of platelet fibrinogen receptor in patients with chronic myeloproliferative neoplasms: how does it change with aspirin?","googleId":"mSO5cYJEJH4J","googleLink":"https://onlinelibrary.wiley.com/doi/abs/10.1111/bjh.16335","googleCitationCount":1,"googleAuthor":"A Lucchesi","doi":"10.1111/bjh.16335","elsevierAuthor":"Lucchesi A.","publicationName":"British Journal of Haematology","elsevierCoverDate":"2020-04-01","elsevierCoverDisplayDate":"1 April 2020","elsevierCitationCount":"1"},{"title":"Angiogenin-mediated tRNA cleavage as a novel feature of stored red blood cells","googleId":"crFRFrTRwMwJ","googleLink":"https://www.ncbi.nlm.nih.gov/pmc/articles/pmc6472987/","googleCitationCount":3,"googleAuthor":"WH Yang"},{"title":"Resource utilization and cost effectiveness of treating acute promyelocytic leukaemia using generic arsenic trioxide","googleId":"_KamP297kFgJ","googleLink":"https://onlinelibrary.wiley.com/doi/abs/10.1111/bjh.16343","googleCitationCount":1,"googleAuthor":"UP Kulkarni","doi":"10.1111/bjh.16343","elsevierAuthor":"Bankar A.","publicationName":"British Journal of Haematology","elsevierCoverDate":"2020-04-01","elsevierCoverDisplayDate":"1 April 2020","elsevierCitationCount":"1"},{"title":"The heparin‐von Willebrand factor interaction and conventional tests of haemostasis–the challenges in predicting bleeding in cardiopulmonary bypass","googleId":"nZrC_kB_UggJ","googleLink":"https://onlinelibrary.wiley.com/doi/abs/10.1111/bjh.17263","googleCitationCount":0,"googleAuthor":"","doi":"10.1111/bjh.17263","elsevierAuthor":"Ranger A.","publicationName":"British Journal of Haematology","elsevierCoverDate":"2020-01-01","elsevierCoverDisplayDate":"2020","elsevierCitationCount":"0"},{"title":"Haematological features, transfusion management and outcomes of massive obstetric haemorrhage: findings from the Australian and New Zealand Massive …","googleId":"If7m_PG0_1oJ","googleLink":"https://onlinelibrary.wiley.com/doi/abs/10.1111/bjh.16524","googleCitationCount":1,"googleAuthor":"","doi":"10.1111/bjh.16524","elsevierAuthor":"Lasica M.","publicationName":"British Journal of Haematology","elsevierCoverDate":"2020-08-01","elsevierCoverDisplayDate":"1 August 2020","elsevierCitationCount":"0"},{"title":"Outcomes of synchronous systemic and central nervous system (CNS) involvement of diffuse large B‐cell lymphoma are dictated by the CNS disease: a collaborative …","googleId":"3fQArm2ZSPAJ","googleLink":"https://onlinelibrary.wiley.com/doi/abs/10.1111/bjh.16064","googleCitationCount":3,"googleAuthor":"","doi":"10.1111/bjh.16064","elsevierAuthor":"Wight J.C.","publicationName":"British Journal of Haematology","elsevierCoverDate":"2019-10-01","elsevierCoverDisplayDate":"1 October 2019","elsevierCitationCount":"2"},{"title":"Novel findings from the multinational DOVE study on geographic and age‐related differences in pain perception and analgesic usage in children with sickle cell …","googleId":"xIdtCzgQ2SUJ","googleLink":"https://onlinelibrary.wiley.com/doi/abs/10.1111/bjh.15250?af=R","googleCitationCount":6,"googleAuthor":"","doi":"10.1111/bjh.15250","elsevierAuthor":"Kanter J.","publicationName":"British Journal of Haematology","elsevierCoverDate":"2019-03-01","elsevierCoverDisplayDate":"March 2019","elsevierCitationCount":"2"},{"title":"Intravenous iron: do we adequately understand the short‐and long‐term risks in clinical practice?","googleId":"7J-mQcByVmQJ","googleLink":"https://onlinelibrary.wiley.com/doi/abs/10.1111/bjh.17202","googleCitationCount":0,"googleAuthor":"","doi":"10.1111/bjh.17202","elsevierAuthor":"Rund D.","publicationName":"British Journal of Haematology","elsevierCoverDate":"2020-01-01","elsevierCoverDisplayDate":"2020","elsevierCitationCount":"0"},{"title":"New insights into red cell rheology and adhesion in patients with sickle cell anaemia during vaso-occlusive crises","googleId":"bYWh7yeDa3AJ","googleLink":"https://hal.univ-antilles.fr/hal-01968397","googleCitationCount":4,"googleAuthor":"P Connes","doi":"10.1111/bjh.15686","elsevierAuthor":"Lapoumeroulie C.","publicationName":"British Journal of Haematology","elsevierCoverDate":"2019-06-01","elsevierCoverDisplayDate":"June 2019","elsevierCitationCount":"2"},{"title":"Atypical haemolytic uraemic syndrome in the eculizumab era: presentation, response to treatment and evaluation of an eculizumab withdrawal strategy","googleId":"mJZANNCZR9QJ","googleLink":"https://onlinelibrary.wiley.com/doi/abs/10.1111/bjh.15899","googleCitationCount":3,"googleAuthor":"","doi":"10.1111/bjh.15899","elsevierAuthor":"Neave L.","publicationName":"British Journal of Haematology","elsevierCoverDate":"2019-07-01","elsevierCoverDisplayDate":"July 2019","elsevierCitationCount":"2"},{"title":"Frontline treatment of elderly non transplant‐eligible multiple myeloma patients using CyBorD with or without thalidomide‐based consolidation: a retrospective multi …","googleId":"9njXR2idNnwJ","googleLink":"https://onlinelibrary.wiley.com/doi/abs/10.1111/bjh.16095","googleCitationCount":2,"googleAuthor":"","doi":"10.1111/bjh.16095","elsevierAuthor":"Chan H.","publicationName":"British Journal of Haematology","elsevierCoverDate":"2019-11-01","elsevierCoverDisplayDate":"1 November 2019","elsevierCitationCount":"2"},{"title":"Early clinical trials in chronic lymphocytic leukaemia in the UK","googleId":"czYsSGLwAGgJ","googleLink":"https://onlinelibrary.wiley.com/doi/abs/10.1111/bjh.17159","googleCitationCount":0,"googleAuthor":"M Else","doi":"10.1111/bjh.17159","elsevierAuthor":"Catovsky D.","publicationName":"British Journal of Haematology","elsevierCoverDate":"2020-11-01","elsevierCoverDisplayDate":"November 2020","elsevierCitationCount":"0"},{"title":"All‐trans‐retinoic acid shifts Th1 towards Th2 cell differentiation by targeting NFAT1 signalling to ameliorate immune‐mediated aplastic anaemia","googleId":"I6IEVJdXkjQJ","googleLink":"https://onlinelibrary.wiley.com/doi/abs/10.1111/bjh.16871","googleCitationCount":0,"googleAuthor":"","doi":"10.1111/bjh.16871","elsevierAuthor":"Tang D.","publicationName":"British Journal of Haematology","elsevierCoverDate":"2020-12-01","elsevierCoverDisplayDate":"December 2020","elsevierCitationCount":"0"},{"title":"Post‐haematopoietic cell transplantation outcomes: why ST2 became a 'golden nugget'biomarker","googleId":"gYsm5Xbg7H8J","googleLink":"https://onlinelibrary.wiley.com/doi/abs/10.1111/bjh.16497","googleCitationCount":0,"googleAuthor":"S Paczesny","doi":"10.1111/bjh.16497","elsevierAuthor":"Paczesny S.","publicationName":"British Journal of Haematology","elsevierCoverDate":"2020-01-01","elsevierCoverDisplayDate":"2020","elsevierCitationCount":"0"},{"title":"Expression of the transcribed ultraconserved region 70 and the related long non‐coding RNA AC 092652.2‐202 has prognostic value in Chronic Lymphocytic …","googleId":"it0NZeUbjcIJ","googleLink":"https://onlinelibrary.wiley.com/doi/abs/10.1111/bjh.15237?af=R","googleCitationCount":5,"googleAuthor":"A Roisman","doi":"10.1111/bjh.15237","elsevierAuthor":"Bomben R.","publicationName":"British Journal of Haematology","elsevierCoverDate":"2019-03-01","elsevierCoverDisplayDate":"March 2019","elsevierCitationCount":"4"},{"title":"The genesis of paediatric haematology in the UK","googleId":"JcliDg6WIRUJ","googleLink":"https://onlinelibrary.wiley.com/doi/abs/10.1111/bjh.17163","googleCitationCount":0,"googleAuthor":"","doi":"10.1111/bjh.17163","elsevierAuthor":"Roberts I.","publicationName":"British Journal of Haematology","elsevierCoverDate":"2020-11-01","elsevierCoverDisplayDate":"November 2020","elsevierCitationCount":"0"},{"title":"Pegylated interferon alpha 2a is an effective and well-tolerated treatment option for lymphocyte-variant hypereosinophilic syndrome","googleId":"xvznEhHJmVkJ","googleLink":"https://pubmed.ncbi.nlm.nih.gov/31721154/","googleCitationCount":3,"googleAuthor":"C Choi","doi":"10.1111/bjh.16332,","elsevierAuthor":"Choi C.","publicationName":"British Journal of Haematology","elsevierCoverDate":"2020-03-01","elsevierCoverDisplayDate":"1 March 2020","elsevierCitationCount":"2"},{"title":"Infections in patients with lymphoproliferative diseases treated with targeted agents: SEIFEM multicentric retrospective study","googleId":"c9F6bvRX4WIJ","googleLink":"https://onlinelibrary.wiley.com/doi/abs/10.1111/bjh.17145","googleCitationCount":0,"googleAuthor":"D Facchinelli","doi":"10.1111/bjh.17145","elsevierAuthor":"Marchesini G.","publicationName":"British Journal of Haematology","elsevierCoverDate":"2020-01-01","elsevierCoverDisplayDate":"2020","elsevierCitationCount":"0"},{"title":"Effect of initial treatment on health‐related quality of life in patients with newly diagnosed multiple myeloma without immediate stem cell transplant intent: results from …","googleId":"d6jiZibi6KIJ","googleLink":"https://onlinelibrary.wiley.com/doi/abs/10.1111/bjh.17131","googleCitationCount":0,"googleAuthor":"","doi":"10.1111/bjh.17131","elsevierAuthor":"Abonour R.","publicationName":"British Journal of Haematology","elsevierCoverDate":"2020-01-01","elsevierCoverDisplayDate":"2020","elsevierCitationCount":"0"},{"title":"Applicability and reproducibility of acute myeloid leukaemia stem cell assessment in a multi‐centre setting","googleId":"rLWTa8pKOPMJ","googleLink":"https://onlinelibrary.wiley.com/doi/abs/10.1111/bjh.16594","googleCitationCount":1,"googleAuthor":"","doi":"10.1111/bjh.16594","elsevierAuthor":"Hanekamp D.","publicationName":"British Journal of Haematology","elsevierCoverDate":"2020-09-01","elsevierCoverDisplayDate":"1 September 2020","elsevierCitationCount":"1"},{"title":"Prospective randomized trial comparing two doses of rabbit anti‐thymocyte globulin in patients with severe aplastic anaemia","googleId":"43_SCA4fTREJ","googleLink":"https://onlinelibrary.wiley.com/doi/abs/10.1111/bjh.16055","googleCitationCount":1,"googleAuthor":"","doi":"10.1111/bjh.16055","elsevierAuthor":"Narita A.","publicationName":"British Journal of Haematology","elsevierCoverDate":"2019-10-01","elsevierCoverDisplayDate":"1 October 2019","elsevierCitationCount":"0"},{"title":"Acute myeloid leukaemia niche regulates response to L‐asparaginase","googleId":"eC4iUi7pL3YJ","googleLink":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6767544/","googleCitationCount":1,"googleAuthor":"","doi":"10.1111/bjh.15924","elsevierAuthor":"Kaspers G.J.L.","publicationName":"British Journal of Haematology","elsevierCoverDate":"2019-08-01","elsevierCoverDisplayDate":"August 2019","elsevierCitationCount":"2"},{"title":"Venetoclax-induced tumour lysis syndrome in acute myeloid leukaemia","googleId":"-FbIJVQIFKMJ","googleLink":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7574315/","googleCitationCount":2,"googleAuthor":""},{"title":"Skipping a step or „impatientitis “: what happened to the design of randomized clinical trials in chronic lymphocytic leukaemia?","googleId":"gXVT6UakQccJ","googleLink":"https://onlinelibrary.wiley.com/doi/abs/10.1111/bjh.17215","googleCitationCount":0,"googleAuthor":"","doi":"10.1111/bjh.17215","elsevierAuthor":"Smolej L.","publicationName":"British Journal of Haematology","elsevierCoverDate":"2020-01-01","elsevierCoverDisplayDate":"2020","elsevierCitationCount":"0"},{"title":"CD 13 expression in B cell malignancies is a hallmark of plasmacytic differentiation","googleId":"aHrNU_Ej8OEJ","googleLink":"https://onlinelibrary.wiley.com/doi/abs/10.1111/bjh.15584","googleCitationCount":5,"googleAuthor":"","doi":"10.1111/bjh.15584","elsevierAuthor":"Raimbault A.","publicationName":"British Journal of Haematology","elsevierCoverDate":"2019-02-01","elsevierCoverDisplayDate":"Februaryy 2019","elsevierCitationCount":"4"},{"title":"Incidence and outcomes of rare paediatric non‐Hodgkin lymphomas","googleId":"OkxqCUSXJvsJ","googleLink":"https://onlinelibrary.wiley.com/doi/abs/10.1111/bjh.15194?af=R","googleCitationCount":5,"googleAuthor":"","doi":"10.1111/bjh.15194","elsevierAuthor":"Sorge C.","publicationName":"British Journal of Haematology","elsevierCoverDate":"2019-03-01","elsevierCoverDisplayDate":"March 2019","elsevierCitationCount":"4"},{"title":"Variation in the Human Leukocyte Antigen system and risk for endemic Burkitt lymphoma in northern Uganda","googleId":"PUQXeMi5ceYJ","googleLink":"https://onlinelibrary.wiley.com/doi/abs/10.1111/bjh.16398","googleCitationCount":0,"googleAuthor":"","doi":"10.1111/bjh.16398","elsevierAuthor":"Kirimunda S.","publicationName":"British Journal of Haematology","elsevierCoverDate":"2020-05-01","elsevierCoverDisplayDate":"1 May 2020","elsevierCitationCount":"0"},{"title":"The top 10 research priorities in bleeding disorders: a James Lind Alliance Priority Setting Partnership","googleId":"cce7Z_Q9iVAJ","googleLink":"https://pubmed.ncbi.nlm.nih.gov/31016727/","googleCitationCount":2,"googleAuthor":"","doi":"10.1111/bjh.15928,","elsevierAuthor":"Shapiro S.","publicationName":"British Journal of Haematology","elsevierCoverDate":"2019-01-01","elsevierCoverDisplayDate":"2019","elsevierCitationCount":"2"},{"title":"Daratumumab monotherapy for relapsed/refractory multiple myeloma, focussed on clinical trial‐unfit patients and subsequent therapy","googleId":"X0_M-UdGmxcJ","googleLink":"https://onlinelibrary.wiley.com/doi/abs/10.1111/bjh.17071","googleCitationCount":0,"googleAuthor":"","doi":"10.1111/bjh.17071","elsevierAuthor":"Park S.S.","publicationName":"British Journal of Haematology","elsevierCoverDate":"2020-01-01","elsevierCoverDisplayDate":"2020","elsevierCitationCount":"0"},{"title":"Low educational level of head of household, as a proxy for poverty, is associated with severe anaemia among children with sickle cell disease living in a low‐resource …","googleId":"CnxP4phKUdQJ","googleLink":"https://onlinelibrary.wiley.com/doi/abs/10.1111/bjh.16746","googleCitationCount":0,"googleAuthor":"","doi":"10.1111/bjh.16746","elsevierAuthor":"Bello-Manga H.","publicationName":"British Journal of Haematology","elsevierCoverDate":"2020-09-01","elsevierCoverDisplayDate":"1 September 2020","elsevierCitationCount":"1"},{"title":"A prognostic index for extranodal marginal‐zone lymphoma based on the mucosa‐associated lymphoid tissue International Prognostic Index and serum β2 …","googleId":"X4nYQ06TEUYJ","googleLink":"https://onlinelibrary.wiley.com/doi/abs/10.1111/bjh.17222","googleCitationCount":0,"googleAuthor":"HD Kim","doi":"10.1111/bjh.17222","elsevierAuthor":"Kim H.D.","publicationName":"British Journal of Haematology","elsevierCoverDate":"2020-01-01","elsevierCoverDisplayDate":"2020","elsevierCitationCount":"0"},{"title":"Improved survival after offspring donor transplant compared with older aged‐matched siblings for older leukaemia patients","googleId":"tpwJAaPwlkgJ","googleLink":"https://onlinelibrary.wiley.com/doi/abs/10.1111/bjh.16303","googleCitationCount":1,"googleAuthor":"","doi":"10.1111/bjh.16303","elsevierAuthor":"Wang Y.","publicationName":"British Journal of Haematology","elsevierCoverDate":"2020-04-01","elsevierCoverDisplayDate":"1 April 2020","elsevierCitationCount":"1"},{"title":"Trabectedin is a novel chemotherapy agent for diffuse large B cell lymphoma","googleId":"1i0t67124zoJ","googleLink":"https://pubmed.ncbi.nlm.nih.gov/29611184/","googleCitationCount":5,"googleAuthor":"F Spriano","doi":"10.1111/bjh.15212,","elsevierAuthor":"Spriano F.","publicationName":"British Journal of Haematology","elsevierCoverDate":"2019-03-01","elsevierCoverDisplayDate":"March 2019","elsevierCitationCount":"3"},{"title":"Risk factors affecting outcome of unrelated cord blood transplantation for children with familial haemophagocytic lymphohistiocytosis","googleId":"cM7TrhAtWF0J","googleLink":"https://onlinelibrary.wiley.com/doi/abs/10.1111/bjh.15642","googleCitationCount":5,"googleAuthor":"","doi":"10.1111/bjh.15642","elsevierAuthor":"Furtado-Silva J.M.","publicationName":"British Journal of Haematology","elsevierCoverDate":"2019-02-01","elsevierCoverDisplayDate":"Februaryy 2019","elsevierCitationCount":"5"},{"title":"Clinical and biological features of B‐cell neoplasms with CDK6 translocations: an association with a subgroup of splenic marginal zone lymphomas displaying frequent CD5 …","googleId":"YkGjOUjC3ssJ","googleLink":"https://onlinelibrary.wiley.com/doi/abs/10.1111/bjh.17141","googleCitationCount":0,"googleAuthor":"","doi":"10.1111/bjh.17141","elsevierAuthor":"Gailllard B.","publicationName":"British Journal of Haematology","elsevierCoverDate":"2020-01-01","elsevierCoverDisplayDate":"2020","elsevierCitationCount":"0"},{"title":"Statin and cyclooxygenase‐2 inhibitors improve survival in newly diagnosed diffuse large B‐cell lymphoma: a large population‐based study of 4913 subjects","googleId":"caOE2MIWscsJ","googleLink":"https://onlinelibrary.wiley.com/doi/abs/10.1111/bjh.16635","googleCitationCount":1,"googleAuthor":"","doi":"10.1111/bjh.16635","elsevierAuthor":"Smyth L.","publicationName":"British Journal of Haematology","elsevierCoverDate":"2020-11-01","elsevierCoverDisplayDate":"1 November 2020","elsevierCitationCount":"0"},{"title":"Molecular heterogeneity unravelled by single‐cell transcriptomics in patients with essential thrombocythaemia","googleId":"TStO4xXx0ogJ","googleLink":"https://onlinelibrary.wiley.com/doi/abs/10.1111/bjh.16225","googleCitationCount":1,"googleAuthor":"","doi":"10.1111/bjh.16225","elsevierAuthor":"Hsu C.C.","publicationName":"British Journal of Haematology","elsevierCoverDate":"2020-03-01","elsevierCoverDisplayDate":"1 March 2020","elsevierCitationCount":"0"},{"title":"Peripheral blood mononuclear cells show prominent gene expression by erythroid progenitors in diseases characterized by heightened erythropoiesis","googleId":"wE-vYiqL0ZQJ","googleLink":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7798416/","googleCitationCount":0,"googleAuthor":""},{"title":"A new efficient tool for non‐invasive diagnosis of fetomaternal platelet antigen incompatibility","googleId":"RS_GKAYpm3MJ","googleLink":"https://onlinelibrary.wiley.com/doi/abs/10.1111/bjh.16593","googleCitationCount":0,"googleAuthor":"","doi":"10.1111/bjh.16593","elsevierAuthor":"Ouzegdouh Mammasse Y.","publicationName":"British Journal of Haematology","elsevierCoverDate":"2020-09-01","elsevierCoverDisplayDate":"1 September 2020","elsevierCitationCount":"0"},{"title":"At three years, patients with acute lymphoblastic leukaemia are still at risk for relapse. Results of the international MRC UKALLXII/ECOG E2993 trial","googleId":"3UnFfh6U26gJ","googleLink":"https://onlinelibrary.wiley.com/doi/abs/10.1111/bjh.16616","googleCitationCount":0,"googleAuthor":"","doi":"10.1111/bjh.16616","elsevierAuthor":"Ganzel C.","publicationName":"British Journal of Haematology","elsevierCoverDate":"2020-10-01","elsevierCoverDisplayDate":"1 October 2020","elsevierCitationCount":"0"},{"title":"Expression of ELF 1, a lymphoid ETS domain‐containing transcription factor, is recurrently lost in classical Hodgkin lymphoma","googleId":"8nZ92zGWxCkJ","googleLink":"https://onlinelibrary.wiley.com/doi/abs/10.1111/bjh.15757","googleCitationCount":2,"googleAuthor":"","doi":"10.1111/bjh.15757","elsevierAuthor":"Paczkowska J.","publicationName":"British Journal of Haematology","elsevierCoverDate":"2019-04-01","elsevierCoverDisplayDate":"April 2019","elsevierCitationCount":"2"},{"title":"The association of psychiatric comorbidities with emergency visits and hospitalisations in adult sickle‐cell patients: a cohort study","googleId":"wwiPG2FniyQJ","googleLink":"https://hal.archives-ouvertes.fr/hal-02503167/document","googleCitationCount":1,"googleAuthor":""},{"title":"Combination of a mitogen‐activated protein kinase inhibitor with the tyrosine kinase inhibitor pacritinib combats cell adhesion‐based residual disease and prevents re …","googleId":"8cF2SMV84zcJ","googleLink":"https://onlinelibrary.wiley.com/doi/abs/10.1111/bjh.16665","googleCitationCount":0,"googleAuthor":"","doi":"10.1111/bjh.16665","elsevierAuthor":"Zabkiewicz J.","publicationName":"British Journal of Haematology","elsevierCoverDate":"2020-10-01","elsevierCoverDisplayDate":"1 October 2020","elsevierCitationCount":"0"},{"title":"Raman imaging highlights biochemical heterogeneity of human eosinophils versus human eosinophilic leukaemia cell line","googleId":"sIOyWrtCj8UJ","googleLink":"https://onlinelibrary.wiley.com/doi/abs/10.1111/bjh.15971","googleCitationCount":1,"googleAuthor":"","doi":"10.1111/bjh.15971","elsevierAuthor":"Rygula A.","publicationName":"British Journal of Haematology","elsevierCoverDate":"2019-01-01","elsevierCoverDisplayDate":"2019","elsevierCitationCount":"0"},{"title":"Investigating the response of paediatric leukaemia‐propagating cells to BCL‐2 inhibitors","googleId":"4HnkS_qpqhEJ","googleLink":"https://onlinelibrary.wiley.com/doi/abs/10.1111/bjh.16773","googleCitationCount":0,"googleAuthor":"","doi":"10.1111/bjh.16773","elsevierAuthor":"Diamanti P.","publicationName":"British Journal of Haematology","elsevierCoverDate":"2021-02-01","elsevierCoverDisplayDate":"February 2021","elsevierCitationCount":"0"},{"title":"Allogeneic cord blood transfusions prevent fetal haemoglobin depletion in preterm neonates. Results of the CB‐TrIP study","googleId":"ookhYWegmngJ","googleLink":"https://onlinelibrary.wiley.com/doi/abs/10.1111/bjh.16851","googleCitationCount":0,"googleAuthor":"","doi":"10.1111/bjh.16851","elsevierAuthor":"Teofili L.","publicationName":"British Journal of Haematology","elsevierCoverDate":"2020-10-01","elsevierCoverDisplayDate":"1 October 2020","elsevierCitationCount":"0"},{"title":"Telemedicine in patients with haematological diseases during the coronavirus disease 2019 (COVID‐19) pandemic: selection criteria and patients' …","googleId":"AT6_8ldPyw0J","googleLink":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7753380/","googleCitationCount":0,"googleAuthor":"","doi":"10.1111/bjh.17208","elsevierAuthor":"Palandri F.","publicationName":"British Journal of Haematology","elsevierCoverDate":"2021-01-01","elsevierCoverDisplayDate":"January 2021","elsevierCitationCount":"0"},{"title":"Characteristics and outcomes of adults with cytomegalovirus‐associated thrombocytopenia: a case series and literature review","googleId":"gKEC19ayjhUJ","googleLink":"https://onlinelibrary.wiley.com/doi/abs/10.1111/bjh.17017","googleCitationCount":0,"googleAuthor":"","doi":"10.1111/bjh.17017","elsevierAuthor":"Shragai T.","publicationName":"British Journal of Haematology","elsevierCoverDate":"2020-12-01","elsevierCoverDisplayDate":"December 2020","elsevierCitationCount":"0"},{"title":"Mass cytometry identifies expansion of double positive and exhausted T cell subsets in the tumour microenvironment of patients with POEMS syndrome","googleId":"1gzXssg1bCEJ","googleLink":"https://onlinelibrary.wiley.com/doi/abs/10.1111/bjh.16522","googleCitationCount":0,"googleAuthor":"TV Kourelis","doi":"10.1111/bjh.16522","elsevierAuthor":"Kourelis T.V.","publicationName":"British Journal of Haematology","elsevierCoverDate":"2020-07-01","elsevierCoverDisplayDate":"1 July 2020","elsevierCitationCount":"0"},{"title":"Gabapentin alleviates chronic spontaneous pain and acute hypoxia‐related pain in a mouse model of sickle cell disease","googleId":"8Qqlw0pdjfsJ","googleLink":"https://onlinelibrary.wiley.com/doi/abs/10.1111/bjh.16067","googleCitationCount":1,"googleAuthor":"KE Sadler","doi":"10.1111/bjh.16067","elsevierAuthor":"Sadler K.E.","publicationName":"British Journal of Haematology","elsevierCoverDate":"2019-10-01","elsevierCoverDisplayDate":"1 October 2019","elsevierCitationCount":"0"},{"title":"Frailty score of older patients with haematological malignancies: unsuspected role of mild cognitive impairment","googleId":"pyIRaJBVKpEJ","googleLink":"https://onlinelibrary.wiley.com/doi/abs/10.1111/bjh.16469","googleCitationCount":0,"googleAuthor":"","doi":"10.1111/bjh.16469","elsevierAuthor":"Thibaud V.","publicationName":"British Journal of Haematology","elsevierCoverDate":"2020-07-01","elsevierCoverDisplayDate":"1 July 2020","elsevierCitationCount":"0"},{"title":"Retroviral sero‐reactivity in LGL leukaemia patients and family members","googleId":"4R6gJQqEQ4sJ","googleLink":"https://onlinelibrary.wiley.com/doi/abs/10.1111/bjh.16223","googleCitationCount":4,"googleAuthor":"","doi":"10.1111/bjh.16223","elsevierAuthor":"Nyland S.B.","publicationName":"British Journal of Haematology","elsevierCoverDate":"2020-02-01","elsevierCoverDisplayDate":"1 February 2020","elsevierCitationCount":"2"},{"title":"Identification of patients with smouldering multiple myeloma at ultra‐high risk of progression using serum parameters: the Czech Myeloma Group model","googleId":"pKRCz3qGeFIJ","googleLink":"https://onlinelibrary.wiley.com/doi/abs/10.1111/bjh.16572","googleCitationCount":0,"googleAuthor":"","doi":"10.1111/bjh.16572","elsevierAuthor":"Hájek R.","publicationName":"British Journal of Haematology","elsevierCoverDate":"2020-07-01","elsevierCoverDisplayDate":"1 July 2020","elsevierCitationCount":"0"},{"title":"Impact of imaging modality on clinical outcome in Hodgkin lymphoma in a resource constraint setting","googleId":"mLMiUGTvNXIJ","googleLink":"https://onlinelibrary.wiley.com/doi/abs/10.1111/bjh.16289","googleCitationCount":1,"googleAuthor":"","doi":"10.1111/bjh.16289","elsevierAuthor":"Korula A.","publicationName":"British Journal of Haematology","elsevierCoverDate":"2020-03-01","elsevierCoverDisplayDate":"1 March 2020","elsevierCitationCount":"1"},{"title":"Implications of detecting serum monoclonal protein by MASS‐fix following stem cell transplantation in multiple myeloma","googleId":"ijfazCALVNAJ","googleLink":"https://onlinelibrary.wiley.com/doi/abs/10.1111/bjh.17195","googleCitationCount":0,"googleAuthor":"","doi":"10.1111/bjh.17195","elsevierAuthor":"Abeykoon J.P.","publicationName":"British Journal of Haematology","elsevierCoverDate":"2020-01-01","elsevierCoverDisplayDate":"2020","elsevierCitationCount":"0"},{"title":"A case series of MGUS and COVID‐19","googleId":"XqBsTRzO46MJ","googleLink":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7300638/","googleCitationCount":3,"googleAuthor":"","doi":"10.1111/bjh.16906","elsevierAuthor":"Gonzalez-Lugo J.D.","publicationName":"British Journal of Haematology","elsevierCoverDate":"2020-08-01","elsevierCoverDisplayDate":"1 August 2020","elsevierCitationCount":"2"},{"title":"Increased cytotoxic potential of CD8+ T cells in immune thrombocytopenia","googleId":"K9-32HNJDjIJ","googleLink":"https://pubmed.ncbi.nlm.nih.gov/31850531/","googleCitationCount":1,"googleAuthor":"","doi":"10.1111/bjh.16334,","elsevierAuthor":"Vrbensky J.R.","publicationName":"British Journal of Haematology","elsevierCoverDate":"2020-03-01","elsevierCoverDisplayDate":"1 March 2020","elsevierCitationCount":"1"},{"title":"Clinical features and therapeutic challenges of cytopenias belonging to alps and alps‐related (ARS) phenotype","googleId":"PRZ8FZlkzpIJ","googleLink":"https://onlinelibrary.wiley.com/doi/abs/10.1111/bjh.15178?af=R","googleCitationCount":4,"googleAuthor":"","doi":"10.1111/bjh.15178","elsevierAuthor":"Palmisani E.","publicationName":"British Journal of Haematology","elsevierCoverDate":"2019-03-01","elsevierCoverDisplayDate":"March 2019","elsevierCitationCount":"3"},{"title":"Risk‐adapted bendamustine+ rituximab is a tolerable treatment alternative for elderly patients with chronic lymphocytic leukaemia: a regional real‐world report on 141 …","googleId":"5ZwklI2AiEkJ","googleLink":"https://onlinelibrary.wiley.com/doi/abs/10.1111/bjh.17032","googleCitationCount":1,"googleAuthor":"","doi":"10.1111/bjh.17032","elsevierAuthor":"Mattsson A.","publicationName":"British Journal of Haematology","elsevierCoverDate":"2020-11-01","elsevierCoverDisplayDate":"1 November 2020","elsevierCitationCount":"0"},{"title":"Comparative analysis of melphalan versus busulphan T-cell deplete conditioning using alemtuzumab in unrelated donor stem cell transplantation for acute …","googleId":"6N8gNnm9KlcJ","googleLink":"https://discovery.ucl.ac.uk/id/eprint/10080489/3/Morris_UCLHRFKCH%20-revisedBJH-240219-VM.pdf","googleCitationCount":2,"googleAuthor":""},{"title":"Diagnostic pathways in multiple myeloma and their relationship to end organ damage: an analysis from the Tackling Early Morbidity and Mortality in Myeloma (TEAMM …","googleId":"by7rcGh4U3cJ","googleLink":"https://onlinelibrary.wiley.com/doi/abs/10.1111/bjh.17044","googleCitationCount":0,"googleAuthor":"","doi":"10.1111/bjh.17044","elsevierAuthor":"Atkin C.","publicationName":"British Journal of Haematology","elsevierCoverDate":"2020-01-01","elsevierCoverDisplayDate":"2020","elsevierCitationCount":"0"},{"title":"Von Willebrand factor propeptide in severe coronavirus disease 2019 (COVID‐19): evidence of acute and sustained endothelial cell activation","googleId":"eIopHeyhEt8J","googleLink":"https://onlinelibrary.wiley.com/doi/abs/10.1111/bjh.17273","googleCitationCount":6,"googleAuthor":"","doi":"10.1111/bjh.17273","elsevierAuthor":"Ward S.E.","publicationName":"British Journal of Haematology","elsevierCoverDate":"2020-01-01","elsevierCoverDisplayDate":"2020","elsevierCitationCount":"0"},{"title":"Engulfment and cell motility 1 (ELMO1) and apolipoprotein A1 (APOA1) as candidate genes for sickle cell nephropathy","googleId":"iC0cTS4PoVcJ","googleLink":"https://onlinelibrary.wiley.com/doi/abs/10.1111/bjh.17224","googleCitationCount":0,"googleAuthor":"","doi":"10.1111/bjh.17224","elsevierAuthor":"Saraf S.L.","publicationName":"British Journal of Haematology","elsevierCoverDate":"2020-01-01","elsevierCoverDisplayDate":"2020","elsevierCitationCount":"0"},{"title":"Comments on pre‐fibrotic myelofibrosis and how should it be managed","googleId":"lyXtAZyi-_IJ","googleLink":"https://air.unimi.it/bitstream/2434/677709/2/Barbui_et_al-2019-British_Journal_of_Haematology.pdf","googleCitationCount":2,"googleAuthor":""},{"title":"Association between ANXA2* 5681 polymorphism (rs7170178) and osteonecrosis in haemoglobin SS-genotyped patients","googleId":"w665JldlL5sJ","googleLink":"https://pubmed.ncbi.nlm.nih.gov/31710691/","googleCitationCount":1,"googleAuthor":"DA Pereira-Martins","doi":"10.1111/bjh.16267,","elsevierAuthor":"Pereira-Martins D.A.","publicationName":"British Journal of Haematology","elsevierCoverDate":"2020-02-01","elsevierCoverDisplayDate":"1 February 2020","elsevierCitationCount":"1"},{"title":"Mature (non‐anaplastic, non‐cutaneous) T‐/NK‐cell lymphomas in children, adolescents and young adults: state of the science","googleId":"BTQSaWbDt8wJ","googleLink":"https://onlinelibrary.wiley.com/doi/abs/10.1111/bjh.15767","googleCitationCount":1,"googleAuthor":"","doi":"10.1111/bjh.15767","elsevierAuthor":"Flower A.","publicationName":"British Journal of Haematology","elsevierCoverDate":"2019-05-01","elsevierCoverDisplayDate":"May 2019","elsevierCitationCount":"2"},{"title":"Acute myeloid leukaemia therapeutic innovation and clinical trials: past, present and future","googleId":"O8EiX_Gisi0J","googleLink":"https://onlinelibrary.wiley.com/doi/abs/10.1111/bjh.17146","googleCitationCount":0,"googleAuthor":"C Craddock","doi":"10.1111/bjh.17146","elsevierAuthor":"Craddock C.","publicationName":"British Journal of Haematology","elsevierCoverDate":"2020-11-01","elsevierCoverDisplayDate":"November 2020","elsevierCitationCount":"0"},{"title":"Allogeneic cord blood transfusions for extremely preterm neonates: an extremely promising proof of concept","googleId":"y-9o7Hpa0mEJ","googleLink":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7689904/","googleCitationCount":0,"googleAuthor":"","doi":"10.1111/bjh.16918","elsevierAuthor":"Lopriore E.","publicationName":"British Journal of Haematology","elsevierCoverDate":"2020-10-01","elsevierCoverDisplayDate":"1 October 2020","elsevierCitationCount":"0"},{"title":"Exhaustion of tumour‐infiltrating T‐cell receptor repertoire diversity is an age‐dependent indicator of immunological fitness independently predictive of clinical …","googleId":"DO_G_-jbBvIJ","googleLink":"https://onlinelibrary.wiley.com/doi/abs/10.1111/bjh.17083","googleCitationCount":0,"googleAuthor":"","doi":"10.1111/bjh.17083","elsevierAuthor":"Rieken J.","publicationName":"British Journal of Haematology","elsevierCoverDate":"2020-01-01","elsevierCoverDisplayDate":"2020","elsevierCitationCount":"0"},{"title":"Cancer risk following post-transplant lymphoproliferative disorders in solid organ transplant recipients","googleId":"g9g7Z0zgzcYJ","googleLink":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6606327/","googleCitationCount":2,"googleAuthor":"P Mahale"},{"title":"Complement as the enabler of carfilzomib‐induced thrombotic microangiopathy","googleId":"-EL0yeI0OB0J","googleLink":"https://onlinelibrary.wiley.com/doi/abs/10.1111/bjh.16796","googleCitationCount":2,"googleAuthor":"","doi":"10.1111/bjh.16796","elsevierAuthor":"Blasco M.","publicationName":"British Journal of Haematology","elsevierCoverDate":"2020-01-01","elsevierCoverDisplayDate":"2020","elsevierCitationCount":"1"},{"title":"Acute lymphoblastic leukaemia (ALL) things come to those who wait: 60 years of progress in the treatment of adult ALL","googleId":"JFwbCp9x12IJ","googleLink":"https://onlinelibrary.wiley.com/doi/abs/10.1111/bjh.17166","googleCitationCount":0,"googleAuthor":"","doi":"10.1111/bjh.17166","elsevierAuthor":"Fielding A.K.","publicationName":"British Journal of Haematology","elsevierCoverDate":"2020-11-01","elsevierCoverDisplayDate":"November 2020","elsevierCitationCount":"0"},{"title":"Allogeneic haematopoietic stem cell transplantation for primary mediastinal large B-cell lymphoma patients relapsing after high dose chemotherapy with autologous …","googleId":"FyHxF9iRhDcJ","googleLink":"https://pubmed.ncbi.nlm.nih.gov/31355916/","googleCitationCount":2,"googleAuthor":"","doi":"10.1111/bjh.16115,","elsevierAuthor":"Kondo E.","publicationName":"British Journal of Haematology","elsevierCoverDate":"2019-09-01","elsevierCoverDisplayDate":"1 September 2019","elsevierCitationCount":"1"},{"title":"Progress in treating chronic granulomatous disease","googleId":"6Xe14831Rs8J","googleLink":"https://onlinelibrary.wiley.com/doi/abs/10.1111/bjh.16939","googleCitationCount":0,"googleAuthor":"","doi":"10.1111/bjh.16939","elsevierAuthor":"Gennery A.R.","publicationName":"British Journal of Haematology","elsevierCoverDate":"2021-01-01","elsevierCoverDisplayDate":"January 2021","elsevierCitationCount":"0"},{"title":"Improved stenosis outcome in stroke‐free sickle cell anemia children after transplantation compared to chronic transfusion","googleId":"dZNxFpjyRGMJ","googleLink":"https://onlinelibrary.wiley.com/doi/abs/10.1111/bjh.17178","googleCitationCount":0,"googleAuthor":"","doi":"10.1111/bjh.17178","elsevierAuthor":"Verlhac S.","publicationName":"British Journal of Haematology","elsevierCoverDate":"2020-01-01","elsevierCoverDisplayDate":"2020","elsevierCitationCount":"0"},{"title":"Deciphering molecular heterogeneity of Indian families with hereditary spherocytosis using targeted next‐generation sequencing: First South Asian study","googleId":"xE6SDGsu_8MJ","googleLink":"https://onlinelibrary.wiley.com/doi/abs/10.1111/bjh.16244","googleCitationCount":6,"googleAuthor":"","doi":"10.1111/bjh.16244","elsevierAuthor":"Aggarwal A.","publicationName":"British Journal of Haematology","elsevierCoverDate":"2020-03-01","elsevierCoverDisplayDate":"1 March 2020","elsevierCitationCount":"5"},{"title":"Prospective, real‐time monitoring of pegylated Escherichia coli and Erwinia asparaginase therapy in childhood acute lymphoblastic leukaemia and non‐Hodgkin …","googleId":"H8QxcVFomnEJ","googleLink":"https://onlinelibrary.wiley.com/doi/abs/10.1111/bjh.16495","googleCitationCount":0,"googleAuthor":"","doi":"10.1111/bjh.16495","elsevierAuthor":"Mondelaers V.","publicationName":"British Journal of Haematology","elsevierCoverDate":"2020-07-01","elsevierCoverDisplayDate":"1 July 2020","elsevierCitationCount":"0"},{"title":"Baseline correlations and prognostic impact of serum monoclonal proteins in follicular lymphoma","googleId":"3_fjlccsBP0J","googleLink":"https://onlinelibrary.wiley.com/doi/abs/10.1111/bjh.17138","googleCitationCount":0,"googleAuthor":"","doi":"10.1111/bjh.17138","elsevierAuthor":"Mozas P.","publicationName":"British Journal of Haematology","elsevierCoverDate":"2020-01-01","elsevierCoverDisplayDate":"2020","elsevierCitationCount":"0"},{"title":"Outcomes of acute lymphoblastic leukaemia in adolescent and young adult Korean patients","googleId":"6qQFxw1kOaMJ","googleLink":"https://onlinelibrary.wiley.com/doi/abs/10.1111/bjh.16242","googleCitationCount":1,"googleAuthor":"","doi":"10.1111/bjh.16242","elsevierAuthor":"Kim Y.A.","publicationName":"British Journal of Haematology","elsevierCoverDate":"2020-03-01","elsevierCoverDisplayDate":"1 March 2020","elsevierCitationCount":"1"},{"title":"Role of bone marrow‐derived mesenchymal stem cell defects in CD8+CD28– suppressor T‐lymphocyte induction in patients with immune thrombocytopenia and …","googleId":"nvuQeqUC2pgJ","googleLink":"https://onlinelibrary.wiley.com/doi/abs/10.1111/bjh.16953","googleCitationCount":0,"googleAuthor":"","doi":"10.1111/bjh.16953","elsevierAuthor":"Li H.","publicationName":"British Journal of Haematology","elsevierCoverDate":"2020-12-01","elsevierCoverDisplayDate":"December 2020","elsevierCitationCount":"0"},{"title":"Effect of low or high doses of low molecular weight heparin on thrombin generation and other hemostasis parameters in COVID‐19 critical patients","googleId":"HJKd0Svd624J","googleLink":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7361613/","googleCitationCount":2,"googleAuthor":"","doi":"10.1111/bjh.17003","elsevierAuthor":"Chistolini A.","publicationName":"British Journal of Haematology","elsevierCoverDate":"2020-08-01","elsevierCoverDisplayDate":"1 August 2020","elsevierCitationCount":"3"},{"title":"Polymorphisms in the promotor region of the CRBN gene as a predictive factor for peripheral neuropathy in the course of thalidomide‐based chemotherapy in …","googleId":"IE-pwgWd7DsJ","googleLink":"https://onlinelibrary.wiley.com/doi/abs/10.1111/bjh.15972","googleCitationCount":3,"googleAuthor":"","doi":"10.1111/bjh.15972","elsevierAuthor":"Mlak R.","publicationName":"British Journal of Haematology","elsevierCoverDate":"2019-01-01","elsevierCoverDisplayDate":"2019","elsevierCitationCount":"2"},{"title":"Diagnostic performance of 18F‐FDG‐PET/CT compared to standard skeletal survey for detecting bone destruction in smouldering multiple myeloma: time to move …","googleId":"aWcfsTrsLkQJ","googleLink":"https://onlinelibrary.wiley.com/doi/abs/10.1111/bjh.17088","googleCitationCount":0,"googleAuthor":"","doi":"10.1111/bjh.17088","elsevierAuthor":"Hill E.","publicationName":"British Journal of Haematology","elsevierCoverDate":"2020-01-01","elsevierCoverDisplayDate":"2020","elsevierCitationCount":"1"},{"title":"Long‐term outcomes of patients treated with rituximab as second‐line treatment for adult immune thrombocytopenia–Follow‐up of the RITP study","googleId":"TSPbw6UWKKgJ","googleLink":"https://onlinelibrary.wiley.com/doi/abs/10.1111/bjh.16672","googleCitationCount":1,"googleAuthor":"","doi":"10.1111/bjh.16672","elsevierAuthor":"Tjønnfjord E.","publicationName":"British Journal of Haematology","elsevierCoverDate":"2020-11-01","elsevierCoverDisplayDate":"1 November 2020","elsevierCitationCount":"0"},{"title":"USP7 inhibition inhibits proliferation and induces megakaryocytic differentiation in MDS cells by upregulating gelsolin","googleId":"zIorKe8vPLgJ","googleLink":"https://onlinelibrary.wiley.com/doi/abs/10.1111/bjh.16549","googleCitationCount":0,"googleAuthor":"","doi":"10.1111/bjh.16549","elsevierAuthor":"Deng J.","publicationName":"British Journal of Haematology","elsevierCoverDate":"2020-08-01","elsevierCoverDisplayDate":"1 August 2020","elsevierCitationCount":"0"},{"title":"Use of an anti‐CD200‐blocking antibody improves immune responses to AML in vitro and in vivo","googleId":"mXz3L1GZ3tsJ","googleLink":"https://onlinelibrary.wiley.com/doi/abs/10.1111/bjh.17125","googleCitationCount":1,"googleAuthor":"","doi":"10.1111/bjh.17125","elsevierAuthor":"Rastogi N.","publicationName":"British Journal of Haematology","elsevierCoverDate":"2020-01-01","elsevierCoverDisplayDate":"2020","elsevierCitationCount":"0"},{"title":"Acute kidney injury in paediatric patients with sickle cell disease is associated with increased morbidity and resource utilization","googleId":"yWQjsJSEVQEJ","googleLink":"https://onlinelibrary.wiley.com/doi/abs/10.1111/bjh.16384","googleCitationCount":2,"googleAuthor":"","doi":"10.1111/bjh.16384","elsevierAuthor":"McCormick M.","publicationName":"British Journal of Haematology","elsevierCoverDate":"2020-05-01","elsevierCoverDisplayDate":"1 May 2020","elsevierCitationCount":"0"},{"title":"Study of gene polymorphisms as predictors of treatment efficacy and toxicity in patients with indolent non‐hodgkin lymphomas and mantle cell lymphoma receiving …","googleId":"MmhmUY_b5z4J","googleLink":"https://onlinelibrary.wiley.com/doi/abs/10.1111/bjh.15582","googleCitationCount":4,"googleAuthor":"","doi":"10.1111/bjh.15582","elsevierAuthor":"Cencini E.","publicationName":"British Journal of Haematology","elsevierCoverDate":"2019-01-01","elsevierCoverDisplayDate":"January 2019","elsevierCitationCount":"3"},{"title":"COVID‐19 and haemoglobin oxygen affinity: some clarity?","googleId":"9A3Noro8RioJ","googleLink":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7460983/","googleCitationCount":0,"googleAuthor":"","doi":"10.1111/bjh.17053","elsevierAuthor":"Shattock M.J.","publicationName":"British Journal of Haematology","elsevierCoverDate":"2020-09-01","elsevierCoverDisplayDate":"1 September 2020","elsevierCitationCount":"0"},{"title":"Prediction of significant bleeding during vitamin K antagonist treatment for venous thromboembolism in outpatients","googleId":"zu1JUvBbgtkJ","googleLink":"https://onlinelibrary.wiley.com/doi/abs/10.1111/bjh.16383","googleCitationCount":0,"googleAuthor":"","doi":"10.1111/bjh.16383","elsevierAuthor":"Martinez C.","publicationName":"British Journal of Haematology","elsevierCoverDate":"2020-05-01","elsevierCoverDisplayDate":"1 May 2020","elsevierCitationCount":"0"},{"title":"The COVID‐19 pandemic and management of GIMEMA clinical trials: changes and challenges","googleId":"FV_9ujV5hy0J","googleLink":"https://onlinelibrary.wiley.com/doi/abs/10.1111/bjh.16996","googleCitationCount":0,"googleAuthor":"","doi":"10.1111/bjh.16996","elsevierAuthor":"Piciocchi A.","publicationName":"British Journal of Haematology","elsevierCoverDate":"2020-08-01","elsevierCoverDisplayDate":"1 August 2020","elsevierCitationCount":"0"},{"title":"Tumour‐immune microenvironment in duodenal‐type follicular lymphoma","googleId":"rM5ldwJhM_0J","googleLink":"https://onlinelibrary.wiley.com/doi/abs/10.1111/bjh.16715","googleCitationCount":0,"googleAuthor":"","doi":"10.1111/bjh.16715","elsevierAuthor":"Inoue H.","publicationName":"British Journal of Haematology","elsevierCoverDate":"2020-10-01","elsevierCoverDisplayDate":"1 October 2020","elsevierCitationCount":"0"},{"title":"Large deletions of the 5'region of IKZF1 lead to haploinsufficiency in B-cell precursor acute lymphoblastic leukaemia","googleId":"s-xta5IdJZIJ","googleLink":"https://pubmed.ncbi.nlm.nih.gov/31148164/","googleCitationCount":2,"googleAuthor":"","doi":"10.1111/bjh.15994,","elsevierAuthor":"Morel G.","publicationName":"British Journal of Haematology","elsevierCoverDate":"2019-01-01","elsevierCoverDisplayDate":"2019","elsevierCitationCount":"2"},{"title":"The meninges enhance leukaemia survival in cerebral spinal fluid","googleId":"39pPwrI7_L8J","googleLink":"https://onlinelibrary.wiley.com/doi/abs/10.1111/bjh.16270","googleCitationCount":1,"googleAuthor":"","doi":"10.1111/bjh.16270","elsevierAuthor":"Basile P.","publicationName":"British Journal of Haematology","elsevierCoverDate":"2020-05-01","elsevierCoverDisplayDate":"1 May 2020","elsevierCitationCount":"1"},{"title":"Treatment patterns and outcomes among mantle cell lymphoma patients treated with ibrutinib in the United States: a retrospective electronic medical record database …","googleId":"KH1skMvztD0J","googleLink":"https://onlinelibrary.wiley.com/doi/abs/10.1111/bjh.16922","googleCitationCount":0,"googleAuthor":"","doi":"10.1111/bjh.16922","elsevierAuthor":"Sharman J.","publicationName":"British Journal of Haematology","elsevierCoverDate":"2020-01-01","elsevierCoverDisplayDate":"2020","elsevierCitationCount":"0"},{"title":"The landscape of genetic mutations in patients with chronic lymphocytic leukaemia and complex karyotype","googleId":"puZBP7mx6ZkJ","googleLink":"https://onlinelibrary.wiley.com/doi/abs/10.1111/bjh.16117","googleCitationCount":1,"googleAuthor":"","doi":"10.1111/bjh.16117","elsevierAuthor":"Strati P.","publicationName":"British Journal of Haematology","elsevierCoverDate":"2019-10-01","elsevierCoverDisplayDate":"1 October 2019","elsevierCitationCount":"1"},{"title":"Results of a UK National Cancer Research Institute Phase II study of brentuximab vedotin using a response‐adapted design in the first‐line treatment of patients with …","googleId":"VFg5V_tjP6IJ","googleLink":"https://onlinelibrary.wiley.com/doi/abs/10.1111/bjh.17073","googleCitationCount":0,"googleAuthor":"","doi":"10.1111/bjh.17073","elsevierAuthor":"Gibb A.","publicationName":"British Journal of Haematology","elsevierCoverDate":"2020-01-01","elsevierCoverDisplayDate":"2020","elsevierCitationCount":"0"},{"title":"Maternal and neonatal outcomes in 80 patients diagnosed with non‐Hodgkin lymphoma during pregnancy: results from the International Network of Cancer, Infertility …","googleId":"eSNRVVsMjvUJ","googleLink":"https://onlinelibrary.wiley.com/doi/abs/10.1111/bjh.17103","googleCitationCount":1,"googleAuthor":"","doi":"10.1111/bjh.17103","elsevierAuthor":"Maggen C.","publicationName":"British Journal of Haematology","elsevierCoverDate":"2020-01-01","elsevierCoverDisplayDate":"2020","elsevierCitationCount":"1"},{"title":"Quantitative sensory testing in children with sickle cell disease: additional insights and future possibilities","googleId":"ffEflCCOaZIJ","googleLink":"https://onlinelibrary.wiley.com/doi/abs/10.1111/bjh.15876","googleCitationCount":1,"googleAuthor":"","doi":"10.1111/bjh.15876","elsevierAuthor":"Miller R.E.","publicationName":"British Journal of Haematology","elsevierCoverDate":"2019-06-01","elsevierCoverDisplayDate":"June 2019","elsevierCitationCount":"1"},{"title":"An upsurge of the serum free light chains as a possible missing link in tumour lysis syndrome in multiple myeloma","googleId":"C6R8r2KGk4sJ","googleLink":"https://onlinelibrary.wiley.com/doi/abs/10.1111/bjh.16231","googleCitationCount":2,"googleAuthor":"","doi":"10.1111/bjh.16231","elsevierAuthor":"Yavorkovsky L.L.","publicationName":"British Journal of Haematology","elsevierCoverDate":"2020-03-01","elsevierCoverDisplayDate":"1 March 2020","elsevierCitationCount":"0"},{"title":"Longitudinal changes in red blood cell distribution width decades after radiation exposure in atomic‐bomb survivors","googleId":"R2y5qfy1FbcJ","googleLink":"https://onlinelibrary.wiley.com/doi/abs/10.1111/bjh.17296","googleCitationCount":0,"googleAuthor":"","doi":"10.1111/bjh.17296","elsevierAuthor":"Yoshida K.","publicationName":"British Journal of Haematology","elsevierCoverDate":"2020-01-01","elsevierCoverDisplayDate":"2020","elsevierCitationCount":"0"},{"title":"Paradoxical effect of SARS‐CoV‐2 infection in patients with immune thrombocytopenia","googleId":"X3P4FlM3l4oJ","googleLink":"https://onlinelibrary.wiley.com/doi/abs/10.1111/bjh.17077","googleCitationCount":1,"googleAuthor":"","doi":"10.1111/bjh.17077","elsevierAuthor":"de la Cruz-Benito B.","publicationName":"British Journal of Haematology","elsevierCoverDate":"2020-01-01","elsevierCoverDisplayDate":"2020","elsevierCitationCount":"0"},{"title":"Durable response of multiple myeloma and non‐small cell lung cancer with simultaneous, biologically targeted treatment","googleId":"_3wxKDA5VQgJ","googleLink":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7155080/","googleCitationCount":0,"googleAuthor":"","doi":"10.1111/bjh.16393","elsevierAuthor":"Kaiser M.F.","publicationName":"British Journal of Haematology","elsevierCoverDate":"2020-04-01","elsevierCoverDisplayDate":"1 April 2020","elsevierCitationCount":"0"},{"title":"Outcomes of second allogeneic haematopoietic stem cell transplantation in patients with relapse of myelodysplastic syndrome","googleId":"bmdueDhJjdEJ","googleLink":"https://onlinelibrary.wiley.com/doi/abs/10.1111/bjh.15898","googleCitationCount":1,"googleAuthor":"","doi":"10.1111/bjh.15898","elsevierAuthor":"Shimomura Y.","publicationName":"British Journal of Haematology","elsevierCoverDate":"2019-07-01","elsevierCoverDisplayDate":"July 2019","elsevierCitationCount":"1"},{"title":"Thrombophilia screening and thromboprophylaxis may benefit specific ethnic subgroups with paediatric acute lymphoblastic leukaemia","googleId":"wFUZDXzmNfcJ","googleLink":"https://onlinelibrary.wiley.com/doi/abs/10.1111/bjh.15752","googleCitationCount":3,"googleAuthor":"","doi":"10.1111/bjh.15752","elsevierAuthor":"Barzilai-Birenboim S.","publicationName":"British Journal of Haematology","elsevierCoverDate":"2019-03-01","elsevierCoverDisplayDate":"March 2019","elsevierCitationCount":"2"},{"title":"Reduced intensity allogeneic stem cell transplantation for younger patients with myelofibrosis","googleId":"AKRGe1rpEmMJ","googleLink":"https://onlinelibrary.wiley.com/doi/abs/10.1111/bjh.15952","googleCitationCount":2,"googleAuthor":"","doi":"10.1111/bjh.15952","elsevierAuthor":"Mannina D.","publicationName":"British Journal of Haematology","elsevierCoverDate":"2019-08-01","elsevierCoverDisplayDate":"August 2019","elsevierCitationCount":"2"},{"title":"Cytoreductive treatment in patients with CALR‐mutated essential thrombocythaemia: a study comparing indications and efficacy among genotypes from the Spanish …","googleId":"-UnGvvUrs_EJ","googleLink":"https://onlinelibrary.wiley.com/doi/abs/10.1111/bjh.16988","googleCitationCount":0,"googleAuthor":"","doi":"10.1111/bjh.16988","elsevierAuthor":"Alvarez-Larrán A.","publicationName":"British Journal of Haematology","elsevierCoverDate":"2020-01-01","elsevierCoverDisplayDate":"2020","elsevierCitationCount":"1"},{"title":"Personal tales of venous thromboembolism in the UK the last 60 years: from no interest to clinical excellence","googleId":"LnuNA6yBiI8J","googleLink":"https://onlinelibrary.wiley.com/doi/abs/10.1111/bjh.17152","googleCitationCount":0,"googleAuthor":"","doi":"10.1111/bjh.17152","elsevierAuthor":"Hunt B.J.","publicationName":"British Journal of Haematology","elsevierCoverDate":"2020-11-01","elsevierCoverDisplayDate":"November 2020","elsevierCitationCount":"0"},{"title":"Effect of direct‐acting oral anticoagulants (DOACs) on bleeding and blood product usage in cardiac surgery compared to warfarin and controls","googleId":"4AkJdH1pMToJ","googleLink":"https://onlinelibrary.wiley.com/doi/abs/10.1111/bjh.16521","googleCitationCount":0,"googleAuthor":"","doi":"10.1111/bjh.16521","elsevierAuthor":"Little C.","publicationName":"British Journal of Haematology","elsevierCoverDate":"2020-07-01","elsevierCoverDisplayDate":"1 July 2020","elsevierCitationCount":"0"},{"title":"Aplastic anaemia in pregnancy–a single centre, North American series","googleId":"PIeEQufczQEJ","googleLink":"https://onlinelibrary.wiley.com/doi/abs/10.1111/bjh.15654","googleCitationCount":2,"googleAuthor":"","doi":"10.1111/bjh.15654","elsevierAuthor":"McGowan K.","publicationName":"British Journal of Haematology","elsevierCoverDate":"2019-02-01","elsevierCoverDisplayDate":"Februaryy 2019","elsevierCitationCount":"1"},{"title":"MIR29B mediates epigenetic mechanisms of HBG gene activation","googleId":"ltFeqT9n0EAJ","googleLink":"https://onlinelibrary.wiley.com/doi/abs/10.1111/bjh.15870","googleCitationCount":1,"googleAuthor":"","doi":"10.1111/bjh.15870","elsevierAuthor":"Starlard-Davenport A.","publicationName":"British Journal of Haematology","elsevierCoverDate":"2019-07-01","elsevierCoverDisplayDate":"July 2019","elsevierCitationCount":"1"},{"title":"SARS‐CoV‐2 screening for asymptomatic health care workers in UK stem cell transplant units","googleId":"jTzliQPVvZgJ","googleLink":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7753340/","googleCitationCount":0,"googleAuthor":"","doi":"10.1111/bjh.17196","elsevierAuthor":"Bloor A.J.C.","publicationName":"British Journal of Haematology","elsevierCoverDate":"2021-01-01","elsevierCoverDisplayDate":"January 2021","elsevierCitationCount":"0"},{"title":"Possibility of a risk‐adapted treatment strategy for untreated aggressive adult T‐cell leukaemia‐lymphoma (ATL) based on the ATL prognostic index: a supplementary …","googleId":"k8IfmPIKIbAJ","googleLink":"https://onlinelibrary.wiley.com/doi/abs/10.1111/bjh.15950","googleCitationCount":1,"googleAuthor":"","doi":"10.1111/bjh.15950","elsevierAuthor":"Toyoda K.","publicationName":"British Journal of Haematology","elsevierCoverDate":"2019-08-01","elsevierCoverDisplayDate":"August 2019","elsevierCitationCount":"1"},{"title":"Platelet factor 4 inhibits ADAMTS13 activity and regulates the multimeric distribution of von Willebrand factor","googleId":"F1Zz8xJm2gIJ","googleLink":"https://onlinelibrary.wiley.com/doi/abs/10.1111/bjh.16553","googleCitationCount":0,"googleAuthor":"","doi":"10.1111/bjh.16553","elsevierAuthor":"Nazy I.","publicationName":"British Journal of Haematology","elsevierCoverDate":"2020-08-01","elsevierCoverDisplayDate":"1 August 2020","elsevierCitationCount":"0"},{"title":"Expression and function of phosphoinositide 3‐kinase delta in mesenchymal stromal cells from normal and leukaemic bone marrow","googleId":"FRBTkZqyB-gJ","googleLink":"https://onlinelibrary.wiley.com/doi/abs/10.1111/bjh.15865","googleCitationCount":1,"googleAuthor":"","doi":"10.1111/bjh.15865","elsevierAuthor":"Ali A.Y.","publicationName":"British Journal of Haematology","elsevierCoverDate":"2019-06-01","elsevierCoverDisplayDate":"June 2019","elsevierCitationCount":"1"},{"title":"TKI dose reduction can effectively maintain major molecular remission in patients with chronic myeloid leukaemia","googleId":"GcctIQRa-CIJ","googleLink":"https://onlinelibrary.wiley.com/doi/abs/10.1111/bjh.17286","googleCitationCount":0,"googleAuthor":"","doi":"10.1111/bjh.17286","elsevierAuthor":"Claudiani S.","publicationName":"British Journal of Haematology","elsevierCoverDate":"2020-01-01","elsevierCoverDisplayDate":"2020","elsevierCitationCount":"0"},{"title":"Double‐bright (CD56bright/CD16bright) natural killer cell adoptive immunotherapy for SARS‐CoV‐2","googleId":"qz0YreE4f6EJ","googleLink":"https://onlinelibrary.wiley.com/doi/abs/10.1111/bjh.17010","googleCitationCount":0,"googleAuthor":"","doi":"10.1111/bjh.17010","elsevierAuthor":"Silla L.","publicationName":"British Journal of Haematology","elsevierCoverDate":"2020-09-01","elsevierCoverDisplayDate":"1 September 2020","elsevierCitationCount":"0"},{"title":"Brain-derived neurotrophic factor as a potential biomarker of chemotherapy-induced peripheral neuropathy and prognosis in haematological malignancies; …","googleId":"QyNPsqF_ELQJ","googleLink":"https://www.researchgate.net/profile/David_Azoulay/publication/342280540_Brain-derived_neurotrophic_factor_as_a_potential_biomarker_of_chemotherapy-induced_peripheral_neuropathy_and_prognosis_in_haematological_malignancies_what_we_have_learned_the_challenges_and_a_need_for/links/5ef88824299bf18816edeb94/Brain-derived-neurotrophic-factor-as-a-potential-biomarker-of-chemotherapy-induced-peripheral-neuropathy-and-prognosis-in-haematological-malignancies-what-we-have-learned-the-challenges-and-a-need-fo.pdf","googleCitationCount":1,"googleAuthor":""},{"title":"Validation of the RHL30 digital gene expression assay as a prognostic biomarker for relapsed Hodgkin lymphoma","googleId":"rFFYhSHdPsIJ","googleLink":"https://onlinelibrary.wiley.com/doi/abs/10.1111/bjh.16777","googleCitationCount":0,"googleAuthor":"","doi":"10.1111/bjh.16777","elsevierAuthor":"Calvente L.","publicationName":"British Journal of Haematology","elsevierCoverDate":"2020-09-01","elsevierCoverDisplayDate":"1 September 2020","elsevierCitationCount":"0"},{"title":"Platelets beyond their count, as a key element of the innate immune system in the fight against malaria","googleId":"RjY0shIv9f0J","googleLink":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7540259/","googleCitationCount":0,"googleAuthor":"A Lucchesi","doi":"10.1111/bjh.16754","elsevierAuthor":"Lucchesi A.","publicationName":"British Journal of Haematology","elsevierCoverDate":"2020-09-01","elsevierCoverDisplayDate":"1 September 2020","elsevierCitationCount":"0"},{"title":"Recurrent histone mutations in T‐cell acute lymphoblastic leukaemia","googleId":"9xeQ90nGXToJ","googleLink":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6766952/","googleCitationCount":4,"googleAuthor":"I Martincorena","doi":"10.1111/bjh.15155","elsevierAuthor":"Collord G.","publicationName":"British Journal of Haematology","elsevierCoverDate":"2019-02-01","elsevierCoverDisplayDate":"Februaryy 2019","elsevierCitationCount":"1"},{"title":"Standardised immunophenotypic analysis of myeloperoxidase in acute leukaemia","googleId":"jWOp5WDMOJkJ","googleLink":"https://onlinelibrary.wiley.com/doi/abs/10.1111/bjh.17210","googleCitationCount":0,"googleAuthor":"AE Bras","doi":"10.1111/bjh.17210","elsevierAuthor":"Bras A.E.","publicationName":"British Journal of Haematology","elsevierCoverDate":"2020-01-01","elsevierCoverDisplayDate":"2020","elsevierCitationCount":"0"},{"title":"Prognostic value of POD24 validation in follicular lymphoma patients initially treated with chemotherapy‐free regimens in a pooled analysis of three randomized trials …","googleId":"XNAYeDj5wK0J","googleLink":"https://onlinelibrary.wiley.com/doi/abs/10.1111/bjh.17045","googleCitationCount":0,"googleAuthor":"","doi":"10.1111/bjh.17045","elsevierAuthor":"Moccia A.A.","publicationName":"British Journal of Haematology","elsevierCoverDate":"2020-01-01","elsevierCoverDisplayDate":"2020","elsevierCitationCount":"0"},{"title":"Bone marrow transplantation in the United Kingdom–past, present and future","googleId":"dhOa5Nhg_D4J","googleLink":"https://onlinelibrary.wiley.com/doi/abs/10.1111/bjh.17151","googleCitationCount":0,"googleAuthor":"","doi":"10.1111/bjh.17151","elsevierAuthor":"Barrett J.","publicationName":"British Journal of Haematology","elsevierCoverDate":"2020-11-01","elsevierCoverDisplayDate":"November 2020","elsevierCitationCount":"0"},{"title":"Temporal changes in survival among adult patients with acute myeloid leukaemia in the period 2000–2016: a Danish population‐based study","googleId":"0dqsmGNNM60J","googleLink":"https://onlinelibrary.wiley.com/doi/abs/10.1111/bjh.17213","googleCitationCount":0,"googleAuthor":"","doi":"10.1111/bjh.17213","elsevierAuthor":"Hjort Jakobsen L.","publicationName":"British Journal of Haematology","elsevierCoverDate":"2020-01-01","elsevierCoverDisplayDate":"2020","elsevierCitationCount":"0"},{"title":"Anti-CD20 immunotherapy as a bridge to tolerance, after allogeneic stem cell transplantation for patients with chronic lymphocytic leukaemia: results of the CLLX4 trial","googleId":"t0zG2_2vtxEJ","googleLink":"https://pubmed.ncbi.nlm.nih.gov/29528122/","googleCitationCount":4,"googleAuthor":"","doi":"10.1111/bjh.15181,","elsevierAuthor":"Schetelig J.","publicationName":"British Journal of Haematology","elsevierCoverDate":"2019-03-01","elsevierCoverDisplayDate":"March 2019","elsevierCitationCount":"3"},{"title":"Eltrombopag preferentially expands haematopoietic multipotent progenitors in human aplastic anaemia","googleId":"QxEAP1RdFGMJ","googleLink":"https://onlinelibrary.wiley.com/doi/abs/10.1111/bjh.17140","googleCitationCount":0,"googleAuthor":"","doi":"10.1111/bjh.17140","elsevierAuthor":"Quintino de Oliveira B.","publicationName":"British Journal of Haematology","elsevierCoverDate":"2020-01-01","elsevierCoverDisplayDate":"2020","elsevierCitationCount":"0"},{"title":"MicroRNA‐2355‐5p regulates γ‐globin expression in human erythroid cells by inhibiting KLF6","googleId":"Ea9bB8b6U0AJ","googleLink":"https://onlinelibrary.wiley.com/doi/abs/10.1111/bjh.17134","googleCitationCount":0,"googleAuthor":"","doi":"10.1111/bjh.17134","elsevierAuthor":"Cheng Y.","publicationName":"British Journal of Haematology","elsevierCoverDate":"2020-01-01","elsevierCoverDisplayDate":"2020","elsevierCitationCount":"0"},{"title":"Unfolding of sickle cell trait by coronavirus disease 2019 (COVID‐19) infection","googleId":"T_Pi0jvrqGAJ","googleLink":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7537001/","googleCitationCount":0,"googleAuthor":"","doi":"10.1111/bjh.17089","elsevierAuthor":"Sheha D.","publicationName":"British Journal of Haematology","elsevierCoverDate":"2020-10-01","elsevierCoverDisplayDate":"1 October 2020","elsevierCitationCount":"0"},{"title":"Long‐term results of the MCL01 phase II trial of rituximab plus HyperCVAD alternating with high‐dose cytarabine and methotrexate for the initial treatment of patients …","googleId":"n4F6u07G7hgJ","googleLink":"https://onlinelibrary.wiley.com/doi/abs/10.1111/bjh.16714","googleCitationCount":1,"googleAuthor":"","doi":"10.1111/bjh.16714","elsevierAuthor":"Massaro F.","publicationName":"British Journal of Haematology","elsevierCoverDate":"2020-01-01","elsevierCoverDisplayDate":"2020","elsevierCitationCount":"1"},{"title":"Long survival in patients with Waldenström macroglobulinaemia diagnosed at a young age","googleId":"Wa4gTF4Jk0wJ","googleLink":"https://iwmf.com/wp-content/uploads/2020/12/bjh.15634.pdf","googleCitationCount":3,"googleAuthor":""},{"title":"Predisposition to prolonged neutropenia after chemotherapy for paediatric acute myeloid leukaemia is associated with better prognosis in the Japanese Paediatric …","googleId":"TAzlqH62ACoJ","googleLink":"https://onlinelibrary.wiley.com/doi/abs/10.1111/bjh.16656","googleCitationCount":0,"googleAuthor":"","doi":"10.1111/bjh.16656","elsevierAuthor":"Aoki T.","publicationName":"British Journal of Haematology","elsevierCoverDate":"2020-01-01","elsevierCoverDisplayDate":"2020","elsevierCitationCount":"0"},{"title":"High-dose therapy and autologous transplantation for POEMS Syndrome: effective, but how to optimise?","googleId":"NKrruIhhe58J","googleLink":"https://discovery.ucl.ac.uk/id/eprint/10078196/","googleCitationCount":2,"googleAuthor":"","doi":"10.1111/bjh.16057","elsevierAuthor":"Tomkins O.","publicationName":"British Journal of Haematology","elsevierCoverDate":"2019-09-01","elsevierCoverDisplayDate":"1 September 2019","elsevierCitationCount":"1"},{"title":"Clonal relationship in multisited mucosa‐associated lymphoid tissue lymphomas: a single‐centre experience","googleId":"1ecCVc9fk3sJ","googleLink":"https://onlinelibrary.wiley.com/doi/abs/10.1111/bjh.16717","googleCitationCount":0,"googleAuthor":"","doi":"10.1111/bjh.16717","elsevierAuthor":"Condom M.","publicationName":"British Journal of Haematology","elsevierCoverDate":"2020-01-01","elsevierCoverDisplayDate":"2020","elsevierCitationCount":"0"},{"title":"Altered expression of metabolic pathways in CLL detected by unlabelled quantitative mass spectrometry analysis","googleId":"BSjRgfXaPVMJ","googleLink":"https://onlinelibrary.wiley.com/doi/abs/10.1111/bjh.15751","googleCitationCount":4,"googleAuthor":"","doi":"10.1111/bjh.15751","elsevierAuthor":"Thurgood L.A.","publicationName":"British Journal of Haematology","elsevierCoverDate":"2019-04-01","elsevierCoverDisplayDate":"April 2019","elsevierCitationCount":"2"},{"title":"Comparative analysis of gene expression platforms for cell‐of‐origin classification of diffuse large B‐cell lymphoma shows high concordance","googleId":"-zqDFt4nGyIJ","googleLink":"https://onlinelibrary.wiley.com/doi/abs/10.1111/bjh.17246","googleCitationCount":0,"googleAuthor":"","doi":"10.1111/bjh.17246","elsevierAuthor":"Ahmed S.","publicationName":"British Journal of Haematology","elsevierCoverDate":"2021-02-01","elsevierCoverDisplayDate":"February 2021","elsevierCitationCount":"0"},{"title":"Prognostic impact of trisomy 21 in follicular lymphoma","googleId":"aKhJJqig0f0J","googleLink":"https://onlinelibrary.wiley.com/doi/abs/10.1111/bjh.15664","googleCitationCount":2,"googleAuthor":"","doi":"10.1111/bjh.15664","elsevierAuthor":"Mitsui T.","publicationName":"British Journal of Haematology","elsevierCoverDate":"2019-02-01","elsevierCoverDisplayDate":"Februaryy 2019","elsevierCitationCount":"3"},{"title":"Radioimmunotherapy (RIT) for Follicular Lymphoma achieves long term lymphoma control in first line and at relapse: 8‐year follow‐up data of 281 patients from the …","googleId":"kke__AusVcUJ","googleLink":"https://onlinelibrary.wiley.com/doi/abs/10.1111/bjh.15712","googleCitationCount":2,"googleAuthor":"","doi":"10.1111/bjh.15712","elsevierAuthor":"Hohloch K.","publicationName":"British Journal of Haematology","elsevierCoverDate":"2019-03-01","elsevierCoverDisplayDate":"March 2019","elsevierCitationCount":"1"},{"title":"Rituximab for treatment of autoimmune acquired platelet function disorders: description of two cases of acquired Glanzmann thrombasthenia and one case of acquired …","googleId":"M_rSfpKwd14J","googleLink":"https://pubmed.ncbi.nlm.nih.gov/31612461/","googleCitationCount":1,"googleAuthor":"","doi":"10.1111/bjh.16243,","elsevierAuthor":"Alberelli M.A.","publicationName":"British Journal of Haematology","elsevierCoverDate":"2019-12-01","elsevierCoverDisplayDate":"1 December 2019","elsevierCitationCount":"0"},{"title":"Lenalidomide as a second-line therapy after failure of hypomethylating agents in patients with myelodysplastic syndrome","googleId":"5Q0CsGti-NcJ","googleLink":"https://pubmed.ncbi.nlm.nih.gov/31177524/","googleCitationCount":2,"googleAuthor":"","doi":"10.1111/bjh.15991,","elsevierAuthor":"Kim H.","publicationName":"British Journal of Haematology","elsevierCoverDate":"2019-01-01","elsevierCoverDisplayDate":"2019","elsevierCitationCount":"0"},{"title":"International external quality assessment for measurements of direct oral anticoagulants: results and recommendations","googleId":"1QE3Z_5xVsUJ","googleLink":"https://onlinelibrary.wiley.com/doi/abs/10.1111/bjh.16179","googleCitationCount":1,"googleAuthor":"","doi":"10.1111/bjh.16179","elsevierAuthor":"Hollestelle M.J.","publicationName":"British Journal of Haematology","elsevierCoverDate":"2020-02-01","elsevierCoverDisplayDate":"1 February 2020","elsevierCitationCount":"1"},{"title":"Upsetting the apple CAR‐T (chimeric antigen receptor T‐cell therapy)‐sustainability mandates USA innovation","googleId":"C4brWv5lwOIJ","googleLink":"https://onlinelibrary.wiley.com/doi/abs/10.1111/bjh.16685","googleCitationCount":0,"googleAuthor":"","doi":"10.1111/bjh.16685","elsevierAuthor":"Pantin J.","publicationName":"British Journal of Haematology","elsevierCoverDate":"2020-09-01","elsevierCoverDisplayDate":"1 September 2020","elsevierCitationCount":"0"},{"title":"Association between plasma and urinary orosomucoid and chronic kidney disease in adults with sickle cell disease","googleId":"IEBOULaDwH8J","googleLink":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7359636/","googleCitationCount":0,"googleAuthor":""},{"title":"Altered immune response to the annual influenza A vaccine in patients with myeloproliferative neoplasms","googleId":"zDbT-ekWlnYJ","googleLink":"https://onlinelibrary.wiley.com/doi/abs/10.1111/bjh.17096","googleCitationCount":0,"googleAuthor":"","doi":"10.1111/bjh.17096","elsevierAuthor":"Alimam S.","publicationName":"British Journal of Haematology","elsevierCoverDate":"2020-01-01","elsevierCoverDisplayDate":"2020","elsevierCitationCount":"0"},{"title":"Harnessing HLA‐E‐restricted CD8 T lymphocytes for adoptive cell therapy of patients with severe COVID‐19","googleId":"0lGLZY7kPegJ","googleLink":"https://onlinelibrary.wiley.com/doi/abs/10.1111/bjh.16895","googleCitationCount":1,"googleAuthor":"","doi":"10.1111/bjh.16895","elsevierAuthor":"Caccamo N.","publicationName":"British Journal of Haematology","elsevierCoverDate":"2020-08-01","elsevierCoverDisplayDate":"1 August 2020","elsevierCitationCount":"1"},{"title":"The Kg‐antigen, RhAG with a Lys164Gln mutation, gives rise to haemolytic disease of the newborn","googleId":"KpXpoDMU0CEJ","googleLink":"https://onlinelibrary.wiley.com/doi/abs/10.1111/bjh.16955","googleCitationCount":0,"googleAuthor":"","doi":"10.1111/bjh.16955","elsevierAuthor":"Tanaka M.","publicationName":"British Journal of Haematology","elsevierCoverDate":"2020-12-01","elsevierCoverDisplayDate":"December 2020","elsevierCitationCount":"0"},{"title":"Long‐term complications in uniformly treated paediatric Langerhans histiocytosis patients disclosed by 12 years of follow‐up of the JLSG‐96/02 studies","googleId":"M2QPD_n5pd0J","googleLink":"https://onlinelibrary.wiley.com/doi/abs/10.1111/bjh.17243","googleCitationCount":0,"googleAuthor":"","doi":"10.1111/bjh.17243","elsevierAuthor":"Sakamoto K.","publicationName":"British Journal of Haematology","elsevierCoverDate":"2021-02-01","elsevierCoverDisplayDate":"February 2021","elsevierCitationCount":"0"},{"title":"Erythropoietin and ferritin response in native highlanders aged 4–19 years from the Leh‐Ladakh region of India","googleId":"ynyVqAU__8MJ","googleLink":"https://onlinelibrary.wiley.com/doi/abs/10.1111/bjh.15553","googleCitationCount":2,"googleAuthor":"","doi":"10.1111/bjh.15553","elsevierAuthor":"Yanamandra U.","publicationName":"British Journal of Haematology","elsevierCoverDate":"2019-01-01","elsevierCoverDisplayDate":"January 2019","elsevierCitationCount":"1"},{"title":"Microbiome swings with repeated insults","googleId":"waJXfbJI03cJ","googleLink":"https://pubmed.ncbi.nlm.nih.gov/32043276/","googleCitationCount":1,"googleAuthor":"","doi":"10.1111/bjh.16509,","elsevierAuthor":"Rashidi A.","publicationName":"British Journal of Haematology","elsevierCoverDate":"2020-05-01","elsevierCoverDisplayDate":"1 May 2020","elsevierCitationCount":"0"},{"title":"Bleeding risk for patients with haemophilia under antithrombotic therapy. Results of the French multicentric study ERHEA","googleId":"Zku26Gubhq0J","googleLink":"https://pubmed.ncbi.nlm.nih.gov/30338508/","googleCitationCount":3,"googleAuthor":"","doi":"10.1111/bjh.15606,","elsevierAuthor":"Desjonqueres A.","publicationName":"British Journal of Haematology","elsevierCoverDate":"2019-05-01","elsevierCoverDisplayDate":"May 2019","elsevierCitationCount":"3"},{"title":"CD 99 expression is strongly associated with clinical outcome in children with B‐cell precursor acute lymphoblastic leukaemia","googleId":"CT_zxeHvZawJ","googleLink":"https://onlinelibrary.wiley.com/doi/abs/10.1111/bjh.15683","googleCitationCount":2,"googleAuthor":"","doi":"10.1111/bjh.15683","elsevierAuthor":"Chen D.","publicationName":"British Journal of Haematology","elsevierCoverDate":"2019-02-01","elsevierCoverDisplayDate":"Februaryy 2019","elsevierCitationCount":"3"},{"title":"Autologous 111 In-labelled platelet scan as a predictor of splenectomy outcome in ITP","googleId":"EGdoNQBUK28J","googleLink":"https://pubmed.ncbi.nlm.nih.gov/29676450/","googleCitationCount":3,"googleAuthor":"","doi":"10.1111/bjh.15236,","elsevierAuthor":"Kazi S.","publicationName":"British Journal of Haematology","elsevierCoverDate":"2019-03-01","elsevierCoverDisplayDate":"March 2019","elsevierCitationCount":"3"},{"title":"Concerns about how to use established minimal residual disease monitoring in the treatment of NPM1‐mutant acute myeloid leukaemia (AML) following reduced …","googleId":"OhIkX0oQS3EJ","googleLink":"https://onlinelibrary.wiley.com/doi/abs/10.1111/bjh.16985","googleCitationCount":0,"googleAuthor":"","doi":"10.1111/bjh.16985","elsevierAuthor":"Farah N.","publicationName":"British Journal of Haematology","elsevierCoverDate":"2020-08-01","elsevierCoverDisplayDate":"1 August 2020","elsevierCitationCount":"1"},{"title":"Correlation between high serum alkaline phosphatase levels and denosumab-related hypocalcemia in patients with multiple myeloma","googleId":"iMGJ7iGpUnMJ","googleLink":"https://pubmed.ncbi.nlm.nih.gov/30859556/","googleCitationCount":3,"googleAuthor":"","doi":"10.1111/bjh.15837,","elsevierAuthor":"Miki H.","publicationName":"British Journal of Haematology","elsevierCoverDate":"2019-07-01","elsevierCoverDisplayDate":"July 2019","elsevierCitationCount":"1"},{"title":"Correlation between high serum alkaline phosphatase levels and denosumab-related hypocalcemia in patients with multiple myeloma","googleId":"iMGJ7iGpUnMJ","googleLink":"https://pubmed.ncbi.nlm.nih.gov/30859556/","googleCitationCount":3,"googleAuthor":"","doi":"10.1111/bjh.15837,","elsevierAuthor":"Miki H.","publicationName":"British Journal of Haematology","elsevierCoverDate":"2019-07-01","elsevierCoverDisplayDate":"July 2019","elsevierCitationCount":"1"},{"title":"A phase 1 dose-finding study of intravenous L-citrulline in sickle cell disease: a potential novel therapy for sickle cell pain crisis","googleId":"hlFAoorsN3wJ","googleLink":"https://pubmed.ncbi.nlm.nih.gov/29411862/","googleCitationCount":4,"googleAuthor":"S Majumdar","doi":"10.1111/bjh.15124,","elsevierAuthor":"Majumdar S.","publicationName":"British Journal of Haematology","elsevierCoverDate":"2019-02-01","elsevierCoverDisplayDate":"Februaryy 2019","elsevierCitationCount":"5"},{"title":"Impact of number of cycles on outcomes of patients with relapsed or refractory acute lymphoblastic leukaemia treated with inotuzumab ozogamicin","googleId":"PwlrQc8ou9YJ","googleLink":"https://onlinelibrary.wiley.com/doi/abs/10.1111/bjh.17029","googleCitationCount":0,"googleAuthor":"DI Marks","doi":"10.1111/bjh.17029","elsevierAuthor":"Cassaday R.D.","publicationName":"British Journal of Haematology","elsevierCoverDate":"2020-11-01","elsevierCoverDisplayDate":"1 November 2020","elsevierCitationCount":"0"},{"title":"Results and outcome of intermittent imatinib (ON/OFF schedule) in children and adolescents with chronic myeloid leukaemia","googleId":"q8Nw-RRZCCcJ","googleLink":"https://moh-it.pure.elsevier.com/en/publications/results-and-outcome-of-intermittent-imatinib-onoff-schedule-in-ch","googleCitationCount":0,"googleAuthor":"","doi":"10.1111/bjh.16388","elsevierAuthor":"Giona F.","publicationName":"British Journal of Haematology","elsevierCoverDate":"2020-03-01","elsevierCoverDisplayDate":"1 March 2020","elsevierCitationCount":"0"},{"title":"Anti-thymocyte globulin for graft-versus-host disease prophylaxis in patients with intermediate-or high-risk acute myeloid leukaemia undergoing reduced …","googleId":"h5ghIP961_gJ","googleLink":"https://orbi.uliege.be/bitstream/2268/224868/1/Ofran_et_al-2018-British_Journal_of_Haematology.pdf","googleCitationCount":4,"googleAuthor":""},{"title":"Plasma histamine elevation in a large cohort of sickle cell disease patients","googleId":"M7YIBD6nQZIJ","googleLink":"https://onlinelibrary.wiley.com/doi/abs/10.1111/bjh.15900","googleCitationCount":1,"googleAuthor":"","doi":"10.1111/bjh.15900","elsevierAuthor":"Allali S.","publicationName":"British Journal of Haematology","elsevierCoverDate":"2019-07-01","elsevierCoverDisplayDate":"July 2019","elsevierCitationCount":"1"},{"title":"The effect of 5‐azacytidine treatment delays and dose reductions on the prognosis of patients with myelodysplastic syndrome: how to optimize treatment results and …","googleId":"h_SgAEF-ATwJ","googleLink":"https://onlinelibrary.wiley.com/doi/abs/10.1111/bjh.17062","googleCitationCount":0,"googleAuthor":"","doi":"10.1111/bjh.17062","elsevierAuthor":"Diamantopoulos P.T.","publicationName":"British Journal of Haematology","elsevierCoverDate":"2020-01-01","elsevierCoverDisplayDate":"2020","elsevierCitationCount":"0"},{"title":"Multi‐dimensional analysis identifies an immune signature predicting response to decitabine treatment in elderly patients with AML","googleId":"xqLo9f9RpoMJ","googleLink":"https://onlinelibrary.wiley.com/doi/abs/10.1111/bjh.16228","googleCitationCount":4,"googleAuthor":"","doi":"10.1111/bjh.16228","elsevierAuthor":"Zhao C.","publicationName":"British Journal of Haematology","elsevierCoverDate":"2020-03-01","elsevierCoverDisplayDate":"1 March 2020","elsevierCitationCount":"1"},{"title":"Experience with provisional WHO‐entities large B‐cell lymphoma with IRF4‐rearrangement and Burkitt‐like lymphoma with 11q aberration in paediatric patients of …","googleId":"nyYHPce6raAJ","googleLink":"https://onlinelibrary.wiley.com/doi/abs/10.1111/bjh.16578","googleCitationCount":1,"googleAuthor":"","doi":"10.1111/bjh.16578","elsevierAuthor":"Au-Yeung R.K.H.","publicationName":"British Journal of Haematology","elsevierCoverDate":"2020-09-01","elsevierCoverDisplayDate":"1 September 2020","elsevierCitationCount":"1"},{"title":"British Society of Haematology Guidelines on the spectrum of fresh frozen plasma and cryoprecipitate products: their handling and use in various patient groups …","googleId":"DoeM7hFFLmYJ","googleLink":"https://www.researchgate.net/profile/Paula_Bolton-Maggs/publication/304026255_Addendum_to_the_British_Committee_for_Standards_in_Haematology_BCSH_Guidelines_for_the_use_of_fresh-frozen_plasma_cryoprecipitate_and_cryosupernatant_2004_Br_J_Haematol_200412611-28/links/5fc50c01299bf1a422c2fdb9/Addendum-to-the-British-Committee-for-Standards-in-Haematology-BCSH-Guidelines-for-the-use-of-fresh-frozen-plasma-cryoprecipitate-and-cryosupernatant-2004-Br-J-Haematol-2004-126-11-28.pdf","googleCitationCount":0,"googleAuthor":""},{"title":"Acute deep vein thrombosis suppresses peripheral T cell effector function","googleId":"iGRR6UptutkJ","googleLink":"https://pubmed.ncbi.nlm.nih.gov/29574858/","googleCitationCount":4,"googleAuthor":"","doi":"10.1111/bjh.15192,","elsevierAuthor":"Prochaska J.H.","publicationName":"British Journal of Haematology","elsevierCoverDate":"2019-03-01","elsevierCoverDisplayDate":"March 2019","elsevierCitationCount":"3"},{"title":"Paediatric-type nodal follicular lymphoma in a child diagnosed with chronic myeloid leukaemia","googleId":"0Ho1mLIvylMJ","googleLink":"https://pubmed.ncbi.nlm.nih.gov/31286492/","googleCitationCount":1,"googleAuthor":"","doi":"10.1111/bjh.16089,","elsevierAuthor":"Domínguez-Pinilla N.","publicationName":"British Journal of Haematology","elsevierCoverDate":"2019-09-01","elsevierCoverDisplayDate":"1 September 2019","elsevierCitationCount":"1"},{"title":"Treatment of refractory acute myeloid leukaemia during pregnancy with venetoclax, high-dose cytarabine and mitoxantrone","googleId":"sftRj_E3rcwJ","googleLink":"https://pubmed.ncbi.nlm.nih.gov/33222152/","googleCitationCount":0,"googleAuthor":"","doi":"10.1111/bjh.17220,","elsevierAuthor":"Karagiannis P.","publicationName":"British Journal of Haematology","elsevierCoverDate":"2021-01-01","elsevierCoverDisplayDate":"January 2021","elsevierCitationCount":"0"},{"title":"External validation of International Prognostic Score for asymptomatic early stage chronic lymphocytic leukaemia and proposal of an alternative score","googleId":"7iRqzEawZCcJ","googleLink":"https://onlinelibrary.wiley.com/doi/abs/10.1111/bjh.17074","googleCitationCount":0,"googleAuthor":"","doi":"10.1111/bjh.17074","elsevierAuthor":"Smolej L.","publicationName":"British Journal of Haematology","elsevierCoverDate":"2020-01-01","elsevierCoverDisplayDate":"2020","elsevierCitationCount":"0"},{"title":"Genetic analysis of erythrocytosis reveals possible causative and modifier gene mutations","googleId":"vkJlWGF8IHIJ","googleLink":"https://pubmed.ncbi.nlm.nih.gov/31016714/","googleCitationCount":1,"googleAuthor":"","doi":"10.1111/bjh.15931,","elsevierAuthor":"Gurnari C.","publicationName":"British Journal of Haematology","elsevierCoverDate":"2019-01-01","elsevierCoverDisplayDate":"2019","elsevierCitationCount":"1"},{"title":"Treating Rosai-Dorfman disease and RAS-associated autoimmune leucoproliferative disorder with malignant transformation","googleId":"UfjEgwjteHYJ","googleLink":"https://pubmed.ncbi.nlm.nih.gov/33238033/","googleCitationCount":0,"googleAuthor":"","doi":"10.1111/bjh.17258,","elsevierAuthor":"Wilson N.R.","publicationName":"British Journal of Haematology","elsevierCoverDate":"2021-02-01","elsevierCoverDisplayDate":"February 2021","elsevierCitationCount":"0"},{"title":"Transduction with BBF2H7/CREB3L2 upregulates SEC23A protein in erythroblasts and partially corrects the hypo‐glycosylation phenotype associated with …","googleId":"vXRYPti0HEIJ","googleLink":"https://www.ncbi.nlm.nih.gov/pmc/articles/pmc6491999/","googleCitationCount":5,"googleAuthor":"","doi":"10.1111/bjh.15189","elsevierAuthor":"Pellegrin S.","publicationName":"British Journal of Haematology","elsevierCoverDate":"2019-03-01","elsevierCoverDisplayDate":"March 2019","elsevierCitationCount":"2"},{"title":"Incidence and survival of multiple myeloma: a population‐based study of 10 524 patients diagnosed 1982–2017","googleId":"kF0MojYT28AJ","googleLink":"https://onlinelibrary.wiley.com/doi/abs/10.1111/bjh.16674","googleCitationCount":4,"googleAuthor":"TÅ Myklebust","doi":"10.1111/bjh.16674","elsevierAuthor":"Langseth Ø.O.","publicationName":"British Journal of Haematology","elsevierCoverDate":"2020-11-01","elsevierCoverDisplayDate":"1 November 2020","elsevierCitationCount":"2"},{"title":"Role of B cells in chronic graft-versus-host disease after allogeneic stem cell transplantation in children and adolescents","googleId":"r_YKGhb1dbkJ","googleLink":"https://pubmed.ncbi.nlm.nih.gov/31134622/","googleCitationCount":1,"googleAuthor":"","doi":"10.1111/bjh.15977,","elsevierAuthor":"Wiegering V.","publicationName":"British Journal of Haematology","elsevierCoverDate":"2019-01-01","elsevierCoverDisplayDate":"2019","elsevierCitationCount":"1"},{"title":"Comprehensive geriatric assessment is useful in an elderly Australian population with diffuse large B‐cell lymphoma receiving rituximab‐chemotherapy combinations","googleId":"pm6LejqcjWAJ","googleLink":"https://onlinelibrary.wiley.com/doi/abs/10.1111/bjh.16049","googleCitationCount":4,"googleAuthor":"","doi":"10.1111/bjh.16049","elsevierAuthor":"Ong D.M.","publicationName":"British Journal of Haematology","elsevierCoverDate":"2019-10-01","elsevierCoverDisplayDate":"1 October 2019","elsevierCitationCount":"3"},{"title":"Loss-of-function mutations in CSF3R cause moderate neutropenia with fully mature neutrophils: two novel pedigrees","googleId":"aCD-0RPeGVwJ","googleLink":"https://pubmed.ncbi.nlm.nih.gov/32966608/","googleCitationCount":0,"googleAuthor":"","doi":"10.1111/bjh.17081,","elsevierAuthor":"Sprenkeler E.G.G.","publicationName":"British Journal of Haematology","elsevierCoverDate":"2020-12-01","elsevierCoverDisplayDate":"December 2020","elsevierCitationCount":"0"},{"title":"Characterization of VWF gene conversions causing von Willebrand disease","googleId":"whDbnzAAGHMJ","googleLink":"https://onlinelibrary.wiley.com/doi/abs/10.1111/bjh.15709","googleCitationCount":2,"googleAuthor":"","doi":"10.1111/bjh.15709","elsevierAuthor":"Ahmad F.","publicationName":"British Journal of Haematology","elsevierCoverDate":"2019-03-01","elsevierCoverDisplayDate":"March 2019","elsevierCitationCount":"2"},{"title":"Plasma metabolomics analysis in sickle cell disease patients with albuminuria-an exploratory study.","googleId":"dwhO-1bUSR8J","googleLink":"https://europepmc.org/articles/pmc6409098/bin/nihms986841-supplement-supp_tables1.docx","googleCitationCount":3,"googleAuthor":"","doi":"10.1111/bjh.15592","elsevierAuthor":"Elsherif L.","publicationName":"British Journal of Haematology","elsevierCoverDate":"2019-05-01","elsevierCoverDisplayDate":"May 2019","elsevierCitationCount":"1"},{"title":"Eltrombopag, low‐dose rituximab, and dexamethasone combination as frontline treatment of newly diagnosed immune thrombocytopaenia","googleId":"n6ubE9vDdMEJ","googleLink":"http://eprints.uanl.mx/15810/1/12.pdf","googleCitationCount":9,"googleAuthor":""}]